www.nature.com/natureneuroscience
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
EDITORIAL OFFICE 345 Park Avenue South, New York, NY 10010-1707 Tel: (212) 726 9319, Fax: (212) 696 0978 Editor: Sandra Aamodt Senior Editor: Kalyani Narasimhan Associate Editors: Cara Allen, I-han Chou, Annette Markus Assistant Editor: Charvy Narain Copy Editor: Dorothy Moore Senior Production Editor: Nicole D. Fournier Production Editor: Ivelisse Robles Assistant Production Editor: Lana Cheng Cover Design: Erin Boyle Editorial Assistant: Jessica Chen
[email protected]
MANAGEMENT OFFICES NPG New York 345 Park Avenue South, New York, NY 10010-1707 Tel: (212) 726 9200, Fax: (212) 696 9006 Publisher: Beatrice Renault Executive Editor: Linda Miller Chief Technology Officer: Howard Ratner Global Head of Advertising: Fabien Savenay Head of Nature Research & Reviews Marketing: Sara Girard Marketing Manager: Naomi Mulgrave Production Coordinator: Diane Temprano Associate Director, Web Publishing: Timo Hannay New Technology Director: Greg Suprock Head of Web Services: Anthony Barrera Associate Director, Content Systems: Joe Landolfi Web Production Editor: Edwina Hay NPG London The Macmillan Building, 4 Crinan Street, London N1 9XW Tel: 44 207 833 4000, Fax: 44 207 843 4996 Managing Director: Annette Thomas Publishing Director: Peter Collins Editor-in-Chief, Nature Publications: Philip Campbell Marketing Director: Della Sar NPG Tokyo Chiyoda Building 2-37 Ichigayatamachi, Shinjuku-ku, Tokyo 162-0843 Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 Asia-Pacific Publisher: Antoine E. Bocquet Manager: Koichi Nakamura Senior Marketing Manager: Peter Yoshihara Asia-Pacific Sales Director: Kate Yoneyama Asia-Pacific Sales Manager: Rinoko Asami DISPLAY ADVERTISING
[email protected] (US/Canada)
[email protected] (Europe)
[email protected] (Japan) US Head of Display Advertising: Stephen Schwartz, Tel: (212) 726 9256, Fax: (212) 696 9481 Global Head of Display Advertising Sales: John Michael, Tel: 44 207 843 4960, Fax: 44 207 843 4996 Head of Display Advertising—Europe: Gerard Preston, Tel: 44 207 843 4960, Fax: 44 207 843 4996 Business Development Manager: Claire Hines, Tel: 44 207 843 4960, Fax: 44 207 843 4996 Asia-Pacific Sales Manager: Rinoko Asami, Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 Western Region Sales Manager: George Lui, Tel: (415) 781 3804, Fax: (415) 781 3805 Sales Executives: New England: Sheila Reardon, Tel: (617) 399 4098, Fax: (617) 426 3717 New York, Mid-Atlantic, Southeast: Jim Breault, Tel: (212) 726 9334, Fax: (212) 696 9481 Midwest: Mike Rossi, Tel: (212) 726 9255, Fax: (212) 696 9481 Northwest: Mathieu DesJardins, Tel: (415) 781 6422, Fax: (415) 781 3805 Eastern England/Scotland/Italy/Spain/Israel: Matthew Wilkinson, Tel: 44 207 843 4960, Fax: 44 207 843 4749 South/West United Kingdom/Scandinavia/Holland: Marianne Boulakas, Tel: 44 207 843 4969, Fax: 44 207 843 4749 Northern Germany: Gerard Preston, Tel: 44 207 843 4960, Fax: 44 207 843 4749 Southern Germany/Austria/Switzerland/France/Belgium: Sabine Hugi-Fürst, Tel: 41 52761 3386, Fax: 41 52761 3419 NATUREJOBS
[email protected] (US/Canada)
[email protected] (Europe)
[email protected] (Japan) Publisher: Ben Crowe, Tel: (212) 726 9245, Fax: (212) 696 9482 US Sales Manager: Peter Bless, Tel: (212) 726 9248, Fax: (212) 696 9482 Japan Sales Manager: Rinoko Asami, Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 naturejobs Sales Director: Nevin Bayoumi, Tel: 44 207 843 4961, Fax: 44 207 843 4996 CUSTOMER SERVICE www.nature.com/help Senior Global Customer Service Manager: Gerald Coppin For all print and online assistance, please visit www.nature.com/help Purchase subscriptions: Americas: Nature Neuroscience, Subscription Dept., 303 Park Avenue South #1280, New York, NY 10010-3601. Tel: (866) 363 7860, Fax: (212) 689 9108 Europe/ROW: Nature Neuroscience, Subscription Dept., Macmillan Magazines Ltd., Brunel Road, Houndmills, Basingstoke RG21 6XS, United Kingdom. Tel: 44 1256 329 242, Fax: 44 1256 812 358 Japan: Nature Neuroscience, Nature Japan K.K., MG Ichigaya Bldg. 5F, 19-1 Haraikatamachi, Shinjuku-ku, Tokyo 162-0841. Tel: 81 3 3267 8751, Fax: 81 3 3267 8746 India: Harpal Singh Gill, Macmillan Magazines Ltd, 5A/12 Ansari Road, Darya Ganj, New Delhi, 110 002 India. Tel: 00 91 11 324 4186, Tel/Fax: 00 91 11 327 2010 REPRINTS
[email protected] Nature Neuroscience Reprint Department, Nature Publishing Group, 345 Park Avenue South, New York, NY 10010-1707, USA. For commercial reprint orders of 600 or more, please contact: UK Reprints Sales Executive: Christine Fothergill, Tel: 44 207 843 4967, Fax: 44 207 843 4749 US Reprints Sales Executive: Sharda Tulsie, Tel: (212) 726 9631, Fax: (212) 679 0843
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
VOLUME 8 NUMBER 8 AUGUST 2005
E D I TO R I A L 971
Brewing a pot of hysteria
BOOK REVIEW During embryonic neurogenesis, HMG-box transcription factors Sox1/2/3 suppress neural differentiation, maintaining progenitors in a proliferative state. Muhr and colleagues now demonstrate that the related transcriptional repressor Sox21 is induced by proneural transcription factors. Sox21 counteracts the activity of Sox1/2/3 and enables neuronal differentiation. The cover shows a coronal section through the spinal cord of a 4 day-old chick embryo. Sox21 is labeled in red, Sox3 in green and the neuron marker NF1 in blue. (p 995)
973
Imaging in Neuroscience and Development: A Laboratory Manual edited by Rafael Yuste and Arthur Konnerth Reviewed by Marla B Feller
NEWS AND VIEWS 975
How visual salience wins the battle for awareness Steven Yantis 왘 see also p 1110
977
The synaptic Aβ hypothesis of Alzheimer disease Rudolph E Tanzi 왘 see also p 1051
979
Beyond migration: Dlx1 regulates interneuron differentiation Carl Wonders & Stewart Anderson 왘 see also p 1059
981
Less is more: progenitor death and cortical size Pasko Rakic
983
Rethinking the thalamus Paul W Glimcher & Brian Lau
Origins of Cajal-Retzius cells (p 1002)
Nature Neuroscience (ISSN 1097-6256) is published monthly by Nature Publishing Group, a trading name of Nature America Inc. located at 345 Park Avenue South, New York, NY 10010-1707. Periodicals postage paid at New York, NY and additional mailing post offices. Editorial Office: 345 Park Avenue South, New York, NY 10010-1707. Tel: (212) 726 9319, Fax: (212) 696 0978. Annual subscription rates: USA/Canada: US$199 (personal), US$1,240 (institution). Canada add 7% GST #104911595RT001; Euro-zone: €289 (personal), €1,279 (institution); Rest of world (excluding China, Japan, Korea): £175 (personal), £775 (institution); Japan: Contact Nature Japan K.K., MG Ichigaya Building 5F, 19-1 Haraikatamachi, Shinjuku-ku, Tokyo 162-0841. Tel: 81 (03) 3267 8751, Fax: 81 (03) 3267 8746. POSTMASTER: Send address changes to Nature Neuroscience, Subscriptions Department, 303 Park Avenue South #1280, New York, NY 10010-3601. Authorization to photocopy material for internal or personal use, or internal or personal use of specific clients, is granted by Nature Publishing Group to libraries and others registered with the Copyright Clearance Center (CCC) Transactional Reporting Service, provided the relevant copyright fee is paid direct to CCC, 222 Rosewood Drive, Danvers, MA 01923, USA. Identification code for Nature Neuroscience: 1097-6256/04. Back issues: US$45, Canada add 7% for GST. CPC PUB AGREEMENT #40032744. Printed by Publishers Press, Inc., Lebanon Junction, KY, USA. Copyright © 2005 Nature Publishing Group. Printed in USA.
i
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
VOLUME 8 NUMBER 8 AUGUST 2005
B R I E F C O M M U N I C AT I O N S 985
Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1 C-H Kim, K Takamiya, R S Petralia, R Sattler, S Yu, W Zhou, R Kalb, R Wenthold & R Huganir
988
Cortical calcium waves in resting newborn mice H Adelsberger, O Garaschuk & A Konnerth
991
Neural correlates of genetically abnormal social cognition in Williams syndrome A Meyer-Lindenberg, A R Hariri, K E Munoz, C B Mervis, V S Mattay, C A Morris & K F Berman
Dlx1 regulates interneuron survival (p 979 and 1059)
ARTICLES 995
Sox21 promotes the progression of vertebrate neurogenesis M Sandberg, M Källström & J Muhr
1002 Multiple origins of Cajal-Retzius cells at the border of the developing pallium F Bielle, A Griveau, N Narboux-Nême, S Vigneau, M Sigrist, S Arber, M Wassef & A Pierani 1013 Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus A D Huberman, K D Murray, D K Warland, D A Feldheim & B Chapman
Ephrin-As guide retinogeniculate axons (p 1013 and 1022)
1022 Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping C Pfeiffenberger, T Cutforth, G Woods, J Yamada, R C Renteria, D R Copenhagen, J G Flanagan & D A Feldheim 1028 Hair bundle motion of outer hair cells and the cochlear amplifier D Z Z He & S Jia 1035 A deafness mutation isolates a second role for the tectorial membrane in hearing P K Legan, V A Lukashkina, R J Goodyear, A N Lukashkin, K Verhoeven, G Van Camp, I J Russell & G P Richardson 1043 Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses W Morishita, H Marie & R C Malenka 1051 Regulation of NMDA receptor trafficking by amyloid-β E M Snyder, Y Nong, C G Almeida, S Paul, T Moran, E Y Choi, A C Nairn, M W Salter, P J Lombroso, G K Gouras & P Greengard 왘 see also p 977 1059 Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy I Cobos, M E Calcagnotto, A J Vilaythong, M T Thwin, J L Noebels, S C Baraban & J L R Rubenstein 왘 see also p 979 1069 Activation of p75NTR by proBDNF facilitates hippocampal long-term depression N H Woo, H K Teng, C-J Siao, C Chiaruttini, P T Pang, T A Milner, B L Hempstead & B Lu
Glial ATP increases postsynaptic efficacy (p 1078)
NATURE NEUROSCIENCE
1078 Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy G R J Gordon, D V Baimoukhametova, S A Hewitt, W R A K J S Rajapaksha, T E Fisher & J S Bains
iii
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
VOLUME 8 NUMBER 8 AUGUST 2005
1087 Synchronized retinal oscillations encode essential information for escape behavior in frogs H Ishikane, M Gangi, S Honda & M Tachibana Synchronized retinal oscillations and escape behavior (p 1087)
1096 Continuous flash suppression reduces negative afterimages N Tsuchiya & C Koch 1102 Visual field maps and stimulus selectivity in human ventral occipital cortex A A Brewer, J Liu, A R Wade & B A Wandell 1110 Stimulus context modulates competition in human extrastriate cortex D M Beck & S Kastner 왘 see also p 975 1117 Probabilistic word pre-activation during language comprehension inferred from electrical brain activity K A DeLong, T P Urbach & M Kutas
N AT U R E N E U R O S C I E N C E C L A S S I F I E D See back pages.
Functional mapping of ventral visual cortex (p 1102)
NATURE NEUROSCIENCE
v
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
E D I TO R I A L
Brewing a pot of hysteria
O
n June 6th, the US Supreme Court dealt a blow to patients who use marijuana for medical purposes, ruling that a doctor’s approval is no protection against legal action by federal authorities such as the Drug Enforcement Administration (DEA). The court ruled that using marijuana to treat medical conditions violates federal law, despite laws in several states allowing the use of marijuana to treat symptoms of diseases like cancer. Both sides of this controversy cite scientific findings to support their positions, but selective citations can act as a smokescreen for moral beliefs about drug use that it would be more productive to discuss directly. Because of marijuana’s popularity as a recreational drug— according to one news report1, 95 million Americans over the age of 12 have tried it at least once—the debate over medical marijuana rapidly gets bogged down in politics. Scientific results need not be the last word in such decisions, but they should be represented fairly in the debate. The 1970 Controlled Substances Act (CSA) lists marijuana and its most active ingredient THC (∆9-tetrahydrocannabinol) as schedule I drugs, indicating that they have no medical value, are illegal to possess and/or distribute, and are not considered safe for use under medical supervision. Does this accurately reflect the scientific evidence? Marijuana and THC clearly can cause harm. A single marijuana exposure can affect driving ability in humans2 or impair spatial navigation in rats. Although researchers disagree on whether moderate marijuana use causes cognitive impairment, heavy users have lower overall IQ scores than non-users and are slower at immediate and delayed memory tasks3. Prolonged exposure to THC or marijuana may also cause addiction. Squirrel monkeys can learn to self-administer THC at doses comparable to those found in marijuana smoke inhaled by humans, and synthetic CB1 cannabinoid agonists have reinforcing effects in rats and mice4. Withdrawal from marijuana causes relatively mild symptoms, including loss of appetite, irritability and depression. Although the benefits of smoking marijuana remain controversial, the government has already decided that THC itself has medical benefits. Marinol—a synthetic derivative of THC—is federally approved to reduce nausea and stimulate appetite in patients suffering from cancer or HIV infection. (Curiously, Marinol is classified as a schedule III drug, indicating that it is considered less dangerous than THC, with which it shares both chemical structure and biological activity.) Marinol is effective in treating vocal and physical tics due to Tourette’s syndrome5. In clinical trials, oral sprays of a marijuana plant extract called Sativex reduce muscle spasms in patients with multiple sclerosis6. THC also seems to be beneficial in treating neuropathic pain or glaucoma. Moreover, THC is a relatively safe drug: according to Daniele Piomelli, the director for the Center for Drug Discovery at the University of California, Irvine, it would take about 70 grams of pure THC to cause serious damage to a 150-pound adult. It is therefore difficult to justify the DEA classification of THC as a class I drug with no medical value.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
This decision has potentially dangerous implications for science. It reflects a belief that there can be no value in investigating the medical properties of marijuana because the issue is settled. Igor Grant, the Director for the University of California Center for Medicinal Cannabis Research in San Diego, notes that even though the US National Institutes of Health continue to fund cannabinoid research, investigators are bound to have some reluctance to move into such a charged area, particularly when budgets are tight and the paperwork burdens intense. The extra bureaucratic hurdles involved in getting permission to obtain and use schedule I drugs can deter even established scientists. Piomelli once dropped a project on cannabidiol because the paperwork would have required an extra year. Donald Abrams, the chief of Oncology at the San Francisco General Hospital, points out that he sometimes needs as many as eight different agencies to approve his projects. This intellectual atmosphere cannot help but delay progress in understanding how cannabis works and whether it has medical benefits. The federal government, moreover, would prefer to steer clear of all other marijuana substitutes; this June, John Walters, the director for the US National Drug Control Policy issued a statement that “Our national medical system relies on proven scientific research, not popular opinion. Marinol—the synthetic form of THC and the psychoactive ingredient contained in marijuana—is already legally available for prescription by physicians whose patients suffer from pain and chronic illness…” (http://www.whitehousedrugpolicy.gov/pda/060605.html). However, advocates of medical marijuana point out that natural marijuana contains other ingredients such as cannabidiol, which may not only counterbalance the psychotropic effects of pure THC, but may also afford some therapeutic benefits on its own. Smoking also provides relief quickly, whereas orally administered THC may take hours to produce an effect and has variable effects across individuals. In light of the data, more research into the medical effects of marijuana is clearly warranted. Indeed, a report from the US National Academy of Sciences (http://books.nap.edu/html/marimed) on medical marijuana concluded that “…the existing data are consistent with the idea that this would not be a problem if the medical use of marijuana were as closely regulated as other medications with abuse potential.” Thus it seems hard to justify regulations that allow doctors to prescribe cocaine and morphine, but not marijuana. Lumping marijuana and THC in the same category as LSD and heroin also reflects a failure to identify the different degrees of danger posed by the different substances. As Piomelli notes7, “Any young person who has smoked marijuana and seen a friend ravaged by heroin can tell the difference between these drugs. Why can’t we?” 1. 2. 3. 4. 5. 6. 7.
Peplow, M.
[email protected] 7 June 2005 (doi:10.1038/news050606-6). Kurzthaler, I. et al. J. Clin. Psychiatry 60, 395–399 (1999). Fried, P.A. et al. Neurotoxicol. Teratol. 27, 231–239 (2005). Justinova, Z. et al. Pharmacol. Biochem. Behav. 81, 285–299 (2005). Muller-Vahl, K.R et al. Pharmacopsychiatry 34, 19–24 (2001). Wade, D.T. et al. Mult. Scler. 10, 339–340 (2004). Piomelli, D. The Washington Post June 12 (2005), p. B03.
971
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS
How visual salience wins the battle for awareness Steven Yantis Voluntarily paying attention to one object in a crowded scene enhances perception of that object and increases the activity of neurons representing it. Attention can also be drawn involuntarily by salient objects—for example, by the sudden onset of a bright stimulus. A study now shows how this involuntary type of attention may mediate competition between representations in human visual cortex.
The intuition that we open our eyes and see all that is before us has long been known to be an illusion. In fact, vision is highly selective. Even without moving our eyes, we can choose voluntarily to attend to one or another object in a scene, and this leads to improved sensitivity and more rapid detection1 as well as a more vivid appearance2. In other words, conscious experience of a scene depends both on the contents of the retinal image and on the attentive state of the brain. When multiple stimuli are present in a scene, they compete for cortical representation3. Voluntary deployments of attention can resolve the competition: ‘top-down’ signals that originate in executive control regions of prefrontal cortex promote increased spiking in neurons that represent the attended object. However, not all attention is voluntary: when a door slams in the library, every head looks up to the source. In this issue, Beck and Kastner report important new evidence about how this type of control—attentional capture by salient stimuli—may arise from a purely ‘bottom-up’ form of cortical competition in visual parts of the brain4. Competition for cortical representation is a consequence of the hierarchical architecture of the visual system: neural receptive fields are small (0.5–1.5°) in primary visual cortex (V1) and represent simple, local visual properties such as edge orientation and contrast (Fig. 1). Neurons in later visual areas such as V2, V4 and inferotemporal (IT) cortex have receptive fields that increase in size and in complexity of visual properties to which they are tuned5. Neurons in area Steven Yantis is in the Department of Psychological and Brain Sciences, Johns Hopkins University, 3400 N. Charles St., Baltimore, Maryland 21218, USA. e-mail:
[email protected]
V4 have receptive field diameters that are roughly equal to the distance of their centers from the fovea, and respond to moderately complex contours6. In IT, neurons can have large receptive fields that encompass much of a hemifield, and they can respond to complex shapes and faces7. This hierarchical structure efficiently codes complex visual object properties, but the efficiency comes at a cost. When
both an effective sensory stimulus and an otherwise ineffective sensory stimulus are present within the receptive field of, say, a V4 or IT neuron, competition for representation arises: should the neuron’s response be robust, reflecting the effective stimulus, or weak, reflecting the ineffective stimulus? Without attention, the response is a compromise: roughly the mean of the strong and weak responses. When voluntary attention is
Figure 1 The visual system is organized hierarchically; receptive field size and complexity increase from V1 to V4 to inferotemporal (IT) cortex. Cartoons below V1, V4 and IT represent oriented edges, simple contours and complex object shape, respectively. This presents a problem: when two objects appear with the same large receptive field (say, of the highlighted neuron in IT), which of the stimuli should drive the neuron’s response? In this example, the competition for representation has been biased in favor of the cube, either by a top-down signal that reflects current behavioral goals, or by differences in local feature contrast (salience). Every level of the visual hierarchy now cooperates to represent the attended object, which enters awareness. RF, receptive field.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
975
NEWS AND VIEWS Time1: display onset
Time2: after inhibitory interactions
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Het
Pop
Ann Thomson
directed to one of the stimuli, the competition is biased so that the attended stimulus in the receptive field drives the cell8, and that stimulus ultimately enters awareness and becomes available for report or encoding into memory. The effects of attention are propagated throughout the visual hierarchy so that a stable, coherent ensemble of neurons distributed across cortical areas represents the attended object via synchronized activity and reentrant feedback signals. Kastner and colleagues previously documented how attention can bias competition in human cortex9. They compared brain activity evoked by a display containing multiple stimuli presented one at a time (so that inhibitory interactions could not occur), which produced a strong response, or presented simultaneously (allowing inhibitory interactions), which produced a weaker response. When attention was directed to one of the stimuli, it reduced the suppression caused by the competing stimuli, causing an increased response, particularly in area V4. Such voluntary deployments of attention allow observers to actively seek information needed to achieve current behavioral goals and can modulate activity in the representation of different spatial locations, sensory dimensions or objects10. Activity in a network of cortical regions that include the posterior parietal cortex and the frontal eye fields is critical for voluntary deployments of attention11. On the other hand, it is sensible that certain sensory events should capture attention involuntarily, providing an ‘early warning system’ for rapid assessment and response to salient and potentially harmful events, obviating deliberation and saving precious time12. Many behavioral studies have documented the efficiency with which salient visual objects can be detected in visual search1. In the new paper4, Beck and Kastner have investigated human brain activity to salient and non-salient visual stimuli using fMRI.
976
Figure 2 Cartoon of the context effects described by Beck and Kastner4. Each panel shows an array of four colored, oriented Gabor patches; the size of each patch represents the magnitude of the neural response to that stimulus, and the thickness of the black lines between them (representing inhibitory connections) represents the strength of the inhibitory interaction. Left column represents initial appearance of stimuli, and right column represents relative neural response to the stimuli after some time has passed to allow inhibitory interactions to occur. Stimuli with different feature values (colors and orientations) show moderate-strength mutual inhibition, whereas stimuli with the same color and orientation produce strong isofeature inhibition. When stimuli first appear (left), their physical contrasts initially produce approximately equal neural responses. Following inhibitory interactions, (right), mutual inhibition in the heterogeneous displays (top) produces an approximately equal degree of sensory suppression for all stimuli. However, the unbalanced inhibitory pattern in the pop-out displays (bottom) produces more sensory suppression in the stimuli that share features (blue horizontal Gabor patches), which in turn reduces the degree to which they inhibit the feature singleton (red vertical Gabor patch), producing a relatively enhanced response to that object. Het, heterogeneous display; Pop, pop-out display.
To ensure that the effects they measured were purely stimulus-driven (and not a consequence of voluntary attention), they required observers to carry out an attentionally demanding visual task at the fovea, and they measured response times in the foveal task to ensure that attention was not diverted to the peripheral stimuli that were the focus of their brain measurements. Beck and Kastner found that the sensory suppression that usually results from simultaneous presentation of multiple competing stimuli is reduced if one of the objects is a feature singleton (that is, an object that differs in both color and orientation from the remaining items in the display). In a heterogeneous display (Fig. 2, top), multiple stimuli with different features interact in a mutually inhibitory, competitive fashion, producing a moderate degree of sensory suppression. Stimuli with identical features show stronger mutual inhibition, a phenomenon sometimes termed ‘isofeature suppression’13. Thus, when the contextual elements all have the same color and orientation (Fig. 2, bottom), they strongly inhibit one another, and this reduces their combined inhibitory effects on the unique item, which in turn increases the neural response to that item. In the Beck and Kastner study, this was manifested in less sensory suppression for pop-out displays than for heterogeneous displays. In other words, the suppression caused by context items was greater for the heterogeneous displays, where mutual suppression was balanced among the items, than for the pop-out displays, where the strong isofeature suppression of the homogenous background reduced its inhibitory effect on the singleton. This finding can be viewed as an instance of the very general principle that perceptual systems encode contrast, rather than the absolute level of some attribute. This kind of contrast effect has been documented through measurements of single-cell responses in macaque
area V1 (ref. 14). An oriented bar was placed in the receptive field of the cell, and a field of identically oriented bars, all outside the classical receptive field, was introduced. The presence of any context suppressed the cell’s response compared with a blank surround, reflecting competitive intracortical interactions. When the bars in the contextual field had the same orientation as the center bar, the cell’s response was more strongly suppressed than when they had a contrasting orientation. The authors interpreted this as a neural correlate of the perceptual salience of feature singletons. Once the neural response to the salient item dominates the responses to the uniform contextual items, this signal can propagate to other levels of the visual hierarchy and increase the likelihood that this stimulus enters visual awareness. These stimulus-driven effects are combined with and modulated by top-down effects to determine the overall attentive state of the brain. For example, when two stimuli are presented within a V4 receptive field, increasing the contrast of one of them biases the competition in its favor15. This stimulus-driven effect is magnified if the animal is also induced to voluntarily attend to that stimulus. These findings contribute to a growing understanding of the role of attention in perception. Cooperative interactions across levels of the visual hierarchy give rise to robust perceptual representations of attended objects; competitive interactions within visual areas lead to the suppression of competing representations. As the visual scene changes, local feature contrast will bias competition in favor of newly salient events. As behavioral goals change, modulatory signals from prefrontal and parietal cortex bias competition in favor of task-relevant information. The dynamic interplay of stimulusdriven and goal-directed factors determines the content of perceptual experience as it evolves over time.
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
NEWS AND VIEWS
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
1. Egeth, H.E. & Yantis, S. Annu. Rev. Psychol. 48, 269– 297 (1997). 2. Carrasco, M., Ling, S. & Read, S. Nat. Neurosci. 7, 308–313 (2004). 3. Desimone, R. & Duncan, J. Annu. Rev. Neurosci. 18, 193–222 (1995). 4. Beck, D.M. & Kastner, S. Nat. Neurosci. 8, 1108–1114 (2005). 5. Rousselet, G.A., Thorpe, S.J. & Fabre-Thorpe, M. Trends Cog. Sci. 8, 363–370 (2004).
6. Pasupathy, A. & Connor, C.E. Nat. Neurosci. 5, 1332– 1338 (2002). 7. Grill-Spector, K. Curr. Opin. Neurobiol. 13, 159–166 (2003). 8. Reynolds, J.H., Chelazzi, L. & Desimone, R. J. Neurosci. 19, 1736–1753 (1999). 9. Kastner, S., De Weerd, P., Desimone, R. & Ungerleider, L.G. Science 282, 108–111 (1998). 10. Yantis, S. & Serences, J. Curr. Opin. Neurobiol. 13, 187–193 (2003).
11. Corbetta, M. & Shulman, G.L. Nat. Rev. Neurosci. 3, 201–215 (2002). 12. Rauschenberger, R. Psychon. Bull. Rev. 10, 814–842 (2003). 13. Li, Z. Proc. Natl. Acad. Sci. USA 96, 10530–10535 (1999). 14. Knierim, J.J. & Van Essen, D.C. J. Neurophysiol. 67, 961–980 (1992). 15. Reynolds, J.H. & Desimone, R. Neuron 37, 853–863 (2003).
The synaptic Aβ hypothesis of Alzheimer disease Rudolph E Tanzi Aβ peptide is linked to Alzheimer pathology, but its toxic mechanism remains unclear. New work shows that Aβ leads to internalization of NMDA receptors, reducing their availability at synapses. The authors also suggest a molecular mechanism for this endocytosis.
The amyloid hypothesis of Alzheimer disease states that the accumulation and deposition of fibrillar β-amyloid is the primary driver of neurodegeneration and cognitive decline leading to dementia1,2. Recent studies, however, are prompting a shift to the synaptic Aβ hypothesis, which places a greater emphasis on the pathogenic role of non-fibrillar Aβ oligomers specifically at the synapse. Now, in this issue, Snyder and colleagues3 report a signaling pathway through which Aβ may act to impair glutamatergic transmission, compromise synaptic function and reduce long-term potentiation (LTP), a form of synaptic plasticity associated with learning and memory4. Over the past twenty years, the amyloid hypothesis has been strongly supported by a wealth of evidence, including data from genetic studies of Alzheimer disease5. All four of the established Alzheimer disease genes, the β-amyloid precursor protein (APP), presenilin 1 and 2 (PSEN1, PSEN2) and apolipoprotein E (APOE) harbor mutations or variants that influence the accumulation of the Aβ peptide. Aβ is generated by cleavage from APP and is the central building block of β-amyloid. In the case of the earlyonset Alzheimer disease genes (APP, PSEN1 and PSEN2), over 160 autosomal dominant mutations have been discovered that cause Alzheimer disease with virtual certainty5, usually before the age of 60. All but a handful of these mutations increase the relative rate of production of Aβ42, the longer form of the peptide that is much more prone to oligoRudolph E. Tanzi is at the Genetics and Aging Research Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA. e-mail:
[email protected]
merization and fibrillization than its more abundant counterpart in the brain, Aβ40. The traditional amyloid hypothesis remains controversial, mainly because spatial and temporal patterns of amyloid deposition (mostly in the form of senile plaques consisting of fibrillar Aβ) do not correlate very well with the clinical degree of dementia in Alzheimer disease. In contrast, cognitive decline correlates very well with synapse loss6. This is particularly interesting in light of studies that strongly implicate non-fibrillar Aβ oligomers in disrupting synaptic function. For example, synaptic perturbations, including impaired LTP, are observed in APP-V717 (PD-APP) mutant transgenic mice before the development of Aβ deposits7. In addition, non-fibrillar, low molecular weight Aβ oligomers block LTP in brain slices8 and, in vivo, in PD-APP mice9. Soluble Aβ oligomers, including dimers and trimers, are both necessary and sufficient to transiently disrupt learned behavior in APP-Swedish ('APPSwe’ or TG2576) transgenic mice10. Collectively, these data implicate soluble Aβ oligomers (as opposed to fibrillar β-amyloid deposits, such as senile plaques) in promoting ‘synaptoxicity’ and ensuing neurodegeneration in Alzheimer disease. These findings, together with the strong correlation of synapse loss with degree of clinical dementia in Alzheimer disease, suggest that the original amyloid hypothesis may be in need of revision to a synaptic Aβ hypothesis, underscoring the role of prefibrillar Aβ oligomers in Alzheimer disease pathogenesis, particularly at synapses. The role of Aβ oligomers in Alzheimer disease pathology has been further bolstered by the finding that auto-antibodies to small oligomeric cross-linked Aβ peptides are selectively depleted in Alzheimer disease plasma11.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
Researchers have only recently begun to address the mechanism by which Aβ oligomers impair synaptic function. These studies have included attempts to identify the cell surface receptors and signaling pathways mediating Aβ-induced synaptoxicity. For example, Aβ42 can inhibit presynaptic nicotinic acetylcholine receptors (nAChR) and evoke changes in presynaptic Ca2+ levels in rat hippocampus and neocortex12. Given that only picomolar concentrations of Aβ42 were effective in those experiments, the inhibitory action of Aβ42 was postulated to be the result of competing with nicotine to prevent it from stimulating the receptors. The effects were sensitive to α-bungarotoxin and other agents, specifically implicating α7-nAChRs in the pathway by which Aβ42 disrupts synaptic plasticity. Now, in a major leap forward, Snyder et al.3 report a very elegant set of experiments elucidating a potential pathway by which Aβ reduces glutamatergic transmission and NMDA receptor–dependent LTP. In their study, the application of Aβ42 to cultured cortical neurons promoted endocytosis of NMDA receptors, effectively reducing the density of NMDA receptors at synapses. In agreement with this result, reduced levels of surface NMDA receptors were observed on neurons in APPSwe (TG2576) transgenic mice that overproduce Aβ42. Aβ42 also engendered a rapid and persistent depression of NMDA-evoked currents. Delving further into the mechanism by which Aβ42 induces endocytosis of NMDA receptors, Snyder et al.3 found that α7 nicotinic receptors, protein phosphatase 2B (PP2B; calcineurin) and the cytosolic form of the tyrosine phosphatase ‘striatal enriched phosphatase’ (STEP46) were required in the synaptotoxic pathway (Fig. 1). Aβ42, derived from processing of APP, enters into the synaptic cleft and binds the α7-nicotinic receptor, leading to
977
NEWS AND VIEWS
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
APP
?
?
Glutamate
Aβ42 Ca
2+
Na+
NMDAR NR2B
α7-nicotinic receptor
Fyn
Tyr1472
Endocytosis PO4
PP2B
STEP46
(DARPP-32)
CCV
Figure 1 Effects of Aβ42 on NMDA receptor internalization at the synapse. Aβ42 promotes the endocytosis of NMDA receptors, reducing the density of NMDA receptors at synapses. Aβ42 can be secreted into the synaptic cleft via sequential cleavage of the Aβ precursor protein (APP, shown presynaptically) by β-secretase and γ-secretase. Familial Alzheimer disease mutations in genes encoding APP and the presenilins (PSEN1 and PSEN2) selectively increase the production of Aβ42. Aβ42 binds the α7-nicotinic receptor (shown postsynaptically), which then leads to the activation of calcineurin (PP2B). PP2B then promotes the dephosphorylation of the tyrosine phosphatase, striatal enriched phosphatase (STEP46), either directly, or through DARPP-32. This leads to the activation of STEP46, which gates NMDA receptor activation and LTP. STEP46 activation promotes the dephosphorylation of Tyr1472 of the NMDA receptor subunit NR2B. This may occur either directly or via STEP46-mediated dephosphorylation or downregulation of the NMDA receptor-associated kinase, Fyn. Tyr1472 regulates binding of the NMDA receptor to PSD-95 and adaptor protein (AP2); dephosphorylation of this residue is postulated to promote endocytosis of the NMDA receptor in clathrin-coated vesicles (CCV). In this manner, persistent binding of Aβ42 to α7-nicotinic receptor leads to reduced NMDA receptor density at synapses, decreasing glutamatergic transmission and impairing synaptic plasticity.
the activation of PP2B. PP2B then promotes the dephosphorylation and thus activation of STEP46, which is known to gate NMDA receptor activation and LTP. STEP46 activation is then postulated to promote dephosphorylation of Tyr1472 of the NMDA receptor subunit, NR2B. This is followed by increased endocytosis of NMDA receptors in clathrin-coated vesicles. The end result is a reduced density of NMDA receptors and impairments in glutamatergic transmission and synaptic plasticity, including reduced LTP. Clearly, this previously unknown pathway, along with the impressive tour de force used to delineate it, will require further investigation and confirmation in future studies. Moreover, several key questions remain to be addressed.
978
For example, it is not clear whether PP2B directly activates STEP46 or does so through other factors, such as DARPP-32. Likewise, it is not clear whether STEP46 directly dephosphorylates Tyr1472 of NR2B, or promotes this event by means of downregulation of the NMDA receptor-associated kinase, Fyn, which is believed to phosphorylate Tyr1472. It is also not obvious how dephosphorylation of NR2B-Tyr1472 actually leads to endocytosis of the NMDA receptor. One possibility proposed by Snyder and colleagues is that the phosphorylation state at this tyrosine regulates binding of the NMDA receptor to PSD-95 and the adaptor protein AP-2, and dephosphorylation of this residue promotes endocytosis of the NMDA receptor
in clathrin-coated vesicles (CCV). Finally, given that the authors3 could not completely block NMDA receptor endocytosis with αbungarotoxin, it is possible that additional receptor mechanisms may be involved in Aβ42-induced NMDA receptor internalization. While these and many other details will need to be worked out, Snyder et al.3 have put forward a compelling working model for how Aβ42 reduces NMDA receptor density at synapses, leading to attenuated glutamatergic transmission and impaired synaptic plasticity. This synaptotoxic Aβ pathway raises two critical questions. First, can synaptic plasticity be restored by reducing levels of Aβ42 in synapses, thereby ameliorating cognitive deficits in Alzheimer disease? Second, regarding potential therapies aimed at achieving this goal, should we be concerned that Aβ may have a physiological role in regulating LTP in glutamatergic and other synapses? Regarding the second question, low, non-toxic concentrations of Aβ can reduce LTP and glutamatergic transmission13. Based on these data, these authors proposed that activity-dependent modulation of Aβ may normally provide negative feedback to keep neuronal hyperactivity in check. Furthermore, they suggested that disruption of this feedback system and prolonged depression of NMDA receptor-mediated transmission by Aβ could contribute to Alzheimer disease pathogenesis. Others have suggested a potential role for Aβ in mediating oxidative stress, which can detrimentally affect synaptic integrity (reviewed in ref. 14). These concerns indicate a need for careful scrutiny of any potential therapeutics aimed at diminishing Aβ levels in synapses. With regard to the therapies that might be used to alleviate Aβ-induced synaptoxicity, two basic strategies can be considered. First, production of Aβ itself can be reduced, for example by inhibiting β-secretase and/or γ-secretase activities. In this option, inhibitors would optimally be selective for APP, to minimize undesirable effects on other secretase substrates. In addition, it would be preferable for the APP-selective γ-secretase inhibitor to preferentially decrease the generation of Aβ42, the species shown by Snyder et al.3 to impair glutamatergic transmission. However, it is important to point out that the relative efficacy of Aβ40 in promoting NMDA receptor internalization is still unclear. In the second therapeutic option, attempts to promote clearance of Aβ42 from synapses could be made. Along these lines, intracerebroventricular injection of naturally secreted human Aβ can inhibit LTP in rat hippocampus, and a monoclonal antibody targeted at Aβ com-
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS pletely blocks this effect15. However, delivering such an antibody safely and effectively to an Alzheimer disease patient’s brain and avoiding adverse effects such as encephalitis might not be trivial. Other therapeutic possibilities might include inhibiting oligomeric Aβ assemblies, for instance, with metal-complexing agents or glycosaminoglycan mimetics. However, in any Aβ clearance strategy it would be important to monitor for the possible effects of dissolution of fibrillar Aβ into potentially synaptotoxic Aβ oligomers. In conclusion, increasing evidence shifts our understanding of Alzheimer disease patho-
genesis toward emphasizing the synaptotoxic properties of oligomeric Aβ rather than fibrillar Aβ, such as is found in β-amyloid plaques. Future investigations addressing the emerging synaptic Aβ hypothesis, and particularly the molecular mechanism by which Aβ promotes synaptic dysfunction, such as that described in the new paper3, will be critical for the design of safe and effective anti–Aβ therapeutics aimed at preventing and treating Alzheimer disease. 1. Glenner, G.G. & Wong, C.W. Biochem. Biophys. Res. Commun. 120, 885–890 (1984). 2. Selkoe, D.J. Neuron 6, 487–498 (1991). 3. Snyder, E. et al. Nat. Neurosci. 8, 1049–1056 (2005).
4. Tanzi, E. Riv. Sperim. Freniatr. Med. 19, 419–472 (1893). 5. Tanzi, R.E. & Bertram, L. Cell 120, 545–555 (2005). 6. Terry, R.D. et al. Ann. Neurol. 30, 572–580 (1991). 7. Larson, J., Lynch, G., Games, D. & Seubert, P. Brain Res. 840, 23–35 (1999). 8. Lambert, M.P. et al. Proc. Natl. Acad. Sci. USA 95, 6448–6453 (1998). 9. Walsh, D.M. et al. Nature 416, 535–539 (2002). 10. Cleary, J.P. et al. Nat. Neurosci. 8, 79–84 (2005). 11. Moir, R.D. et al. J. Biol. Chem. 280, 17458–17463 (2005). 12. Dougherty, J.J., Wu, J. & Nichols, R.A. J. Neurosci. 23, 6740–6747 (2003). 13. Kamenetz, F. et al. Neuron 37, 925–937 (2003). 14. Lee, H.G., Moreira, P.I., Zhu, X., Smith, M.A. & Perry, G. Am. J. Pathol. 165, 1461–1464 (2004). 15. Klyubin, I. et al. Nat. Med. 11, 556–561 (2005).
Beyond migration: Dlx1 regulates interneuron differentiation Carl Wonders & Stewart Anderson A new paper shows that the transcription factor Dlx1, known to be involved in neuronal migration, is also necessary for interneuron survival. Mice lacking Dlx1 show subtype-specific loss of interneurons, a reduction in inhibitory currents and generalized seizures.
A century ago, Cajal speculated that the remarkable diversity of cortical interneuron morphology underlies specific functions that are fundamental to human thought. Later studies revealed that most of these neurons use the inhibitory neurotransmitter GABA, and that the inhibition of GABA signaling produces fear-related behaviors and seizures. In addition, interneuron function has been implicated in the coordinated recruitment of large networks of pyramidal neurons that underlies a key component of prefrontal cortical function: working memory1. Analyses of mutant rodents with abnormal numbers or function of cortical interneurons, with correlated behavioral abnormalities, have advanced our understanding of interneuron function2–6. However, the lack of specificity of these mutations for cortical interneurons has complicated the interpretation of these studies. A paper7 in this issue by Cobos et al. marks an important advance in understanding the genetic regulation of postnatal interneuron development and function. In the basal embryonic forebrain, the transcription factor gene Dlx1 and the related gene Dlx2 regulate the ability of newly born neurons to migrate Carl Wonders and Stewart Anderson are at the Department of Psychiatry, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, USA. e-mail:
[email protected]
away from the proliferative zone. One neuronal subgroup affected in Dlx1/Dlx2 double mutants are cortical interneurons, most of which, in rodents, originate in the basal forebrain. In mice and in humans, both Dlx1 and Dlx2 continue to be expressed as interneurons migrate to and begin to differentiate within the cerebral cortex, but a function of these proteins in later aspects of interneuron development had not been described. Through an impressive combination of histological, electrophysiological and cell transplantation studies, Cobos et al. demonstrate that adult mice lacking Dlx1 develop selective interneuron losses and seizures7. They began by showing that, during the first few postnatal weeks, Dlx2 expression in cortical interneurons subsided, while Dlx1 expression became restricted to subgroups of interneurons expressing calretinin, neuropeptide Y and somatostatin (Fig. 1). Analysis of Dlx1–/– mice revealed selective losses of these same interneuron subgroups by the third or fourth postnatal week. In contrast, interneurons expressing the interneuron subgroup marker parvalbumin were not affected. Although the number of GAD67-expressing, inhibitory interneurons at postnatal day 12 was normal, the Dlx1–/– mice showed increased numbers of apoptotic cells by 4 weeks of age. This suggests that Dlx1 function is required for the survival of many calretinin-, neuropeptideY- and somatostatin-expressing interneurons.
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
Furthermore, this selective loss of interneurons was associated with a reduction of inhibitory postsynaptic current in the hippocampus and neocortex, increased seizures by 2 months of age, and evidence of seizure-induced histological changes. The selective losses of those interneuron subgroups that normally maintain Dlx1 expression is remarkable, but how can one prove that this reflects a cell-intrinsic function of Dlx1? To address this, the authors used a new transplantation assay, in which the Dlx1 mutant mice were crossed into a pan–green fluorescent protein (GFP)-expressing line, and interneuron progenitors from the basal telencephalon of these mutants were transplanted directly into the cortical plate of neonatal pups. This technique allowed the authors to study the role of Dlx1 in transplanted progenitors while they differentiated within a ‘normal’ cortical environment. Like the results from histological analysis of the Dlx1 mutants, two months after transplantation of Dlx1–/– interneuron progenitors, there was a marked reduction in the percentage of surviving neurons that expressed calretinin, neuropeptide Y and somatostatin. Transplanted interneurons expressing parvalbumin were not affected. Analysis of transplants after shorter survival times showed that decreased dendritic length and branching preceded the cell loss. Thus, the authors are able to demonstrate a cell-autonomous requirement for Dlx1 within a subset of
979
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS cortical interneurons and also identify a new potential function of Dlx1 in the maturation of dendritic morphology. In outbreeding the Dlx1-null mice to the GFP-expressing line for transplantation studies, Cobos et al. produced a remarkable alteration in mutant phenotype. Inbred Dlx1–/– mice on a C57/B6 background generally die by the fourth postnatal week. Thus, a single generation of outbreeding resulted in a dramatic shift in survival. This shift raises the question of whether inbred Dlx1 nulls also have normal numbers of GAD67-expressing cells at P12, or whether the apparent selectivity of the interneuron phenotype to the post-migratory phase of their development is a product of the outbreeding itself. In addition, would further outbreeding attenuate the observed phenotype, and what other genetic variations are interacting with Dlx1 to cause such a profound change? Several other questions remain. First, how does the postnatal phenotype of the Dlx1 mutants relate to the prenatal loss of most interneuron migration into the cerebral cortex in the Dlx1/Dlx2 double mutants? The authors point out that the Dlx1-null phenotype develops roughly as the postnatal expression of Dlx2 subsides, raising the possibility that this timing reflects the functional redundancy of these genes at both embryonic and postnatal stages. Knockin strategies that test the ability of one gene to substitute for the other should shed light on this issue. Beyond that, could the targets of Dlx1 and Dlx2 be similar at embryonic and postnatal stages? It has been suggested that disinhibition of Notch signaling accounts for aspects of the phenotype of Dlx1/Dlx2–/– mice with respect to the developing striatum8. The postnatal Dlx1 phenotype could be directly connected to the developmental phenotype through Notch regulation of dendritogenesis, in which increased Notch signaling is associated with restriction or retraction of dendritic growth (by cortical projection neurons in vitro)9. Alternatively, a link between the Dlx1/Dlx2-null prenatal and the Dlx1-null postnatal phenotypes could involve the regulation of cytoskeletal components of neurite extension and neuronal migration. Indeed, treatment of dissociated striatal cultures with antisense oligonucleotides against Dlx2 reduces dendritic extension10. To date, however, specific targets of Dlx1 include only the Dlx5/Dlx6 intergenic enhancer11. A second question relates to the relationships between the observed reduction of cortical interneurons and the changes in physiology that the authors observed. Cobos et al. found that the Dlx1–/– mice had reductions in both the frequency and the amplitude of spontaneous inhibitory postsynaptic currents in both the neocortex and the hippocampus. The mice
980
MGE Cycling progenitors pPV
Cortex Cell cycle exit
Migration to cortex
Cortical migration
Differentiation and survival
pPV
pPV
pPV
PV
Lhx6+ Dlx1–
Nkx2.1 Dlx1/2
Nkx2.1 Dlx1/2 Dlx5/6 Lhx6
Nkx2.1 Dlx1/2 Dlx5/6 Lhx6
Dlx1/2 Dlx5/6 Lhx6
Lhx6+ Som Dlx1–
pSom
pSom
pSom
pSom
+ Som Lhx6+ Dlx1
Som Dlx1+ Lhx6–
(NPY)
CGE pCR
pCR
pCR
pCR
Dlx1/2 ER81?
Dlx1/2 Dlx5/6 ER81?
Dlx1/2 Dlx5/6 ER81?
Dlx1/2 Dlx5/6 ER81?
CR
Dlx1+
Figure 1 Transcription factor markers of cortical interneuron subgroup development. ‘p’ denotes a precursor stage that does not yet express the given marker. MGE, medial ganglionic eminence; CGE, caudal ganglionic eminence; Pv, parvalbumin; Som, somatostatin; NPY, neuropeptide Y; CR, calretinin.
developed seizures when subjected to mild stressors such as noise or handling when they were over 2 months old, and they also showed histological changes (increased neuropeptide Y immunoreactivity, ectopic expression of neuropeptide Y in projecting neurons and axonal sprouting) associated with seizures at this age. Dlx1–/– mice also had greater theta rhythm amplitude during exploratory activity than did wild-type littermates, and they developed cortical seizures. Detailed electrophysiological and connectivity studies comparing normal and Dlx1–/– mice, in a homogeneous genetic background, will be required to connect these levels of GABAergic phenotypes. Finally, what causes the 1-month delay between the detectable loss of somatostatinand calretinin-expressing interneurons and the onset of seizures? The authors discuss several plausible explanations, including the possibility that compensatory mechanisms such as increased feedback inhibition can temporarily prevent epileptogenesis. An alternative possibility is that the onset of seizure activity is determined by the interaction between interneuron losses and the normal maturation of cortical circuitry. There is considerable refinement in both excitatory and inhibitory aspects of cortical circuitry during the peripubertal period12. Moreover, in mice, maturation of cortical inhibition mediates the alterations in cortical plasticity that occur over the peripubertal age range13. This effect is mediated by
the GABAA receptor α1 subunits that mainly localize to the cell soma and axon initial segment of projection neurons, the primary targets of parvalbumin-expressing interneurons (not directly affected in the Dlx1 mutants). Thus, the refinement of cortical connectivity during puberty, in combination with the loss of some somatostatin- and calretinin-expressing interneurons, may dictate the onset of seizure activity. Interestingly, parvalbumin knockout mice themselves have a lower seizure threshold, apparently owing to increased activity in the normally parvalbumin-expressing interneurons that produces hypersynchrony6. This discussion raises a crucial point concerning the importance of the Cobos et al. paper in its implication for cortical disease. The authors point out that the brains of people with schizophrenia show a tendency for reduced connectivity of a subtype of parvalbumin-expressing interneuron. As a model of schizophrenia per se, Dlx1 mutants may not be useful, as people with schizophrenia have neither reductions in calretinin-expressing interneurons14 nor increases in epilepsy, and their abnormality of cortical synchrony is primarily in the gamma band15 rather than in the theta band as reported for the Dlx1–/– mice. However, as a model of a phenotype that may be fairly specific for postnatal interneuron development, studied with a combination of histological, electrophysiological and cell transplantation methods, this paper raises the bar
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS for future studies on the relationship between interneuron development and cortical function. Further extension of this analysis to the question of how the histological and behavioral phenotypes affect, and are affected by, normal developmental changes will begin to bridge the connection between gene function and ‘late’ developmental phenotypes. Armed with conditional knockout and knock-in strategies, more detailed stereological and behavioral methods and electrophysiological recording from transplanted cells, researchers may find that answers to some of the most complex questions of
interneuron development and cortical function are finally ripe for the picking. 1. Wang, X.J., Tegner, J., Constantinidis, C. & GoldmanRakic, P.S. Proc. Natl. Acad. Sci. USA 101, 1368– 1373 (2004). 2. Sarkisian, M.R., Frenkel, M., Li, W., Oborski, J.A. & LoTurco, J.J. Cereb. Cortex 11, 734–743 (2001). 3. Powell, E.M. et al. J. Neurosci. 23, 622–631 (2003). 4. Pillai-Nair, N. et al. J. Neurosci. 25, 4659–4671 (2005). 5. Erbel-Sieler, C. et al. Proc. Natl. Acad. Sci. USA 101, 13648–13653 (2004). 6. Schwaller, B. et al. Mol. Cell. Neurosci. 25, 650–663 (2004).
7. Cobos, I. et al. Nat. Neurosci. 8, 1057–1066 (2005). 8. Yun, K. et al. Development 129, 5029–5040 (2002). 9. Sestan, N., Artavanis-Tsakonas, S. & Rakic, P. Science 286, 741–746 (1999). 10. Ding, M. et al. J. Mol. Neurosci. 8, 93–113 (1997). 11. Zhou, Q.P. et al. Nucleic Acids Res. 32, 884–892 (2004). 12. Anderson, S.A., Classey, J.D., Conde, F., Lund, J.S. & Lewis, D.A. Neuroscience 67, 7–22 (1995). 13. Fagiolini, M. et al. Science 303, 1681–1683 (2004). 14. Daviss, S.R. & Lewis, D.A. Psychiatry Res. 59, 81–96 (1995). 15. Spencer, K.M. et al. Proc. Natl. Acad. Sci. USA 101, 17288–17293 (2004).
Less is more: progenitor death and cortical size Pasko Rakic Cerebral cortex size in individuals and species is determined by cortical progenitor mitosis and death during embryogenesis. EphA signaling—important in axon guidance and patterning—also seems to be critical in regulating the survival of cortex progenitors.
Nothing in biology, it is said, makes sense unless viewed in light of evolution. Thus the mechanisms underlying expansion of the cerebral cortex are central to understanding the potential and limits of our mental capacity. The species-specific size of the cerebral cortex is determined by proliferation and apoptosis rates in the embryonic proliferative zones situated near the surface of the fluid-filled cerebral ventricles. Genetic and cellular mechanisms by which the neocortex expands have only begun to be explored, and a number of candidate genes that control cell proliferation have been identified. A recent report in Nature by Depaepe et al.1 adds another potentially important player, the ephrin-A/EphA signaling pathway, to the list of genes involved in the managed production of cortical neurons. Their finding, that the level of EphA signaling determines the rate of programmed death (apoptosis) of neuronal progenitors, is surprising because ephrin signaling has not been previously implicated in regulating cell death or in the apoptosis of neural progenitor cells. Furthermore, the new paper1, along with several previous studies, provides an instructive example of the synergy between pro- and antiapoptotic effects and how less (i.e., progenitor death) can result in more (i.e., adult neurons) in the cerebral cortex (Fig. 1). Pasko Rakic is in the Department of Neurobiology and the Kavli Institute for Neuroscience, Yale University School of Medicine, 333 Cedar Street, New Haven, Connecticut 06511, USA. e-mail:
[email protected]
The cerebral cortex is by far the largest structure of the human brain, but its constituent neurons are not generated locally in the cortex itself. As in other mammalian species, human cortical neurons are produced in the proliferative ventricular and subventricular zones (VZ and SVZ) and migrate from there into distinct cerebral cortical areas. Postmitotic cells, produced in succession within these zones, migrate across the intermediate and subplate zones following transient radial glial scaffolding before entering the increasingly more distant cortical plate where they form arrays of radial columns2. According to the radial unit hypothesis, increased cell production at early stages (before the onset of neurogenesis) would result in increased numbers of founder cells that give rise to radial columns, whereas increases in production at later stages would increase the number of neurons within each column2 (Fig. 1). There are several examples of how these two phases of cell proliferation can be regulated by distinct sets of genes. For example, overexpression of β-catenin in the mouse brain produces a larger number of neuronal progenitors and eventually more neurons by inhibiting the decision of progenitors to exit the cell cycle in the proliferative zones at early stages3. The increase in the number of radial columns in the cortical plate leads to the formation of elaborate cortical convolutions in this rodent species that normally has a smooth (lissencephalic) hemispheric surface3. In contrast, overexpression of cyclin-depen-
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
dent kinase (cdk) inhibitor p27 at later stages increases production of neurons that form radial columns, thus increasing the thickness of the superficial layers of the cortex, without increasing its surface area4,5. Programmed cell death of progenitor cells can also affect cerebral cortical size6,7. For example, activation of the Notch signaling pathway induces apoptosis in the VZ by activation of the p53 tumor suppressing pathway, leading to a smaller telencephalon8. Conversely, reduction in the apoptosis of founder cells in the ventricular zone can produce supernumerary progeny. Thus, when caspases, the mammalian homologs of the nematode CED-3 family of killer genes, are knocked out, apoptosis decreases in the cerebral ventricular zone, resulting in the formation of supernumerary cells in the telencephalon9,10. Many of these cells accumulate in the white matter. However, in confirmation of the radial unit hypothesis2 (Fig. 1), a larger-than-normal number of founder cells resulted in a cortex with an increased surface area and the formation of convolutions11. This suggests that the observed phenotype resulted from interference with the programmed death of progenitors in the VZ during early neurogenesis without affecting the ability of excessive cells to migrate normally and deploy radially in the cortex. Interestingly, the survival of cells can also be increased by slowing down the clearance of apoptotic cells by preventing the normal course of phagocytosis in the VZ with a similar effect on cortical expansion12.
981
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS
Figure 1 Radial unit lineage model of cortical neurogenesis. The model illustrates how changes in the mode and the rates of cell proliferation and/or programmed cell death within the pool of neural stem cells in the ventricular zone that divide symmetrically at early embryonic stages causes an exponential increase in the number of radial columns. That in turn results in surface expansion of the cerebral cortex without changes in its thickness. In contrast, similar changes in proliferation kinetics occurring in the founder cells, which divide asymmetrically, cause a linear increase in number of neurons within radial columns without a change in the cortical surface area. VZ, ventricular zone. SD, symmetrical division. CC, cerebral cortex. AsD, asymmetrical division. Figure adapted from ref. 2.
Now, Depaepe et al.1 provide evidence that ephrins and Eph receptor genes, which are generally considered important players in pattern formation and axonal guidance, are also involved in controlling neuronal production in the telencephalon. Their experiments using dissociated cortical progenitors show that stimulation with soluble ephrin-A5-Fc can induce caspase-3 activity and produce TUNEL-positive apoptotic cells, all within 15 min. This rapid induction of apoptosis suggests that some specific effector pathway downstream of the ephrin-Eph receptor interaction can directly trigger apoptosis in neural progenitors. It is surprising that this rapid pro-apoptotic effect of ephrin signaling has not been previously identified. Depaepe et al.1 also generated doubly transgenic mice that express ephrin-A5 under the control of the EphA7 regulatory elements.
982
Overexpression of ephrin-A5 in progenitors expressing EphA7 resulted in increased apoptosis of neuron-producing progenitors, which in turn resulted in an overall smaller cerebral cortex. In addition, the authors used a battery of tests, including expression of pan-neuronal and class-specific neuronal markers, to show that cell migration, the settling pattern and even initial differentiation of neural precursors were normal. These gain-of-function experiments indicate that over-activation of ephrin/Eph signaling can decrease production of cortical founder progenitors. Next, Depaepe et al. showed that the opposite occurred when ephrinA/EphA7 signaling was abolished. In mice lacking EphA7 (ref. 13), apoptosis was reduced by about half, resulting in formation of a larger-than-normal cerebral cortex. Again, probably owing to preservation of radial scaffolding, most
overproduced neurons migrated properly, resulting in a larger cortical surface that begins to show incipient convolutions. The overproduced neurons did not make a large lump or thicker cortical plate but rather produced a relatively normal-looking cortex with an enlarged surface, indicating that the saved progenitors have retained the cellular machinery that delivers their progeny sequentially into overlying radial columns. All of the diverse metabolic pathways mentioned above are involved in some way in regulating production of neurons destined for the cerebral cortex. No one has expected that so many molecules would be involved. As a next step, it will be important to find out how such complex and diverse molecular cascades are orchestrated. Future studies are also needed to discern the molecular mechanism that couples ephrin signaling to apoptosis. Moreover, it will be of interest to determine whether ephrin signaling can trigger caspase activity locally to regulate cell migration and/or growth cone guidance during axon pathfinding. It may be significant that all effects occur predominantly in the forebrain. Finally, because ephrins and Eph receptors often show reciprocal expression patterns in the developing cerebral wall, one may wonder whether the ephrin signaling–induced apoptosis may serve as a mechanism to confine the distribution of neural progenitor cells to specific areas. Regional differences in the expression of ephrins in the embryonic cerebrum have been detected in both rodents and higher primates14,15, opening the opportunity to investigate molecular mechanisms and cellular events that have driven expansion of the cerebral cortex during evolution. 1. Depaepe, V. et al. Nature 435, 1244–1250 (2005). 2. Rakic, P. Trends Neurosci. 18, 383–388 (1995). 3. Chenn, A. & Walsh, C.A. Cereb. Cortex 13, 599–606 (2003). 4. Delalle, I. et al. Cereb. Cortex 9, 824–832 (1999). 5. Tarui, T. Cereb. Cortex 15, published online 12 January 2005 (doi:10.1093/cercor/bhi017). 6. Blaschke, A.J., Staley, K. & Chun, J. Development 122, 1165–1174 (1996). 7. Thomaidou, D., Mione, M.C., Cavanagh, J.F. & Parnavelas, J.G. J. Neurosci. 17, 1075–1085 (1997). 8. Yang, X. et al. Dev. Biol. 269, 81–94 (2004). 9. Kuida, K. et al. Nature 384, 368–372 (1996). 10. Kuida, K. et al. Cell 94, 325–333 (1998). 11. Haydar, T.F., Kuan, C.-Y., Flavell, R.A. & Rakic, P. Cereb. Cortex 9, 621–626 (1999). 12. Li, M., Sarkisian, M.R., Mehal, W., Rakic, P. & Flavell, R.A. Science 302, 1560–1563 (2003). 13. Dufour, A. et al. Neuron 39, 453–465 (2003). 14. Campbell, D.C. & Holt, C.E. Neuron 37, 939–952 (2003). 15. Donoghue, M.J. & Rakic, P. Cereb. Cortex 9, 586–600 (1999).
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
NEWS AND VIEWS
Rethinking the thalamus Paul W Glimcher & Brian Lau
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Reward-sensitive neurons are present throughout the brain. A report in Science now shows that a subset of thalamic neurons respond selectively to the smaller of two rewards, as opposed to just reflecting reward magnitude, as do neurons in other brain areas.
Most neurobiologists working today were brought up to believe in a few fundamental truths: the neuron doctrine, the electrical nature of the action potential and that the thalamus is uninteresting. Recently, however, neuroscientists have been trying to explain why so many neural circuits seem to involve multiple, highly organized passes through this ‘uninteresting’ structure. Surely this indicates that the thalamus must do something, but what? One group of theoreticians proposed that striatal loops involving the thalamus may help select a single action for execution out of the multiple actions competing for access to the musculature1,2. In parallel, physiologists have recorded from neurons throughout these striatal loops in monkeys performing visuomotor tasks. The most recent physiological study of these loops attempts to consolidate these two approaches by adding a twist to the competition hypothesis. In Science, Kimura and colleagues3 present neurophysiological data from the intralaminar thalamus suggesting the existence of a previously unknown process that is activated when an animal must execute an action that yields a relatively small reward. To understand this new work, however, one has to place it within the context of other studies of the thalamus. Besides containing sensory nuclei such as the lateral and medial geniculate nuclei, the thalamus seems to be locked into at least two interrelated sets of processing loops4–6. The first are the parallel corticostriatal loops proposed in ref. 4 and later elaborated upon anatomically7. These loops consist of cortical projections to the striatum, which, through the basal ganglia output nuclei, connect to the thalamus and then back to the originating cortical regions. These pathways are segregated into five largely independent functional subloops that have been the subject of much physiological inquiry8,9. There is also compelling evidence for the existence of five additional loops6 that pass Paul Glimcher and Brian Lau are at the Center for Neural Science, New York University, New York, New York 10003, USA. e-mail:
[email protected]
through midline regions of the thalamus (Fig. 1a). These connect the striatum, an area known to process reward-related information, to itself. The thalamostriatal loops involve the midline intralaminar nuclei, particularly the caudal intralaminar group, which is composed primarily of the centromedian-parafascicular complex. It is this complex that forms the main way station for most of the thalamostriatal loops. In the skeletomotor thalamostriatal loop, for example, the centromedian nucleus projects to the postcommisural putamen, a skeletomuscular nucleus of the basal ganglia. This region of the putamen projects, in turn, to the globus pallidus, which closes the loop by projecting back to the centromedian thalamus (Fig. 1b). Kimura and colleagues have been examining the properties of neurons in the skeletomuscular thalamostriatal loop for some time now, focusing on neurons of the centromedian-parafascicular complex. Their initial studies10,11 showed that these neurons are multimodal, responding to a variety of sensory signals both during and outside of operantly conditioned reaching tasks. They have classified neurons into two physiologically distinct groups on the basis of the speed with which they respond to visual or auditory stimuli: short-latency facilitatory neurons found mostly in the parafascicular nucleus (and thus associated with limbic and cognitive thalamostriatal loops) and long-latency facilitatory neurons found mostly in the centromedian nucleus (and thus associated primarily with the skeletomotor thalamostriatal loop). Furthermore, inactivation of the centromedian-parafascicular complex decreases the reward-related responses of tonically active neurons in the regions of the striatum to which they project10. Kimura and colleagues3 now report recordings from long-latency facilitatory centromedian neurons in macaques trained to perform a traditional ‘go’/‘no-go’ reaching task. In this task, the monkey placed one hand on a central button to begin each trial. After a delay, a second button was illuminated yellow at one of two possible locations; then it changed either to green or to red. As soon as the monkey detected the onset of the green
NATURE NEUROSCIENCE VOLUME 8 | NUMBER 8 | AUGUST 2005
button (a ‘go’ trial) he had to reach for it to earn a fluid reward. If, however, he detected a red button instead (a ‘no-go’ trial,) he had to hold position on the initial yellow button for 0.75 s to be rewarded. Across blocks of 60–120 trials, the authors varied which action was associated with a large reward (+R) and which was associated with a small reward (–R). Therefore, on the first block, the monkey might have earned a large reward for the go response on go trials and a small reward for the no-go response on no-go trials. This was then reversed in the next block. Of course, making the wrong response—for example, a go response on a no-go trial—earned the monkey no reward regardless of whether it was a +R or a –R condition. The authors found that many neurons in the centromedian thalamus responded more vigorously on –R trials than on +R trials irrespective of trial type (go or no-go). This finding is important for three reasons. First, this is the first time that thalamic neurons—in this case, in the thalamostriatal loop associated with skeletal movements—have been shown to be influenced by reward magnitude. Second, the neurons responded strongly for both go and no-go trials that yielded low rewards, indicating that the neurons were not selective for the action that the monkey was required to produce, but rather for the more abstract value of the trial. Third, this modulation seems to be reversed compared with most of the reward-related responses that have been observed in other areas. For example, neurons in posterior and frontal cortex respond more strongly to larger rewards. In contrast, centromedian neurons responded more for small rewards than for large rewards, a phenomenon that has not been reported previously. To interpret these findings, it is important to note that the activity of many neurons outside the thalamus has been correlated with response bias, the behavioral observation that subjects are often biased toward selecting one particular response over another. If reaching for a lighted button earns a large reward and withholding that action earns a small reward, then human and animal subjects are more likely to reach for the button than to withhold the movement; they show a response bias that favors reaching. Neurons
983
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NEWS AND VIEWS
Figure 1 Parallel thalamostriatal loops involving the basal ganglia and the thalamus in monkeys (after ref. 6). (a) These loops have been classified on the basis of the anatomical segregation of neurons in the striatum, which project to distinct pallidal regions, either the internal segment of the globus pallidus (GPi) or the substantia nigra pars reticulata (SNr). The intralaminar loops are closed after passing through distinct nuclei of the centromedian (CM)-parafascicular (PF) complex. (b) Major thalamic nuclei involved in corticostriatal and thalamostriatal loops.
throughout the visual-oculomotor pathway, for example, show enhanced responses such as shifts in baseline activity12,13 that are correlated with these behavioral biases. The thalamic signal Kimura and colleagues have identified does not correspond directly to a response bias of this type. Their neuronal signal is strongest when the animal must choose between a movement that will yield a small reward and withholding that movement, where withholding the movement will yield no reward on this trial but has yielded large rewards on other trials. They therefore propose that the behaviorally observed phenomenon of response bias may be the product of two complementary underlying neural processes. The first of these would be, in essence, a pre-bias process (a process more strongly correlated with large rewards than the choice behavior of the animal), and the second would be a complementary pre-anti-bias process (a process that is active when an animal must choose a relatively small reward action). They hypothesize that it is the combination of these two signals that yields the overall response bias we observe in behavior and that the thalamic signals they have observed reflect this antibias process. Although the precise form of their hypothesis is unique in some ways, previous work14 has identified signals in the basal ganglia that may be related to the pre-bias process that Kimura and colleagues propose, and another study15 has identified signals in the frontal eye fields that can also be characterized as competing go and no-go processes. As well, signals in the supplementary eye fields
984
are correlated with the interactions of these go and no-go processes. Working with their notion that a pre-bias process would be most active whenever a large-reward go trial was imminent, one might expect that the complementary anti-bias process would also have to be more active if the monkey had to withhold that go response for some reason. To examine this prediction, they trained another monkey on a version of the go/no-go task where a large reward trial was guaranteed after a maximum of three small reward trials. They found that centromedian responses were strongest on small-reward nogo trials that were the third and last in a series of small-reward trials. So it was not just a small reward that activated these neurons; instead, a small reward certain to be followed by a large reward activated these neurons more than a small reward likely to be followed by another small reward. Kimura and colleagues hypothesize that this is the case specifically because thalamic activity serves as a compensatory anti-bias process that offsets a growing prebias signal, which was suggested by the error rate data in this version of the task. If these centromedian neurons inhibit or counteract a pre-bias signal, then strong artificial activation of centromedian neurons should reveal the anti-bias process by eliciting the incorrect action—an action the monkeys know to be unreinforced. To test this, Kimura and colleagues microstimulated in the centromedian nucleus just before a small fraction of high-reward go trials. They found that stimulation on these trials did slow reaction
times, although it only rarely stopped the go movement completely. This inhibition of a go response, in effect causing a no-go response, is consistent with the predictions of their model. The result, however, raises the question of whether stimulation during large-reward no-go trials might result in accidental go responses. It also leads one to ask what effect centromedian microstimulation has when the animal is equally reinforced on go and no-go trials? Is centromedian stimulation effective only when the rewards for two or more actions have different magnitudes? Kimura and colleagues have suggested a bold new hypothesis for response selection. They have proposed that the tight linkage that has been observed between behavior and activity in a number of decision-making areas may reflect the activity of two processes: a pre-bias process and a complementary process driven by neurons of the centromedian thalamus. Even more exciting, however, is that they are exploring this hypothesis in the thalamus. Response bias–related signals have been observed throughout the cortex and basal ganglia, both of which are intimately connected with the thalamus. By exploring issues related to cognitive processes in the thalamus, Kimura and colleagues are helping to open a critical avenue for future research. Future experiments will have to be conducted to test this new model against its competitors, but now those tests will have to include physiological studies in the thalamus, a development that has been long overdue. 1. Redgrave, P., Prescott, T.J. & Gurney, K. Neuroscience 89, 1009–1023 (1999). 2. Wise, S.P., Murray, E.A. & Gerfen, C.R. Crit. Rev. Neurobiol. 10, 317–356 (1996). 3. Minamimoto, T., Hori, Y. & Kimura, M. Science 308, 1798–1801 (2005). 4. Alexander, G.E., DeLong, M.R. & Strick, P.L. Annu. Rev. Neurosci. 9, 357–381 (1986). 5. Parent, A. & Hazrati, L.N. Brain Res. Rev. 20, 91–127 (1995). 6. Smith, Y., Raju, D.V., Pare, J.F. & Sidibe, M. Trends Neurosci. 27, 520–527 (2004). 7. Middleton, F.A. & Strick, P.L. Brain Res. Rev. 31, 236–250 (2000). 8. Sommer, M.A. Curr. Opin. Neurobiol. 13, 663–670 (2003). 9. Wyder, M.T., Massoglia, D.P. & Stanford, T.R. J. Neurophysiol. 91, 2628–2648 (2004). 10. Minamimoto, T. & Kimura, M. J. Neurophysiol. 87, 3090–3101 (2002). 11. Matsumoto, N., Minamimoto, T., Graybiel, A.M. & Kimura, M. J. Neurophysiol. 85, 960–976 (2001). 12. Platt, M.L. & Glimcher, P.W. Nature 400, 233–238 (1999). 13. Shadlen, M.N. & Newsome, W.T. J. Neurophysiol. 86, 1916–1936 (2001). 14. Lauwereyns, J., Watanabe, K., Coe, B. & Hikosaka, O. Nature 418, 413–417 (2002). 15. Schall, J.D., Stuphorn, V. & Brown, J.W. Neuron 36, 309–322 (2002).
VOLUME 8 | NUMBER 8 | AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S
Persistent hippocampal CA1 LTP in mice lacking the C-terminal PDZ ligand of GluR1 Chong-Hyun Kim1, Kogo Takamiya1, Ronald S Petralia2, Rita Sattler1, Sandy Yu1, Weiguo Zhou3, Robert Kalb3, Robert Wenthold2 & Richard Huganir1 The C-terminal PDZ ligand of the AMPA receptor GluR1 subunit may be important for expression of CA1 hippocampal long-term potentiation. To test this directly in vivo, we generated a knock-in mouse lacking the last seven residues of GluR1, comprising the PDZ ligand. This deletion did not affect basal GluR1 synaptic localization, basal synaptic transmission, long-term potentiation or long-term depression, indicating that the ligand is not required for CA1 hippocampal synaptic plasticity. Recent studies have suggested that the regulated exocytosis and endocytosis of vesicles containing AMPA receptors or the lateral movement of AMPA receptors along the plasma membrane could be an important mechanism regulating the level of synaptic AMPA receptors after the induction of long-term potentiation (LTP) and long-term depression (LTD)1. A variety of data have indicated that
Figure 1 Generation of GluR1 mutant mice lacking the last seven amino acids comprising the PDZ ligand. (a) Schematic representation of GluR1 protein and C-terminal amino acid sequence after modification of stop codon. (b) Immunoblot analysis of wild-type (+/+), heterozygous mutant (+/) and homozygous mutant (/) mice. GluR1 with the seven-amino-acid deletion can be detected by an antibody raised against the last 80 amino acids of the GluR1 C terminus (a GluR1-C80) but not by an antibody against the last 20 amino acids of the GluR1 C terminus (a GluR1-C20). aSAP97N, antibody against the N terminus of SAP97; aGluR2/3, antibody against GluR2/3. (c) Co-immunoprecipitation of GluR1 and SAP97 in vivo. Membrane fractions of brain homogenate of wild-type (WT), homozygous GluR1D7 mutant (D7) and GluR1 knockout mice (KO; Supplementary Fig. 4) were solubilized and immunoprecipitated with antibody to SAP97 (a SAP97) and detected with an antibody to the GluR1 N terminus (a GluR1N). Lower panel shows immunoprecipitated SAP97. (d) Gross hippocampal anatomy and localization of GluR1 immunoreactivity in wild-type and GluR1D7 mutant mice. Left, Nissl staining; right, GluR1 N-terminal immunocytochemistry. (e) Immunoelectron microscopic labeling of GluR1 receptor localization in wild-type and GluR1D7 mutant mice. ‘Pre’ indicates presynaptic terminal. Scale bar, 200 nm. All experiments were done in accordance with the policies of the Animal Care and Use Committee at the Johns Hopkins School of Medicine.
AMPA receptor interactions with PDZ domain–containing proteins may be an important regulatory step during these cellular processes1–7. A recent study has reported that a single amino acid mutation (T887A) within the PDZ ligand of GluR1 blocks the synaptic delivery of virally overexpressed GluR1 during LTP induction in CA1 region of organotypic hippocampal slices8. These results indicate a critical role of the GluR1 PDZ ligand in the membrane insertion of AMPA receptors during activity-dependent processes. To test the role of the GluR1 PDZ ligand in the synaptic targeting of GluR1 and synaptic plasticity in vivo directly, we generated a knock-in mouse (GluR1D7) that lacks the last seven amino acids of GluR1, which constitute the PDZ ligand (Fig. 1a and Supplementary Fig. 1 online). The GluR1D7 mutant mice are viable, breed normally and have no obvious behavioral or developmental phenotypes. We first examined whether the GluR1 PDZ ligand deletion mutation affected the expression of GluR1, by western blotting using an N-terminal GluR1 antibody. The expression of the mutated GluR1 was normal compared to that in wild-type mice (Fig. 1b), as was the expression of GluR2 and GluR3. Previous studies have shown that GluR1 interacts with the PDZ domain–containing synapse associated protein 97 (SAP97) through its C-terminal PDZ ligand9–11. We therefore measured the expression of SAP97 in the GluR1D7 mice and found
a
b
GluR1
Wild-type GluR1– H S S G M P L G A T G L Stop GluR1 ∆7– H S S G M Stop
c
Input
IP:α SAP97
WT ∆7 KO
WT ∆7 KO
α GluR1-C80
α GluR1-C20
(+/+) (+/–) (–/–)
(+/+) (+/–) (–/–)
GluR1
GluR1
α GluR1N
α SAP97N
α GluR2/3
(+/+) (+/–) (–/–)
(+/+) (+/–) (–/–)
SAP97N
GluR2/3
α SAP97N
d
Nissl stain
α GluR1-N
e
(+/+)
(+/+)
(–/–)
(–/–)
1Department
of Neuroscience and Howard Hughes Medical Institute, The Johns Hopkins University, Baltimore, Maryland 21205, USA. 2Laboratory of Neurochemistry, National Institute on Deafness and Other Communication Disorders, National Institute of Health, Bethesda, Maryland 20892, USA. 3Children’s Hospital of Philadelphia, Joseph Strokes, Jr. Research Institute, ARC 814, 3615 Civic Center Blvd., Philadelphia, Pennsylvania, 19104, USA. Correspondence should be addressed to R.H. (
[email protected]). Published online 10 July 2005; doi:10.1038/nn1432
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
985
B R I E F C O M M U N I C AT I O N S
b
c
6
(+/+) (–/–)
(+/+)
3
1 0
(+/+)
1 0
(+/+) (–/–)
4
2
2 1.5 (+/+) (–/–)
2
1.0 1
0
(+/+) (–/–)
1
1
2 0
20
(+/+) (–/–)
40
60
80
100
120
Time (min)
e
f Normalized EPSC amplitude
d
6
Normalized EPSC amplitude
(–/–)
Decay time constant (ms)
2
(–/–)
2.0 2
(–/–)
2
0
5 0
3
1
1.50 (+/+) Normalized fEPSP slope
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
(–/–)
4
Rise time (10–90%, ms)
Slope (1,000 s−1)
5
10
Normalized fEPSP slope
Amplitude (pA)
(+/+)
(+/+)
Frequency (Hz)
a
(+/+) (–/–)
1.25
(–/–)
2
2 1
1
2
1
1.00
0.75
2
4
1 1 2
2 2
2
1 0.50
0
20
40 Time (min)
60
0
0
20
1 1.0
2
0.5
1
40
60
0
Time (min)
20 Time (min)
2 1 40
Figure 2 Basal and activity-dependent synaptic properties of CA1 pyramidal neurons from GluR1D7 mice. (a) Left, sample fEPSP traces evoked with incremental stimulus strength. Scale: 200 mV, 10 ms. Right, plot of input-output slopes from slices from both wild-type (+/+) and mutant (/) mice. Two-tailed t-test (a ¼ 0.05) showed that slopes from the mutant mice are not significantly different from those from wild-type mice (wild-type, 1.98 7 0.17; mutant, 2.46 7 0.21, P ¼ 0.06). Open squares indicate mean values and error bars s.e.m. (b) Analysis of mEPSC from 3-month-old mice shows no significant difference in mEPSC amplitude, mEPSC frequency, rise time (10–90%) or decay time constant between wild-type and mutant mice. Sample traces are shown at left. Scale: 10 pA, 125 ms. (c) Single theta burst–induced LTP shows no significant difference 60 min after LTP induction between wild-type and mutant mice (3 months old). Arrow indicates the time when single theta burst was applied. Inset, sample average traces recorded at time 1 and 2; scale: 200 mV, 10 ms. (d) Low-frequency stimulus (LFS, 1 Hz, 900 pulses)-induced LTD shows normal depression 30 min after LFS in mutant mice. Insets, sample average traces recorded at times 1 and 2 (scale: 300 mV, 10 ms). Gray box indicates the period when LFS was applied. (e) Pairing-induced whole-cell LTP shows similar potentiation 40 min after pairing between wild-type and mutant mice. Arrow indicates the time when pairing stimuli were applied. Filled symbols: LTP path; open symbols: non-LTP path. Circles: wild-type mice; triangles: mutant mice. Insets, sample average traces recorded at time 1 and 2 from mutant mice. Left traces are from LTP path and right traces are from non-LTP path (scale: 200 mA, 10 ms). (f) Pairing-induced whole-cell LTD also shows no significant difference in depression 30 min after pairing between wild-type and mutant mice (3 to 6 weeks old). Gray box indicates the period when pairing stimuli were applied. Filled symbols: LTD path; open symbols: non-LTD path. Circles: wild-type mice; triangles: mutant mice. Insets, sample average traces recorded at time 1 and 2 from mutant mice. Left traces are from LTD path and right traces are from non-LTD path (scale: 100 mA, 10 ms).
that it was similar to that in wild-type mice (Fig. 1b). To examine the interaction of GluR1 and SAP97 in wild-type and GluR1D7 mutant mice, we carried out co-immunoprecipitation experiments, using GluR1 knockout mouse brain samples as a negative control. The interaction of GluR1 with SAP97 in vivo was abolished in GluR1D7 mutant mice (Fig. 1c). These results strongly indicate that the GluR1D7 mutation severely diminishes GluR1 binding to PDZ domains in mutant mice. Next, we examined the distribution of GluR1 in hippocampal sections by immunostaining using an antibody against the N terminus of GluR1 (Fig. 1d). Mutant mice show a pattern of immunostaining similar to that in wild-type mice. To analyze the localization of the mutant GluR1 subunit at synapses, we used immunogold electron microscopic methods with two different antibodies against the GluR1 N terminus (Fig. 1e). Three independent analyses, each with two pairs of animals, showed no significant difference in the distribution of GluR1 in wild-type and homozygous mutant mice (GluR1D7), either in the average number of gold particles per synapse (wild-type, 0.41 7 0.028, n ¼ 846 synapses; mutant, 0.37 7 0.025, n ¼ 846 synapses; two-tailed t-test, P ¼ 0.352) or in the average number of gold particles
986
per labeled synapse (wild-type, 1.47 7 0.062, n ¼ 233 labeled synapses; mutant, 1.44 7 0.052, n ¼ 217 labeled synapses; P ¼ 0.714; Fig. 1e). This suggested that there are no major changes in the GluR1 synaptic trafficking in the mutant mice. We also analyzed the extrasynaptic distribution of GluR1 and found no obvious difference in the number of gold particles per postsynaptic process between wild-type and mutant mice (wild-type, 0.11 7 0.03, total 983 counts; mutant, 0.14 7 0.03, total 1,120 counts; P ¼ 0.46). To check the basal synaptic transmission properties, we first examined the evoked synaptic input-output relationship in acute hippocampal slices. To do this, we first plotted the rising slope of field excitatory postsynaptic potential (fEPSP) against the amplitude of presynaptic fiber volley potential with ten incremental input strengths per slice (not shown). We then calculated the slope of the plot (fEPSP slope vs. fiber volley potential amplitude) of each slice by linear regression (wild-type, n ¼ 28; mutant, n ¼ 26 slices; Supplementary Methods and Fig. 2a). The result showed that mutant mice have a postsynaptic response range similar to that in wild-type mice, indicating that there was no significant difference in synaptic input-output relationship. Next, to test the role of GluR1 PDZ ligand on the basal
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S synaptic AMPA receptor (AMPAR) trafficking, we measured AMPARmediated miniature excitatory postsynaptic current (mEPSC) in the presence of 1 mM tetrodotoxin and 100 mM AP5 (Fig. 2b). The results showed no significant difference in the amplitude (in pA: wild-type, 10.42 7 0.28; mutant, 9.72 7 0.22, P ¼ 0.06), frequency (in Hz: wild-type, 2.99 7 0.19; mutant, 3.02 7 0.19, P ¼ 0.89), rise time (10–90% of peak amplitude, in ms: wild-type, 2.11 7 0.08; mutant, 2.21 7 0.07, P ¼ 0.34) or decay time constant (in ms: wild-type, 5.89 7 0.13; mutant, 5.90 7 0.11, P ¼ 0.97) of mEPSC between wild-type (n ¼ 30) and mutant mice (n ¼ 26), suggesting no major perturbation in basal synaptic AMPAR trafficking in CA1 pyramidal neurons of GluR1D7 mutant mice. This result is consistent with the immunoelectron microscopy data that showed no changes in the number of synaptic GluR1 in the mutant mice. Furthermore, the whole-cell current and voltage relationship of both AMPAR- and NMDA receptor (NMDAR)-mediated currents in the mutant mice were similar to those in wild-type mice (Supplementary Fig. 2). These results suggest that removal of GluR1 PDZ ligand does not affect the basal AMPAR and NMDAR trafficking at synapses. To test whether the mutation had any effect on presynaptic vesicle release properties, we measured paired-pulse facilitation, but we did not find any significant change in mutant mice (Supplementary Fig. 2). To investigate the role of the GluR1 PDZ ligand in synaptic plasticity, we first examined LTP induced by single theta burst in the CA1 dendritic region of hippocampal slices (Fig. 2c). We observed LTP in slices from the GluR1D7 mutant mice, and we did not find any significant change in the magnitude of LTP for up to 2 h of recording as compared with wild-type slices (wild-type, 131 7 8%, n ¼ 14; mutant, 132 7 4%, n ¼ 12, measured 60 minute after theta burst and normalized to the baseline, P ¼ 0.59). Although not significant (P ¼ 0.251, 2 h after LTP induction), there was a slight difference in the apparent decay of LTP in the mutant mice, suggesting that there may be a small difference in the late phase of LTP in the GluR1D7 mutant mice. Induction of LTD (induced by 1 Hz, 900 pulses) in the mutant mice was also similar to induction in wild-type mice (Fig. 2d, wild-type, 83 7 3%, n ¼ 18; mutant, 87 7 5%, n ¼ 13, 30 min after LFS, P ¼ 0.11). To further confirm the field LTP data, we induced whole-cell LTP by a pairing protocol from CA1 pyramidal neurons. We found no significant difference in the magnitude of LTP between the wild type and mutants in 3-week-old to 6-month-old mice. Figure 2e shows the LTP data from 6-month-old male mouse pairs (wild-type, 417 7 71%, n ¼ 11; knockout, 378 7 36%, n ¼ 9, 40 min after wholecell LTP, P ¼ 0.68). The pairing-induced LTP was NMDAR-dependent and CaMKII-dependent, as AP5 or CaMKII inhibitory peptide could block LTP induction in both wild-type and mutant mice (Supplementary Fig. 3). We also tested pairing-induced LTD and found no significant difference 30 min after pairing (Fig. 2f, wild-type, 81 7 4%, n ¼ 11; mutant, 76 7 7%, n ¼ 11, P ¼ 0.22). De-depression after LTD induction was also induced normally compared to wild-type mice (Supplementary Fig. 2). These results show that removal of the GluR1 PDZ ligand has no obvious effect on the induction of activitydependent synaptic plasticity such as LTP and LTD.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
In another approach, we tried to acutely inhibit the function of the endogenous GluR1 PDZ ligand in wild-type mice by perfusing a peptide corresponding to the GluR1 PDZ ligand (15 amino acids, 200 mM) into the cell and then waiting 30 min before LTP induction. The results show that postsynaptic perfusion of the GluR1 PDZ ligand peptide had no effect on the induction of pairing-induced LTP in rat hippocampal CA1 pyramidal neurons (Supplementary Fig. 3). This data is in contrast with a previous report that showed that overexpression of GFP-tagged constructs containing the whole C-terminal domain of GluR1 (80 amino acids) blocks LTP induction in CA1 pyramidal neurons in slice culture12. However, the experimental conditions for this study are quite different from the peptide perfusion experiments: the whole C terminus, which contains many other protein-protein interaction sites, was overexpressed in the previous experiments, and the GFP-tagged C-terminal domain was expressed for 24 h, whereas our peptide perfusion experiments were acute experiments. Taken together, these results indicate that NMDAR-dependent LTP can be induced in the absence of the GluR1 PDZ ligand in vivo. This is in contrast to previous results using overexpression of GluR1 PDZ ligand point mutants (T887A) in hippocampal slice culture, which implicate the GluR1 PDZ ligand as a critical factor for CA1 LTP expression8. The reason for the discrepancy between these studies is not clear. It is possible that the point mutation of the GluR1 PDZ ligand has different functional effects compared with a complete deletion of the PDZ ligand, or alternatively, the properties of the trafficking of overexpressed GluR1 in organotypic cultures may be different from those seen in vivo. However, our studies clearly show that deletion of the GluR1 PDZ ligand has little effect on activity-dependent synaptic plasticity and basal synaptic targeting of GluR1 in vivo. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS This work was supported by US National Institutes of Health grant NS36715 and the Howard Hughes Medical Institute. COMPETING INTERESTS STATEMENT The authors declare competing financial interests (see the Nature Neuroscience website for details). Received 1 February; accepted 24 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. 2. 3. 4. 5. 6.
Song, I. & Huganir, R.L. Trends Neurosci. 25, 578–588 (2002). Kim, E. & Sheng, M. Nat. Rev. Neurosci. 5, 771–781 (2004). Bredt, D.S. & Nicoll, R.A. Neuron 40, 361–379 (2003). Malinow, R. & Malenka, R.C. Annu. Rev. Neurosci. 25, 103–126 (2002). Sheng, M. & Lee, S.H. Cell 105, 825–828 (2001). Carroll, R.C., Beattie, E.C., von Zastrow, M. & Malenka, R.C. Nat. Rev. Neurosci. 2, 315–324 (2001). 7. Turrigiano, G.G. Neuron 26, 5–8 (2000). 8. Hayashi, Y. et al. Science 287, 2262–2267 (2000). 9. Leonard, A.S., Davare, M.A., Horne, M.C., Garner, C.C. & Hell, J.W. J. Biol. Chem. 273, 19518–19524 (1998). 10. Colledge, M. et al. Neuron 27, 107–119 (2000). 11. Cai, C., Colman, S.K., Miemi, K. & Keinanen, K. J. Biol. Chem. 277, 31484–31490 (2002). 12. Shi, S., Hayashi, Y., Esteban, J.A. & Malinow, R. Cell 105, 331–343 (2001).
987
Cortical calcium waves in resting newborn mice Helmuth Adelsberger1,2, Olga Garaschuk1,2 & Arthur Konnerth1 Using a new optical fiber–based approach, we demonstrate the presence of recurrent Ca21 transients in cortical neurons of non-anesthetized newborn mice in vivo. These Ca21 waves reflect the correlated activity of thousands of cells and were detected only in resting, but not in moving pups. Our results suggest that Ca21-dependent cortical maturation occurs predominantly during the intermittent sleep-like resting periods that are characteristic for the first days of postnatal life. The first two weeks after birth represent a period of decisive changes in the organization of the rodent cortex. The total mass of the brain tissue increases fourfold1, the density of cortical synapses increases 30-fold1 and cortical columns start to form2. During these early stages of development, in which cortical activation through extrinsic (sensory) stimuli is very restricted, various forms of intrinsic firing patterns guide the wiring of the neural networks (reviewed in refs. 2,3). Several in vitro studies, including pioneering work performed in the spinal cord4 and in the retina5, have indicated that such patterned early forms of network activity are associated with changes in neuronal intracellular Ca2+ concentration3,6,7. Such Ca2+ signals regulate, at least under in vitro conditions, various developmental processes including gene expression8, neuronal growth and differentiation9, neurite outgrowth9 and synapse formation3. In the neocortex, the most prominent type of patterned spontaneous activity are the so-called early network oscillations (ENOs)6. To monitor intracellular Ca2+ signals in the neonatal mouse cortex in vivo, we first stained a column-like region of the neocortex (of about 400–600 mm diameter) with the fluorescent Ca2+ indicator dye Oregon green 488 BAPTA-1 using the multi-cell bolus loading method10. For both excitation of the fluorescent dye and collection of the emitted light
we used a single optical fiber (+ ¼ 200 mm, Fig. 1a–c) implanted in the stained cortical region (see Supplementary Methods online), usually at a depth of 300–400 mm. Recordings from the temporal cortex of non-anesthetized newborn mice showed spontaneous calcium transients (Fig. 1d, upper panel). These periodically recurring transients reflect the correlated activity of thousands of neurons (see below). A similar pattern of activity, albeit with smaller amplitudes, was detected when placing the tip of the fiber just on top of the cortical surface (Fig. 1d inset), indicating that damage through fiber insertion does not contribute to or induce the activity. At the end of the in vivo experiments, the mice were decapitated, the brains removed and cortical slices including the stained cortical regions prepared using standard methods6. Without additional staining, slices were used for two-photon calcium imaging experiments (Fig. 1c). We found, as in vivo, periodically recurring spontaneous Ca2+ transients (Fig. 1d, lower panel). These were strongly reminiscent of the ENOs described previously in cortical slices from newborn rats6 and mice7.
a
b
PMT
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S
Optical fiber Skull
Em. filter
Dental cement
Ex. filter ND filter Shutter
Cortex
Beamsplitter Argon-laser
Stained region
IIIuminated area
Collimator Optical fiber
c
d TE
Surface
In vivo
500 µm
0.01 ∆F/F
Inserted (300 µm)
10 s
PA
EN
0.02 ∆F/F
10 s Brain removed and sliced
Slice
Figure 1 In vivo recordings of spontaneous Ca2+ waves in the neonatal cortex. (a) The experimental setup. (b) Schematic diagram of the implanted optical fiber. (c) Top: transmitted light image of a slice obtained from the in vivo stained brain; entorhinal (EN), temporal (TE) and parietal (PA) cortex. Bottom and inset: two-photon images of the stained area. (d) In vivo optical fiber recordings (top) and two-photon slice recordings (bottom) of spontaneous Ca2+ waves from the same in vivo stained brain. Inset at top: in vivo recordings with optical fiber placed on the pial surface. (e) Combined transmitted light and fluorescence image of a cortical slice. The dashed circle delimits the region of interest from which fluorescence signals shown in f (top) were collected. (f) Ca2+ waves recorded simultaneously with the CCD camera and the optical fiber.
0.2 ∆F/F 200 µm 10 s
e
f
Optical fiber
Slice
Camera 0.04 ∆F/F Optical fiber 400 µm
10 s
1Physiologisches
Institut, Ludwig-Maximilians Universita¨t Mu¨nchen, Pettenkoferstr. 12, 80336 Mu¨nchen, Germany. 2These authors contributed equally to this work. Correspondence should be addressed to A.K. (
[email protected]).
Published online 10 July 2005; doi:10.1038/nn1502
988
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
B R I E F C O M M U N I C AT I O N S
a
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
0.01 ∆F/F
b
Slice 0.01 ∆F/F
Average
Average τ = 905 ms
τ = 946 ms 1s
1s
d
15 10
n = 111 events
5
20 Number of waves
In vivo Slice
20 Number of waves
c
Ca2+
0
2 1 4 3 Decay time constant (s)
10
n = 84 events
5
5
0
20
40 60 Interval (s)
80
20 Number of waves
40 30 20
n = 107 events
10 0
15 10
n = 84 events
5 0
0
2 1 4 3 Decay time constant (s)
2.5
n = 15
0
5
f Mean interval (s)
e
15
0
0
Number of waves
To determine how many cells contributed to the signals, we made simultaneous recordings with a CCD (charge-coupled device) camera and the optical fiber (Fig. 1e,f). The recordings, obtained by delivering the excitation light through the fiber, demonstrated that both systems reported highly similar Ca2+ signals. The analysis of the imaging data (Supplementary Methods) suggested that individual transients recorded through the fiber were the result of the correlated activity of thousands of cells. Asynchronous Ca2+ transients occurring in single cells did not produce detectable signals in the fiber recordings (data not shown). The Ca2+ waves had variable amplitudes (Figs. 1d and 2a,b). Highmagnification (4120) two-photon imaging in slices indicated that similar proportions of the cortical cells contributed to the large and smaller waves (on average, 85% of all imaged cells, n ¼ 142 Ca2+ waves, 862 cells, 11 mice). The smaller size of some waves was due to a general reduction in the amplitudes of the active cells contributing to that wave. Whereas 94.9 7 2.1% of all neurons participated in the Ca2+ waves, the astrocytes did not (Supplementary Fig. 1). The time-course analysis showed that the Ca2+ waves had rather fast rise times (559 7 51 ms) and decay time constants in the range of 1–4 s (Fig. 2a–e). On average, the in vivo Ca2+ waves lasted for 3.8 7 0.1 s (481 waves, 11 mice) and were markedly similar to their in vitro counterparts (Fig. 2b–e). In 9/15 experiments conducted with implanted (n ¼ 11) as well as surfaceattached (n ¼ 4) optical fibers there was no significant difference between the decay time constants of the Ca2+ waves and their frequency in vivo and in vitro (Fig. 2e,f). The similarity between Ca2+ waves recorded in slices and those found in vivo suggests that even reduced cortical networks can sustain this global activity. The surgical separation of the cortex from the thalamus in slice recordings did not alter the Ca2+ waves significantly (wave frequency after separation was 107.6 7 4.6% of the control frequency, n ¼ 4), indicating that they result from intrinsic cortical activity. We first tried to use two-photon Ca2+ imaging to analyze Ca2+ waves in vivo (Supplementary Fig. 2). However, Ca2+ waves were never detected under urethane (n ¼ 8 mice) or isoflurane (n ¼ 5 mice) anesthesia. The absence of Ca2+ waves in anesthetized mice was confirmed in several in vivo optical fiber measurements (n ¼ 20 mice). However, as soon as the action of the anesthetics had vanished, spontaneous Ca2+ transients appeared. Furthermore, in vivo Ca2+ waves were blocked completely and reversibly by isoflurane (Supplementary Fig. 2) and irreversibly by urethane. Notably, correlated electrical activity persists in the developing hippocampus11 (Supplementary Note) and retina12 in the presence of anesthetics. To elucidate the relation between ENOs and animal behavior, simultaneous analyses of Ca2+ waves and motion patterns were performed in vivo (Fig. 3). After recovery from anesthesia, mouse pups showed a behavior that is typical for newborn rodents13,14, namely a frequent alternation between resting and motion periods. Overall they spent most of the time in a state with virtually no detectable motion (Fig. 3a,d). The relative amount of time that a fiber-implanted pup spent in the resting state was not significantly
In vivo
Mean decay time constant (s)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Figure 2 Comparison of Ca2+ waves recorded in vivo and in brain slices. (a,b) Superposition (left) and average (right) of ten consecutive Ca2+ transients recorded in vivo (a) and in the slice (b). Solid black lines represent mono-exponential fits. (c,d) Distribution of decay time constants (c) and intervals of Ca2+ waves (d) in the same experiment in vivo (top) and in the slice (bottom). Bin width of histograms 0.2 s in c and 4 s in d. (e,f) Summary of mean 7 s.e.m. decay time constants (e) and intervals (f) of Ca2+ waves (n ¼ 15 experiments). See Supplementary Note for pharmacological profile of Ca2+ waves.
2.0 1.5 1.0 0.5 0.0 In vivo
Slice
20
40 60 Interval (s)
35 30 25 20 15 10 5 0
80
n = 15
In vivo
Slice
different from that of its non-implanted littermate (Fig. 3e). The motion periods were characterized by fast, irregular displacement signals extracted from digitized video clips (Fig. 3a,b, upper right). Notably, the simultaneous Ca2+ recordings showed a pronounced wave activity during the resting period and a very low activity level during the motion periods (Student’s t-test, P o 0.05; Fig. 3b,f). Similar results were obtained when the neck muscle activity, recorded with an intramuscular electromyogram (EMG), and cortical Ca2+ signals were monitored simultaneously (Fig. 3c). Furthermore, there was a silent post-motion period that was markedly longer than the corresponding mean inter-wave interval at rest (202 7 28%, P o 0.01; n ¼ 7 mice, Fig. 3g). A cross-correlation analysis of the digitized Ca2+ waves and the motion (Fig. 3h) or EMG (Fig. 3i) traces showed no correlation between ENOs and motion episodes. Moreover, the mean cross-correlograms had minima around zero, indicating that the probability of a Ca2+ wave occurring is decreased during motion periods (Fig. 3h,i, inset). Taken together, the data suggest that in vivo Ca2+ waves represent an endogenous brain rhythm, expressed primarily during sleep-like resting states and vanishing or becoming inhibited during the animal’s movements (Supplementary Note). In adults, the sleep-associated slow wave activity is thought to underlie neuronal plasticity and consolidation of memory traces acquired during wakefulness15. In the immature brain, large-scale Ca2+ waves are present during a highly plastic time period in the development of the brain, associated with prominent synaptogenesis and an extensive growth of axons and dendrites1,3. Many of these processes are critically controlled by intracellular Ca2+ signals3,9. As mice (ref. 14 and this study) and rats13 spend 60–80% of their neonatal life in a sleep-like resting state, our results suggest that Ca2+ dependent neuronal maturation in the cortex is driven primarily by ENOassociated neuronal Ca2+ waves.
989
B R I E F C O M M U N I C AT I O N S
1 min Motion sensor
g
100 80 60 40 20
*
250 200 150 100 50 0
0
e
10% ∆L
Displacement
0.01 ∆F/F
Ca
80 60 40 20 Po on st tro -a l ne s + th. Fi be r
0
15
4
10
2 0 –40
0 –300 –150
0.01 ∆F/F
2 1 0 M
ot
R
5s
io
es
t
Ca
3
40
0 150 Time (s)
300
Cross-correlogram ENOs-EMG (av. n = 4)
i
*
4
Number of events
f
n
100 µV
EMG
Frequency (waves/min)
c
0
5
C
5s
Cross-correlogram ENOs-motion (av. n = 7)
h
100
Number of events
b
Relative resting time (%)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
M
.s
en
so r EM G
R es P t m ost ot io n
Time
d
Resting period Motion period
Relative ENO interval (%)
Ca
Relative resting time (%)
a
15 10
4 2 0 –40
0
40
5 0 –300 –150
0 150 Time (s)
300
Figure 3 Spontaneous Ca2+ waves in behaving mice. (a) Experimental arrangement. Alternation of motion and resting periods in a newborn mouse. (b) Measurement of mouse displacement and cortical Ca2+ transients (bottom) at rest (left) and during motion (right). (c) Simultaneous nuchal EMG and optical fiber–based Ca2+ recordings (bottom) at rest (left) and during motion (right). (d) Summary resting time determined with motion analysis (n ¼ 7, left) and EMG (n ¼ 5). (e) Distribution of resting periods in control animals, in animals anesthetized for 1 h (recordings taken 30 min after anesthesia (post-anesth.)) and in fiber-implanted mouse pups (n ¼ 5, 5 and 7 mice, respectively). (f) Mean frequency of Ca2+ waves at rest and during motion (n ¼ 6 mice) (g) Interval between the end of the motion period and the first Ca2+ wave (post-motion) normalized to the corresponding mean interval at rest (n ¼ 7 mice). *, P o 0.05 in f; *, P o 0.01 in g (Student’s t-test). (h,i) Average cross-correlograms between digitized ENOs and motion traces (h, n ¼ 7) or ENOs and EMG recordings (i, n ¼ 4). Insets: higher magnification of central portion.
Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank F. Rucker and M. Noll-Hussong for technical help and J. Davis for comments on the manuscript. The work was supported by the Deutsche Forschungsgemeinschaft. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 2 June; accepted 23 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Uylings, H.B.M., Van Eden, C.G., Parnavelas, J.G. & Kalsbeek, A. in The Cerebral Cortex of the Rat (eds. Kolb, B. & Tees, R.C.) 36–76 (MIT Press, Cambridge, Massachusetts, 1990).
990
2. 3. 4. 5.
Feller, M.B. & Scanziani, M. Curr. Opin. Neurobiol. 15, 94–100 (2005). Katz, L.C. & Shatz, C.J. Science 274, 1133–1138 (1996). Gu, X., Olson, E.C. & Spitzer, N.C. J. Neurosci. 14, 6325–6335 (1994). Wong, R.O., Chernjavsky, A., Smith, S.J. & Shatz, C.J. Nature 374, 716–718 (1995). 6. Garaschuk, O., Linn, J., Eilers, J. & Konnerth, A. Nat. Neurosci. 3, 452–459 (2000). 7. Corlew, R., Bosma, M.M. & Moody, W.J. J. Physiol. (Lond.) 560, 377–390 (2004). 8. Buonanno, A. & Fields, R.D. Curr. Opin. Neurobiol. 9, 110–120 (1999). 9. Spitzer, N.C., Root, C.M. & Borodinsky, L.N. Trends Neurosci. 27, 415–421 (2004). 10. Stosiek, C., Garaschuk, O., Holthoff, K. & Konnerth, A. Proc. Natl. Acad. Sci. USA 100, 7319–7324 (2003). 11. Leinekugel, X. et al. Science 296, 2049–2052 (2002). 12. Maffei, L. & Galli-Resta, L. Proc. Natl. Acad. Sci. USA 87, 2861–2864 (1990). 13. Jouvet-Mounier, D., Astic, L. & Lacote, D. Dev. Psychobiol. 2, 216–239 (1970). 14. Daszuta, A. & Gambarelli, F. Brain Res. 354, 39–47 (1985). 15. Steriade, M. & Timofeev, I. Neuron 37, 563–576 (2003).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
Andreas Meyer-Lindenberg1–3, Ahmad R Hariri3,6, Karen E Munoz2,3, Carolyn B Mervis4, Venkata S Mattay2,3, Colleen A Morris5 & Karen Faith Berman1,3 Williams-Beuren syndrome (WBS), caused by a microdeletion of approximately 21 genes on chromosome 7q11.23, is characterized by unique hypersociability combined with increased non-social anxiety. Using functional neuroimaging, we found reduced amygdala activation in individuals with WBS for threatening faces but increased activation for threatening scenes, relative to matched normal controls. Activation and interactions of prefrontal regions linked to amygdala, especially orbitofrontal cortex, were abnormal, suggesting a genetically controlled neural circuitry for regulating human social behavior. Social neuroscience continues to grow in importance1, but little is known about specific genetic factors influencing human social cognition, although social skills are highly heritable and critical for survival. Great interest has therefore been directed at a unique social-behavioral phenotype, high sociability2,3 and empathy, found in individuals with WBS, who eagerly, often impulsively, engage in social interaction, even with strangers4. Associated with this remarkable persistent hypersociability is an undercurrent of anxiety3: individuals with WBS show extremely high rates of excessive worrying (57%; ref. 4) and specific phobia (symptoms in 96%; ref. 4). The neural mechanisms underlying this social phenotype remained unknown, partly because of the intellectual impairment usually associated with the syndrome, which limits comparison to a normal control group. We addressed this problem by examining a highly select group of normal-intelligence participants with WBS5, reasoning that abnormalities found even there would be characteristic of the syndrome and reflect its genetic substrate. In addition to the amygdala’s role in reward, its response and regulation are believed to be central to socially protective neural processing through the monitoring of environmental events such as danger1. Lesions of the amygdala and linked cortical regions, such as orbitofrontal cortex (OFC), impair social function6 and can cause disinhibition7. Of great importance to the WBS phenotype, the effects of neonatal amygdala lesions in nonhuman primates suggest dissociable systems for social and non-social fear6. In the present study, we used two tasks requiring processing of threatening visual stimuli
previously established to reliably engage amygdala8. The first task required matching one of two simultaneously presented faces with a different target face of the same emotion (angry or afraid)8. In the other task, participants matched one of two simultaneously presented fearful/threatening scenes with an identical target9. As a control task, participants matched simple shapes (circles or ellipses). Thirteen participants with WBS and controls matched for age, sex and IQ participated in this study after giving written informed consent (see Supplementary Methods). Performance during the matching tasks (but not the control tasks) did not differ between groups (Supplementary Table 1) and showed that the faces task (where all three identities differed) was more difficult for both groups. In normal controls, ventral amygdala was more highly activated for faces than for scenes, as shown previously8. The opposite pattern (scenes 4 faces) was observed in this region in individuals with WBS. Single-subject analyses in native space confirmed these findings (Supplementary Figs. 1,2). Controls showed significantly greater amygdala activation for faces than did individuals with WBS, whereas the response was significantly higher for scenes in individuals with WBS than in controls (Fig. 1 and Supplementary Table 2). Subsequent analyses focused on right amygdala, where differential effects were more pronounced. ANOVA of differential BOLD signal change (Fig. 2) confirmed a significant group-by-task interaction (F1,46 ¼ 5.7, P o 0.03). Overall amygdala BOLD signal change was comparable for both groups (Fig. 2b). Normal controls
WBS
Diff
Faces
Neural correlates of genetically abnormal social cognition in Williams syndrome
Scenes
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S
Figure 1 Amygdala activation by task. Significant activations (P o 0.05, corrected for multiple comparisons in amygdala region of interest) rendered on normal coronal MRI at 71 mm to the anterior commissure (left ¼ left) for face (top) and scene (bottom) stimuli. First column: normal controls; second column: participants with WBS; third column: significant differences between groups (blue: normal controls4WBS, red: WBS4normal controls). See Supplementary Table 2 for detailed statistical information.
1Section
on Integrative Neuroimaging and 2Neuroimaging Core Facility of the 3Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA. 4Neurodevelopmental Sciences Laboratory, Department of Psychological and Brain Sciences, University of Louisville, Louisville, Kentucky 40292, USA. 5Department of Pediatrics, University of Nevada School of Medicine, Las Vegas, Nevada 89102, USA. 6Present address: Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania 15213, USA. Correspondence should be addressed to A.M.L. (
[email protected]). Published online 10 July 2005; doi:10.1038/nn1494
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
991
B R I E F C O M M U N I C AT I O N S
d
Right amygdala activation
c
0.2
0.1
0.0
Faces
e
Right mPFC activation
f DLPFC
Normal controls Williams syndrome
0.46
–0.13
0.2 mPFC
OFC
–0.34
0.1
–0.36 AMY
0.0
Scenes
0.3
0.3
Faces
Scenes
g
0.3
Right DLPFC activation
Right OFC activation Percentage change in BOLD
DLPFC Percentage change in BOLD
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
0.3
Percentage change in BOLD
b Percentage change in BOLD
a
0.2
0.1
0.0
0.2
0.28
0.1 mPFC
OFC 0.0 –0.13 –0.1
AMY
–0.2 Faces
Scenes
Faces
Scenes
Figure 2 Differential activation and interaction in a network regulating amygdala. (a) Group difference in reactivity to face versus scene matching, rendered on standard brain surface at P o 0.05, corrected for multiple comparisons. (b–e) Estimated percentage change in BOLD response (mean 7 s.e.m.) at maximum coordinates (Supplementary Tables 2,3) in right amygdala (b), medial prefrontal cortex (c; F1,46 ¼ 17.4, P o 0.0002), dorsolateral prefrontal cortex (d; F1,46 ¼ 13.0, P o 0.001) and orbitofrontal cortex (e; F1,46 ¼ 10.1, P o 0.002). (f–g) Best-fitting path models for normal controls (f) and participants with WBS (g). Positive paths: filled arrows; negative paths: open arrows. AMY, amygdala.
Amygdala reactivity to threatening faces was significantly diminished in individuals with WBS. This was not likely to be attributable to abnormal visual processing because, as previously5, we did not observe activation differences in the ventral visual stream (Supplementary Table 3). As amygdala signaling is critical for appropriate avoidance behavior1, abnormal activation to threatening faces may contribute to diminished fear of strangers and consequent social disinhibition in individuals with WBS3 because of reduced responsivity to social danger. Conversely, and again in excellent agreement with the clinical profile of WBS, amygdala reactivity to scenes was not simply preserved, but was in fact abnormally increased. As specific phobia has been associated with increased amygdala reactivity10, this observation suggests a potential mechanism for high non-social anxiety in WBS4. Because abnormal amygdala reactivity in individuals with WBS was not attributable to general functional impairment, our data suggested alterations in amygdala modulation and regulation. We therefore examined whole brain group-by-task interaction maps to identify regions outside the amygdala showing differential reactivity as a function of task (Fig. 2a and Supplementary Table 3). These were located exclusively in prefrontal cortex (Fig. 2c–e), where normal controls differentially activated dorsolateral-prefrontal (DLPFC), medial-prefrontal (MPFC) and orbitofrontal cortex in the more difficult condition (face matching). In contrast, participants with WBS showed a task-invariant pattern: OFC was not differentially activated, and both MPFC and DLPFC were activated to similar degrees in both tasks. Both MPFC and OFC are densely interconnected with amygdala and DLPFC11 and have been implicated in the regulation of amygdala function, social cognition1 and representation of social knowledge12. Structural abnormalities in OFC have been reported both in these same participants5 and in participants with WBS and mental retardation13. Our finding of the absence of OFC activation also provides evidence for a deficiency during social processing. OFC activity and OFC-amygdala
992
interactions have been associated with representation and reevaluation of relative reward value and stimulus-reinforcement association learning14. In social cognition, OFC-amygdala interactions are hypothesized to link sensory representations with social judgments on the basis of motivational value1, and OFC lesions are associated with social disinhibition and impaired ability to detect faux pas. In this context, our observation of functionally abnormal OFC is consistent with the observations of social disinhibition and impairments in adjusting behavior according to social clues in individuals with WBS3. We also found a perigenual MPFC region persistently activated in individuals with WBS. Convergent evidence suggests that dynamic interactions of this area with amygdala are critical for inhibitory amygdala regulation, especially for fear extinction15. MPFC has been associated with empathy, representation of social knowledge12 and integration of emotional information about others and self1. Again, the relatively preserved, or even increased, activity of MPFC maps well on phenotypic characteristics of relative social strengths of individuals with WBS, such as increased empathy2. To directly investigate regulatory interactions between identified prefrontal regions and amygdala, we employed path analysis5, a method allowing assessment of functional interregional interactions (which should not, however, be interpreted to indicate direct anatomical connections). Using data from OFC, MPFC, DLPFC and right amygdala during face processing (where both groups showed prefrontal engagement), we obtained a well-fitting model for both participant groups (Fig. 2f–g). The final model included efferent pathways from MPFC and OFC to amygdala, and from DLPFC to MPFC and OFC, consistent with anatomical data11. The overall pattern of connections within this regulatory system was highly significantly different between groups (w2(4) ¼ 13.91, P o 0.008). In normal individuals, both MPFC and OFC were strongly negatively linked to amygdala. DLPFC showed a positive interaction with OFC and a negative path to MPFC (Fig. 2f).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
B R I E F C O M M U N I C AT I O N S In contrast, in individuals with WBS, OFC showed no connection either with amygdala or DLPFC (Fig. 2g). While the negative link between MPFC and amygdala was similar to that in controls (w2(1) ¼ 1.87, P 4 0.17), DLPFC and MPFC were strongly positively linked in individuals with WBS, a significant difference from the negative interaction in controls (w2(1) ¼ 4.32, P o 0.03). Our path analyses suggested that OFC did not participate in regulatory interactions with amygdala in WBS, whereas normal controls showed a highly significant connection of OFC with both amygdala and DLPFC. Moreover, DLPFC, although not directly linked to amygdala, showed a differentiated reciprocal interaction with both ventral prefrontal regions (OFC and MPFC) that was significantly altered in WBS. These results support abnormal regulatory interactions between the PFC and amygdala in WBS. In particular, the finding that OFC was not only not differentially activated but also functionally disconnected from amygdala provided evidence for impairment of this regulatory mechanism in WBS. In normal controls, although signs of path coefficients cannot be directly interpreted as neural excitation or inhibition, our data do indicate a differential network by which DLPFC can adjust amygdala reactivity in both directions according to task demand. Evidence indeed suggests that activation of DLPFC modulates the amygdala in a task-specific fashion9. Our data extend understanding of this regulation by illustrating that DLPFC may exert this influence on the amygdala despite the absence of direct connections11 through reciprocal interactions with MPFC and OFC. It is commonly assumed that a primary role of DLPFC in social cognition is the representation of goal states and consequent modification of relevant social-emotional interactions1. Our results suggest a regulatory system through which these goal-directed demands can be neurally instantiated. In WBS, this modulation was significantly altered: OFC connections were absent and interactions between DLPFC and MPFC had a positive sign. Moreover, in individuals with WBS, both DLPFC and MPFC were found to be active to the same degree in both tasks, suggesting that this abnormal modulation is enduring, whereas normal controls recruited only prefrontal cortex as required by task type or difficulty. On the basis of the cross-sectional data presented here, it is impossible to determine whether the abnormal interaction between DLPFC and MPFC represents a primary abnormality or is secondary to the lack of OFC function in this regulatory network in individuals with WBS. We propose that the observed task-independent facilitation of MPFC by DLPFC may represent a compensatory mechanism using the intact pathway in the context of congenitally non-functional OFC in individuals with WBS. Together with nonhuman primate findings of increased social but decreased non-social fear after neonatal amygdala lesions6, our data suggest the possibility that the opposite pattern of
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
dissociated fear (decreased social fear and increased non-social fear) found in individuals with WBS may be a consequence of a congenital deficiency in a prefrontal system involved in inhibitory amygdala regulation (and by implication, possibly associated with relatively disinhibited amygdala activity during maturation). In this first study of the neural basis of emotional cognition in WBS, we opted for a low-level baseline task in order to increase our power to detect amygdala activity, which had been hypothesized to be deficient3. As our data indicated no reduction of overall magnitude of amygdala activation (Fig. 2b), further research should use other emotional stimuli (such as happy or sad, compared to neutral) in fully factorial designs to further characterize amygdala response in WBS and link these suggestive findings to emotional regulation with certainty. We anticipate that identification of an intermediate neural phenotype for a genetically dependent abnormality in social cognition will facilitate the search for specific genes underlying social cognition in individuals with WBS and in healthy individuals. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank N. Dixit, A. Bonner-Jackson, R. Olsen and J. Holt for research assistance; A. Goldman and Q. Chen for single-subject analyses and D. Weinberger for helpful discussion. This work was supported by the US National Institute of Mental Health intramural program and National Institute on Neurological Disorders and Stroke grant NS35102 to C.B.M. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 25 May; accepted 17 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Adolphs, R. Nat. Rev. Neurosci. 4, 165–178 (2003). 2. Klein-Tasman, B.P. & Mervis, C.B. Dev. Neuropsychol. 23, 269–290 (2003). 3. Bellugi, U., Adolphs, R., Cassady, C. & Chiles, M. Neuroreport 10, 1653–1657 (1999). 4. Dykens, E.M. Dev. Neuropsychol. 23, 291–316 (2003). 5. Meyer-Lindenberg, A. et al. Neuron 43, 623–631 (2004). 6. Prather, M.D. et al. Neuroscience 106, 653–658 (2001). 7. Amaral, D.G. Biol. Psychiatry 51, 11–17 (2002). 8. Hariri, A.R., Tessitore, A., Mattay, V.S., Fera, F. & Weinberger, D.R. Neuroimage 17, 317–323 (2002). 9. Hariri, A.R., Mattay, V.S., Tessitore, A., Fera, F. & Weinberger, D.R. Biol. Psychiatry 53, 494–501 (2003). 10. Dilger, S. et al. Neurosci. Lett. 348, 29–32 (2003). 11. Ghashghaei, H.T. & Barbas, H. Neuroscience 115, 1261–1279 (2002). 12. Wood, J.N., Romero, S.G., Knutson, K.M. & Grafman, J. Neuropsychologia 43, 249– 259 (2005). 13. Reiss, A.L. et al. J. Neurosci. 24, 5009–5015 (2004). 14. Kringelbach, M.L. & Rolls, E.T. Prog. Neurobiol. 72, 341–372 (2004). 15. Quirk, G.J., Likhtik, E., Pelletier, J.G. & Pare, D. J. Neurosci. 23, 8800–8807 (2003).
993
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Sox21 promotes the progression of vertebrate neurogenesis Magnus Sandberg, Magdalena Ka¨llstro¨m & Jonas Muhr The generation of neurons constitutes the foundation of nervous system development, yet the mechanisms underlying neurogenesis are not well established. The HMG-box transcription factors Sox1, Sox2 and Sox3 (Sox1–3) have previously been shown to suppress neurogenesis by maintaining neural cells in an undifferentiated state. Here we report that another HMG-box protein, Sox21, has the opposite activity and promotes neuronal differentiation. Using genetic studies in the chick embryo, we found that Sox21 mediates this function by counteracting the activity of Sox1–3. Accordingly, the balance of Sox21 and Sox1–3 activities determines whether neural cells remain as progenitors or commit to differentiation. Proneural basic helix-loop-helix proteins are essential for the establishment of neuronal fates. We now show that proneural proteins promote neurogenesis by upregulating Sox21 expression. These data establish a key role for Sox21 in the progression of neuronal differentiation and indicate that an important role of proneural proteins is their capacity to upregulate the expression of Sox21.
Neurons are generated from self-renewing precursor cells residing in the ventricular zone of the developing CNS. During neurogenesis, precursor cells exit the division cycle, downregulate progenitor markers and migrate toward the marginal zone to begin to express neuronal properties. Although progress has been made in defining genetic pathways that regulate neurogenesis, the molecular mechanisms that prompt neural cells to initiate programs of neuronal differentiation remain poorly defined. Proneural basic helix-loop-helix (bHLH) transcription factors are essential for the establishment of neuronal fates1,2. The fraction of progenitor cells expressing proneural bHLH proteins is determined by the interaction between Notch receptors and their ligands3. Notch receptor signaling restricts the expression of proneural proteins, whereas other positive-feedback mechanisms upregulate the expression of proneural proteins in selected progenitors4,5. A high level of proneural protein activity is sufficient to drive neurogenesis by directing cell-cycle exit6 and by activating the expression of downstream differentiation markers7,8. Proneural proteins function as transcriptional activators, but it is not yet known how these proteins induce neural cells to suppress progenitor features and commit to the irreversible set of events that results in terminal neuronal differentiation1,2. The HMG-box transcription factors Sox1–3 are expressed by most progenitor cells within the developing CNS9–12. Sox1–3 proteins have previously been shown to counteract neurogenesis by maintaining neural cells in an undifferentiated state12,13. However, the ability of Sox1–3 proteins to block neurogenesis is not due to the suppression of proneural gene expression. Instead, Sox1–3 proteins hinder the capacity of proneural proteins to induce downstream events of neuronal differentiation12. Thus, suppression of Sox1–3 activities seems to be a
prerequisite for proneural proteins to promote neuronal differentiation12,13. Sox1–3, together with Sox14 and Sox21, constitute the B group of the Sox gene family14. Although the HMG domains of these proteins are highly conserved, transcriptional analyses have shown that Sox14 and Sox21, in contrast to Sox1–3, harbor a transcriptional repressor motif in their C-terminal portions14,15. Whereas the expression of Sox14 is limited to a population of post-mitotic interneurons, Sox21 is expressed within the ventricular zone and at all axial levels of the CNS15,16, raising the possibility that Sox21 could have a more general role in regulating the progression of neurogenesis. In the present study, we examined the role of Sox21 in the regulation of neurogenesis in the chick neural tube. We show that Sox21 promotes differentiation of neural cells, an activity opposite to that of Sox1–3. Notably, Sox21 mediates this function by counteracting the activity of Sox1–3 proteins. Thus, the balance of Sox21 and Sox1–3 activity determines whether neural cells remain in a progenitor state or commit to neuronal differentiation. The ability of Sox21 to direct neural cells to a differentiated state is independent of the intrinsic status of proneural protein activity. However, the ability of proneural bHLH proteins to promote neurogenesis seems to be based on their capacity to upregulate the level of Sox21 expression. Together, these findings establish a key role for Sox21 in the progression of neurogenesis and further indicate that an important function of proneural bHLH proteins during neurogenesis is the capacity to upregulate the expression of Sox21. RESULTS Expression of Sox21 in CNS progenitors To examine the role of Sox21 during neurogenesis, we first defined its expression profile in the caudal part of the chick neural tube at
Ludwig Institute for Cancer Research, Karolinska Institute, Box 240, SE-171 77, Stockholm, Sweden. Correspondence should be addressed to J.M. (
[email protected]). Published online 3 July 2005; doi:10.1038/nn1493
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
995
ARTICLES Sox21
a
Sox21 Sox3
b
Sox21 BrdU
that Sox21 suppression starts before differentiating cells upregulate the expression of neuronal markers.
Sox21 Ngn2
d
e
Myc-Sox21
Lim2
996
h
VP16 BrdU
j
i
Lim2
k
m
NeuN
[
NUMBER 8
30 20 10 0
Ctrl Sox21
n
l
VOLUME 8
40 BrdU+ cells (%)
g
NeuN
Cells expressing neuronal marker (%)
Sox21HMG-EnR
Myc BrdU
Figure 2 Sox21 functions as a transcriptional repressor. (a–f) Forced expression of Sox21-myc suppressed progenitor identities (a,b) and facilitated the expression of Lim2 (c) and NeuN (d), but not Tuj1 or NF1 (e,f). (g–i) Twenty hours after HMG-EnR transfection, most cells were in a post-mitotic state (g) and had upregulated expression of Lim2 (h) and NeuN (i). (j–l) Cells electroporated with HMG-VP16 were maintained in a progenitor state (j) and did not upregulate the expression of neuronal markers (k,l). Scale bars, 60 mm in a–i and 100 mm in j–l. (m) Percentage of cells incorporating BrdU 20 h after Sox21 transfection. Ctrl: nontransfected control side. (n) Percentage of cells expressing the neuronal markers after Sox21, HMG-EnR or HMG-VP16 transfection (mean 7 s.d.).
Sox21HMG-VP16
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Spinal cord
Sox21 promotes neuronal differentiation Sox1 and Sox2 activate the d1-crystallin enhancer DC5, whereas Sox21 inhibits this Sox21 NeuroM Sox21 NeuN Sox1/Sox2–activated gene expression15. Thus, f g one possible function of Sox21 during neurogenesis is to counterbalance the activity of c Sox1–3 in differentiating progenitor cells. The ability of Sox1–3 to suppress the formation of neurons12,13 prompted us to examine, by chick embryo electroporation, whether Figure 1 Expression of Sox21 in the developing CNS. (a,b) Pattern of Sox21 mRNA (a) and Sox21 and Sox21 could influence neurogenesis when Sox3 protein (b) expression in a chick spinal cord at HH stage 20. (c–g) Analysis of Sox21 expression + + + + + misexpressed in the neural tube. Electroin Sox3 (c), BrdU (d), Ngn2 (e), NeuroM (f) and NeuN (g) cells. Scale bar, 60 mm in a, 45 mm in b porated cells were analyzed 10–20 h after and 15 mm in c–g. transfection for the expression of markers defining progenitor cells or differentiated Hamburger-Hamilton (HH) stage 20 (see ref. 17 for description of neurons. Forced expression of Sox21 caused cells to exit the cell cycle, stages). Sox21 mRNA was detected at most levels of the dorsoventral as detected by the lack of BrdU incorporation, and to downregulate the axis, but it was predominately expressed in three stripes that encom- expression of the progenitor markers Sox3 and Pax6 (ref. 23; Fig. 2 and passed a dorsal, medial and ventral domain of the ventricular zone15,16 data not shown). The suppression of progenitor features was accom(Fig. 1a). Sox21 protein was generally confined to Sox1–3+ progenitor panied by premature expression of Lim2 and NeuN, but not Tuj1 or cells10,12 (Fig. 1b,c and data not shown) and was detected in all NF1 (Fig. 2c–f,n). Thus, a high level of Sox21 expression induces cells proliferating cells incorporating BrdU (Fig. 1d), although the expres- to leave their proliferative progenitor state and to upregulate an array of sion level of Sox21 varied between different cells (Fig. 1c,d). Moreover, neuronal markers, the opposite of the effects of Sox1–3. Electroporation the majority of cells expressing the proneural bHLH protein Ngn2 of Sox21 did not, however, result in an upregulation of Ngn2 expression (ref. 18) were Sox21+ (Fig. 1e), whereas expression of the bHLH (data not shown). Furthermore, the capacity of Sox21 to promote the protein NeuroM19 was identified only in the most lateral Sox21+ cells formation of differentiated cells expressing neuronal markers was not (Fig. 1f). Additional Ngn2- and NeuroM-expressing cells were detected affected by co-electroporated Id2 (see Supplementary Fig. 1 online). As in a narrow domain lateral to the Sox21+ boundary, defined as the Id2 blocks the activity of proneural proteins24 and suppresses neuronal intermediate zone19. Thus, the expression of Sox21 appears to be differentiation25 (Supplementary Fig. 1), these results suggest that the downregulated simultaneously as differentiating NeuroM+ cells depart ability of Sox21 to direct neural cells to a differentiated state is from the ventricular zone. Furthermore, cells expressing the definitive independent of the expression of proneural proteins. neuronal markers6,20 NeuN, Tuj1 or NF1, or the interneuron marker21 Lim2, were generally Sox21-negative (Fig. 1g and data not Myc Sox3 Myc BrdU Lim2 NeuN Tuj1 NF1 shown). Post-mitotic V2 interneurons cond e f a b c tinued to express Sox21 together with the V2 interneuron-specific marker Chx10 (ref. 22, data not shown). Together, these analyses show that the expression of Sox21 is mainly limited to Sox1–3+ progenitor cells10,12 and
[
100
Lim2 NeuN
80 60 40 20 0
Sox21
HMG-EnR
HMG-Vp16
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Myc
Constructs Sox3-myc
Sox21-myc C-term
CtSox3-myc
C-term
NeuN
NF1
b
c
d
e
f
g
h
i
j
k
CtSox21-myc C-term
HMGSox3-CtSox21-myc HMG
C-term
HMGSox21-CtSox3-myc HMG
C-term
Figure 3 The activities of Sox21 and Sox3 are distinguished by their C-terminal regions. (a) Constructs used: C-terminal regions of Sox3 (blue) and Sox21 (yellow) were fused to a myc-epitope tag (dark gray; CtSox3-myc and CtSox21-myc) and to the HMG domains of Sox21 (green; HMGSox21-CtSox3-myc) and Sox3 (red; HMGSox3-CtSox21-myc). (b–f) Forced expression of HMGSox3-CtSox21 suppressed progenitor features (b,c) and promoted the expression of Lim2 (d) and NeuN (e) but not NF1 (f). (g–k) Misexpression of HMGSox21-CtSox3 maintained transfected cells in a progenitor state (g,h) and hindered the expression of neuronal markers (i–k). Scale bars, 60 mm in b–f and 100 mm in g–k.
Next, we determined whether the capacity of Sox21 to promote differentiation of progenitor cells reflects its function as a transcriptional repressor or activator. To examine this, the HMG domain of Sox21 was either expressed alone or fused to heterologous transcriptional repressor or activator domains. The HMG domain, misexpressed alone, had no detectable activity (data not shown). However, transfection of the HMG domain fused to the repressor domain of the Drosophila melanogaster protein Engrailed26 (HMG-EnR) mimicked the activity of full-length Sox21 protein and promoted electroporated cells to exit the cell cycle and upregulate the expression of the neuronal markers Lim2 and NeuN (Fig. 2g–i,n). Similar to full-length Sox21, HMG-EnR did not promote the expression of Tuj1 or NF1 (data not shown). In contrast, Myc cells transfected with the HMG domain fused Sox21:Sox3 a to the activator domain of the viral protein ratio
VP16 (HMG-VP16; ref 27) did not upregulate the expression of neuronal proteins and continued to incorporate BrdU even 45 h after electroporation (Fig. 2j–l,n). Together, these results indicate that Sox21 promotes neural cell differentiation through its function as a transcriptional repressor, whereas an activator form of Sox21 had similar activity as Sox1–3 (ref. 12,13) and maintained neural cells as progenitors. Specification of Sox21 and Sox3 activities Our results support the idea that Sox21 and Sox1–3 regulate a similar repertoire of target genes15. Accordingly, the distinct activities
Pax6
NeuN
Myc
b
Sox21:Sox3 ratio
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
d
Myc-Sox21/Sox3
c
NeuN
i
j
k
l
0:1
1:1
e
f m
100
2:1
g
h
Transfected cells (%)
75 50 25
BrdU
[
AUGUST 2005
:1 1: 1 2: 1 1: 2
25 0.
25
Ratio
:1 1: 1 2: 1 1: 2
1:2
0.
Figure 4 Sox21 counterbalances the activity of Sox1–3. (a,b) Cells transfected with Sox21 and Sox3 for 20 h at a vector ratio of 0.25:1 expressed the progenitor marker Pax6 (a) but not the neuronal marker NeuN (b). (c,d) Cells transfected with Sox21 and Sox3 at a vector ratio of 1:1 showed suppressed progenitor identities (c) but did not upregulate the expression of NeuN (d). (e–h) Cotransfection of Sox21 and Sox3 at a vector ratio of 2:1 promoted cells to suppress progenitor features (e) and upregulate the expression of NeuN (f), whereas cells electroporated with Sox21 and Sox3 at the reverse vector ratio, 1:2, remained in a progenitor state (g) and did not upregulate neuronal traits (h). (i–l) Transfection of Sox21 alone (0.25:0, which equals a Sox21 vector concentration of 0.25 mg/ml) promoted cells to suppress progenitor characteristics (i) and to upregulate the expression of NeuN (j), whereas electroporation of Sox3 without Sox21 (0:1, which equals a Sox3 vector concentration of 1 mg/ml) blocked the generation of neurons (l) and maintained cells in a progenitor state (k). Scale bars, 60 mm in a–j and 100 mm in k and l. (m) Percentage of cells incorporating BrdU or expressing NeuN after Sox21 and Sox3 cotransfection (mean 7 s.d.).
Pax6
0.25:0
0.25:1
Myc-Sox21/Sox3
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
C-term
HMG
Lim2
HMGSox21Ct-Sox3
HMG
Pax6
HMGSox3Ct-Sox21
a
NeuN
997
Sox21
b
GFP
Lim2
c
GFP
NeuN
d
GFP
NF1
k
e
l i
j
p
GFP
n
q
NeuroM
BrdU
30 20 10 Ctrl shRNA shRNA
Ctrl shRNA Sox21 shRNA
80 60 40 20 Lim2
NeuN
Tuj1
Ngn2
o
r
s
t
Ctrl shRNA Sox21 shRNA
Control side Electroporated side 40
100 Brdu/Ngn2-positive cells (%)
m
Ngn2
Cells expressing neuronal marker (%)
Sox21 shRNA
GFP
40
100
Ctrl shRNA
h
Cells expressing neuronal marker (%)
g
f
Ctrl shRNA
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Sox21 shRNA
a
Sox3
Reduction in Sox21 expression (%)
ARTICLES
80 60 40 20 Ngn2
30 20 10
Control shRNA
NeuroM
shRNA
Figure 5 Decreased levels of Sox21 protein inhibit neurogenesis. (a–e) Expression of Sox21 shRNA decreased the endogenous level of Sox21 protein expression by 32 7 5% (n ¼ 400 cells; 6 sections; a). Under these conditions the generation of differentiated cells expressing neuronal markers was reduced by more than 55% (n ¼ 6 sections) (c–e) compared with the nonelectroporated control side. (f–j) Expression of Sox21 (f) and the progenitor marker Sox3 (g) and the neuronal markers Lim2, NeuN, NF1 and Tuj1 (h–j) in cells electroporated with control shRNA. (k,l) Histograms show reduction in expression of Sox21 (k) and neuronal markers (l) after Sox21 and control shRNA transfection, compared with nonelectroporated control side of neural tube. (m,n) Expression of Sox21 shRNA reduced the number of NeuroM-expressing cells by approximately 60% (n), whereas the number of Ngn2-expressing cells remained relatively constant, compared with the nonelectroporated control side (m). (o) Expression of Sox21 shRNA increased the number of BrdU-incorporating Ngn2+ cells more than fivefold, compared with the control side. (p–r) Control shRNA did not alter the number of Ngn2- or NeuroM-expressing cells (p,q) or the number of BrdU-incorporating Ngn2+ cells (r). (s) Reduction in expression of Ngn2 and NeuroM after Sox21 and control shRNA transfection, compared with nonelectroporated control side. (t) Percentage of Ngn2+ cells incorporating BrdU after Sox21 transfection and control shRNA transfection, compared with nonelectroporated control side. All data are mean 7 s.d. Scale bars: 100 mm (a–j); 60 mm (m–r).
measured with Sox21 and Sox1–3 proteins12,13 might be based primarily on regulatory differences outside their respective HMG domains. To examine this notion, the C-terminal portion14 of Sox21 was either misexpressed alone or fused with the HMG domain of Sox3 (Fig. 3a). Alone, the C-terminal domain of Sox21 did not alter the expression profile of progenitor and neuronal markers (data not shown). However, a derivative containing the Sox21 C-terminal domain fused to the Sox3 HMG domain (Fig. 3a) induced cells to exit the division cycle, suppress Pax6 expression and upregulate neuronal markers, all within 15 h of electroporation (Fig. 3b–f). Thus, the ability of Sox21 to promote differentiation appears to be conferred by its C-terminal region. Conversely, cells transfected with a derivative containing the C-terminal portion of Sox3 fused to the Sox21 HMG domain (Fig. 3a) were maintained in a proliferative and Pax6+ progenitor state and failed to upregulate the expression of Lim2, NeuN or NF1, even 45 h after transfection (Fig. 3g–k). The C-terminal domain of Sox3 had no measurable activity when transfected alone (data not shown). Hence, the opposite activities of Sox21 and Sox3
998
appear to be conferred by the distinct regulatory functions of their C-terminal regions14 and are independent of their HMG domains. Sox21 counterbalances the activity of Sox1–3 The varying expression levels of Sox21 within Sox1–3+ progenitor cells (Fig. 1c) raise the possibility that the intrinsic balance of Sox21 and Sox1–3 expression determines whether neural cells remain as progenitors or commit to neuronal differentiation. To examine this possibility, we co-electroporated a fixed amount of vector expressing Sox3 with different amounts of vector expressing Sox21. Sox21 could not promote premature expression of neuronal markers when cotransfected with Sox3 at a vector ratio of 0.25:1 (Fig. 4). Instead, electroporated cells remained in a self-renewing Pax6+ progenitor state (Fig. 4a,m). Electroporation of Sox21 alone at this specific concentration caused cells to differentiate and upregulate the expression of neuronal markers, whereas transfection of Sox3 for 48 h on its own blocked the formation of neurons and maintained transfected cells in a Pax6+ progenitor state12,13 (Fig. 4i–l). Transfection of Sox21 and Sox3 expression vectors
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Myc
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Myc
b
Sox21
c
d
Id2
Ngn2
a
Sox21
Figure 6 Sox21 expression is upregulated by proneural protein activity. (a,b) Ten hours after Ngn2 electroporation, the expression of Sox21 was markedly upregulated in transfected progenitor cells. Scale bar, 60 mm. (c,d) Forty-five hours after electroporation, cells transfected with Id2 had reduced Sox21 expression. Scale bars, 100 mm.
in a 1:1 ratio induced cells to exit the cell cycle and downregulate progenitor markers, but it did not induce the expression of NeuN (Fig. 4c,d,m). Transfection of Sox21 together with Sox3 at a vector ratio of 2:1 suppressed progenitor cell features and upregulated neuronal markers (Fig. 4e,f,m), whereas cells electroporated with Sox21 and Sox3 at the reverse vector ratio, 1:2, remained in a Pax6+ progenitor state and did not upregulate neuronal markers (Fig. 4g,h,m). Thus, transfected cells are prompted to express either progenitor, post-mitotic or neuronal traits, depending on the relative levels of Sox21 and Sox3 activities. The amount of Sox21 protein was approximately five times greater in cells transfected with Sox21 and Sox3 expression vectors at a ratio of 2:1, respectively, compared with cells transfected at a vector ratio of 0.25:1 (confocal measurements, data not shown). Notably, similar results were obtained when Sox21 was co-electroporated with vectors expressing Sox1 or Sox2 (data not shown). Together, these findings indicate that the intrinsic balance of Sox21 and Sox1–3 activities determines the status of differentiation of neural cells. Decreased level of Sox21 inhibits neurogenesis To examine the necessity of Sox21 activity for the progression of neurogenesis, we next reduced the endogenous level of Sox21 expression by RNA interference28. Short RNA hairpins (shRNA)29 directed against a chick Sox21-specific sequence lowered Sox21 protein expression by more than 32% (Fig. 5a). Under these conditions the generation of cells expressing definitive neuronal markers was decreased by more than 55% (Fig. 5b–e). The ability to suppress neurogenesis could not be mimicked by control RNA hairpins containing a scrambled but identical repertoire of nucleotides (Fig. 5f–l). Together these results indicate that Sox21 activity is required for the generation of neurons. We next investigated at which step during neurogenesis Sox21 activity is required for progenitor cells to differentiate into neurons. High levels of Sox3 have previously been shown to suppress neurogenesis by blocking the step at which differentiating progenitor cells upregulate the expression of the intermediate zone marker NeuroM12,19. Thus, one possible function of Sox21 is to facilitate differentiating neural cells to progress from an Ngn2+ to a NeuroM+ state. Indeed, misexpression of Sox21 shRNA reduced the number of NeuroM+ cells but did not lower the number of cells expressing Ngn2 (Fig. 5m,n). Instead, transfection of Sox21 shRNA markedly increased the number of Ngn2+ cells incorporating BrdU (Fig. 5o). Control shRNA did not alter the expression of NeuroM or the amounts of Ngn2+ cells incorporating BrdU (Fig. 5p–t). Thus, Sox21 seems to counteract the activity of Sox1–3 and promote the step at which differentiating progenitor cells leave the division cycle to upregulate the expression of NeuroM. In contrast, Sox21 does not seem to influence the earlier generation of Ngn2-expressing cells.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
Sox21 is upregulated by proneural protein activity The finding that reduced levels of Sox21 expression hindered Ngn2+ cells in committing to differentiation prompted us to investigate whether the capacity of Ngn2 to drive the generation of neurons from progenitor cells30,31 is accompanied by increased Sox21 expression. Indeed, 10 h after electroporation, Sox21 was substantially upregulated in Ngn2-transfected cells (Fig. 6a,b). Furthermore, transfection of another proneural bHLH protein, Ascl1 (also known as Mash1) had similar activity as electroporated Ngn2 and induced high levels of Sox21 expression (data not shown). Notably, Sox21 was upregulated before Ngn2 had initiated the expression of post-mitotic neuronal markers (Supplementary Fig. 2). Thus, the generation of neurons by Ngn2 overexpression seemed to be preceded by increased expression of Sox21, whereas overexpression of Id2 decreased the level of Sox21 expression (Fig. 6c,d) and suppressed the generation of neurons (Supplementary Fig. 1). Together, these results demonstrate that proneural protein activity can upregulate the level of Sox21 expression in neural cells. Furthermore, transfection of Sox21 together with Ngn2 promoted the expression of a full array of neuronal markers, including NF1 and Tuj1, within 10 h of transfection (Supplementary Fig. 2). Thus, in addition to the regulatory relationship between Ngn2 and Sox21, they seem to function synergistically in the formation of neurons from progenitor cells. DISCUSSION Our data suggest that the generation of neurons from precursor cells depends on Sox21 repressor activity, which promotes neurogenesis by counteracting the function of Sox1–3. Thus, whether neural cells remain as progenitors or commit to neuronal differentiation seems to depend on the intrinsic balance of Sox21 and Sox1–3 activity. Our data show that proneural proteins upregulate the expression of Sox21 and thereby shift the balance of Sox21 and Sox1–3 activity. Our findings position Sox21 in a central role during neurogenesis and suggest that an important function of proneural bHLH proteins is their capacity to upregulate the expression of Sox21. Sox21 and Sox1–3 have distinct regulatory functions during neurogenesis, yet their opposite activities seem to be conferred by regions outside of their DNA-binding HMG domains. We have shown that a chimeric protein consisting of the HMG domain of Sox21 fused to the heterologous transcriptional activator VP16 mimics the activity of Sox1–3 proteins and thus blocks neurogenesis. Moreover, swapping the C-terminal regions of Sox21 and Sox3 proteins confirms that specific properties of Sox21 and Sox3 rely on protein domains other than the HMG domain. The most plausible interpretation of these results is that Sox21 and Sox1–3 regulate a common set of target genes and that the expression status of these genes determines whether neural cells commit to differentiation or remain undifferentiated (Supplementary Fig. 3). In line with this idea, in vitro analyses have shown that Sox21 can counteract Sox1/Sox2–mediated activation of the d-crystalline minimal enhancer DC5 (ref. 15). Furthermore, our data show that high levels of Sox3 prevent Sox21 from promoting differentiation, whereas Sox3-transfected cells readily differentiate when co-electroporated with high levels of Sox21. These findings are consistent with a model in which Sox1–3 and Sox21 activate and repress, respectively, a common set of target genes which, in turn, maintain the undifferentiated state of neural progenitor cells (Supplementary Fig. 3). According to our model, whether neural cells differentiate or remain as progenitors depends on the relative balance of Sox21 and Sox1–3 activities. Thus, one possible developmental mechanism is that the amount of Sox21 expression progressively increases in progenitor cells
999
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES until a critical level is reached at which Sox1–3–activated genes are repressed, inducing these cells to commit to differentiation. Indeed, our findings favor this idea, as the expression of Sox21 was most pronounced in the lateral aspect of the ventricular zone. Hence, the activity of Sox21, and its ability to promote differentiation, may be reflected by its level of expression. However, the widespread expression pattern of Sox21 within the ventricular zone indicates that the activity level of Sox21 is likely to be regulated by other mechanisms as well. For instance, the specificity and stability of the interaction between Sox proteins and DNA have been shown to be influenced by the presence of specific partner factors14. Furthermore, the activity of Sox proteins can be altered by small ubiquitin-like modifiers32, and Sox21 has been reported to be antagonized by the transcription factor YB-1 (ref. 33). Thus, the expression of such factors may provide an alternative post-transcriptional mechanism for the regulation of the activity of Sox21. Notch receptor signaling restricts the neurogenic potential of precursor cells by activating transcriptional repressors of the Hes gene family3 which, in turn, suppress the expression of proneural genes34. Hence, Notch receptor activation determines whether neural cells should commit to differentiation by controlling the expression of proneural genes. In contrast, neither Sox1–3 nor Sox21 seems to control the expression of proneural genes. Sox1–3 proteins suppress, instead, the capacity of proneural proteins to induce downstream events of neuronal differentiation12, and we now show that the function of proneural proteins is dependent on Sox21. Thus, the expression of proteins regulated by Sox1–3 and Sox21 seems to control the ability of proneural proteins to coordinate downstream events of neuronal differentiation. Accordingly, the capacity of proneural proteins to upregulate Sox21 activity is likely to represent a mechanism that enables proneural proteins to promote neural cells to suppress progenitor features and commit to downstream events of neuronal differentiation. Collectively, our results demonstrate that the generation of neurons from progenitor cells is regulated by Sox and proneural bHLH proteins. Interestingly, neural crest differentiation and muscle cell differentiation are coordinated by bHLH transcription factors35,36 and counteracted by Sox10 and Sox15 proteins, respectively37,38. In light of this, it is plausible to speculate that the mechanism committing neural cells to differentiation has parallels in stem cell populations outside the developing CNS. METHODS This work was approved by the Swedish Animal Research Committee in Stockholm (approval number n211/02). Immunohistochemistry and in situ hybridization. Antibody staining was performed as described previously21. Rabbit antisera were generated against the chick Ngn2 peptide (C terminus: CEHWPPPRGRFAPPPPPHR) and guinea pig antisera against the chick Sox21 peptide (N terminus: GGHTHSHPSPGNPGY MIPC). Additional antibodies and BrdU labeling methods are described elsewhere12. The procedure for in situ hybridization was performed as described previously39 using chick probes for Sox21 (ref. 15). Expression constructs and in ovo electroporation. cDNAs encoding chick Sox21 and Sox3 were used. DNA encoding the HMG domains of Sox21 (amino acids (given in parentheses) 8–82) and Sox3 (43–120) were fused to the following: a myc tag, a VP16 activator domain (400–488), a myc-tagged En repressor (2–298), a myc-tagged C-terminal domain of Sox3 (141–313) and a myc-tagged C-terminal domain of Sox21 (102–281). cDNAs were subcloned into the CMV-based vectors pCS+MT and pCAGGS. Vectors expressing short RNA hairpins were constructed basically as described29 to specifically target chick Sox21 mRNA (nucleotides 302–332). Expression vectors were
1000
electroporated into the neural tube of HH stage 10 chick embryos12. After 5–48 h of incubation, embryos were fixed and processed for immunohistochemistry and in situ hybridization. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank H. Kondoh for Sox21 chick cDNA, and we are grateful to J. Ericson, T. Perlmann and members of the Muhr lab for discussions and comments on the manuscript. J.M. is supported by The Swedish Natural Research Council, The Swedish Foundation for Strategic Research, the Ake Wiberg Research Foundation, the Magnus Bergvall Foundation, the Jeansson Research Foundations and the Ludwig Institute for Cancer Research. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 20 May; accepted 2 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Kintner, C. Neurogenesis in embryos and in adult neural stem cells. J. Neurosci. 22, 639–643 (2002). 2. Bertrand, N., Castro, D.S. & Guillemot, F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517–530 (2002). 3. Davis, R.L. & Turner, D.L. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20, 8342–8357 (2001). 4. Koyano-Nakagawa, N., Kim, J., Anderson, D. & Kintner, C. Hes6 acts in a positive feedback loop with the neurogenins to promote neuronal differentiation. Development 127, 4203–4216 (2000). 5. Bae, S., Bessho, Y., Hojo, M. & Kageyama, R. The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development 127, 2933–2943 (2000). 6. Farah, M.H. et al. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127, 693–702 (2000). 7. Lee, J.E. et al. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helixloop-helix protein. Science 268, 836–844 (1995). 8. Ma, Q., Kintner, C. & Anderson, D.J. Identification of neurogenin, a vertebrate neuronal determination gene. Cell 87, 43–52 (1996). 9. Kamachi, Y., Uchikawa, M., Collignon, J., Lovell-Badge, R. & Kondoh, H. Involvement of Sox1, 2 and 3 in the early and subsequent molecular events of lens induction. Development 125, 2521–2532 (1998). 10. Pevny, L.H., Sockanathan, S., Placzek, M. & Lovell-Badge, R. A role for SOX1 in neural determination. Development 125, 1967–1978 (1998). 11. Uwanogho, D. et al. Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neuronal development. Mech. Dev. 49, 23–36 (1995). 12. Bylund, M., Andersson, E., Novitch, B.G. & Muhr, J. Vertebrate neurogenesis is counteracted by Sox1–3 activity. Nat. Neurosci. 6, 1162–1168 (2003). 13. Graham, V., Khudyakov, J., Ellis, P. & Pevny, L. SOX2 functions to maintain neural progenitor identity. Neuron 39, 749–765 (2003). 14. Kamachi, Y., Uchikawa, M. & Kondoh, H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 16, 182–187 (2000). 15. Uchikawa, M., Kamachi, Y. & Kondoh, H. Two distinct subgroups of Group B Sox genes for transcriptional activators and repressors: their expression during embryonic organogenesis of the chicken. Mech. Dev. 84, 103–120 (1999). 16. Rex, M., Uwanogho, D.A., Orme, A., Scotting, P.J. & Sharpe, P.T. cSox21 exhibits a complex and dynamic pattern of transcription during embryonic development of the chick central nervous system. Mech. Dev. 66, 39–53 (1997). 17. Hamburger, V. The stage series of the chick embryo. Dev. Dyn. 195, 273–275 (1992). 18. Fode, C. et al. The bHLH protein NEUROGENIN 2 is a determination factor for epibranchial placode-derived sensory neurons. Neuron 20, 483–494 (1998). 19. Roztocil, T., Matter-Sadzinski, L., Alliod, C., Ballivet, M. & Matter, J.M. NeuroM, a neural helix-loop-helix transcription factor, defines a new transition stage in neurogenesis. Development 124, 3263–3272 (1997). 20. Caccamo, D.V. et al. An immunohistochemical study of neuropeptides and neuronal cytoskeletal proteins in the neuroepithelial component of a spontaneous murine ovarian teratoma. Primitive neuroepithelium displays immunoreactivity for neuropeptides and neuron-associated beta-tubulin isotype. Am. J. Pathol. 135, 801–813 (1989). 21. Tsuchida, T. et al. Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes. Cell 79, 957–970 (1994). 22. Tanabe, Y., William, C. & Jessell, T.M. Specification of motor neuron identity by the MNR2 homeodomain protein. Cell 95, 67–80 (1998). 23. Ericson, J. et al. Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell 90, 169–180 (1997). 24. Yokota, Y. Id and development. Oncogene 20, 8290–8298 (2001). 25. Dubreuil, V., Hirsch, M.R., Jouve, C., Brunet, J.F. & Goridis, C. The role of Phox2b in synchronizing pan-neuronal and type-specific aspects of neurogenesis. Development 129, 5241–5253 (2002). 26. Smith, S.T. & Jaynes, J.B. A conserved region of engrailed, shared among all en-, gsc-, Nk1-, Nk2- and msh-class homeoproteins, mediates active transcriptional repression in vivo. Development 122, 3141–3150 (1996).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 27. Berk, A.J. et al. Mechanisms of viral activators. Cold Spring Harb. Symp. Quant. Biol. 63, 243–252 (1998). 28. Hannon, G.J. RNA interference. Nature 418, 244–251 (2002). 29. Paddison, P.J., Caudy, A.A., Bernstein, E., Hannon, G.J. & Conklin, D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948–958 (2002). 30. Mizuguchi, R. et al. Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Neuron 31, 757–771 (2001). 31. Novitch, B.G., Chen, A.I. & Jessell, T.M. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 31, 773–789 (2001). 32. Komatsu, T. et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 18, 2451– 2462 (2004). 33. Ohba, H. et al. Sox21 is a repressor of neuronal differentiation and is antagonized by YB1. Neurosci. Lett. 358, 157–160 (2004).
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
34. Kageyama, R. & Nakanishi, S. Helix-loop-helix factors in growth and differentiation of the vertebrate nervous system. Curr. Opin. Genet. Dev. 7, 659–665 (1997). 35. Tajbakhsh, S., Rocancourt, D., Cossu, G. & Buckingham, M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127–138 (1997). 36. Ma, Q., Fode, C., Guillemot, F. & Anderson, D.J. Neurogenin1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia. Genes Dev. 13, 1717–1728 (1999). 37. Kim, J., Lo, L., Dormand, E. & Anderson, D.J. SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17–31 (2003). 38. Beranger, F., Mejean, C., Moniot, B., Berta, P. & Vandromme, M. Muscle differentiation is antagonized by SOX15, a new member of the SOX protein family. J. Biol. Chem. 275, 16103–16109 (2000). 39. Schaeren-Wiemers, N. & Gerfin-Moser, A. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431–440 (1993).
1001
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Multiple origins of Cajal-Retzius cells at the borders of the developing pallium Franck Bielle1, Ame´lie Griveau1,5, Nicolas Narboux-Neˆme1,5, Se´bastien Vigneau1,4, Markus Sigrist2, Silvia Arber2, Marion Wassef1 & Alessandra Pierani1,3 Cajal-Retzius cells are critical in cortical lamination, but very little is known about their origin and development. The homeodomain transcription factor Dbx1 is expressed in restricted progenitor domains of the developing pallium: the ventral pallium (VP) and the septum. Using genetic tracing and ablation experiments in mice, we show that two subpopulations of Reelin1 Cajal-Retzius cells are generated from Dbx1-expressing progenitors. VP- and septum-derived Reelin1 neurons differ in their onset of appearance, migration routes, destination and expression of molecular markers. Together with reported data supporting the generation of Reelin1 cells in the cortical hem, our results show that Cajal-Retzius cells are generated at least at three focal sites at the borders of the developing pallium and are redistributed by tangential migration. Our data also strongly suggest that distinct Cajal-Retzius subtypes exist and that their presence in different territories of the developing cortex might contribute to region-specific properties.
The cerebral cortex has a laminar organization in which earlier- and later-born neurons accumulate according to an inside-out gradient. Until recently, it was thought that neuronal classes were produced by the local pallium ventricular zone and reached their final laminar destination by means of radial glia–mediated migration1,2. This model has now been complemented by evidence supporting the existence of tangential migration from the subpallium to the cerebral cortex3. Retzius (1893) and Cajal (1899) described cells with a complex morphology located in the marginal zone of humans at the time of cortical lamination, and now named Cajal-Retzius cells. Similar cells with simpler morphology have been described in the marginal zone of rodents4. The number of Cajal-Retzius cells seems to decrease after the completion of cortical lamination1,5. The most well documented function of Cajal-Retzius cells is to control the formation of cortical layers by means of the expression of the extracellular glycoprotein Reelin3,6,7. Additional functions for Cajal-Retzius cells have been proposed as in the regulation of the radial glia phenotype8 and in the development of hippocampal connections9. Until now, the term ‘Cajal-Retzius cells’ has been used to identify a heterogeneous population of morphologically and molecularly distinct cell types in the marginal zone/layer I of different species and at different times during embryogenesis and postnatal life4,5,10,11. However, the lineage relationship between these cell types is unresolved. The consensus emerging from recent reports is that Cajal-Retzius cells are glutamatergic and express pallial markers11. Their pallial origin has
been demonstrated by genetic tracing using an Emx1-Cre mouse line12, as Emx-1 is expressed exclusively in the pallium. They seem to be born between embryonic day (E) 10.5 and E12.5 in mice and are thus among the first neurons to be generated in the developing cortex. In addition, it is now agreed that Reelin in the marginal zone is a marker of CajalRetzius cells in the embryonic cortex of several species. Despite many years of study, the origins and molecular properties of Cajal-Retzius cells are still unresolved. Cajal-Retzius cells were thought to be produced by the local pallium ventricular zone1 and thus throughout the neocortical neuroepithelium11,13, but focal pallial and subpallial sources for Cajal-Retzius cells have also been proposed: the retrobulbar area14, the olfactory primordium5, the cortical hem13,15 and the medial ganglionic eminence16. Evidence supporting a cortical hem source has come from studies of the IG17 transgenic mouse using in utero electroporation17. However, several sources of Reelin+ cells in the developing marginal zone remain hypothetical, and the roles of putative subpopulations are largely unknown. The investigation of these questions has been limited so far because of the lack of molecular markers available to identify subclasses of Cajal-Retzius cells and to trace them from their site of origin to the time of neural network formation in the postnatal cortex. Cell fate allocation and cell diversity are determined at very early stages in progenitor cells at precise coordinates along the dorsoventral and anteroposterior axis18–20. The Dbx1 homeodomain transcription factor is expressed in progenitors at the boundary between the dorsal and ventral plates21–23 of the caudal neural tube, from
1Centre National de la Recherche Scientifique-Unite ´ Mixte de Recherche 8542, Ecole Normale Supe´rieure, 46 rue d’Ulm, 75005 Paris, France. 2Biozentrum, Department of Cell Biology, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland, and Friedrich Miescher Institute, Maulbeerstrasse 66, 4058 Basel, Switzerland. 3Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Center for Neurobiology and Behavior, Columbia University, New York, New York 10032, USA. 4Current address: Unite´ Ge´ne´tique Mole´culaire Murine, Institut Pasteur, 28 rue du docteur Roux, 75724 Paris, France. 5These authors contributed equally to this work. Correspondence should be addressed to A.P. (
[email protected]).
Published online 24 July 2005; doi:10.1038/nn1511
1002
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
a
c
Dbx1Cre;βactin:LacZ
X-gal
b
th
c
mRNA
X-gal
d PSB
PSB
PSB
Dbx1nlsLacZ/+
e
f
X-gal
g th
Chick E4
mRNA
h
PSB
hy se
se
i
Dbx1nlsLacZ/+
j
X-gal
k
Dbx1Cre;βactin:LacZ X-gal
l
PSB PSB
p
q
r
PSB PSB
POA
o
se
se
mRNA
n
Rostral PSB
mRNA
m
Caudal PSB
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
PSB
th
X-gal
Septum
Dbx1nlsLacZ/+
mRNA
r
se
A
Pallium
pir
se
D
s
P
t
V
PSB
pir se
PSB Subpallium
Septum
Subpallium
Figure 1 Dbx1 expression at dorsoventral boundaries in the telencephalon: septum and ventral pallium. (a,e,f) Whole-mount in situ hybridization of Dbx1 mRNA in E11.5 wild-type mouse embryos. (b,c,d,g) Whole-mount X-gal staining in E11.5 Dbx1nlslacZ/+ (b,g), E11.5 Dbx1Cre/+;bactin:lacZ (c) and E12.5 Dbx1Cre/+;bactin:lacZ (d) embryos. (h) Dbx1 mRNA is detected only in the septum but not at the PSB in E4 chick embryos. a–d show lateral views of dissected forebrains; e, medial view of a sagittally hemisected brain; f and g, dorsal views. Black lines in a correspond to rostral (r) and caudal (c) sections shown in m–r. Brackets in f and g show rostrocaudal extension of mRNA and X-gal detection, respectively. In a–e and h, rostral is at the left; in f,g, rostral is at the bottom. (i,j) In situ hybridization of Dbx1 mRNA on cryostat sections of E11.5 caudal (i) and E12.5 rostral (j) wild-type telencephalons. (k,l) X-gal staining on cryostat sections of E12.5 Dbx1nlslacZ/+ (k) and Dbx1Cre/+;bactin:lacZ (l) telencephalon at comparable rostral levels as j. In i–l, dorsal is at the top. Se: septum; hy: hypothalamus; th: thalamus. (m–r) Comparison of Dbx1 mRNA in situ hybridization (m,o,q) and X-gal staining (n,p,r) in E11.5 Dbx1nlsLacZ/+ embryos (serial sections). Brackets mark dorsoventral extent of mRNA and X-gal detection. Open arrowheads: sites of Dbx1 expression; filled arrowheads: b-gal+ cells located at the farthest distance from sites of Dbx1 expression. Scale bar: 1 mm (a–g), 50 mm (m–r), 300 mm (i–l). (s,t) Putative migration routes of Dbx1-derived b-gal+ cells.
which postmitotic cells migrate tangentially to their final destination. In the spinal cord, the spatially restricted expression of Dbx1 in progenitors is critical in establishing the distinction between Evx1/2 (V0) and En1 (V1) interneuron cell fates and helps to coordinate diverse phenotypic features24,25. In the telencephalon, Dbx1 is expressed in restricted progenitor domains at the borders of the developing pallium: the VP at the pallial-subpallial boundary (PSB), the septum and the preoptic area/anterior entopeduncular area (POA/AEP)26,27. In this study, we trace the fate of cells derived from Dbx1 progenitors in the telencephalon from embryonic to postnatal stages using a genetic approach in mice. By combining genetic tracing and DiI labeling, we show that Dbx1-derived cells migrate from the septum to the medial and piriform cortex and from the PSB to the dorsolateral and piriform cortex. Cells derived from Dbx1+ progenitors express Reelin and are Cajal-Retzius cells in the postnatal cortex. These Dbx1-derived CajalRetzius cells seem to have distinct origins, onsets of appearance and final destinations, and they differ in expression of calretinin. Our genetic approach proves the existence of two previously unknown sites of origin for Cajal-Retzius cells and suggests that distinct subpopulations of Cajal-Retzius cells are present in different territories of the developing cortex.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
RESULTS Dbx1 is expressed at border regions of the telencephalon The expression of the Dbx1 gene is restricted to a narrow domain at the dorsoventral boundary in the spinal cord and telencephalon21–23,26,27. We mapped the onset and location of Dbx1 expression in the telencephalon of mouse embryos using in situ hybridization (Fig. 1). Expression began around E10.5 in the septum and POA/AEP. At E11.5 it reached its maximum in the septum, in the POA/AEP and near the PSB in the VP with a caudalhighrostrallow gradient (Fig. 1a,e,f,i,j)26. Dbx1 expression was restricted to progenitor cells in the ventricular zone. Dbx1 mRNA was detected on cells located close to the pial surface of the septum (Fig. 1j,m), whereas it is detected throughout the ventral pallium neuroepithelium (Fig. 1i,o,q). Dbx1 transcripts and protein were never observed in the ventricular zone of the lateral and medial ganglionic eminences (LGE and MGE, respectively) or in the neuroepithelium of the dorsal and medial pallium (Fig. 1i,j)26,27. Dbx1 expression progressively declined after E12.5 (ref. 27) but was still detectable during late embryogenesis (data not shown). Genetic manipulation of the Dbx1 locus As Dbx1 expression was transitory and exclusively detected in the ventricular zone, we used a mouse genetic approach to label cells
1003
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES derived from Dbx1-expressing progenitors. In the Dbx1nlslacZ line the insertion of the lacZ gene into the Dbx1 locus allows for short-term lineage tracing24. To permanently label Dbx1-derived cells, we generated a Dbx1Cre knock-in mouse line, which we subsequently crossed to reporter strains. Animals obtained by crossing Dbx1Cre and bactin: loxP-stop-loxP-nlslacZ28 or TauloxP-stop-loxP-MARCKSeGFP-IRES-nlslacZ reporter mice will be called Dbx1Cre/+;bactin:lacZ and Dbx1Cre/+;TauGFP, respectively. The use of these animals allowed us to label Dbx1-derived cells at various times after their generation (mitotic and early postmitotic in Dbx1nlslacZ/+ versus early- and late-postmitotic in Dbx1Cre/+;bactin:lacZ embryos). Representative images of cryostat sections from E12.5 Dbx1nlslacZ/+ and Dbx1Cre/+;bactin:lacZ embryos (Fig. 1k,l) show the subsequent labeling of Dbx1-expressing progenitors at the ventral pallium ventricular zone using a Dbx1 mRNA in situ probe (Fig. 1j) and Dbx1-derived b-galhigh (early postmitotic) and b-gallow (postmitotic) cells spanning from the ventricular zone to the mantle zone in Dbx1nlslacZ/+ embryos at more ventral and dorsal positions (Fig. 1k). Finally, permanently labeled Dbx1-derived postmitotic cells and their arborizations were detected in the mantle zone of Dbx1Cre/+;bactin:lacZ and Dbx1Cre/+;TauGFP embryos (Fig. 1l and data not shown). Dbx1-derived cells are highly motile We compared Dbx1 expression and b-gal activity at E11.5 in Dbx1nlslacZ/+ and Dbx1Cre/+;bactin:lacZ telencephalons using wholemount in toto preparations. Dbx1nlslacZ/+ embryos showed broader 5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-gal) activity with respect to the detection of the Dbx1 mRNA along the rostrocaudal axis at the PSB and the septum, and along the dorsoventral axis at the PSB (compare Fig. 1a,b and Fig. 1f,g). Notably, Dbx1Cre/+;bactin:lacZ telencephalons at E12.5 showed even more X-gal cells along the rostral PSB, suggesting that Dbx1-derived cells migrate rostrally along the PSB. In addition, scattered X-gal cells were observed in the dorsofrontal half of the developing cortex (Fig. 1d). To better map the position of Dbx1-derived b-gal+ cells with respect to the sites of Dbx1 mRNA production, we analyzed serial sections of E11.5 Dbx1nlslacZ/+ embryos for Dbx1 transcripts by in situ hybridization and X-gal staining. At E11.5 in the telencephalon, b-gal+ cells were located at a distance from Dbx1+ cells, dorsally and ventrally to the rostral and caudal PSB ventricular zone and to the septum (compare Fig. 1m to Fig. 1n, Fig. 1o to Fig. 1p and Fig. 1q to Fig. 1r). b-gal+ cells were observed in the forming preplate of the medial, dorsolateral and ventral pallium (Supplementary Fig. 1). b-gal+ cells were located mostly dorsal to the PSB at rostral levels (Fig. 1o,p) and preferentially ventral to the PSB at more caudal levels (Fig. 1q,r). Between E11.5 and E12.5 Dbx1-derived b-gal+ cells seemed to be streaming ventrally and dorsally (Fig. 1k), and many were located in the preplate/marginal zone of the piriform territory and of the medial and dorsal pallium. b-gal+ nuclei in the marginal zone were oriented both parallel and perpendicular to the pial surface, and the number of nuclei and cell bodies oriented perpendicular to the surface increased with time (Supplementary Fig. 1). We believe that round nuclei perpendicular to the pial surface correspond to cells that have stopped migrating and have reached their final position. Thus, Dbx1 progenitors in the septum and VP generate mostly preplate/marginal zone cells between E10.5 and E12.5, and some Dbx1-derived cells seem to have already reached their final destination at E12.5. In order to test the capacity of Dbx1-derived cells to migrate, explants containing Dbx1+ progenitors were grown in a collagen matrix. Beginning at 1 d in vitro (DIV), b-gal+ cells were observed within and at a distance from rostral PSB (n ¼ 6) and caudal PSB
1004
(n ¼ 6) explants of Dbx1nlslacZ/+ E12.5 telencephalons (Supplementary Fig. 1). Similar results were obtained using septum and caudal PSB explants of E11.5 Dbx1Cre;bactin:lacZ embryos after 3 DIV (data not shown). Compared with interneuronal migration from MGE explants at E12.5, both speed and distance of Dbx1-derived b-gal+ cells in PSB and septum explants was very similar (data not shown). Taken together, these results suggest that Dbx1-derived cells are highly motile and migrate from their sites of origin to populate different cortical regions. Dbx1Cre/+;TauGFP cells migrate both dorsally and ventrally To study the routes of migration of Dbx1-derived b-gal+ cells, DiI labeling experiments were performed on coronal slices of E12.0–E12.5 Dbx1Cre/+;TauGFP telencephalons cultured in vitro. One DIV after the insertion of a crystal in the rostral septum (n ¼ 4; Fig. 2a,d–f), DiI+ cells were observed dorsally and ventrally in the marginal zone of the medial and ventral wall (Fig. 2b), respectively, and had traveled a long distance up to the dorsal cortex. Several DiI+ cells were colabeled with GFP (Fig. 2d–f, white arrow) and had a morphology consistent with migrating cells. However, when DiI crystals were inserted at progressively more caudal levels of the medioventral wall, the extent of dorsal migration decreased, whereas that of ventral migration remained unchanged (n ¼ 14, Fig. 2c and data not shown). DiI+/GFP+ cells were detected in a ventral stream up to the ventrolateral wall at the level of the piriform territory. When crystals were inserted at the PSB (n ¼ 11; Fig. 2g–r), DiI+ cells were observed ventrally (Fig. 2h,i), as expected from previous reports29–31. We were surprised to find that DiI+ cells were also detected dorsally in the intermediate zone and marginal zone of the dorsal pallium (Fig. 2g,h,j–r). The migration in the intermediate zone was more prominent in caudal sections. Colabeling of DiI and GFP was observed in cells in the marginal zone of the ventral pallium (Fig. 2i) and the dorsal pallium (Fig. 2j,o,p). DiI+/GFP+ cells were observed reaching as far dorsal as the prospective isocortex and as far ventral as the prospective piriform cortex. The extent of dorsal and ventral migration was quite similar at all caudorostral levels at this stage. DiI+/GFP– cells were also present in the migrating stream (about 30–50% of the total DiI+ cells were GFP–). These results reflect either an incomplete expression of the IRES in Dbx1-derived cells of Dbx1Cre/+ animals or that cells derived from progenitors other than Dbx1-expressing cells, most probably from the ganglionic eminences, can also migrate through the DiI-labeled area toward the cortex. Many GFP+ cells are present at this stage in the basal telencephalon in caudal sections and are likely to have been derived from Dbx1 progenitors in the POA. Thus, Dbx1-derived cells generated in the septum and the ventral pallium ventricular zone migrate in culture dorsally and ventrally along superficial routes of migration and reach the piriform cortex/isocortex and the medial wall/piriform cortex, respectively, within 24 h. Early-born Dbx1-derived cells express Reelin To begin investigating the identity of the cells derived from septum and PSB Dbx1+ progenitors, we first analyzed the time and position of their first appearance in the telencephalon. The first b-gal+ cells to be detected in Dbx1nlslacZ/+ embryos were located in the area of the septum at E10.5 (Fig. 3a and data not shown). At this stage, very few b-gal+ cells were present in proximity to the caudal PSB, whereas cells were detected between E11.0 and E11.5 at the rostral PSB (Fig. 3a,b,i,n and Fig. 1m–r). Dbx1-derived b-gal+ cells were among the first postmitotic cells to be generated, as suggested by their superficial position and by the lack of BrdU colabeling upon injection of BrdU at E10.75 (Fig. 3a,b).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Bright-field
a
b
c
Dil
d
GFP
e
f
Septum
d
DP
g
h
i
j
k
l
p
q
r
j
LGE
i
PSB
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Merge
DP
m
o
n
DP
o
DP
LGE
Figure 2 Dbx1Cre;TauGFP cells migrate dorsally and ventrally from the PSB and the septum in vitro. DiI+/GFP+ cells reach as far as the dorsal cortex in 24 h. (a,g,m) Bright-field images of DiI crystals inserted in the rostral septum (a) and PSB (g,m). (b,h,n) Dark-field images using a rhodamine filter of a,g,m, respectively. (c,d,i,j,o,p) Confocal images of double-labeled DiI and GFP cells. Areas enlarged in d,i,j,o are indicated by boxes in b,h,n. (d–f,j–l) d–f show medial wall dorsal to the septum; c shows basal wall of the telencephalon lateral to the septum; h,j–l,m–r show dorsal cortex and i ventral cortex after DiI insertion at the caudal PSB. (e,k,q) DiI single-label images. (f,l,r) Single-label GFP images. c,d,i,j,o,p show merged images (DiI and GFP). White arrowheads indicate DiI+/GFP+ double-labeled cells and black arrowheads DiI-only labeled cells. Scale bars ¼ 400 mm (a,b,g,h), 100 mm (m,n), 40 mm (c,d,i,j), 20 mm (o,p).
As Reelin seems to be a specific marker for the early-born CajalRetzius neurons in the marginal zone4, we tested whether Dbx1-derived cells express Reelin. The majority of Reelin+ cells at E10.5 are concentrated in the septum and rostral pallium and few in the caudomedial hem (Fig. 3d). Very few, if any, scattered Reelin+ cells are detected in the forming preplate in other telencephalic regions at this stage. Most (98%, n ¼ 153) postmitotic preplate Dbx1-derived cells in Dbx1nlslacZ/+ embryos expressed Reelin at E10.5–E11.0 (Fig. 3a–c). These results strongly suggest that Reelin+ neurons derived from Dbx1 progenitors in the septum were born at E10.5 and are consistent with the reported generation of a vast proportion of Reelin+ layer I neurons at this stage11. In addition, in Dbx1nlslacZ/+ embryos at E11.5 and E12.5, b-gal+/Reelin+ cells were detected at progressively longer distances from the Dbx1 progenitor zones (septum and PSB) up to the medial pallium, dorsal pallium and piriform cortex (Fig. 3e–s). A large proportion of b-gallow (differentiating Dbx1-derived) cells in the marginal zone of Dbx1nlslacZ/+ embryos between E10.5 and E12.5 expressed Reelin (rostrally 82%, n ¼ 116; caudally 67%, n ¼ 30 at E11.5). Rostrally, Dbx1-derived Reelin+ cells were scattered in the marginal zone around the whole telencephalic vesicles including the dorsal cortex (data not shown). Furthermore, at E11.0–E11.5 in the rostral half of the telencephalon, 72% of Reelin+ cells (n ¼ 57) in the piriform region, dorsolateral and medial pallium preplate and 50–60% of Reelin+ cells (n ¼ 84) in the superficial layer of
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
the basolateral telencephalon express b-gal and thus derive from Dbx1 progenitors. As b-gal expression is lost in late postmitotic cells in Dbx1nlslacZ/+ animals, we analyzed Dbx1Cre embryos to trace later derivatives of Dbx1 progenitors (Fig. 3h). In the marginal zone of E12.5 Dbx1Cre/+; bactin:lacZ embryos, about 50–98% of b-gal+ cells were Reelin+, depending on the cortical or subcortical zones, the highest percentage being detected in the septum (98%) and in the rostral and caudal piriform cortex (80–85%). In addition, different proportions of Reelin+ cells were b-gal+ in distinct regions of the telencephalic vesicles. Rostrally and caudally, 90 to 43%, respectively, of Reelin+ cells colabeled with b-gal in the piriform territory, 40–50% in the lateral cortex, 12–20% in the dorsal-most cortex (medial and lateral), 99% in the intermediate medial wall (dorsal to the septum) and around 50–78% in the basal telencephalon. Moreover, beginning at E12.5, not all b-gal+ cells in the cortex expressed Reelin, and b-gal+/Reelin– cells were also detected in the caudal intermediate zone. As we did not observe colabeling of GABA and b-gal in PSB explants of E12.5 Dbx1nlslacZ/+ embryos kept in culture for 48 h (Fig. 6m), and no interneurons seem to be generated from the PSB until at least E12.5–E13.5, we believe that b-gal+ cells in the caudal intermediate zone represent populations of interneurons derived from Dbx1 progenitors in the caudal/ventral septum or AEP/POA (data not shown). These data strongly suggest that between E10.5 and E12.5, Reelin+ marginal zone neurons derived
1005
ARTICLES
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
from the septum and the PSB preferentially populate rostral and dorsolateral/piriform cortex, respectively. As Reelin+ cells are homogeneously distributed around the telencephalic vesicles at E12.5, our results also suggest that caudodorsal and caudomedial cortical regions are populated by Reelin+ cells derived from a Dbx1-independent caudal source, which is likely to be the cortical hem17.
β-gal
BrdU β-gal
Reelin
a
Dbx1 nlslacZ/+ Reelin
b
Dbx1-derived Reelin+ cells are layer I Cajal-Retzius cells As Cajal-Retzius cells are defined by morphological criteria in layer I of the developed cortex, we genetically traced the fate of early Dbx1derived neurons in the late embryonic and postnatal cortex. b-gal+ cells were observed in the marginal zone/layer I and the cortical plate (CP) of the piriform cortex and the isocortex and in the hippocampus at E17
WT BrdU β-gal
Reelin
mRNA
c
Reelin
d
Rostral
c
hem r se
β-gal
β-gal
e
g
h
Reelin
f
pir
r
c
pa d
Septum
r
12–20%
Ige se
mge
98%
40–50% 60% 50–78%
Rostral
Caudal
c
v
Dbx1 nlslacZ/+
Rostral PSB
i
j
k
l
m
pir
pir
pir
Dbx1Cre;βactin:LacZ
n
o
q
p
r
Caudal PSB
r
pir
s
pir s
Figure 3 Early-born Dbx1-derived cells in the preplate/marginal zone express Reelin. (a,b) Immunohistochemistry on a rostral section at septum level of an E10.75 Dbx1nlsLacZ/+ embryo labeled with BrdU 1 h before collection. b A higher-magnification view of a in PSB area. (c) High-magnification views of boxed area in a. (d) Whole-mount in situ hybridization of Reelin mRNA in E10.5 wild-type embryos; lateral view of telencephalic vesicle. Inset: frontal view of the right part of the head. (e–j,n–o) b-gal and Reelin staining in E11.5 Dbx1nlsLacZ/+ telencephalon at the level of the septum (e,f) rostral PSB (i,j) and caudal PSB (n,o). g shows the rostrocaudal level and the areas of confocal images acquisition. h shows schematic representation of Dbx1-derived b-gal+/Reelin+ cells in different regions of E12.5 Dbx1Cre/+;bactin:lacZ telencephalons (coronal section, lateral and dorsal views). (k) X-gal staining of an E12.5 Dbx1nlsLacZ/+ telencephalon section at an intermediate level along the rostrocaudal axis. Inset: magnification of marginal zone in lateral cortex of an E14.5 Dbx1Cre/+;bactin:lacZ embryo showing b-gal+ nuclei parallel (migrating) and perpendicular (resident) to the pial surface. (l,m) b-gal (green) and Reelin (red) staining in E12.5 Dbx1nlsLacZ/+ telencephalon sections at the same level as k. m shows high-magnification view of the piriform cortex. (p) X-gal staining of an E12.5 Dbx1Cre/+;bactin:lacZ section at the same level as k. (q–s) b-gal (red) and Reelin (green) staining in E12.5 Dbx1Cre/+;bactin:lacZ telencephalon sections at the same level as p. r,s are high-magnification images of areas indicated in p. White arrowheads: double-labeled b-gal+/Reelin+ cells. Black arrowheads: Reelin+-only cells. Immunohistochemical images were acquired with a confocal microscope. r: rostral; c: caudal; d: dorsal; v: ventral; se: septum; pir: piriform territory; pa: pallium. Scale bars ¼ 100 mm (a,i,j,l,n,o,q), 40 mm (b), 20 mm (c,e,f,m,r,s).
1006
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
c
pa
E17.5 X-gal
d
d
mz
mz
CA1
DG
cp st
iz
D L
c
i
e
e
VZ/SVZ
M
CA3
f
pa
g
g
mz
h
CA1
cp
j
mz
st f
iz
D L
M
Dbx1Cre ;Tau GFP
VZ/SVZ CA3
V
β-gal
P8
P8 X-gal
DG cp
h
Reelin
BrdU
k
Reelin
l
β-gal
BrdU
m
n
o
P2
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
V
b
Reelin
Hippocampus
Dbx1Cre;βactin:lacZ
a
β-gal
Dbx1Cre;βactin:lacZ Isocortex
Piriform area
Figure 4 Populations of Cajal-Retzius neurons in layer I are derived from Dbx1+ progenitors. (a,b) Location of areas enlarged in c–h. (c–e) X-gal staining on sections from the telencephalon of Dbx1Cre/+;bactin:lacZ E17.5 embryos. (f–h) Same view as c–e in P8 mice. White arrowheads: b-gal+ cells in the marginal zone. Black arrowheads: b-gal+ cells in other cortical layers. (d,g) b-gal+ cells (of which some were Reelin+; data not shown) were also located in the other layers (ventricular zone (VZ)/subventricular zone (SVZ) and cortical plate (CP) of the isocortex of P8 Dbx1Cre/+;bactin:lacZ animals. (i,j) Double labeling with Reelin and b-gal in Dbx1Cre/+;bactin:lacZ P8 animals. CA1, CA3: Ammon’s horn field 1 and 3; DG: dentate gyrus; pa: pallium; st: striatum; mz: marginal zone; cp: cortical plate; iz: intermediate zone; D, dorsal; L, lateral; M, medial; V, ventral. (k–o) Triple labeling with b-gal, Reelin and BrdU on cryostat sections of P2 Dbx1Cre/+;TauGFP cingulate cortex after BrdU injection at E10.5 during gestation. m–o show single confocal images corresponding to merge in l: Reelin (m), BrdU (n) and b-gal (o). l–o show high-magnification view of layer 1 in k. Scale bars ¼ 40 mm (i,j,l–o); 200 mm (c–h,k).
(Fig. 4a,c–e) and P8 (Fig. 4b,f–h) in Dbx1Cre/+;bactin:lacZ animals. In order to determine the birthdates of Dbx1-derived cells present in the postnatal cortex, we analyzed b-gal+ cells in Dbx1Cre/+;TauGFP-IRESnlslacZ animals at P2 after a single BrdU injection at E10.5 of gestation. Dbx1derived b-gal+ cells were observed as in P8 animals in the marginal zone/layer I and the CP (Fig. 4k). However, only b-gal+ cells in the marginal zone/layer I coexpressed Reelin (Fig. 4k,l). In addition, cells in the marginal zone/layer I exclusively were labeled with BrdU, and some of the BrdU+ cells in the marginal zone/layer I were bgal+ and Reelin+ (Fig. 4l–o). We conclude that b-gal+/Reelin+ cells present in the marginal zone/layer I were born at least in part at E10.5; this is consistent with the early birth date of Cajal-Retzius cells. b-gal+ cells (of which some were Reelin+) were also located in the other layers (ventricular zone (VZ)/subventricular zone (SVZ) and CP) of the isocortex of P8 Dbx1cre/+;bactin:lacZ animals (Fig. 4d,g and data not shown). As Reelin+ interneurons have been described in the postnatal cortical plate starting at P5 (refs. 10,11), b-gal+/Reelin+ cells in the CP at P8 are probably later-born Dbx1-derived interneurons. Moreover, b-gal+ cells seemed to start decreasing in number in the isocortex and hippocampus at P8, consistent with the reported progressive disappearance of Cajal-Retzius cells from the marginal zone/layer I after P7 (Fig. 4d,g,e,h). Finally, some b-gal+/Reelin+ cells in the marginal zone/ layer I of Dbx1Cre/+;bactin:lacZ animals at P8 had the typical morphology, position and orientation of Cajal-Retzius neurons: at this stage their cell body had reached a final depth of about 20–30 mm, but they still had ascending branchlets that contacted the pial membrane (Fig. 4i,j).
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
We conclude that Dbx1+ progenitors at the septum and PSB give rise to Reelin+ bona fide postnatal Cajal-Retzius neurons on the basis of the following evidence: (i) the Reelin immunoreactivity of Dbx1-derived cells between E10.5 and E12.5 in the pallial preplate/marginal zone, (ii) the localization of these cells in the marginal zone/layer I of the isocortex, piriform and hippocampus at P8, (iii) their birth date at E10.5 in BrdU-injected P2 animals and (iv) their morphology. Loss of Reelin+ cells upon ablation of Dbx1-expressing cells In order to analyze the effect of eliminating Dbx1 progenitors on Reelin+ cell development, we inserted an IRES-loxP-stop-pGKneo-loxPDTA (diphtheria toxin) cassette into the Dbx1 locus by homologous recombination (Dbx1loxP-stop-loxP-DTA). A functional DTA is expressed exclusively upon Cre-mediated recombination. Mutant animals were crossed with a Nes:Cre mouse line which expresses the Cre recombinase ubiquitously in the neuroepithelium starting around E11.0 (ref. 32), allowing spatially and temporally restricted expression of the toxin. Because of the multiple origins of Reelin+ cells, we first analyzed Reelin mRNA expression using whole-mount in situ hybridization. Although Reelin is widely expressed throughout the telencephalic vesicles at E11.5, some areas seemed to be more intensively stained, namely the septum and the piriform territory (Fig. 5b,c). These same regions show stronger X-gal activity in E11.5 Dbx1Cre/+;bactin:lacZ (Fig. 5a) and thus seem to correspond to areas where two of the migratory routes of Dbx1-derived cells are located. We observed a strong decrease in the number of Reelin-expressing cells in the most rostral and caudal piriform cortex in recombined Dbx1DTA;Nes:Cre
1007
ARTICLES Dbx1Cre/+ ;βactin:LacZ
a
b
e
f se
Dbx1loxP-stop-loxP-DTA
E12.5
E11.5
pir
Dbx1DTA ;Nes:Cre
c
d
se
g
h
pir pir
pir se Dbx1loxP-stop-loxP-DTA
Dbx1loxP-stop-loxP-DTA
Dbx1DTA ;Nes:Cre
i
j
MP
LP
Dbx1DTA ;Nes:Cre
k
l
MP LP PSB
LP
LP PSB
se
Dbx1loxP-stop-loxP-DTA
p
Dbx1DTA ;Nes:Cre
s
q
Dbx1DTA ;Nes:Cre
o
Dorsolateral cortex
Dbx1
n
Cortex loxP-stop-loxP-DTA
Lateral Dbx1loxP-stop-loxP-DTA
m
Dbx1DTA ;Nes:Cre
Cortical hem
Dbx1DTA ;Nes:Cre
se
Dbx1loxP-stop-loxP-DTA
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Dbx1DTA ;Nes:Cre
Dbx1loxP-stop-loxP-DTA
WT
Dbx1loxP-stop-loxP-DTA
t
u hi
se se
embryos at E11.5 (Fig. 5d, white arrowhead) as well as an almost complete loss in the septum (Fig. 5d, black arrowheads). At E12.5, we detected a strong loss of Reelin staining in the rostral piriform, caudal piriform/amygdaloid complex and septum as well as a significant reduction in the ‘intermediate rostrocaudal’ piriform cortex (Fig. 5e– h). An overall reduction of the rostrocaudal axis of the telencephalic vesicles and of the olfactory bulb was also observed. Using a TUNEL reaction we showed that Dbx1-derived cells start to die around E11.0 in the septum and at E11.5 at the PSB (Supplementary Fig. 2). Therefore, it is possible that some early Dbx1-derived cells are spared from cell death and thus account for some of the Reelin+ neurons still present in the piriform cortex and in the most rostrodorsal cortex. Notably, a strong reduction of Reelin expression was detected in the septum as well as in the dorsolateral, medial and caudal piriform cortex in E12.5 Dbx1DTA;Nes:Cre embryo sections (Fig. 5i,j,o–r and data not shown). No differences were observed between wild-type mice and mutants in the cortical hem (Fig. 5m,n). In contrast, when Reelin expression was
1008
hi
Figure 5 Ablation of Dbx1-derived cells results in loss of Reelin+ cells in different cortical regions and in cortical defects. (a) Whole-mount X-gal staining (blue) in E11.5 Dbx1Cre/+;bactin:lacZ telencephalon. (b–h) Whole-mount in situ hybridization with a Reelin mRNA probe (purple) in E11.5 wild-type (Dbx1LoxP-Stop-LoxP-DTA; b,c), E11.5 Dbx1DTA;Nes:Cre (d), E12.5 wild-type (e,g) and E12.5 Dbx1DTA;Nes:Cre (f,h) embryos. White arrowheads: rostral and caudal piriform areas. Black arrowheads: septum. (i,j,m–r) In situ hybridization with a Reelin mRNA probe on sections of E12.5 wild-type (i,m,o,q) and Dbx1DTA;Nes:Cre (j,n,p,r) embryos at rostral (i,j) and caudal (m–r) levels. m–r show highmagnification views of different telencephalic regions. (k,l) In situ hybridization with a Reelin mRNA probe on rostral sections of E14.5 wildtype (k) and Dbx1DTA;Nes:Cre (l) embryos at level equivalent to i,j. High-magnification view of the lateral pallium. LP: lateral pallium; MP: medial pallium; se: septum; pir: piriform cortex. (s–v) Cresyl violet staining of P0 wild-type (s,u) and Dbx1DTA;Nes:Cre (t,v) telencephalons at rostral (s,t) and caudal levels (u,v) showing differences in cortical cytoarchitecture. Insets in s,t: high-magnification view of the cingulate cortex. White arrowheads: position of rhinal fissure. Black arrowheads: position of Layer VIb. hi: hippocampus. Scale bars ¼ 1 mm (a–h), 500 mm (i,j,s–v), 50 mm (k,l–r).
r analyzed at E14.5, no significant differences were observed between the wild-type and ablated cortex (Fig. 5k,l), suggesting that Reelin+ cells from other sources rapidly cover up the regions deprived of Dbx1-derived CajalDbx1DTA ;Nes:Cre Retzius cells. Since these animals die at birth, v to study the effect of Dbx1-derived cell ablation on later cortical development, we analyzed P0 Dbx1DTA;Nes:Cre animals. Differences were consistently observed in the cytoarchitecture of the cerebral cortex between wild-type and mutant animals at both rostral and caudal levels (Fig. 5s–v; n ¼ 3). Defects were more pronounced in the lateral regions of the cortex. The thickness of the cingulate cortex appeared fairly normal (compare insets in Fig. 5s,t). As expected from the rapid repopulation of the ablated cortex with Cajal-Retzius cells from other sources, the mutant cortex did not show a Reeler phenotype, which is characterized by failure of preplate splitting, disorganized cortical plate and cell-dense layer I. Indeed, a cell-poor marginal zone and a distinguishable Layer VIb were present in the mutant cerebral cortex (Fig. 5s–v), suggesting a normal splitting of the preplate. We conclude that ablation of Dbx1 progenitors starting at E11.0 results in (i) loss of Cajal-Retzius cells in distinct regions of the developing cortex, in particular the medial and dorsolateral pallium, and (ii) alteration of the early postnatal cortical cytoarchitecture. VP but not septum-derived Reelin+ cells express calretinin A high proportion, but not all, of the Reelin+ neurons in the marginal zone express calretinin11. In order to determine if Dbx1-derived cells give rise to calretinin+/Reelin+ cells, triple immunolabeling using antibodies against b-gal, Reelin and calretinin were performed on coronal
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Dbx1nlsLacZ/+
E11.5
β-gal Reelin Calr
Calr
GFP
d
Calr
Reelin
e
f
GFP
Calr
g
Piriform
c
Dbx1Cre/+;Tau:GFP
E11.5 β-gal
Dbx1nlsLacZ/+
Reelin
h
β-gal
Calr
i
j
Reelin
k
Piriform
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Reelin
b
Septum
a
E12.5
Dbx1nlsLacZ/+ GABA
l
β-gal
Dbx1Cre;β-actin:lacZ Tub
m
Reelin
n
β-gal
Septum
o
PSB
S
MGE
sections of E11.5 Dbx1nlslacZ/+ telencephalon. In the presumptive piriform cortex marginal zone, almost all (95%) b-gal+ cells were Reelin+, of which 40–50% were calretinin+ (Fig. 6h–k). We were surprised to find that at the pial surface in the septum 95–98% of b-gal+ cells were Reelin+, but none of these b-gal+/Reelin+ cells coexpressed calretinin (Fig. 6a,b). b-gal+/Reelin+/calretinin– cells were also located ventrally and dorsally to the septum. Consistent with these results, in E12.5 Dbx1Cre/+;TauGFP telencephalon, mediorostral cortical GFP+/Reelin+ cells very rarely coexpressed calretinin (5–10%) whereas 43–55% of piriform and isocortical marginal zone GFP+/Reelin+ cells expressed calretinin (Fig. 6c–g). At later stages (E14.5), likely because of the extensive migration from their multiple sites of origin, Reelin+/calretinin+ or Reelin+/calretinin– cells intermingle in different cortical regions. To test whether the lack of calretinin expression in Dbx1-derived septal Reelin+ cells was not just a temporal delay, we cultured PSB and septum explants of E11.5 Dbx1Cre/+;bactin:lacZ embryos in collagen for 3 DIV and immunolabeled for b-gal, Reelin and calretinin. PSB explants (n ¼ 3) contained many b-gal+/Reelin+ cells, and most of them also expressed calretinin (Fig. 6o). Very few b-gal+/Reelin+/ calretinin– cells were observed in these explants compared with the piriform territory in vivo (Fig. 6f,k). These results suggest that b-gal+/Reelin+/calretinin– cells in the VP of E11.5 Dbx1nlslacZ/+ and E12.5 Dbx1Cre/+;TauGFP telencephalons are likely to express calretinin at later stages rather than representing a real ability of VP Dbx1 progenitors to give rise to two distinct Reelin+ cell populations. On the contrary, explants dissected from the septum (n ¼ 3) contained many b-gal+/Reelin+ cells which were mostly calretinin– (Fig. 6n) after 3 DIV. These results suggest that the ventral pallium and the septum are the origin of b-gal+/Reelin+/calretinin+ and b-gal+/Reelin+/ calretinin– cells, respectively, and that the lack of calretinin expression in septum-derived cells is not due to a developmental delay. We conclude that two subpopulations of Cajal-Retzius neurons with distinct
NATURE NEUROSCIENCE VOLUME 8
[
Calr
Figure 6 Dbx1-derived Reelin+ cells from the PSB express calretinin, but those from the septum do not. Confocal microscope images of triple labeling with b-gal (red), Reelin (green) and calretinin (blue) in E11.5 Dbx1nlsLacZ/+ (a,b,h–k) and Reelin (red), GFP (green) and calretinin (blue) in E12.5 Dbx1Cre/+;TauGFP telencephalon (c–g). g shows ventral telencephalic wall including the ventral piriform territory. White arrowheads: triple-labeled b-gal+/Reelin/+calretinin+ cells. Black arrowheads: Reelin+/calretinin+-only cells. Young b-gal+ (b-galhigh) cells in the VZ of the septum and VP are Reelin–/calretinin–. (l) Schematic of the areas dissected as explants of the septum and PSB in m–o. Explants were dissected from E12.5 Dbx1nlsLacZ/+ embryos and kept in culture for 2 d in m and from E11.5 Dbx1Cre/+;bactin:lacZ and for 3 d in n,o. m shows triple labeling with GABA (red), b-gal (green) and b-tubulin (blue). n,o show triple labeling with Reelin (green), bgal (red) and calretinin (blue). Scale bars ¼ 20 mm.
NUMBER 8
[
AUGUST 2005
Calr PSB
characteristics (origin, onset of appearance, migration route, destination and gene expression profile) derive from Dbx1+ progenitors of the septum and the ventral pallium.
DISCUSSION Using mouse genetics we have identified two previously unknown sites of origin of CajalRetzius cells: the septum and the PSB. Two distinct subsets of Cajal-Retzius cells are generated during early development from Dbx1+ septal and PSB progenitors and differ in their site of origin, onset of appearance, migration routes, destination and expression of molecular markers. We propose that distinct subpopulations of Cajal-Retzius cells originate from at least three distinct focal areas, including the caudomedial hem17, at the borders of the developing pallium. Different cortical regions are populated by specific combinations of these Cajal-Retzius subtypes. Genetic tracing of cell populations derived from Dbx1+ progenitors Morphological and immunohistological studies have been used to describe populations of cells according to their position, morphology and gene expression profile. Nevertheless, they have limits in determining the relationship between the cell types observed at different stages and their sites of origin and migration routes. We have used a knock-in strategy at the Dbx1 locus to follow the fate of Dbx1-derived cells. Dbx1 is expressed by progenitors in restricted domains of the telencephalon: the VP at the PSB22,26,27, the septum and the AEP/POA. Anatomical studies of often transient and non-overlapping expression profiles in progenitors or differentiated cells had suggested that the VP gives rise to part of the claustroamygdaloid complex27. However, the transient expression of Dbx1 in the ventricular zone has thus far prevented from tracing the derivatives of this domain. Moreover, because of the lack of specific molecular markers, derivatives of the septum have not yet been analyzed in detail. The analysis of Dbx1nlslacZ and Dbx1Cre/+; reporter:LacZ/GFP animals has permitted us to follow the progeny of Dbx1+ progenitors through their entire lifespan from the ventricular zone to their adult location and thus analyze cell identity, migration routes and final location of Dbx1+ progenitors-derived cells. Indeed, we were able to genetically trace the progeny of Dbx1 progenitors and to identify them as the first Reelin+ neurons to appear in the preplate of the septum and of the VP.
1009
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES Migration routes of Dbx1-derived neurons Subpallial regions have been shown to be the source of tangentially migrating cells into the cortex3,31. We show that tangential migration also occurs between different pallial territories and that Cajal-Retzius cells migrate from focal progenitor sites at the border of the pallium to different regions of the developing cortex. Indeed, septal Cajal-Retzius cells are clearly pallial, as they coexpress Emx1 (A.P., unpublished results), and the expression of the Dbx1 gene in the lateral wall corresponds to the ventral pallium ventricular zone26,27. DiI has been used to study migration of interneurons from the subpallium to the cortex (for review see refs. 3,31). However, migration from the PSB has been particularly difficult to address, as the PSB does not correlate with morphological landmark (angle) and is crossed by many cells from the subpallium migrating towards the cortex. Previous studies using DiI labeling near the PSB suggested that subpallial cells cross the PSB to form the piriform area29, but the origin and molecular identity of these cells was not determined. Moreover, DiI labeling close to the PSB was reported in the rat16,33. However, these studies failed to identify the PSB as the source of dorsally migrating cells. In addition, it has been suggested16 that Reelin+ but calretinin– Cajal-Retzius cells migrate like interneurons from the MGE to the pallium through the marginal zone. We suggest that these Cajal-Retzius cells traverse the MGE by rostrocaudal and ventrodorsal migration but were born in the septum or AEP/POA. Thus, DiI labeling has fallen short in determining the progenitor sites for some migrating cells. The combination of genetic tracing and DiI labeling has allowed us to unequivocally determine the routes of migration of genetically labeled progenies of Dbx1 progenitors. We provide evidence that populations of Reelin+ Cajal-Retzius cells in the marginal zone of the cortex are derived from progenitors in the VP and septum. We describe ventral and a dorsal migration trajectories from the VP ventricular zone and the septum (Supplementary Fig. 3). If the ventral migration from the VP has already been suggested and might correspond to the lateral/ ventral migratory stream29–31, the others had not been reported previously. Three streams of migration for interneurons, similar to the ones we describe in this work, have been identified34, beginning at E11.5 in the mouse. The authors suggested that an interplay might occur between Cajal-Retzius cells and interneurons to ensure proper cortical integration. Dbx1-derived Cajal-Retzius cell migration is in place earlier than that of interneurons from the subpallium and correlates with the time of appearance of the first-born neurons in the preplate. Thus, they may release cues (if any exist) along these early migration paths (E10.5), which could influence the migration of laterborn cells, including interneurons. Regional differences in Dbx1-derived Cajal-Retzius subtypes Our data show that PSB-derived cells migrate dorsally up to the isocortex and ventrally to the piriform cortex. Dbx1-derived cells from the septum reach the medial cortex dorsally and at least as far as the piriform region ventrolaterally. The piriform cortex might, therefore, be of mixed origin with respect to Cajal-Retzius cells and might be populated by cells derived from the VP and the septum. Taking into account recent results17, we believe that at rostral levels, an early Dbx1-derived population of Cajal-Retzius cells generated from the septum will preferentially populate the frontomedial cortex, whereas populations of Cajal-Retzius cells derived from the hem and the PSB (Dbx1-derived) will colonize the caudomedial/dorsal and lateral cortex, respectively (Supplementary Fig. 3). Because of the high motility of Dbx1-derived Cajal-Retzius cells in vitro and in vivo and that of hem-derived Reelin+ cells in utero17, classes of Cajal-Retzius cells generated at different sites have the capacity to intermingle in
1010
certain regions of the developing cortex. Our genetic ablation experiments of Dbx1-derived Cajal-Retzius cells using DTA confirm the tracing studies and show a differential loss of Reelin+ cells in cortical regions. Thus, cortical territories are populated by different combinations of molecularly distinct Cajal-Retzius subtypes from early stages of development, when regionalization takes place, and this might contribute to rendering these territories molecularly distinct. Septum and VP-derived Cajal-Retzius subtypes are distinct Our results suggest that two subpopulations of Cajal-Retzius neurons with distinct characteristics (origin, onset of appearance, migration route, destination and gene expression profile) derive from Dbx1+ progenitors of the septum and the ventral pallium. First, the onset of generation of Dbx1-derived cells in the VP seems to be later than that in the septum and correlates precisely with that of Reelin+ cells. VP and septum-derived Reelin+ cells migrate along distinct routes to different regions of the embryonic pallium and are observed in the marginal zone of their postnatal derivatives. Septum- and VP-derived cells preferentially populate rostral and lateral cortical territories, respectively, and some seem to have reached their final destination very early during development. Finally, Dbx1-derived cells of the VP and septum differ in expression of calretinin in vivo and in vitro. These results strongly suggest that two distinct populations of Reelin+ cells are derived from Dbx1+ progenitors: a calretinin+ population from the VP and a calretinin– population from the septum. The origins of Cajal-Retzius cells have been a long unresolved question. The olfactory primordium was proposed as a source of Cajal-Retzius cells in macaque monkeys5. Our results show that the ventral pallium is the source of a calretinin+ population of Cajal-Retzius neurons invading the mouse isocortical and piriform marginal zone. However, b-gal+/Reelin+/calretinin– cells are also present in the piriform cortex and the isocortex at E12.5. These cells might have been generated in the VP and/or the septum, or alternatively might acquire calretinin expression later. The retrobulbar area was also proposed as the source of a population of Cajal-Retzius neurons4 and calretinin– Cajal-Retzius neurons were described in the marginal zone of the hippocampus10. We show that the septum, close to the retrobulbar area, is a source of calretinin– Cajal-Retzius neurons, invading the rostral cortex and possibly the marginal zone of the hippocampus by rostrocaudal migration. The two subpopulations of Cajal-Retzius neurons (septum- and VP-derived) that we describe are likely to intermingle in the dorsal pallium (Supplementary Fig. 3), consistent with the previous observation in the isocortex of a few calretinin– and a majority of calretinin+ Cajal-Retzius neurons11. Recently, the caudomedial wall of the telencephalic vesicles, including the hem, has been reported to be a site of origin of Reelin+ neurons17. Calretinin is expressed in the majority of these cells at late stages of development. These cells migrate extensively throughout the neocortical marginal zone with a caudomedial-rostrolateral gradient and are likely, therefore, to provide Cajal-Retzius calretinin+ cells to dorsal cortical regions. Our experiments do not exclude that additional sites of origin for Cajal-Retzius cells might exist and that some Cajal-Retzius cells could also be generated in the dorsal pallium ventricular zone, as it has been shown for humans5. However, the three focal sites (hem17, septum and ventral pallium) account for a vast proportion of CajalRetzius cells in the mouse, and molecular evidence is lacking that the dorsal pallium neuroepithelium does produce Cajal-Retzius cells under normal conditions in the mouse. The relative importance of focal sources and local production of Cajal-Retzius cells by the dorsal pallium could distinguish primates and rodents, as in the case of interneurons, and may represent a mechanism to ensure cell
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES diversity and increase complexity required for the evolution of the human cortex. Several reports have described differences between cortical regions that are consistent with the existence of distinct Cajal-Retzius populations and with the fact that the presence of different CajalRetzius subtypes correlates with region-specific properties. In Tbr1 mutant animals35 the piriform and isocortex are hypocellular, but the hippocampus is not. This correlates with a decrease of Reelin expression in Cajal-Retzius cells in the lateral and piriform cortex but not in the medial cortex. In these animals, differences in lamination are also observed in different cortical territories. Moreover, the differences in the phenotype in the medial versus the lateral cortex in Emx1/2 single and double mutants suggest the existence of Cajal-Retzius populations with different origins13,36,37. Notably, we have detected Emx1 expression in Dbx1-derived cells in the septum but not at the PSB at E11.5 (A.P., unpublished results) suggesting that septum- and PSB-derived Cajal-Retzius cells might differ in expression of Emx genes. These results, together with the role of Cajal-Retzius cells in maintenance of the radial glia phenotype8 and in axonal growth38, strongly suggest additional functions of Cajal-Retzius cells besides their general role in lamination and strongly supports the notion of functional heterogeneity of Cajal-Retzius cells. What is the purpose of subtypes of Cajal-Retzius cells in the cortex? Together with the data from previous reports11,17,39, our results show that molecularly distinct Cajal-Retzius subtypes migrate tangentially from at least three focal sources at the borders of the pallium and populate different cortical territories at early stages of development. Even if these three populations of Cajal-Retzius cells intermingle afterwards, cortical territories will differ in the percentage of distinct Cajal-Retzius subtypes, and this might contribute to determine region and/or area-specific properties. Notably, in animals with mutated p73 (a gene expressed in the caudal hem and tenia tecta), hem-derived Cajal-Retzius cells are lost, and an expansion of calretinin expression is detected in dorsal cortical regions15. These data are consistent with our results that show the existence of a rapid compensation mechanism between distinct classes of Cajal-Retzius cells. In addition, a dorsal shift of the entorhinal cortex and a transformation of occipital and posterior temporal areas into an enthorhinal-like cortex is observed in the p73 mutants40. Consistent with these findings, lamination also differs between cortical regions, and the presence of Cajal-Retzius subtypes correlates with differences in the numbers of cell layers (three in allocortical regions, such as the hippocampus or the piriform cortex, four in mesocortical regions and six in the isocortex), and thus it is possible that distinct Cajal-Retzius classes might have a role in regionspecific lamination. Notably, Dbx1 expression is conserved in the septum of the chick telencephalon but not in the PSB (VP) and correlates with the medial cortex being a laminated region in this species, unlike the dorsal ventricular ridge, a derivative of the VP/LP (lateral pallium) in birds and reptiles41. In addition, the presence of an anterior piriform cortex in this species is consistent with a contribution from the septum as we have suggested in the mouse. Thus, the PSB expression of Dbx1 might have been recruited during evolution to support a function or functions specific to mammals. METHODS Generation of Dbx1 mutant mice. The Dbx1nlsLacZ mutant mouse line was generated by replacing the Dbx1 gene coding sequence with an nlslacZ/pGK-neo cassette as previously reported24. In this construct, the lacZ gene coding for a nuclear b-galactosidase protein is translated at the first ATG of the Dbx1 gene. Dbx1loxP-stop-loxP-DTA animals were generated by inserting an IRES-loxP-stoppGK-neo-loxP-DTA cassette into the BamHI restriction site present in the 3¢ UTR of the Dbx1 gene. In this cassette, the open reading frame of the diphtheria
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
toxin gene (DTA)42 is interrupted by a pGK-neo cassette (for selection in embryonic stem cells) flanked by loxP sites43. The cassette is preceded by an IRES (internal ribosome entry site). Dbx1Cre animals were generated by inserting an IRES-CRE-pGK-Hygror cassette into the BamHI site present in the 3¢ UTR of the Dbx1 gene. Recombination was achieved in two steps using the I-SceI-induced gene replacement system developed previously44. Both the Dbx1Cre and Dbx1loxP-stop-loxP-DTA were constructed by inserting an IRES cassette in the same 3¢ UTR site; therefore, expression from the recombinant loci are expected to be very similar. Differences in labeling in Dbx1nlslacZ/+ and Dbx1Cre/+; bactin:lacZ embryos were observed. These are likely to correspond to a delay in the recombination and expression of the reporter gene in Dbx1Cre/+;bactin:lacZ embryos, and thus the earliest Dbx1-derived cells are not labeled in these animals. Use of mice in this study was approved by Veterinary Services of Paris. Animal strains. bactin:loxP-stop-loxP-lacZ reporter animals were a gift from D. Anderson, (California Institute of Technology, Pasadena, California)28. In this transgenic line, the lacZ gene under the control of the chick b-actin promoter is preceded by a transcription-translation stop cassette surrounded by two loxP sites. TauloxP-stop-loxP-MARCKSeGFP-IRES-nlslacZ was obtained by replacing the coding sequence of the Tau gene (microtubule associated protein) with a sequence coding for a MARCKS (myristoylated alanine-rich C-kinase substrate) protein fused to green fluorescent protein (GFP) and followed by an IRESnlslacZ cassette45. The gene coding for the MARCKS protein is preceded by a transcription-translation stop cassette surrounded by two loxP sites. All animals are kept in a C57B6 background. The deleter Nes:Cre animals expressing the Cre recombinase under the control of the Nestin promoter were previously described and were a gift from F. Tronche32 (College de France, Paris). Embryos and postnatal animals were genotyped by PCR using primers specific for the different alleles (Cre, lacZ, GFP, Dbx1 and DTA). Dbx1Cre;TauGFP recombined embryos were sorted directly with a fluorescence binocular lens. In situ hybridization, X-gal staining and immunocytochemistry. For staging of embryos, midday of the vaginal plug was considered as embryonic day 0.5 (E0.5). Embryos for immunocytochemistry were fixed at 4 1C using 4% paraformaldehyde (PFA) in 0.1 phosphate buffer (PB) pH 7.3 for 2 h; rinsed in PBS for 2 h; cryoprotected overnight using 30% sucrose, 0.1 M PB and embedded in O.C.T. compound (Sakura). Embedded tissue was sectioned on a cryostat with a 12 mm step. b-gal activity was revealed by incubating sections or whole-mount embryos for 3 h to overnight at 37 1C in a 600 mg/ml X-gal solution in 0.1 M PB, 2.0 mM MgCl2, 0.01% sodium desoxycholate, 0.02% NP40, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6. In situ hybridization on sections and antibody staining was performed as previously described24. In situ probes were mouse Reelin46, chick Dbx1 (ref. 23) and mouse Dbx1 (ref. 47). Wholemount in situ hybridization was performed according to a previously described protocol48. Immunohistochemistry on sections and explants were performed as previously described23. Primary antibodies were rabbit anti-b-galactosidase (Rockland; 1:1,000), G10 mouse anti-Reelin (1:1,000; gift of A. Goffinet, University of Louvain Medical School, Brussels), goat anti-calretinin (Swant; 1:500); rat anti-BrdU (Accurate Chemical; 1:400). All fluorescent secondary antibodies were purchased from Jackson ImmunoResearch. TUNEL was performed according to the supplier’s protocol (Roche). Postnatal animals at P2 and P8 were perfused using 4% PFA. Dbx1Cre;TauGFP P2 animals and E10.75–E11.0 embryos were obtained from females injected intraperitoneally with a single dose of BrdU (15 mg/kg) at E10.5 of gestation. Explant and slice cultures and DiI injection. After removal from the placenta, embryos were maintained in PBS containing 50 U/ml penicillin G (Invitrogen), 50 mg/ml streptomycin sulfate (Invitrogen) and 6 mg/ml glucose at 0 1C. The same conditions were used for explant and slice cultures. For explant cultures, the head was dissected, the meninges were removed and explants of PSB and septum were isolated from the telencephalic vesicles. After polymerization of a 20 ml layer of collagen (90% Vitrogen 100, 10% 5 culture medium (DMEM 2.5/F12 2.5 (Invitrogen), 0.15% NaHCO3) in a well 15 min at 37 1C, explants were immersed in a second 20 ml drop of collagen and polymerized 45 min at 37 1C before adding 500 ml of the culture medium. For slice cultures, the dissected telencephalon was embedded in 3% low melting point agarose (Invitrogen) in L15 (Invitrogen) supplemented with 50 U/ml penicillin G,
1011
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 50 mg/ml streptomycin sulfate and 5.4 mg/ml glucose at 37 1C, chilled at 0 1C, and coronal sections of 250 mm were prepared using a vibratome. Sections were positioned on a Millicell membrane (0.4 mm, Millipore) laid on 1.1 ml of culture medium in one well of Nunclon (6 wells, Nunc). The culture medium for both explant and slice cultures was prepared as follow: DMEM 0.5, F12 0.5, 2 mM L-glutamine, 6 mg/ml glucose, 0.075% NaHCO3, 10 mM HEPES, 500 U/ml penicillin G, 500 mg/ml streptomycin sulfate, 1 B27 supplement (Invitrogen). DiI crystals (Molecular Probes) were inserted into the septum or PSB of coronal slices at different rostrocaudal levels of Dbx1Cre/+;TauGFP embryos. Slices and explants were cultured at 37 1C in a humidified atmosphere containing 5% CO2 for 1 and 2–4 d, respectively. We analyzed GFP and DiI colabeling using a confocal microscope, and as DiI strong spots could have bled into the green channel, we considered DiI+/GFP+-only cells in which the GFP staining was homogeneously distributed along all the processes and cell body. Thus, it is likely that we underestimated the number of colabeled cells. Images acquisition. Pictures were acquired using a digital camera coupled to a fluorescence binocular lens or a confocal microscope (Leica TCS Sp2). Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We are indebted to T.M. Jessell for having made this work possible. We thank K. Campbell for suggesting that Dbx1 progenitors give rise to Cajal-Retzius cells; M. Sunshine and D. Littman for helping in the generation of the Dbx1loxP-stop-loxP-DTA mouse line; A. Nemes and M. Mendelsohn for embryonic stem cell transfection and injection of the Dbx1Cre line; F. Tronche for providing the Nes:CRE mouse line, D. Anderson for the bactin:loxP-stop-loxP-lacZ mice and A. Goffinet for the G10 anti-Reelin monoclonal antibodies; M. CohenTannoudji and F. Jaisser for the I-SceI-induced gene replacement system; P. Alexandre and R. Goiame for technical help and advice and M. Ensini, S. Garel, C. Goridis, T.M. Jessell and O. Marin for comments on the manuscript. F.B. was the recipient of a fellowship from the Acade´mie Nationale de Me´decine (France). S.A. and M.S. were supported by a grant from the Swiss National Science Foundation, by the Kanton of Basel-Stadt and by the Novartis Research Foundation. A.P. and M.W. are CNRS (Centre National de la Recherche Scientifique) Investigators. This work was supported by the Ministe`re de la Recherche (ACI grant # 0220575) and the Association pour la Recherche sur le Cancer (grant # 4679) to A.P. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 10 May; accepted 27 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Marin-Padilla, M. Cajal-Retzius cells and the development of the neocortex. Trends Neurosci. 21, 64–71 (1998). 2. Kriegstein, A.R. & Noctor, S.C. Patterns of neuronal migration in the embryonic cortex. Trends Neurosci. 27, 392–399 (2004). 3. Marin, O. & Rubenstein, J.L. Cell migration in the forebrain. Annu. Rev. Neurosci. 26, 441–483 (2003). 4. Meyer, G., Goffinet, A.M. & Fairen, A. What is a Cajal-Retzius cell? A reassessment of a classical cell type based on recent observations in the developing neocortex. Cereb. Cortex 9, 765–775 (1999). 5. Zecevic, N. & Rakic, P. Development of layer I neurons in the primate cerebral cortex. J. Neurosci. 21, 5607–5619 (2001). 6. D’Arcangelo, G. et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719–723 (1995). 7. Ogawa, M. et al. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 14, 899–912 (1995). 8. Super, H., Del Rio, J.A., Martinez, A., Perez-Sust, P. & Soriano, E. Disruption of neuronal migration and radial glia in the developing cerebral cortex following ablation of CajalRetzius cells. Cereb. Cortex 10, 602–613 (2000). 9. Del Rio, J.A. et al. A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 385, 70–74 (1997). 10. Alcantara, S. et al. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 18, 7779–7799 (1998). 11. Hevner, R.F., Neogi, T., Englund, C., Daza, R.A. & Fink, A. Cajal-Retzius cells in the mouse: transcription factors, neurotransmitters, and birthdays suggest a pallial origin. Brain Res. Dev. Brain Res. 141, 39–53 (2003). 12. Gorski, J.A. et al. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J. Neurosci. 22, 6309–6314 (2002). 13. Shinozaki, K. et al. Absence of Cajal-Retzius cells and subplate neurons associated with defects of tangential cell migration from ganglionic eminence in Emx1/2 double mutant cerebral cortex. Development 129, 3479–3492 (2002).
1012
14. Meyer, G. & Wahle, P. The paleocortical ventricle is the origin of reelin-expressing neurons in the marginal zone of the foetal human neocortex. Eur. J. Neurosci. 11, 3937–3944 (1999). 15. Meyer, G., Perez-Garcia, C.G., Abraham, H. & Caput, D. Expression of p73 and Reelin in the developing human cortex. J. Neurosci. 22, 4973–4986 (2002). 16. Lavdas, A.A., Grigoriou, M., Pachnis, V. & Parnavelas, J.G. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J. Neurosci. 19, 7881–7888 (1999). 17. Takiguchi-Hayashi, K. et al. Generation of reelin-positive marginal zone cells from the caudomedial wall of telencephalic vesicles. J. Neurosci. 24, 2286–2295 (2004). 18. Jessell, T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 1, 20–29 (2000). 19. Schuurmans, C. & Guillemot, F. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr. Opin. Neurobiol. 12, 26–34 (2002). 20. Campbell, K. Dorsal-ventral patterning in the mammalian telencephalon. Curr. Opin. Neurobiol. 13, 50–56 (2003). 21. Lu, S., Bogarad, L.D., Murtha, M.T. & Ruddle, F.H. Expression pattern of a murine homeobox gene, Dbx, displays extreme spatial restriction in embryonic forebrain and spinal cord. Proc. Natl. Acad. Sci. USA 89, 8053–8057 (1992). 22. Shoji, H. et al. Regionalized expression of the Dbx family homeobox genes in the embryonic CNS of the mouse. Mech. Dev. 56, 25–39 (1996). 23. Pierani, A., Brenner-Morton, S., Chiang, C. & Jessell, T.M. A sonic hedgehog-independent, retinoid-activated pathway of neurogenesis in the ventral spinal cord. Cell 97, 903–915 (1999). 24. Pierani, A. et al. Control of interneuron fate in the developing spinal cord by the progenitor homeodomain protein Dbx1. Neuron 29, 367–384 (2001). 25. Lanuza, G.M., Gosgnach, S., Pierani, A., Jessell, T.M. & Goulding, M. Genetic identification of spinal interneurons that coordinate left-right locomotor activity necessary for walking movements. Neuron 42, 375–386 (2004). 26. Yun, K., Potter, S. & Rubenstein, J.L. Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon. Development 128, 193–205 (2001). 27. Medina, L. et al. Expression of Dbx1, Neurogenin 2, Semaphorin 5A, Cadherin 8, and Emx1 distinguish ventral and lateral pallial histogenetic divisions in the developing mouse claustroamygdaloid complex. J. Comp. Neurol. 474, 504–523 (2004). 28. Zinyk, D.L., Mercer, E.H., Harris, E., Anderson, D.J. & Joyner, A.L. Fate mapping of the mouse midbrain-hindbrain constriction using a site-specific recombination system. Curr. Biol. 8, 665–668 (1998). 29. de Carlos, J.A., Lopez-Mascaraque, L. & Valverde, F. Dynamics of cell migration from the lateral ganglionic eminence in the rat. J. Neurosci. 16, 6146–6156 (1996). 30. Corbin, J.G., Nery, S. & Fishell, G. Telencephalic cells take a tangent: non-radial migration in the mammalian forebrain. Nat. Neurosci. 4, 1177–1182 (2001). 31. Marin, O. & Rubenstein, J.L. A long, remarkable journey: tangential migration in the telencephalon. Nat. Rev. Neurosci. 2, 780–790 (2001). 32. Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99–103 (1999). 33. Tamamaki, N., Fujimori, K.E. & Takauji, R. Origin and route of tangentially migrating neurons in the developing neocortical intermediate zone. J. Neurosci. 17, 8313–8323 (1997). 34. Ang, E.S., Jr., Haydar, T.F., Gluncic, V. & Rakic, P. Four-dimensional migratory coordinates of GABAergic interneurons in the developing mouse cortex. J. Neurosci. 23, 5805–5815 (2003). 35. Hevner, R.F. et al. Tbr1 regulates differentiation of the preplate and layer 6. Neuron 29, 353–366 (2001). 36. Mallamaci, A. et al. The lack of Emx2 causes impairment of Reelin signaling and defects of neuronal migration in the developing cerebral cortex. J. Neurosci. 20, 1109–1118 (2000). 37. Mallamaci, A., Muzio, L., Chan, C.H., Parnavelas, J. & Boncinelli, E. Area identity shifts in the early cerebral cortex of Emx2 –/– mutant mice. Nat. Neurosci. 3, 679–686 (2000). 38. Borrell, V. et al. Reelin regulates the development and synaptogenesis of the layerspecific entorhino-hippocampal connections. J. Neurosci. 19, 1345–1358 (1999). 39. Meyer, G., Soria, J.M., Martinez-Galan, J.R., Martin-Clemente, B. & Fairen, A. Different origins and developmental histories of transient neurons in the marginal zone of the fetal and neonatal rat cortex. J. Comp. Neurol. 397, 493–518 (1998). 40. Meyer, G. et al. Developmental roles of p73 in Cajal-Retzius cells and cortical patterning. J. Neurosci. 24, 9878–9887 (2004). 41. Aboitiz, F., Montiel, J. & Lopez, J. Critical steps in the early evolution of the isocortex: insights from developmental biology. Braz. J. Med. Biol. Res. 35, 1455–1472 (2002). 42. Palmiter, R.D. et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435–443 (1987). 43. Lee, K.J., Dietrich, P. & Jessell, T.M. Genetic ablation reveals that the roof plate is essential for dorsal interneuron specification. Nature 403, 734–740 (2000). 44. Cohen-Tannoudji, M. et al. I-SceI-induced gene replacement at a natural locus in embryonic stem cells. Mol. Cell. Biol. 18, 1444–1448 (1998). 45. Hippenmeyer, S. et al. A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol. 3, e159 (2005). 46. Schiffmann, S.N., Bernier, B. & Goffinet, A.M. Reelin mRNA expression during mouse brain development. Eur. J. Neurosci. 9, 1055–1071 (1997). 47. Lu, S., Wise, T.L. & Ruddle, F.H. Mouse homeobox gene Dbx: sequence, gene structure and expression pattern during mid-gestation. Mech. Dev. 47, 187–195 (1994). 48. Wilkinson, D.G., Bhatt, S., Ryseck, R.P. & Bravo, R. Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development 106, 465–471 (1989).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus Andrew D Huberman1,4, Karl D Murray1, David K Warland1,2, David A Feldheim3 & Barbara Chapman1,2 Axon guidance cues contributing to the development of eye-specific visual projections to the lateral geniculate nucleus (LGN) have not previously been identified. Here we show that gradients of ephrin-As and their receptors (EphAs) direct retinal ganglion cell (RGC) axons from the two eyes into their stereotyped pattern of layers in the LGN. Overexpression of EphAs in ferret RGCs using in vivo electroporation induced axons from both eyes to misproject within the LGN. The effects of EphA overexpression were competition-dependent and restricted to the early postnatal period. These findings represent the first demonstration of eyespecific pathfinding mediated by axon guidance cues and, taken with other reports, indicate that ephrin-As can mediate several mapping functions within individual target structures.
In mammals, retinal ganglion cell (RGC) axons are segregated into eyespecific layers in the lateral geniculate nucleus (LGN). Early in development, however, retinogeniculate axons from the two eyes are intermingled1–3. The segregation of eye-specific projections into layers is an established model system for studying axon targeting during development4. Technically, the term ‘‘layers’’ refers to discrete cellular groupings. However, ‘‘eye-specific LGN layers’’ is also used to refer to the regions of stereotyped size, shape and position formed by RGC axons arising from each eye. (Hereafter we use the term ‘‘layers’’ only in this latter sense.) The regularity of eye-specific layers is a distinguishing feature of mammalian brains; their spatial arrangement is different between, but invariant within, species5. In carnivores such as cats and ferrets, layer A contains axons from the contralateral eye and always resides in the inner portion of the LGN, whereas layer A1 contains axons from the ipsilateral eye and always resides in the outer LGN5. This invariance is in bold contrast to eye-specific projections found elsewhere along the visual pathway, such as eye-specific patches in the superior colliculus (SC)6 or ocular dominance columns in visual cortex7, which vary tremendously across individuals of a given species in terms of their size, shape and position. Numerous studies have shown that altering neural activity perturbs eye-specific retinogeniculate segregation8–12. However, the invariant positioning of eye-specific LGN layers cannot be explained by purely activity-dependent mechanisms13,14 and recent data have challenged the idea that neural activity plays a direct, instructive role in segregation of eye-specific projections to the LGN15. Non-activity-based explanations for patterning of eye-specific layers have been proposed, such as the differential arrival time of axons from the contralateral versus ipsilateral eye13,16,17. Unfortunately, timing of ingrowth is a difficult variable to manipulate, so this hypothesis has never been directly tested. Another
hypothesis is that axon guidance cues mediate patterning of eye-specific layers10,15,18–21, but a direct role for axon guidance cues in the development of eye-specific connectivity has not previously been reported. What sort of axon guidance cue might regulate patterning of eyespecific layers? In mammals with highly developed binocular vision such as carnivores and primates, each ‘‘eye-specific’’ layer receives RGC axons strictly from either the nasal portion of the contralateral retina or the temporal portion of the ipsilateral retina. Indeed, in the LGN of achiasmatic carnivores, axons arising from the nasal retina segregate from those arising from the temporal retina of the same eye, into regions identical to layers A and A1 (ref. 21). Also, animals with coatcolor mutations, despite having aberrant RGC axon decussation patterns at the optic chiasm, still segregate nasal axons from temporal axons within the LGN22,23. These observations indicate that the nasalretina versus temporal-retina distinction (as opposed to the left-eye versus right-eye distinction) is the key parameter for patterning of eyespecific projections in the LGN. Numerous experiments carried out in lower vertebrates and mice indicate that ephrin-As mediate retinotopic mapping of the nasal-temporal axis in the SC and LGN24–30. We wanted to test whether ephrin-As have a second function in retinogeniculate mapping: dictating the stereotyped patterning of the eyespecific LGN layers. We decided to address this question in ferrets because, unlike in mice31,32, eye-specific layers in ferrets obey the nasalversus temporal-retina distinction33, and retinotopic mapping and eye segregation occur during distinct stages of development34–36. In the normal development of eye-specific retinogeniculate projections in the ferret (Fig. 1a,b), retinal innervation of the LGN occurs from embryonic day (E) 27 until roughly E40 (ferret gestation ¼ 42 d)37. Retinotopic mapping is already adult-like at birth in this species; axons that convey information from the same location
1Center for Neuroscience, 1544 Newton Ct., University of California, Davis, California 95616, USA. 2Section of Neurobiology, Physiology and Behavior, 1 Shields Ave., University of California, Davis, California 95616, USA. 3Department of Molecular, Cellular and Developmental Biology, 225 Sinsheimer Labs, University of California Santa Cruz, Santa Cruz, California 95064, USA. 4Present address: Department of Neurobiology, Fairchild Building, Stanford University School of Medicine, Palo Alto, California 94305, USA. Correspondence should be addressed to B.C. (
[email protected]).
Published online 17 July 2005; doi:10.1038/nn1505
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1013
RESULTS EphA and Ephrin-A expression in postnatal visual system We first used affinity-probe binding of EphA3 linked to alkaline phosphatase (EphA3-AP) to detect all the ephrin-A proteins40 in the ferret LGN. Ephrin-A proteins were seen in an outer 4 inner gradient in the LGN (Fig. 1c,d). No staining was evident in LGNs treated with AP alone (Fig. 1e). We also performed in situ hybridization to detect ephrin-A5 mRNA28–30,41. This confirmed the presence of an outer 4 inner gradient of ephrin-A5 mRNA in the LGN that could be seen in both the horizontal (Fig. 1f) and coronal (Fig. 1g) planes. The outer 4 inner gradient was not simply a consequence of edge artifacts; ephrinA5 gradients were also observed in more medial-residing thalamic nuclei, such as the ventral-posterior nucleus (not shown), and were consistently absent from non-LGN edges of the same tissue sections
1014
N
N
Right retina
b
Contra T
O.C.
Left retina T
Left LGN
N
N
Ipsi
Right retina Contra T
O.C.
Left LGN r
e r Inn
Outer Inner
Oute
P1...P10
O.T.
P
A
Normal development of eye-specific segregation
O.T.
A
P
A1
Ephrin-A protein (horiz.)
SEAP (horiz.)
d
e Ephrin-A
c
A
O.T.
O.T.
A
P
Ephrin-A5 mRNA (horiz.)
P
Ephrin-A5 mRNA (coronal)
g
O. T.
f
A
D
O.T.
in visual space terminate along a common line of projection, which extends along the outer-inner axis of the LGN34,35. The line of decussation (contralateral versus ipsilateral projection pattern of RGC axons at the optic chiasm) is also adult-like at birth33. The binocular overlap in the LGN on postnatal day 0 (P0) is due to RGC axons extending rudimentary arborizations at multiple locations along the outer-inner axis of the LGN and ipsilateral eye axons projecting, along with contralateral eye axons, to the inner limit of the LGN (Fig. 1a)2,20,38. Eye-specific segregation is completed by P10 (refs. 2,20,38). This process reflects (i) the elimination of inappropriate arborizations found along RGC axon shafts, (ii) the retraction of ipsilateral eye arborizations from the inner LGN, (iii) the elaboration of ipsilateral eye arborizations in the outer LGN and (iv) the elaboration of contralateral eye arborizations in the inner LGN (Fig. 1b)38,39. Here we show that, during the period of eye-specific segregation, EphAs are differentially expressed in the contralateral-eye RGC axons versus ipsilateral-eye RGC axons that converge on the same line of projection. We also show that ephrin-As are distributed in an outergreater-than-inner (outer 4 inner) gradient within the LGN. This arrangement should promote the characteristic contralateral:inner, ipsilateral:outer mapping of RGC axons to the principal (A and A1) layers of the LGN. EphA overexpression in RGCs using in vivo electroporation supported this hypothesis, forcing axons from both eyes to project into the inappropriate eye-specific regions of the LGN. EphA overexpression did not alter levels or patterns of spontaneous retinal activity. Thus, ephrin-A:EphA interactions directly mediate targeting of eye-specific retinogeniculate projections through their effects on axon guidance.
Left retina Ipsi T
a
A
Figure 1 Eye-specific development and ephrin-As in the ferret LGN. (a,b) Schematic diagram of RGC axon ingrowth and arborization during eyespecific segregation in the P1 and P10 LGN. Horizontal plane is shown and, for simplicity, only the retinal projection to the left LGN is shown. Asterisks (in the retinas) indicate the location of contralateral and ipsilateral RGCs that project to the left LGN. O.C., optic chiasm; T, temporal pole; N, nasal pole; A, contralateral eye layer; A1, ipsilateral eye layer; C, nonprincipal layers; A/P, anterior-posterior axis; O.T., optic tract. (c) Expression of pan-ephrin-A protein in a horizontal section of the P3 ferret LGN. (d) Color-scaled densitometry plot of ephrin-A protein in the P3 LGN. (e) Secreted embryonic alkaline phosphatase (SEAP)-AP shows no staining in the P3 ferret LGN. (f) Outer 4 inner gradient of ephrin-A5 mRNA expression in horizontal section of the P0 ferret LGN. (g) Outer 4 inner gradient of ephrin-A5 mRNA seen in a coronal plane section of the P1 ferret LGN. Asterisks indicate an edge of the same tissue section that does not exhibit dioxigenin (DIG) labeling, indicating that the outer 4 inner gradient in the LGN is not due to edge artifacts. D-V, dorsal-ventral axis; vLGN, ventral lateral geniculate nucleus. Scale bars, 150 mm (c–g).
C
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
P
V
(asterisks in Fig. 1g). No staining or gradients were observed using sense riboprobe controls (data not shown). Next we examined the expression of EphAs and ephrinAs in the developing ferret retina. Using an ephrin-A5-AP probe to detect EphA proteins, we observed a central-greater-than-peripheral (central 4 peripheral) gradient of EphAs within the RGC layer (Fig. 2a–e). The lowest densities of EphAs were found at the far-nasal and far-temporal poles, and the highest density of EphAs was found near the central retina (Fig. 2a–e). A central 4 peripheral gradient was present at all dorsal-ventral retinal locations (Fig. 2e). We also examined the distribution of EphA5 mRNA by in situ hybridization using antisense riboprobes for mouse EphA5 (refs. 28–30) and ferret EphA5. This confirmed the central 4 peripheral gradient of EphA5 mRNA in the RGC layer (Fig. 2f). In situ hybridization also showed the presence of a nasal 4 temporal gradient of mRNA for ephrin-A5 (Fig. 2g), which indicates that the central 4 peripheral expression of EphA5 in the
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
Figure 2 EphAs in the postnatal ferret retina. (a) Horizontal section through the P3 ferret retina labeled for pan-EphA protein. Scale bar, 500 mm. (b–d) High-magnification images of the (b) nasal, (c) central and (d) temporal retina (corresponding to the boxed regions in a). RGC, retinal ganglion cell layer. The dark staining at the top of each image is the photoreceptor layer and pigmented epithelium and vasculature. Scale bar, 200 mm (b–d). (e) Densitometry plot of EphA concentrations in the RGC layer along the nasal-temporal axis of the retina, averaged from dorsal-, mid- and ventralretina sections. (f,g) In situ hybridization with S35-labeled riboprobes, demonstrating (f) a central 4 peripheral gradient of EphA5 mRNA in the P1 ferret retina (horizontal plane) and (g) a nasal 4 temporal gradient of ephrin-A5 mRNA in the P1 ferret retina (also horizontal plane). pONH, peri-optic nerve head; N, nasal pole; T, temporal pole. (f,g) Dashed line encompasses the neural retina. Scale bar, 250 mm. (h) Model for eye-specific mapping of ipsiprojecting RGCs (red arrow) and contra-projecting RGCs (green arrow) from the two eyes, to different locations along a single line of projection (dashed black line) in the LGN. Axons from the far nasal retina (double-headed green arrow) project to multiple locations along the outer-inner axis in the anterior LGN. A single retina is shown only for schematic purposes; in reality the contralaterally projecting axons and the ipsilateral projecting axons that converge on the same line of projection in the LGN arise from opposite retinas.
retina (Fig. 2f) is not simply due to lower RGC densities in the peripheral versus central retina. The nasal 4 temporal expression of ephrin-A5 (Fig. 2g) may also have implications for mapping of retinal projections to the LGN42. Ephrin-A model for eye-specific targeting Ephrin-As have consistently been shown to repel RGC axons expressing relatively higher levels of EphAs24–30,43. In the ferret, the temporal-most 12–20% of RGCs do not cross at the chiasm and thereby project to the ipsilateral LGN32,33. The central 4 peripheral gradient of EphAs in the retina means that there are relatively higher levels of EphAs expressed in the RGC axons from the contralateral eye than in the RGC axons from the ipsilateral eye that converge on a the same line of projection in the binocular (posterior) region of the LGN. The outer 4 inner gradient of ephrin-As in the LGN should therefore repel the contralateral eye axons into the inner LGN (layer A), whereas the ipsilateral eye axons should map to the more outer LGN (layer A1) (Fig. 2h and Supplementary Fig. 1). Axons from the far-nasal retina of the contralateral eye would still map all along the outer-inner axis in the monocular (anterior) LGN (Fig. 2h and Supplementary Fig. 1). We did not directly consider the C layers in this study. For clarity, however, C layers are labeled in the photomicrographs and are discussed below. In vivo electroporation of RGCs To test whether interactions between ephrin-A and EphA regulate eyespecific layer formation, we developed an electroporation protocol to transfect postnatal ferret RGCs in vivo (Fig. 3a). Electroporation with control cDNAs encoding green fluorescent protein (GFP) resulted in widespread GFP expression in the RGC layer within 24 h (Fig. 3b). Retinal electroporation with GFP on P1 followed by an in vivo injection of the anterograde tracer Cholera toxin b-Alexa 594 (red) into the same eye on P10 resulted in complete concordance between the GFP and tracer label on RGC axons within the P10 LGN (Fig. 3c,d). The GFP/tracer-labeled axons terminated in a pattern normal for the P10 ferret LGN2,9,10,15,20. Thus, our electroporation protocol rapidly and stably transfects a large number of RGCs and the transgene is expressed on retinogeniculate axon terminals. Furthermore, our electroporation/ transfection protocol does not itself alter patterning of eye-specific retinogeniculate projections. When we transfected RGCs with EphA3 or EphA5 constructs (EphA3/5) on P1 and then examined the localization of EphA proteins
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
EphA protein
a
N
T
Nasal
Temporal
Central
b
c
d RGC
RGC
e
RGC
EphA levels (arbitrary units)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
200 –600 –400 –200 0 (Nasal) Distance (µm)
EphA5 mRNA
400 600 (Temporal)
Ephrin-A5 mRNA
g
f
H ON
NH
pO
RGC layer
RGC layer
T
T
N
h
N
EphA/ephrin-A model for eye-specific mapping Eph-A5 in the retina Ephrin-A5 in the LGN Line of decussation vLGN
tra
ye -e e ey
n Co
si-
Ip
A
T LGN P
N
in the retina using ephrin-A5-AP, we observed increased EphA levels in the RGC layer, indicating functional overexpression of EphAs (Fig. 3e). EphA3/5 overexpression did not alter RGC density (Fig. 3f). To examine EphA overexpression on RGC axons within the LGN, we electroporated the retinas of P1 ferrets with an EphA5:V5 fusion construct (Supplementary Methods) and then examined the LGN for expression of the fusion protein, using antibodies directed against the V5 epitope tag. Immunoreactivity for EphA5:V5 was evident throughout the LGN (Fig. 3g), indicating that the overexpressed EphA5 protein was trafficked to retinogeniculate axon terminals. Does EphA overexpression perturb eye-specific targeting? In P10 ferrets electroporated with control plasmids on P1, normal eyespecific projections to the LGN were observed (Fig. 4a). By contrast,
1015
ARTICLES Figure 3 In vivo ganglion cell electroporation. RGC layer (P2) Anti-V5 immuno (LGN contralateral (a) Diagram of the electroporation procedure. RGCs to transfected eye) EphA protein (b) Flat-mount view of a P2 retina that was P5 ** electroporated with GFP on P1. Brightly labeled (Horiz.) + – cell bodies are present throughout the RGC layer. vLGN Ant. Scale bar, 150 mm. (c) GFP-labeled RGC axons in Lens the LGN of a P10 ferret that was monocularly electroporated with GFP on P1. The LGN Control LGN ipsilateral to electroporated eye (P10) 1,200 ipsilateral to the electroporated eye is shown in EphA GFP CTβ-594 the horizontal plane; GFP-positive (GFP+) axons 1,000 LGN are in the normal layer-A1 pattern. The normal 800 ipsilateral C layer is also apparent. (d) The GFP600 A1 A1 electroporated eye was also injected with 400 O.T choleratoxin b (CTb-594) to label all RGC 200 C C axons originating from that eye. (c,d) Scale 0 D/M D/P N/M N/P T/M T/P V/M V/P bar, 150 mm. (e) P10 ferret retina that was transfected with EphA5 on P1 and then processed for ephrin-A5-AP affinity probe binding to detect EphA protein. The far-temporal retina is shown, which normally expresses very low levels of EphAs (see Fig. 2). The same result was observed for the far-nasal retina (not shown). Asterisks indicate pigmented epithelium. Scale bar, 200 mm. (f) RGC densities from control and EphA-electroporated retinas (paired t-test; n ¼ 4 retinas per group; error bars represent s.e.m.; D, dorsal; N, nasal; T, temporal; V, ventral; M, mid retina; P, peripheral retina). No significant differences between groups were present at any location. (g) Axons expressing an EphA5:V5 fusion construct seen on RGC axons in the LGN of a P5 ferret that was electroporated in the contralateral eye on P1. Scale bar, 200 mm.
e
b
g
RGCs porated with EphA5-V5 on P1
DNA
a
d
Inn
er
er
P10 ferrets that had been electroporated with EphA3 or EphA5 cDNAs on P1 showed markedly perturbed retinogeniculate projections (Figs. 4 and 5) (n ¼ 14 ferrets: n ¼ 7 EphA3, n ¼ 7 EphA5). Most notably, axons from the ipsilateral eye were mistargeted to the inner LGN, into territory normally occupied only by axons from the contralateral eye (Figs. 4b and 5b–f). In addition, axons from
1016
a
the contralateral eye made targeting errors (compare top panels in Fig. 4a,b). Thus, in contrast to normal and control-electroporated P10 ferrets, in which retinogeniculate inputs are completely segregated into a highly stereotyped pattern of eye-specific layers by P10 (Fig. 4a)2,9,10,15,20, there were severe eye-specific targeting errors and intermingling of contralateral eye and ipsilateral eye axons in the LGN
b
Control Right LGN
c
EphA5 Left LGN
Right LGN
Activity block Left LGN
Right LGN
Merged
Ipsilateral
Contralateral
Left LGN
d
60 50
***
*
***
40
e
* ***
Control 2.0
***
30 20 10 0 Ipsilateral axons
EphA
[
NUMBER 8
1.5
** 1.0 0.5 0
Ipsilateral & contralateral axons
VOLUME 8
N.S
Activity block Aspect ratio
Percentage LGN
Figure 4 Effect of EphA overexpression on eyespecific targeting and comparison to activity blockade. (a–c) Contralateral eye inputs (top), ipsilateral eye inputs (middle) and their merged representation (bottom) in the left and right LGNs of (a) a P10 control ferret, (b) a P10 ferret that was binocularly electroporated with EphA5 on P1 and (c) a P10 ferret that had all retinal activity blocked from P1 to P10. Horizontal sections are shown. O.T., optic tract; MIN, medial intralaminar nucleus; vLGN, ventral lateral geniculate nucleus; A, contralateral layer; A1, ipsilateral layer; C, nonprincipal C layers; the boundaries of A and A1 and the optic tract are shown with dashed lines for the left LGN. The outer-inner axis (perpendicular to eye-specific layers) is shown by arrows (merged panels). Scale bar, 100 mm. (d) Quantification of the extent of the ipsilateral eye projection area and the degree of binocular intermingling in the LGN. Both EphA overexpression and activity blockade caused significant increases in the area of the LGN containing ipsilateral eye input and the intermingling of ipsi- and contralateral axons, compared to controls (***P o 0.005). The effect of activity blockade was significantly greater than the effect of EphA overexpression on both these measures (*P o 0.05, unpaired t-test; n ¼ 22 control cases; n ¼ 15 binocular EphA5; n ¼ 12 activity blocked). (e) Quantification of aspect ratio (long axis:short axis) for ipsilateral eye input to LGN in control (n ¼ 12), EphA-transfected (n ¼ 15) and retinal activity–blocked (n ¼ 11) ferrets. (P 4 0.05, not significant (N.S.); **P o 0.01; t-test).
Ganglion cells/mm2
c
Inn
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
f
[
Ipsilateral projection
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Control
er
Ipsilateral
Location in the LGN
c
n In
r ne In
A
b
A A1
In
ne
A1
r
Ipsilateral
ne
r
e
Merged
In
ne
r
Location in the LGN
f
In
ne
r
EphA5
In
A A1
In
ne
r
[
NUMBER 8
P10
a Control (axon from temporal ipsilateral retina)
Low-magnification
P12
b
A
A
A1 A1 C C
d
EphA (axon from temporal ipsilateral retina)
c
e Maximum arbor extent along outer-inner axis
100%
***
50%
0%
Control EphA P10
f Control (axon from far nasal contralateral retina)
Figure 6 Effects of EphA overexpression on targeting of individual retinogeniculate axons. (a,b) RGC axons labeled from the far temporal retina of (a) a control P10 ferret and (b) a control P12 ferret, seen in the ipsilateral LGN. Lowmagnification photomicrographs show the location within the LGN where axons were imaged (corresponds to same case as in a). Arrows indicate the optic tract. (c,d) RGC axons labeled from the far temporal retina of (c) a P10 EphA5transfected (binocular electroporation) ferret and (d) a P12 EphA5-transfected (binocular electroporation) ferret, in the ipsilateral LGN. Low-magnification image corresponds to c. (e) Quantification of the maximum extent of the outer-inner axis in which axons from the ipsilateral retina are found. Axons from EphA animals projected significantly farther inward than did those from controls (n ¼ 7 control; n ¼ 7 binocular EphA5; ***P o 0.005, paired t-test). (f) RGC axon originating from the far-nasal retina of a control-transfected ferret, seen within the anterior portion of the contralateral LGN. (g) RGC axon labeled from the far nasal retina of an EphA5-electroporated ferret (binocular) seen in the anterior portion of the contralateral LGN. Low-magnification image shows nasal axon in the anterior LGN from an additional control. (a–g) Scale bar, 200 mm. In low-magnification images, scale bar ¼ 400 mm. Horizontal plane is shown.
C
outer-inner axis of the LGN, perpendicular to eye-specific layers. In activity-blocked ferrets, the degree of expansion of the ipsilateral eye territory was approximately equal along the two axes, resulting in an ipsilateral region of larger size, but with the same aspect ratio, as that of control animals (Fig. 4e). In contrast, EphA-transfected animals showed a large expansion along the outer-inner axis, but very little expansion along the anterior-posterior axis, resulting in a significantly lower aspect ratio (Fig. 4e). We also directly compared the degree of ipsilateral eye axon expansion along the anterior-posterior axis in control, EphA-electroporated and activity-blocked ferrets. In the EphA group, ipsilateral eye axons extended over slightly more of
of EphA-electroporated ferrets (Figs. 4b and 5d–f). Indeed, the degrees of ipsilateral eye axon mistargeting and intermingling of binocular projections caused by EphA overexpression were similar in magnitude to the most extreme cases observed after complete retinal activity blockade from P1 to P10 (refs. 9,20) (Fig. 4b–d). Qualitatively, however, the effects of Eph-A overexpression were somewhat different than those caused by retinal activity blockade; retinal activity blockade resulted in axons from the ipsilateral eye extending much farther than normal across both the anterior-posterior (retinotopic) and outerinner (eye-specific) axes of the LGN9,15,20 (Fig. 4c). Overexpression of EphAs, on the other hand, misdirected RGC axons primarily along the
NATURE NEUROSCIENCE VOLUME 8
C
Figure 5 EphA overexpression causes ipsilateral eye axons to misproject into opposite eye territory. (a–c) Ipsilateral eye inputs to the P10 LGN of (a) a control-electroporated ferret, (b) a ferret monocularly electroporated with EphA3 and (c) a ferret binocularly electroporated with EphA5. (d–f) In a P10 ferret that was binocularly electroporated with EphA5 on P1, (d) contralateral eye axons, (e) ipsilateral eye axons and (f) their merged representation. Ipsilateral eye expansion into contralateral eye territory was observed here and in every EphA-electroporated ferret examined (n ¼ 16 ferrets). Horizontal plane is shown. Scale bars, 100 mm. Boxed areas (in schematics at right) indicate the site in the LGN where the photomicrographs were taken.
[
AUGUST 2005
g
P10
Low-magnification
EphA (axon from far nasal contralateral retina)
Contralateral
d © 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
EphA5
EphA3
r ne In
a
1017
ARTICLES Figure 7 Ephrin-A expression in the ferret LGN is developmentally regulated. Whereas ephrin-As are robustly expressed in the P1–P3 LGN (Fig. 1), by P5 (a) they are absent. EphA3-AP was used to detect all ephrin-A ligands; the same downregulation was seen using in situ hybridization for ephrin-A5 mRNA (data not shown). Scale bar, 150 mm. (b) Low-magnification view of one side of the P5 ferret thalamus shows that, whereas ephrin-A labeling is absent from the LGN (dashed lines), ephrin-As remain high in the SC of the same tissue section. Scale bar, 250 mm. (a,b) Horizontal sections are shown. (c–e) Binocular or monocular EphA5 overexpression at ages P5 and older had no detectable effect on eye-specific retinogeniculate segregation. (Tissue from an animal subjected to binocular electroporation is shown.) Normal eyespecific layers were evident in all P5 EphA-electroporated ferrets examined (n ¼ 6 ferrets; n ¼ 3 EphA5; two binocular, one monocular; n ¼ 3 EphA3; two binocular, one monocular). (c) Scale bar, 150 mm. (d,e) High-magnification views of ipsilateral eye layers in the left (d) and right (e) LGN of a P10 ferret that was electroporated with EphA5 on P5. (d,e) Scale bar, 75 mm.
Ephrin-A protein (P5)
a
b LGN vLGN
O.T.
P
LGN r
ter
e Inn
SC
Ou
c P10 LGN (EphA5 overexpression on P5) Left LGN
Contra and ipsi merged
Ou
Right LGN
r ne In vLGN
r te
C
A C
M
IN
A1 C M
IN
O.T.
e A1 C
er
C
er
A1 Inn
Ipsilateral
d
Inn
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
A
the anterior-posterior axis of the LGN than in controls (control mean ¼ 48.1 ± 1.25%; n ¼ 12; EphA mean ¼ 55.5 ± 2.4%, n ¼ 14), an effect that was statistically significant (P o 0.05; unpaired t-test). In the activity-blocked group, ipsilateral eye axons were found over a much greater extent of the anterior-posterior axis when compared to control or EphA animals (activity block mean ¼ 88.25 ± 1.9%, n ¼ 12, P o 0.001 for activity blockade versus control and activity blockade versus EphA). In sum, EphA overexpression in the ferret induced drastic eye-specific pathfinding errors along the outer-inner axis of the LGN (Fig. 6) and significant but relatively less severe retinotopic errors along the anterior-posterior axis. Activity blockade seems to severely alter both eye-specific and retinotopic pathfinding. EphA overexpression perturbs individual axon targeting Whole-retina anterograde tracing of RGC axons shows the macroscopic organization of eye-specific projections to the LGN, but it cannot show whether individual ganglion cell axons make targeting errors within regions containing predominantly same-eye axons, nor can it indicate whether individual axons are displaced primarily along a single axis. Therefore, we traced individual axons arising from RGCs in defined retinotopic locations within the retina. As expected2,38, in every control P10 ferret examined, RGC axons from the temporal portion of the retina were restricted to layer A1 within the ipsilateral LGN (Fig. 6a). At P12, temporal retina RGC axon arborizations formed a more restricted termination zone within A1, presaging the formation of on-off sublamination38 (Fig. 6b). By contrast, in P10 and P12 ferrets that had been electroporated with EphA5 on P1, RGC axons arising
1018
from the temporal retina extended much farther along the outer-inner axis of the LGN (Fig. 6c,d). In half of the cases examined (n ¼ 4), axons terminated all the way at the innermost limit of the LGN (Fig. 6c). In the remaining cases there was a dense terminal zone formed midway along the outer-inner axis of the LGN, but axon terminals could also be seen projecting ectopically into the inner LGN (Fig. 6d). Neither pattern was ever seen in control ferrets of these ages. Quantification showed that ipsilateral projecting axons in the LGN of EphA-electroporated ferrets terminated significantly further inward along the outerinner axis of the LGN (Fig. 6e). Does EphA overexpression cause targeting errors only in the binocular region of the LGN where axons from the two eyes compete? Normally, axons from the far-nasal retina project to the anterior portion of the contralateral LGN (Fig. 6f), which never receives axons from the ipsilateral eye2,20. In P10 ferrets that were electroporated with EphA5 on P1, axons from the far nasal retina were correctly targeted to the anterior contralateral LGN (Fig. 6g) (n ¼ 5 control; n ¼ 7 EphA far nasal axons). Thus, EphA overexpression seems to cause eye-specific targeting errors only in the posterior portion of the LGN where axons from the two eyes converge, consistent with a competition-based model for ephrin signaling29,43. Ephrin-As are developmentally regulated in the LGN Ephrin-As were robustly expressed in the P0–P3 LGN (Fig. 1), but by P5 their levels were reduced conspicuously (Fig. 7a). This was not a false negative, because ephrin-A expression remained high in the SC and inferior colliculus of the same tissue sections where no LGN label was seen (Fig. 7b). Retinal EphAs, on the other hand, were stably expressed until P10 in the central 4 peripheral pattern described above (data not shown). To determine whether the presence of ephrin-As in the LGN is necessary for EphA overexpression to affect eye-specific pathfinding, we electroporated ferrets with EphA3/5 on P5 or P10. Despite robust overexpression of EphA3/5 in RGCs (data not shown), there was no effect on eye-specific projections to the LGN (Fig. 7c–e) (n ¼ 6 ferrets). This indicates that interactions between retinal EphAs and target-derived ephrin-As are critical for eye segregation. DISCUSSION The results presented here are, to our knowledge, the first direct evidence for axon guidance cue–mediated targeting of eye-specific projections. Our data indicate an outer 4 inner gradient of ephrinA ligand that extends along the axis of projection in the LGN. In addition, along a given line of projection, the RGCs that project to the inner LGN (layer A) express higher levels of EphAs than do the RGCs that project to the more outer LGN (layer A1). Based on the fact that
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES ephrin-A ligands repel RGC axons expressing relatively higher levels of EphAs24–30,43, these ephrin-A:EphA distributions ensure that axons from the contralateral retina will project to the inner LGN and that axons from the ipsilateral retina will project to the more outer LGN. Overexpressing EphAs forced axons from the ipsilateral retina inward, into territory normally occupied only by the contralateral eye. Contralateral eye axons were mistargeted within the binocular region of the LGN as well. The targeting errors we observed following EphA overexpression were similar in magnitude to those observed following complete retinal activity blockade from P1 to P10, which is remarkable given that overexpression was induced on a background of an endogenous central 4 peripheral retinal EphA gradient. Our data indicate that precise levels and distributions of retinal EphAs are important for normal eye-specific pathfinding. Developmentally regulated expression of ephrin-As Ephrin-As are rapidly downregulated in the postnatal ferret LGN and EphA overexpression leads to disruptions in eye-specific layering only when ephrin-As are present in the LGN. Previous experiments20,44 showed that delaying the onset of eye-specific segregation until after P10 permanently abolishes normal patterning of eye-specific inputs to the LGN, indicating that there is a critical period for development of this feature. The present data suggest that temporally restricted expression of ephrin-As within the LGN may regulate this critical period. Because eye-specific segregation occurs gradually from P1 to P10 in the ferret2, we were at first surprised to see downregulated ephrin-As in the LGN by P5. In mice too, however, ephrin-As are downregulated in the LGN and SC prior to the retraction of RGC axons to their retinotopically appropriate locations28,29. It remains unknown why ephrin-A downregulation occurs before axon targeting is complete. Eye-specific versus retinotopic pathfinding The ephrin-A expression patterns and the effects of EphA overexpression we describe here directly implicate these molecules in eye-specific retinogeniculate targeting. The effects of EphA overexpression on retinotopic pathfinding, however, were relatively minor in comparison. This is likely because, in ferrets, retinotopic mapping occurs prenatally, before the onset of eye-specific segregation34–36. Ephrin-As may well mediate retinotopic mapping in the ferret, but this is likely to occur at earlier developmental ages than we consider here. Indeed, over 40 years ago, it was proposed that, in animals with a high degree of binocular vision, a central 4 peripheral gradient of a mapping cue would be present in the retina to induce retinotopic mapping of nasal and temporal RGC axons to the same line of projection45. We thus suspect that the central 4 peripheral gradient of retinal EphAs we observed acts in combination with an anterior 4 posterior gradient of ephrin-A in the prenatal ferret LGN to accomplish this. Unfortunately, examining the pattern of ephrin-A expression in the prenatal ferret LGN has not been possible because of the extremely small size of the nucleus at the relevant ages. In mice, retinotopy and eye-specific segregation emerge during the same developmental period and eye-specific layers do not obey the contralateral:nasal, ipsilateral:temporal distinction; RGCs from throughout the entire retina project contralaterally32. Thus, in mice, disrupting ephrin-As should alter both retinotopy and patterning of eye-specific layers, and indeed this is the case28,46. Do neural activity and ephrin-As interact? Altering neural activity has repeatedly been shown to disrupt eyespecific patterning in the LGN8–12. However, there is debate regarding whether the effects observed in those experiments are caused by
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
disruptions in Hebbian plasticity at retino-geniculate synapses or whether they are nonspecific ‘permissive’ effects of the activity manipulations15. Activity manipulation can strongly affect RGC axon outgrowth47 and pathfinding48, both of which could indirectly impact eye-specific segregation. In theory, activity manipulations could also act permissively by perturbing EphA expression. However, this has not been observed; normal EphA and ephrin-A mRNA expression persists in the face of chronic epibatidine application46—a treatment that markedly alters eye-specific retinogeniculate pathfinding in mice11 and ferrets9,15,20. Its is also noteworthy that altering retinal activity causes RGC axons to extend both anteriorly and across the outer-inner axis of the LGN9,15,20, whereas overexpression of EphAs misdirects RGC axons more along the outer-inner axis of the LGN, perpendicular to eye-specific layers (Figs. 4–6). It is unlikely that the phenotype we observed following EphA overexpression reflects alterations in RGC activity levels; if overexpression of EphAs reduced or eliminated RGC activity, then in monocularly electroporated ferrets, the nontransfected eye would have expanded its projection to the LGN at the expense of the transfected eye9,12. This was never the case. Monocular electroporation always resulted in an expansion of axons ipsilateral to the EphA transfected eye (Fig. 5b). We also directly tested whether EphA overexpression affects spontaneous retinal activity by recording from RGCs using multi-site extracellular recordings in P3, P5 and P7 ferret retinal explants. Those experiments confirmed that normally patterned spontaneous retinal activity is present in EphA-electroporated retinas; at every age examined, ‘waves’9,44 of excitation periodically emerged and spread laterally across restricted domains of the retina, engaging closely spaced RGCs to fire in synchrony (Supplementary Figs. 2–4, Supplementary Table 1 and Supplementary Movies 1,2). No significant differences were evident in the correlation strengths measured in control versus EphA-electroporated retinas at any age (Supplementary Figs. 2–4 and Supplementary Table 1). The presence of normal correlated retinal activity patterns indicates that the effects of EphA overexpression on retinogeniculate pathfinding are not due to eliminating or disrupting spontaneous retinal activity. Rather, they reflect direct actions of ephrin-As and EphAs on RGC axon targeting in the LGN. Non-ephrin-A contributions to eye-specific targeting Our ephrin-A model does not address eye-specific segregation in the C layers because in ferrets, eye specificity within the C layers is not well established anatomically until roughly P20 (ref. 2). Mapping of RGC inputs to the C layers may rely on ephrins and/or other cues. Microarray-based genetic screens have shown the presence of molecular markers that distinguish between the C and A/A1 layers of the ferret LGN49, but whether those molecules mediate RGC axon pathfinding remains untested. Our data do not rule out the possibility of axon guidance molecules expressed strictly in the contralateral versus ipsilateral eye layers of the LGN. Others have attempted to identify genes differentially expressed in layer A versus A1 of the ferret LGN and did not find evidence for such markers. They therefore hypothesized that the cues that mediate eye-specific targeting are expressed in gradients49. Our findings support this hypothesis. Differential timing of ingrowth of RGC axons from the contralateral versus ipsilateral retina could also contribute to the invariant positioning of eye-specific layers13. RGC axons from the contralateral eye arrive earlier in the LGN than do axons from the ipsilateral eye16,17. We think it is unlikely, however, that the invariant positioning of eye-specific layers is due only to differences in timing of ingrowth because modern tracing techniques show that in the P1–P3 ferret, axons from the contralateral and ipsilateral eye project to the inner limit of the
1019
ARTICLES
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
LGN15,20. Timing of ingrowth may, however, impart an advantage to contralateral eye axons for securing the innermost LGN through differences in arborization maturation and synaptic efficacy. CONCLUSION We favor a model whereby, after axons from the two eyes map to their retinotopically appropriate locations in the LGN, axons from the contralateral retina are biased to arborize at more inner LGN locations than retinotopically matched axons from the ipsilateral eye, by virtue of the relatively greater levels of EphAs they express. Ephrin-As that are present directly on RGC axons as well as on LGN cells may be important in this process42. METHODS Animals. Male and female pigmented ferrets (Marshall Farms) were maintained on a 16:8 h light:dark cycle. All procedures were in compliance with approved animal protocols from University of California, Davis and US National Institutes of Health guidelines. Affinity probe detection of ephrin-A and EphA proteins. Procedures for AP probe detection of Ephrin-A ligands and receptors were identical to those described previously28,29,40. For detailed procedures, see Supplementary Methods. In situ hybridization. Riboprobes generated from rodent-specific templates were previously shown to work well in ferrets41. Riboprobe templates for mouse ephrin-A5 and EphA5 were generated from early postnatal mouse SC using primers based on verified sequences from the public database at the National Center for Biotechnology and Information (NCBI, http://www. ncbi.nlm.nih.gov/). We cloned a ferret-specific template for EphA5 from neonatal ferret superior and inferior colliculas using PCR amplification with the same primers used to generate mouse EphA5. For detailed procedures, see Supplementary Methods. EphA5:V5 expression plasmid. To examine the distribution of overexpressed EphA5 in the LGN, we fused the epitope tag V5 to the C terminus of fulllength EphA5. Details of this construct are available in the Supplementary Methods. Expressed EphA5-V5 was detected by immunocytochemistry using a monoclonal antibody against the V5 peptide (Invitrogen) at a dilution of 1:100, and secondary detection was done with goat anti-mouse Alexa 594 (Molecular Probes). Affinity probe densitometry analysis. We quantified sections from the dorsal, mid and ventral portions of the retina (Scion Image). The midpoint along the nasal-temporal axis was aligned, scanned and scaled for length, and densitometry values were averaged. The zero point in the plot represents the half-way point between the nasal and temporal poles. Multiple retinas were examined for each age (n ¼ 3–4 at every postnatal day from P0–P10 and on P15). Results were compared to those achieved with SEAP. In vivo ganglion cell electroporation. Full length cDNAs encoding EphA3 or EphA5 in the mammalian expression vector pcDNA3 were used. cDNAs encoding the reporter gene enhanced green fluorescent protein (EGFP; Clontech) and/or the expression vector pcDNA3 alone were used as controls and for coelectroporation experiments. We injected 2 ml of cDNA solution (1 mg/ml) into the vitreal chamber using a 33-gauge needle inserted at the corneo-scleral junction. The eye was clasped with a paddle electrode (1 3 mm; BTX systems). One or two 950-ms, 10- to 12-V pulses were applied (interpulse interval ¼ 100 ms). Although longer pulse trains (5–10 pulses) with these voltages can be used with no evidence of cell death or eye damage, we consistently achieved the highest transfection efficiency by applying only 1–2 pulses. Quantification of RGC density. Measurements of RGC density were carried out from matched locations in the central and peripheral retina of all four quadrants of age-matched control and electroporated flat-mounted retinas. Dye labeling was used to identify RGCs. Our cell counts were comparable to those reported previously12,20,33.
1020
Whole-retina tracing of retinogeniculate afferents. Retinogeniculate projections were labeled using previously published protocols20. CTb conjugated to Alexa dye 488 (green label) was used for the right eye, and CTb conjugated to Alexa dye 594 (red label) was used for the left eye (Molecular Probes; CTb has no biological activity). For detailed procedures, see Supplementary Methods online. Ages written in this article correspond to age at time of death. All retinas were carefully inspected for damage using previously described criteria20. All animals exhibiting retinal damage were excluded from the study (n ¼ 6 ferrets). Imaging and quantification of eye-specific retinogeniculate projections. Image acquisition and quantification of the extent of ipsilateral eye axons and overlap were identical to previous reports12,15,20. For details of quantification of long and short axis length, aspect ratio and extent of ipsilateral eye terminations, see Supplementary Methods online. Labeling and quantification of individual retinogeniculate axons. A small (B1 mm diameter) crystal of DiI (Molecular Probes) was placed in the ventrotemporal or far nasal retina of ferrets using a 33-gauge sterile needle inserted through the sclera. The animal was perfused with 4% paraformaldyhyde 48 h later, which provided time for diffusion of the DiI while the animal was still alive. A more thorough description of the single-axon labeling procedures is available online. To quantify the extent of arborization along the outer-inner axis of the LGN, the distance between the optic tract and the perigeniculate/ LGN border was measured at the location of the axon arborization of interest. The inward-most termination of each temporal axon arborization was measured along this axis and expressed as a percentage for each case (to normalize for differences in the width of the LGN). Seven cases each were examined for control and EphA transfected groups. Retinal activity blockade. Details of the activity blockade procedure have been described previously9,15,20. Ferrets received binocular injections of epibatidine (1–2 ml per eye;1 mM; Sigma) every 48 h from P1 to 10. Recording spontaneous retinal activity. Retinas were isolated and submerged in buffered and oxygenated medium (Eagle’s minimum essential medium, Sigma M7278; n ¼ 2 control; n ¼ 2 EphA5-electroporated retinas were recorded for three ages, P3, P5 and P7, for a total of 12 retinas). Isolated retinas were placed with the RGC layer side down onto a multi-electrode array50 (Multi-Channel Systems), held in place with a piece of dialysis membrane and superfused at 1–2 ml/min at 37 1C. Simultaneous analog data were acquired from the array of 60 electrodes, and individual spike trains were then identified using Offline Sorter (Plexon) using spike amplitude and width clustering. Because many RGCs fire together during a wave event, this standard spike identification method may result in multiple cells being assigned to one spike event because spike signals overlap. For details on the procedure used for quantifying the correlation index, see Supplementary Methods. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank P. Nguyen, R. Kumar, D. Van Der List and G. Woods for technical assistance, M. Greenberg for the gift of the EphA3 and EphA5 expression plasmids and Colin Akerman for permission to adapt his ferret visuotopic map diagram. This work was supported by the US National Eye Institute (NEI; EY11369 to B.C. and EY14689-01 to D.A.F.), the NEI Vision Science Training Fellowship (EY015387 to A.D.H.), NS39094 (E.G. Jones, University of California, Davis, provided support for K.D.M.) and NEI Core Grant (EY12576 to L.M. Chalupa). COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 29 April; accepted 23 June 2005 Published online at http://www.nature.com/natureneuroscience/
1. Rakic, P. Prenatal genesis of connections subserving ocular dominance in the rhesus monkey. Nature 261, 467–471 (1976). 2. Linden, D.C., Guillery, R.W. & Cucchiaro, J. The dorsal lateral geniculate nucleus of the normal ferret and its postnatal development. J. Comp. Neurol. 203, 189–211 (1981).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 3. Shatz, C.J. The prenatal development of the cat’s retinogeniculate pathway. J. Neurosci. 3, 482–499 (1983). 4. Sengpiel, F. & Kind, P.C. The role of activity in development of the visual system. Curr. Biol. 12, R818–R826 (2002). 5. Jones, E.G. The Thalamus-Revisited (Cambridge University Press, Cambridge, UK, 2005). 6. Thompson, I. & Holt, C. Effects of intraocular tetrodotoxin on the development of the retinocollicular pathway in the Syrian hamster. J. Comp. Neurol. 282, 371–388 (1989). 7. Adams, D.L. & Horton, J.C. Capricious expression of cortical columns in the primate brain. Nat. Neurosci. 6, 113–114 (2003). 8. Shatz, C.J. & Stryker, M.P. Prenatal tetrodotoxin infusion blocks segregation of retinogeniculate afferents. Science 242, 87–89 (1988). 9. Penn, A.A., Riquelme, P.A., Feller, M.B. & Shatz, C.J. Competition in retinogeniculate patterning driven by spontaneous activity. Science 279, 2108–2112 (1998). 10. Chapman, B. Necessity for afferent activity to maintain eye-specific segregation in ferret lateral geniculate nucleus. Science 287, 2479–2482 (2000). 11. Rossi, F.M. et al. Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system. Proc. Natl. Acad. Sci. USA 98, 6453–6458 (2001). 12. Stellwagen, D. & Shatz, C.J. An instructive role for retinal waves in the development of retinogeniculate connectivity. Neuron 33, 357–367 (2002). 13. Shatz, C.J. Competitive interactions between retinal ganglion cells during prenatal development. J. Neurobiol. 21, 197–211 (1990). 14. Sanes, J.R. & Yamagata, M. Formation of lamina-specific synaptic connections. Curr. Opin. Neurobiol. 9, 79–87 (1999). 15. Huberman, A.D. et al. Eye-specific retinogeniculate segregation independent of normal neuronal activity. Science 300, 994–998 (2003). 16. Guillery, R.W., Polley, E.H. & Torrealba, F. The arrangement of axons according to fiber diameter in the optic tract of the cat. J. Neurosci. 2, 714–721 (1982). 17. Walsh, C. & Guillery, R.W. Age-related fiber order in the optic tract of the ferret. J. Neurosci. 5, 3061–3069 (1985). 18. Crowley, J.C. & Katz, L.C. Development of ocular dominance columns in the absence of retinal input. Nat. Neurosci. 2, 1125–1130 (1999). 19. Crowley, J.C. & Katz, L.C. Early development of ocular dominance columns. Science 290, 1321–1324 (2000). 20. Huberman, A.D., Stellwagen, D. & Chapman, B. Decoupling eye-specific segregation from lamination in the lateral geniculate nucleus. J. Neurosci. 22, 9419–9429 (2002). 21. Williams, R.W., Hogan, D. & Garraghty, P.E. Target recognition and visual maps in the thalamus of achiasmatic dogs. Nature 367, 637–639 (1994). 22. Guillery, R.W. & Kaas, J.H. A study of normal and congenitally abnormal retinogeniculate projections in cats. J. Comp. Neurol. 143, 73–100 (1971). 23. Guillery, R.W., Scott, G.L., Cattanach, B.M. & Deol, M.S. Genetic mechanisms determining the central visual pathways of mice. Science 179, 1014–1016 (1973). 24. Cheng, H.J., Nakamoto, M., Bergemann, A.D. & Flanagan, J.G. Complementary gradients in expression and binding of ELF-1 and Mek4 in development of the topographic retinotectal projection map. Cell 82, 371–381 (1995). 25. Drescher, U. et al. In vitro guidance of retinal ganglion cell axons by RAGS, a 25 kDa tectal protein related to ligands for Eph receptor tyrosine kinases. Cell 82, 359–370 (1995). 26. Nakamoto, M. et al. Topographically specific effects of ELF-1 on retinal axon guidance in vitro and retinal axon mapping in vivo. Cell 86, 755–766 (1996). 27. Frisen, J. et al. Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system. Neuron 20, 235–243 (1998). 28. Feldheim, D.A. et al. Topographic guidance labels in a sensory projection to the forebrain. Neuron 21, 1303–1313 (1998).
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
29. Feldheim, D.A. et al. Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron 25, 563–574 (2000). 30. Feldheim, D.A. et al. Loss-of-function analysis of EphA receptors in retinotectal mapping. J. Neurosci. 24, 2542–2550 (2004). 31. Godement, P., Salaun, J. & Imbert, M. Prenatal and postnatal development of retinogeniculate and retinocollicular projections in the mouse. J. Comp. Neurol. 230, 552–575 (1984). 32. Herrera, E. et al. Zic2 patterns binocular vision by specifying the uncrossed retinal projection. Cell 114, 545–557 (2003). 33. Cucchiaro, J.B. Early development of the retinal line of decussation in normal and albino ferrets. J. Comp. Neurol. 312, 193–206 (1991). 34. Jeffery, G. Retinotopic order appears before ocular separation in developing visual pathways. Nature 313, 575–576 (1985). 35. Jeffery, G. Shifting retinal maps in the development of the lateral geniculate nucleus. Brain Res. Dev. Brain Res. 46, 187–196 (1989). 36. Chalupa, L.M. & Snider, C.J. Topographic specificity in the retinocollicular projection of the developing ferret: an anterograde tracing study. J. Comp. Neurol. 392, 35–47 (1998). 37. Johnson, J.K. & Casagrande, V.A. Prenatal development of axon outgrowth and connectivity in the ferret visual system. Vis. Neurosci. 10, 117–130 (1993). 38. Hahm, J.O., Cramer, K.S. & Sur, M. Pattern formation by retinal afferents in the ferret lateral geniculate nucleus: developmental segregation and the role of N-methyl-Daspartate receptors. J. Comp. Neurol. 411, 327–345 (1999). 39. Sretavan, D.W. & Shatz, C.J. Prenatal development of retinal ganglion cell axons: segregation into eye-specific layers within the cat’s lateral geniculate nucleus. J. Neurosci. 6, 234–251 (1986). 40. Flanagan, J.G. et al. Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol. 327, 19–35 (2000). 41. Hayes, S.G., Murray, K.D. & Jones, E.G. Two epochs in the development of gammaaminobutyric acidergic neurons in the ferret thalamus. J. Comp. Neurol. 463, 45–65 (2003). 42. Hornberger, M.R. et al. Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons. Neuron 22, 731–742 (1999). 43. Brown, A. et al. Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling. Cell 102, 77–88 (2000). 44. Muir-Robinson, G., Hwang, B.J. & Feller, M.B. Retinogeniculate axons undergo eyespecific segregation in the absence of eye-specific layers. J. Neurosci. 22, 5259–5264 (2002). 45. Sperry, R.W. Chemoaffinity in the orderly growth of nerve fibers and connections. Proc. Natl. Acad. Sci. USA 50, 703–710 (1963). 46. Pfeiffenberger, C. et al. Ephrin-As and neural activity are required for eye-specific patterning during retinogeniculate mapping. Nat. Neurosci. 8, 1020–1025 (2005). 47. Goldberg, J.L. et al. Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity. Neuron 33, 689–702 (2002). 48. Ming, G., Henley, J., Tessier-Lavigne, M., Song, H. & Poo, M. Electrical activity modulates growth cone guidance by diffusible factors. Neuron 29, 441–452 (2001). 49. Kawasaki, H., Crowley, J.C., Livesey, F.J. & Katz, L.C. Molecular organization of the ferret thalamus. J. Neurosci. 24, 9962–9970 (2004). 50. Meister, M., Wong, R.O., Baylor, D.A. & Shatz, C.J. Synchronous bursts of action potentials in ganglion cells of the developing mammalian retina. Science 252, 939–943 (1991).
1021
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Ephrin-As and neural activity are required for eyespecific patterning during retinogeniculate mapping Cory Pfeiffenberger1, Tyler Cutforth2, Georgia Woods1, Jena Yamada1, Rene´ C Renterı´a3, David R Copenhagen3, John G Flanagan4 & David A Feldheim1 In mammals, retinal ganglion cell (RGC) projections initially intermingle and then segregate into a stereotyped pattern of eyespecific layers in the dorsal lateral geniculate nucleus (dLGN). Here we found that in mice deficient for ephrin-A2, ephrin-A3 and ephrin-A5, eye-specific inputs segregated but the shape and location of eye-specific layers were profoundly disrupted. In contrast, mice that lacked correlated retinal activity did not segregate eye-specific inputs. Inhibition of correlated neural activity in ephrin mutants led to overlapping retinal projections that were located in inappropriate regions of the dLGN. Thus, ephrin-As and neural activity act together to control patterning of eye-specific retinogeniculate layers.
In the mammalian visual system, RGCs project to their main forebrain target, the dLGN of the thalamus, in an orderly and stereotypical manner. This order is established during development and can be described by two main components. First, the projection pattern from each eye is topographic, with neighboring RGCs connecting to neighboring positions in the dLGN. The Eph family of receptor tyrosine kinases and their cell surface–bound ligands, the ephrins, act as graded labels that are required for topographic mapping in several areas in the central nervous system, including the two main targets of RGCs, the dLGN and the superior colliculus (SC)1–5. The second organizing feature of visual connectivity is the segregation of projections from each eye, a phenomenon that is thought to depend mechanistically on neural activity. Early in development, the retinogeniculate projections of the two eyes overlap, but then they segregate and form eye-specific layers postnatally6,7. Inhibiting activity in the retina or in the whole brain prevents the segregation of RGC axons8–10. Neural activity has been theorized to drive axon-axon competition for dLGN territory between the two eyes, and indeed, when the balance of activity in the two eyes is altered, inputs from the more active eye occupy a larger area within the dLGN10–14. It is thought that activity-based competition relies on the ability of inputs from each eye to cooperate with one another to strengthen synaptic connections in a Hebbian manner, although exactly how activity functions in this context remains controversial15,16. Although activity-dependent models can account for how eyespecific inputs segregate, they cannot explain the stereotypical placement of the layers within the dLGN. Segregation models based solely on neural activity predict that layer placement should be stochastic, such that in some animals a given layer of the dLGN would be innervated from the left eye whereas in other animals it would be innervated by the
right eye, or alternatively, that axons from each eye would segregate in a ‘salt-and-pepper’ pattern17,18. Several theories have been proposed to explain the stereotypical placement of the eye-specific layers, including temporal differences between ipsi- and contralateral ingrowth into the dLGN, layer-specific molecular labels, and eyespecific axon guidance molecules18–21. Here we test whether ephrins are important for the segregation of eye inputs within the mouse dLGN. EphA receptors and ligands are expressed in opposing gradients along the nasotemporal axis in the retina and also across the recipient SC and dLGN axes. Ephrin-A2 and ephrin-A5 are the predominant ephrin-A ligands that are present in the SC and dLGN and are required in vivo for topographic mapping of RGCs along these axes1,2,5,22. To test the relative contributions of ephrins and presynaptic activity toward the development of retinogeniculate projections, we analyzed retinal inputs to the dLGN in three populations: ephrin-A mutants, wild-type mice without correlated presynaptic activity and ephrin-A mutants without correlated presynaptic activity. RESULTS Ephrin-A expression in the developing retinogeniculate projection Multiple EphA receptors and ephrin-A ligands were expressed in gradients in the developing retinogeniculate projection (Fig. 1 and Supplementary Fig. 1 online). In the RGC layer of the retina, EphA5 and EphA6 were expressed in a temporal (high)-to-nasal (low) gradient, whereas ephrin-A5 was expressed in the opposite nasal (high)-to-temporal (low) gradient. Ephrin-A2 and ephrin-A3 were expressed in RGCs but not in an obvious gradient (data not shown). In the dLGN, ephrin-A2 and ephrin-A5 were expressed in a ventrallateral-anterior (high)–to–dorsal-medial-posterior (low) gradient
1Department of Molecular, Cellular, and Developmental Biology, University of California at Santa Cruz, Santa Cruz, California 95064, USA. 2Center for Neurobiology and Behavior, Columbia University Medical Center, New York, New York 10032, USA. 3Department of Ophthalmology and Department of Physiology, University of California School of Medicine, San Francisco, San Francisco, California 94143, USA. 4Department of Cell Biology and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts 02115, USA. Correspondence should be addressed to D.A.F. (
[email protected]).
Published online 17 July 2005; doi:10.1038/nn1508
1022
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
Figure 1 Expression of EphA receptors and EphA3-AP Ephrin-A5 EphA3-AP Ephrin-A3 EphA7 ephrin-A ligands in the developing mouse visual wt tko system. (a–c) Coronal sections of mouse P0 brain were treated with RNA hybridization probes for dLGN (a) ephrin-A5, (b) EphA7 and (c) ephrin-A3. dLGN dLGN (d,e) Total ephrin-A ligand expression in the developing thalamus consists of ephrin-A2, vLGN vLGN ephrin-A3 and ephrin-A5. Coronal sections were vLGN stained with EphA3-AP (to detect ephrin-A Retina LGN ligands) in (d) wild-type (wt) or (e) ephrin-A2/A3/ dLGN EphA dLGN dLGN A5 triple mutants (tko) at P0. Ephrin-As are DL EphA expressed in gradients across the whole dLGN at igl these early time points. (f,g) Gray-scale T N photomicrographs of coronal sections at P6 after Ephrin-A injection of cholera toxin B–Alexa Fluor 594 and cholera toxin B–Alexa Fluor 488 into left and right vLGN vLGN vLGN VM eyes, respectively, showing the retinal axons from Ephrin-A (f) contralateral and (g) ipsilateral eyes projecting into the dLGN. (h) The same section treated with EphA3-AP to detect ephrin-A ligands in the LGN at P6. No staining was ever seen when alternate sections were stained with AP alone. (i) Schematic of EphA receptor and ephrin-A ligand in the retina and dLGN during early periods of visual mapping. DL, dorsallateral; igl, intergeniculate layer; N, nasal; T, temporal; vLGN, ventral lateral geniculate nucleus; VM, ventral-medial. Dotted lines denote the approximate boundary of the dLGN. Dorsal is to the top, medial is to the left.
a
b
f
g
(along the nasal-temporal mapping axis), whereas EphA7, and possibly other EphA receptors, were expressed in a countergradient. Ephrin-A3 is expressed in small amounts in the dLGN2,3 (Fig. 1). To determine the role of ephrin-A ligands in the mapping of the retinogeniculate projection, we created ephrin-A2/A3/A5 triple-mutant mice by crossing ephrin-A2/A5 double-mutant mice with ephrin-A3 mutant mice1,23. These mice can be viable and fertile, although a substantial number of triple mutants died in utero (data not shown). We first tested whether ephrin-A2, ephrin-A3 and ephrin-A5 account for the bulk of expression of ephrin-As in the dLGN by treating wild-type or triple-mutant coronal thalamic sections with a soluble EphA3–alkaline phosphatase (EphA3-AP) probe that binds to all ephrin-A proteins24. At postnatal day 0 (P0), EphA3-AP recognized a gradient of ephrin-As throughout the dLGN that was ventrallateral (high) to dorsal-medial (low; Fig. 1d), which is consistent with their role in topographic mapping2. At P6, we found that ephrin-A protein became restricted to the contralateral input area of
100 80 60 40 20 0
Ipsi patch length ** * *
wt
dko tko
d Percent ipsi area
c
b
Ipsi area/dLGN area 25 20 15 10 5 0 wt tko
NATURE NEUROSCIENCE VOLUME 8
[
e Number of patches
a
Percent length
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
NUMBER 8
Number of patches per section **
2.5 2.0 1.5 1.0 0.5 0.0
[
wt
c
h
d
e
i
the dLGN (Fig. 1f–h). At all ages tested, EphA3-AP staining in the dLGN was abolished in ephrin-A2/A3/A5 triple mutants (Fig. 1e and data not shown). Retinogeniculate projections in ephrin-A triple-mutant mice To determine whether ephrin-As are involved in the placement and segregation of eye-specific layers in the dLGN, we used a two-color whole-eye-fill tracing paradigm, which allowed us to test the location of each eye’s projections in the dLGN and to quantify defects in the segregation of inputs18. We compared the retinal innervation patterns in the dLGN from wild-type mice and from mice lacking combinations of ephrin-A ligands, including ephrin-A2/A3/A5 triple-mutant mice1,22,23. As shown by others, the inputs from each eye were segregated in wild-type adult mice, with a single ipsilateral patch located in the dorsomedial quadrant of the dLGN7 (Fig. 2a,c,e). This pattern of innervation was also seen in ephrin-A2, ephrin-A3 and ephrin-A5 single mutants and in ephrin-A3/A5 and ephrin-A2/A3
Figure 2 Defects in eye-specific layer placement but not in eye-specific segregation in ephrin-A2/A3/A5 triple-mutant mice. Axons from the right eye are shown in green; axons from the left eye are shown in red. (a,b) A series of coronal sections from anterior (top) to posterior (bottom) showing left and right dLGN in representative adult (a) wild-type (wt) and (b) ephrin-A2/A3/A5 triple-knockout (tko) mice. (c) Distribution of ipsilateral axon location within the dLGN. Data are expressed as a percentage of dLGN length along the longest dorsal-medial to ventral-lateral axis in coronal sections from wildtype, ephrin-A2/A5 double-mutant (dko) and ephrin-A2/A3/A5 triple-mutant mice, showing that the location of eye-specific inputs is defective in ephrin mutants. (d) Quantification of the ratio of percent ipsilateral projection area to total dLGN area in wild-type and ephrin-A2/A3/A5 triple-mutant mice. (e) Quantification of the average number of ipsilateral patches seen in a coronal section. A comparison of wild-type and ephrin-A2/A3/A5 triplemutant mice shows that the ipsilateral projection in the dLGN is patchy in ephrin mutant mice. Dotted lines show the outline of the dLGN. *P o 0.001; **P { 0.001; ANOVA test. Wild type, n ¼ 3 mice (four sections each); ephrin-A2/A5 mutant, n ¼ 8 mice (four sections each); ephrin-A2/A3/A5 mutant, n ¼ 9 mice (four sections each). Scale bar, 200 mm. Dorsal is to the top.
tko
AUGUST 2005
1023
ARTICLES
a
b i
Overlap/ipsi area 100
f
tko wt
80
Percent overlap
e
d
60 40 20 0
g
P4
h
P6
P8 Age
P10
Adult
Figure 3 Time course of eye-specific segregation in wild-type and ephrin-A2/A3/A5 triple-mutant mice. (a–h) Photomicrographs of 200-mm-thick coronal sections showing the retinal projections from each eye into the dLGN in (a,c,e,g) wild-type and (b,d,f,h) ephrin-A2/A3/A5 triple-mutant mice at (a,b) P4, (c,d) P6, (e,f) P8 and (g,h) P10. Each set of three images represents (from left to right) the ipsilateral projection, the contralateral projection and the merged image of one dLGN. Dorsal is to the top, medial is to the right in each image. Scale bar, 200 mm. Dotted line shows the outline of the dLGN. (i) Percent of the ipsilateral area in which contralateral projections are also present (‘overlap’), comparing wild-type and ephrin-A2/A3/A5 mutant mice at P4, P6, P8, P10 and adult. Error bars represent one s.d. in either direction. Wild-type P4, P6, P10: n ¼ 4 mice (16 dLGN sections); wild-type P8, adult, triple mutant P4, P6, P8, P10, adult: n ¼ 3 mice (12 dLGN sections).
1024
a
b
c
d
Overlap/ipsi area * * ** 100 50 0
wt PBS
wt epi
VOLUME 8
[
tko epi
e
NUMBER 8
Overlap/total dLGN 100 * 50 0
[
*
*
wt wt PBS epi
tko epi
f Percent dLGN length
Figure 4 Area of dLGN overlap is increased in epibatidine-treated ephrin-A2/ A3/A5 triple-mutant mice as compared with epibatidine-treated wild-type mice. (a–c) Photomicrographs of 150-mm-thick coronal dLGN sections from P9 (a,b) wild-type and (c) ephrin-A2/A3/A5 mutant mice that received binocular intravitreal (a) control PBS injections or (b,c) epibatidine injections every 24 h from P3 to P7. The pictures are shown in groups of four representing (from left to right) the ipsilateral projection, the contralateral projection, the merged image and a binary image representing dLGN area with overlapping ipsilateral and contralateral projections. Dorsal is to the top, medial is to the right. Scale bar, 200 mm. (d) Quantification of ipsilateral and contralateral axonal overlap between control (wt PBS), wild-type (wt epi), and ephrin-A2/A3/A5/ or ephrin-A2/A3+/A5/ (tko epi) mutant mice, presented as the percentage of the ipsilateral area containing overlapping contralateral projections. (e) Quantification of ipsilateral and contralateral axonal overlap between control, wild-type and ephrin-A2/A3/A5/ plus ephrin-A2/A3+/A5/ mutant mice, presented as the percentage of the total dLGN area containing overlap. (f) Quantification of the ipsilateral patch length between control, wild-type and ephrin-A2/A3/A5/ (or ephrin-A2/A3+/A5/) mutant mice, expressed as the percentage of the dLGN length covered by the ipsilateral patch along the dorsal-medial to ventral-lateral axis. *P { 0.001; **P o 0.005; ANOVA test. wt + PBS, wt + Epi: n ¼ 4 mice (16 dLGN sections); ephrin-A2/A3/A5/ plus ephrin-A2/A3+/A5/+ Epi: n ¼ 4 mice (two of each genotype; 16 dLGN sections).
than in ephrin-A2/A5 double mutants (Fig. 2c), indicating that ephrin-A3 may contribute to ipsilateral patch location through its expression in the dLGN, in retinal axons or in both locations. Threedimensional reconstruction analysis of triple-mutant dLGNs shows that the ipsilateral projections are continuous and are shaped like a branching tube (Supplementary Videos 1 and 2). Notably, the ipsilateral projection did not seem to be random in the absence of ephrin-As. In all triple mutants examined, the ipsilateral projection branched and formed medial and central patches, although the exact location of these patches varied slightly from mouse to
Percent overlap
double mutants (data not shown). In contrast, ephrin-A2/A5 double mutants and ephrin-A2/A3/A5 triple mutants had severe defects in the location of the layers in the dLGN, but the segregation of inputs from each eye still occurred (Fig. 2b–e and Supplementary Fig. 2). Therefore, ephrin-A ligands are required for ipsilateral patch location but not the segregation of eye inputs in the dLGN. In ephrin-A2/A3/A5 triple-mutant mice, the ipsilateral patch expands along the entire dorsoventral axis of the dLGN, roughly corresponding to the nasotemporal mapping axis of the retina25. This phenotype was more severe in ephrin-A2/A3/A5 triple mutants
Percent overlap
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
c
Ipsi patch length 100 *
*
*
50 0
wt PBS
wt epi
tko epi
AUGUST 2005 NATURE NEUROSCIENCE
mouse. Additionally, the two dLGNs from the same mouse showed symmetrical placement defects (Fig. 2b and Supplementary Fig. 2). This symmetrical positioning of the ipsilateral patch is reminiscent of the global symmetry of ocular dominance columns in the squirrel monkey26, whereby column placement differs among individual monkeys, but the column pattern is symmetric within an individual. These findings may indicate that there are additional molecules that participate in layer positioning. It is possible that the improper ipsilateral patch location seen in ephrin-A2/A3/A5 triple-mutant mice could be due to misrouting of axons at the optic chiasm. Nasal axons that normally cross would instead remain ipsilateral and map to their normal ‘contralateral’ termination zone, leading to an ‘ipsi’ patch located in the wrong position. If this were true, we would expect a greater amount of ipsilateral axons in the dLGN. We compared the ratio of ipsilateral patch area to total dLGN area and saw no significant difference between the wild type and ephrin-A2/A3/A5 triple mutants (Fig. 2d). This indicates that the defect seen in ephrin-A2/A3/A5 mutants may not be due to a larger ipsilateral projection into the dLGN or to defects in axon pruning within the dLGN. We also sectioned through the chiasm of mutant mice after labeling each eye’s inputs and saw no obvious defects in the amount of crossing. Finally, we took advantage of the fact that the SC is an exposed structure in early postnatal mice and retrogradely labeled the ipsilateral retina with an injection of DiI into the SC. In both the retinogeniculate and retinocollicular projections, most ipsilateral axons arise from the ventral-temporal retina27, and this was true in ephrin-A2/A3/A5 triple mutants (Supplementary Fig. 3). Taken together, these experiments indicate that ephrin-As may not be required for chiasm recognition. In wild-type mice, axons from the two eyes are intermixed at birth and then segregate by P10 (refs. 6,7). If coarse topography is a prerequisite for eye-specific segregation, one might expect that the segregation of inputs would be delayed or abolished in ephrin-A2/A3/ A5 triple-mutant mice. Even though adult ephrin-A2/A3/A5 triplemutant mice have segregated inputs (Fig. 2), we assessed whether ephrin-As are involved in the normal developmental timing of segregation by carrying out a time-course experiment in which we traced retinal inputs into the dLGN from P4 through adulthood and quantified the percentage of ipsilateral projection area that overlapped with contralateral projection area. In wild-type P4 mice, 92% of the dLGN that received ipsilateral input also contained inputs from the contralateral eye (Fig. 3a,i). Consistent with the findings of others, this overlap decreased with postnatal age to 15% overlap in adults (Fig. 3a,c,e,g)17. Ipsilateral triple-mutant inputs were erroneously positioned as early as
P4, before segregation occurred. Despite these errors, segregation of inputs occurred by P10, similar to what occurs in wild-type mice (Fig. 3b,d,f,h), indicating that coarse topography may not be a prerequisite for the segregation of eye inputs in the LGN. Ephrin-As and neural activity pattern retinal projections Retinal activity is thought to be important for both the establishment and maintenance of eye-specific segregation. Studies in which activity or molecules thought to act downstream of activity have been disrupted show that overlap of eye inputs occurs primarily in the dorsal dLGN7,10,28,29. To determine whether altering presynaptic activity in ephrin-A mutants allows eye-specific inputs to overlap in all regions of the dLGN, we injected epibatidine into both eyes of neonatal pups and assayed the retinogeniculate projection at P9. Epibatidine is a nicotinic acetylcholine receptor agonist that blocks correlated RGC spiking and all calcium waves in vitro by receptor desensitization and disrupts eyespecific segregation in both ferrets and mice7,10,18. Epibatidine injection into both eyes of wild-type mice every 24 h from P3 to P7 prevented segregation at P9 (98% of ipsilateral dLGN area had overlapping contralateral projections as compared with 53% in PBS-injected controls; Fig. 4a,b). Although there was some spread of ipsilateral axons into more ventral regions of the dLGN, the overlap was predominantly in the dorsal dLGN (Fig. 4b,f). This agrees well with studies in mice and ferrets that used epibatidine to assay the role of activity in eyespecific segregation7,10,18,25. Epibatidine prevented eye-specific segregation to a similar degree in ephrin-A2/A3/A5 triple mutants as compared with wild type, but in triple mutants the overlap extended significantly into the ventral dLGN (Fig. 4c–f). This shows that a combination of molecular labels and neural activity act to determine the placement and segregation of eye-specific inputs within the dLGN and indicates that in the absence of ephrin-As and correlated neural activity, regions of the dLGN that are normally occupied by the contralateral eye become competent for innervation from either eye. Ephrin-A function and neural activity Because spontaneous bursting activity in the developing spinal cord regulates EphA4 expression on chick motor axons30, we tested whether EphA receptors in the retina change their expression after inter-retinal injection of epibatidine. We did this in two different ways. First, we isolated total retinal RNA from mice injected with epibatidine or PBS (every 24 h from P3 to P5) and then carried out RT-PCR. We saw no difference in expression of EphA4, EphA5 or EphA6 under these conditions (data not shown). Second, we found no qualitative difference in the spatial distribution of Eph receptors in the retina or of
Figure 5 Spontaneous retinal waves in ephrin-A2/ Spontaneous retinal activity rasters, ephrin-A2/A3/A5 tko Spike correlations A3/A5 triple-mutant retinas. (a) Spike rasters of 1 Normal saline 10 nM epibatidine 2 Single wave spontaneous retinal activity from an ephrinA2/A3/ wt 3 30 Ephrin-A2/A3/A5 tko A5 triple-mutant mouse at P4. Relative electrode 4 1 1 Ephrin-A2/A3/A5 tko + 10 nM epibatidine positions (1–4) for the example neuronal recordings are illustrated in the inset of the right 20 2 2 panel. Closer examination of a typical wave (left panel, 10 s) shows it traveling from electrode 4 to 3 3 10 electrode 1 at 140 mm/s. In contrast, the activity of the same neurons in the presence of 10 nM 4 4 epibatidine shows no waves. (b) Correlation 0 indices were calculated for all pairs of neurons 10 14 18 0 100 200 300 0 100 200 300 100 300 500 700 Time (s) recorded from a P4 wild-type retina (white Interelectrode distance (µm) Time (s) Time (s) circles), a P4 ephrinA2/A3/A5 triple-mutant retina (black circles) and an epibatidine-treated ephrin-A2/A3/A5 triple-mutant retina (black triangles). These are plotted against the distance between the electrodes from which the neuron’s spikes were recorded. In both the wild-type and ephrinA2/A3/A5 mutant retinas, wave activity led to high correlation indices at small distances and lower ones at larger distances. Epibatidine, which eliminated the wave activity but did not eliminate spike activity in the ephrinA2/A3/A5 mutant retina, abolished correlated activity at all distances. wt: n ¼ 3 retinas; ephrin-A2/A3/A5: n ¼ 3 retinas.
a
b
Correlation index
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1025
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES ephrin-A ligands in the dLGN after epibatidine injection as assayed by RNA in situ hybridization (Supplementary Fig. 1). These experiments show that epibatidine does not have a pronounced effect on EphA or ephrin-A expression in the retina or dLGN; however, these techniques cannot discount post-transcriptional regulation of Ephs and ephrins by neural activity. To test whether neural activity patterns in the retina are affected in ephrin-A2/A3/A5 triple-mutant mice, we compared the patterns of neural activity between wild-type and ephrin-A2/A3/A5 triple mutants by recording extracellularly from P4 retinas using a multielectrode array. Like wild-type RGCs, ephrin-A2/A3/A5 RGCs had bursts of action potentials followed by long periods of silence (Fig. 5a). These bursts were highly correlated among nearby RGCs as propagating waves traveled across the recorded retinal area. The addition of 10 nM epibatidine blocked the waves but did not eliminate spontaneous activity. The activity of neighboring RGCs is highly correlated, and the degree of correlation for small time windows decreases over distance31. Notably, triple-mutant retinas had a higher degree of correlation at larger distances in the array (approximately 800 mm) than the wild-type retinas (Fig. 5b). This effect is likely to be due to the waves being somewhat broader and wider in the triple mutant, which could mean that ephrin-As are somehow required for the normal development of the inner retinal circuitry that is responsible for the waves. Nevertheless, segregation of eye-specific inputs in the dLGN occurred in the presence of the retinal waves in triple-mutant mice.
the topographic mapping phase of dLGN development and then act as layer placement labels during the segregation phase. Notably, ephrin-As at P6 are predominantly expressed in the ventrolateral dLGN where they may act to repel ipsilateral axons toward their location in the dorsomedial dLGN (Fig. 1f–h). This expression may be due to changes in ephrin-A expression in dLGN neurons or to ephrin-A ligands that are present on newly arriving nasal RGC axons. Layer-specific expression of ephrin-A ligands has also been observed in the ferret, where topographic mapping is established at birth and eye-specific segregation occurs postnatally between P1 and P10. During the period of eyespecific segregation in ferrets, ephrin-A5 expression is higher in the ipsilateral layer than in the contralateral layer of the dLGN, and ectopic expression of EphA receptors in the postnatal retina causes layering errors, as described in an accompanying article in this issue32. Therefore, just as ephrin gradients have evolved for use in multiple visual targets2 and are proposed to act first in the intermediate target and later in the final target in thalamic-cortical mapping4, they may be used in multiple aspects of mapping within a particular visual target. The relative contributions of guidance cues and neural activity to the functional wiring of the nervous system have long been debated. Here we show, in the model projection from the retina to the dLGN, that both are required for normal wiring. It will be of note to see if the development of structures in the cerebral cortex, such as the formation of cortical columns, will also use a combination of ephrins and neural activity during development.
DISCUSSION The patterning of RGCs within the dLGN involves correct topographic location of contra- and ipsilateral axons, segregation of right and left eye inputs, and the establishment and placement of eye-specific layers. The relative contributions of activity-dependent and -independent mechanisms to each of these aspects of mapping have long been debated. EphA receptors and ephrin-A ligands are required for topographic mapping of the nasal-temporal axis of the retina onto both the SC and the dLGN1–3,22. We show here that ephrin-As are also required for the proper placement of eye-specific inputs in the mouse dLGN but are not essential for the segregation of these inputs. In agreement with others7,10,17, we find that correlated retinal activity is required for the segregation of eye-specific inputs. Notably, the ephrin-A-mediated aspects of mapping (topography and layer placement) act independently of the activity-dependent segregation of inputs. Ephrin-A2/A3/ A5 triple-mutant mice had severe defects in layer placement but still segregated eye inputs in the dLGN with normal developmental timing. In addition, we show that inhibiting correlated presynaptic retinal activity in ephrin-A2/A3/A5 triple-mutant mice abolishes both segregation and layer placement, indicating that the combination of ephrinAs and presynaptic neural activity is necessary to pattern one axis of the retinogeniculate projection. Our analysis of ephrin mutant mice led us to a model whereby a combination of topographic mapping molecules and neural activity–dependent events are parallel mechanisms that together create the stereotypical connectivity patterns in the primary visual system (Supplementary Fig. 4). How might ephrin-As guide the ipsilateral axons to the appropriate place? One possibility is that ipsilateral axons are directed to a specific region of the dLGN by a unique combination of anterior-posterior and dorsal-ventral topographic labels. Ipsilateral axons arise from the ventrotemporal retina, which has high EphA and EphB receptor expression. Therefore, gradients of ephrin-A2 and ephrin-A5 along one axis of the dLGN, combined with an orthogonal gradient of ephrin-Bs, could steer ipsilateral axons to their final location in the dLGN. Alternatively, ephrin-As could act as topographic labels during
METHODS
1026
Mice were maintained in the animal facility at University of California at Santa Cruz (UCSC) and were used in accordance with protocols approved by the UCSC Institutional Animal Care and Use Committee. Whole-eye labeling and visualization of the dLGN. A pulled pipette adapted to a Picospritzer III pressure injection system (Parker Hannifin Corporation) was used to inject 2–3 ml of a 2 mg/ml solution of cholera toxin B–Alexa Fluor 594 or cholera toxin B–Alexa Fluor 488 (Molecular Probes) in PBS into the eye. Mice were killed 2 or 3 d later and intercardially perfused with 4% paraformaldehyde in PBS, and their brains were fixed overnight. Brains were embedded in 2–3% agarose (Sigma) in PBS and 150- to 200-mm coronal sections were cut using a vibratome (World Precision Instruments Inc.). Images were captured with an AxioCam Hrm digital camera through a 20 objective on an Axioskop 2 Plus microscope (Zeiss) and were merged using Adobe Photoshop. For threedimensional confocal reconstruction analysis, 100-mm coronal sections were cut on a vibratome and were mounted on glass slides with Fluoromount-G (Southern Biotech) overnight in the dark. Optical sections (10 mm thick) from five serial sections per brain were imaged on an Axiovert 200 inverted microscope (Zeiss) through the LSM 5 Pascal laser scanning module. Images were acquired into the accompanying LSM 5 Pascal software and then were stacked anterior to posterior using Image J (http://rsb.info.nih.gov/ij/). Quantification of overlap of projections. ImageJ was first used to reduce background with a rolling ball filter of 250 pixels. The dLGN was then selected and isolated so that further manipulations were done only on this region, disregarding the optic tract and vLGN. The isolated dLGNs were then thresholded in an unbiased manner, whereby the pixels in the lowest-intensity quintile, as determined by histogram analysis, were discarded. This approach sufficiently eliminates background while creating a binary image that closely mimics the predicted structure of the unthresholded projections. The thresholded ipsilateral and contralateral images were then compared using the image calculator ‘OR’ function and the area of the resulting image was determined to be ‘overlap’. Percent dLGN containing overlap ¼ (overlap/total dLGN area) 100; percent ipsilateral projections containing overlapping contralateral projections ¼ (overlap/total ipsilateral area) 100. To quantify the length of the dLGN, a line was drawn at an angle from the dorsal-medial dLGN to the vLGN to yield the maximum dimension of the dLGN in each section. Ipsilateral projection placement along that line was then measured.
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Percent dLGN length ¼ (total length of the ipsilateral projection)/(total length of the dLGN) 100. All quantification of dLGN projections was done by researchers who were blind to treatment and genotype. Epibatidine injections. To image overlap at P9, 1–2 ml of 1 mM epibatidine (Biomol) in PBS was injected intravitreally into both eyes every 24 h from P3 to P7 using a Picospritzer III. Injections at P3 and P4 were given through the skin covering the eye; at P5 the skin was cut open to allow the three final injections to be carried out through the same hole in the eye. Mice were killed at P9 and processed for visualization in the same way as the whole-eye fills. To collect RNA and assay EphA and ephrin-A RNA expression at P6, 1–2 ml of PBS or 1 mM epibatidine in PBS was injected intravitreally into both eyes every 24 h from P3 to P5. The first injection was given through the skin covering the eye; at P4 the skin was cut open to allow the final two injections to be carried out through the same hole in the eye. Mice were killed on P6. In situ RNA hybridization. In situ probes for ephrin-A5 (nucleotides 102–682 of the open reading frame), ephrin-A3 (nucleotides 100–687) and EphA7 (nucleotides 721–1193) were used to make antisense and sense digoxigeninlabeled RNA probes. Frozen-section in situ hybridization was done as previously described2. Stained sections were photographed using a cool-pix digital camera (Nikon) mounted on a dissecting microscope. Affinity probe in situ. An EphA3-AP in situ was done as described33. Briefly, brains were dissected from neonatal pups and rapidly embedded in 5% agarose in PBS. Coronal sections (250 mm) were cut using a vibratome, and those containing dLGN were treated with EphA3-AP as floating sections. Stained sections were photographed using a cool-pix digital camera (Nikon) mounted on a dissecting microscope. Multielectrode extracellular recording from retina. Mice were killed on P3– P5, after which an eye was removed. The neural retina was dissected and placed ganglion cell–side down in a recording chamber using nitrocellulose paper as support. The multielectrode chambers (MEA-60 system; MultiChannel Systems [MCS], Germany) consisted of an array of 60 planar electrodes in eight rows spaced 100 mm apart for a total array size of 700 mm2. Retinas were perfused at room temperature and incubated at 34 1C for 1 h before recordings were started, and the temperature was maintained at 34 1C throughout the recordings. The saline consisted of 124 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3 and 22.2 mM glucose, and the pH was maintained at 7.3–7.4 by bubbling with 95%O2/5%CO2 mixed gas. Data were acquired in a response range of 0.1 Hz–3 kHz at 5-kHz sampling rate (MC_Rack, version 2.0; MCS). After recordings were made, action potential waveforms from high-passfiltered data were clustered based on the first two principal components as described previously34 using a k-means algorithm (OfflineSorter, version 1.3; Plexon, Inc). The algorithm eliminated outlier waveforms at a threshold of 1.3 times the mean distance from the calculated cluster center. Obvious automatic sorting errors were corrected for each cluster manually. Timestamps for each action potential of each sorted unit were used to generate peristimulus spike rasters and to carry out auto- and cross-correlation analyses (NeuroExplorer, version 2.6; Nex Technologies). Correlation indices were calculated as described35 using custom macros (IGOR Pro, version 4.0; WaveMetrics). Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank B. Chapman and A. Huberman for discussions and sharing data prior to publication. We thank C. Chen, P. Vanderhaeghen and C. Mason for discussions and critical reading of the manuscript and R. Axel for support (T.C.). This work was supported by a US National Institutes of Health (NIH) grant EY014689 (D.A.F.), an NIH predoctoral training grant GM08646 (C.P.) and NIH grants R01 DC04209 and P01 CA23767 (T.C.). COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 29 April; accepted 24 June 2005 Published online at http://www.nature.com/natureneuroscience/
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1. Feldheim, D.A. et al. Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping. Neuron 25, 563–574 (2000). 2. Feldheim, D.A. et al. Topographic guidance labels in a sensory projection to the forebrain. Neuron 21, 1303–1313 (1998). 3. Feldheim, D.A. et al. Loss-of-function analysis of EphA receptors in retinotectal mapping. J. Neurosci. 24, 2542–2550 (2004). 4. Vanderhaeghen, P. & Polleux, F. Developmental mechanisms patterning thalamocortical projections: intrinsic, extrinsic and in between. Trends Neurosci. 27, 384–391 (2004). 5. McLaughlin, T., Hindges, R. & O’Leary, D.D. Regulation of axial patterning of the retina and its topographic mapping in the brain. Curr. Opin. Neurobiol. 13, 57–69 (2003). 6. Metin, C., Godement, P., Saillour, P. & Imbert, M. [Physiological and anatomical study of the retinogeniculate projections in the mouse.] C. R. Seances Acad. Sci. III 296, 157– 162 (1983). 7. Rossi, F.M. et al. Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system. Proc. Natl. Acad. Sci. USA 98, 6453–6458 (2001). 8. Sretavan, D.W., Shatz, C.J. & Stryker, M.P. Modification of retinal ganglion cell axon morphology by prenatal infusion of tetrodotoxin. Nature 336, 468–471 (1988). 9. Shatz, C.J. & Stryker, M.P. Prenatal tetrodotoxin infusion blocks segregation of retinogeniculate afferents. Science 242, 87–89 (1988). 10. Penn, A.A., Riquelme, P.A., Feller, M.B. & Shatz, C.J. Competition in retinogeniculate patterning driven by spontaneous activity. Science 279, 2108–2112 (1998). 11. Sretavan, D.W. & Shatz, C.J. Prenatal development of retinal ganglion cell axons: segregation into eye-specific layers within the cat’s lateral geniculate nucleus. J. Neurosci. 6, 234–251 (1986). 12. Rakic, P. Development of visual centers in the primate brain depends on binocular competition before birth. Science 214, 928–931 (1981). 13. Godement, P., Salaun, J. & Metin, C. Fate of uncrossed retinal projections following early or late prenatal monocular enucleation in the mouse. J. Comp. Neurol. 255, 97–109 (1987). 14. Stellwagen, D. & Shatz, C.J. An instructive role for retinal waves in the development of retinogeniculate connectivity. Neuron 33, 357–367 (2002). 15. Crowley, J.C. & Katz, L.C. Ocular dominance development revisited. Curr. Opin. Neurobiol. 12, 104–109 (2002). 16. Huberman, A.D. et al. Eye-specific retinogeniculate segregation independent of normal neuronal activity. Science 300, 994–998 (2003). 17. Muir-Robinson, G., Hwang, B.J. & Feller, M.B. Retinogeniculate axons undergo eyespecific segregation in the absence of eye-specific layers. J. Neurosci. 22, 5259–5264 (2002). 18. Huberman, A.D., Stellwagen, D. & Chapman, B. Decoupling eye-specific segregation from lamination in the lateral geniculate nucleus. J. Neurosci. 22, 9419–9429 (2002). 19. Shatz. Emergence of order in visual system development. Proc. Natl. Acad. Sci. USA 93, 602–608 (1996). 20. Crowley, J.C. & Katz, L.C. Development of ocular dominance columns in the absence of retinal input. Nat. Neurosci. 2, 1125–1130 (1999). 21. Chapman, B. Necessity for afferent activity to maintain eye-specific segregation in ferret lateral geniculate nucleus. Science 287, 2479–2482 (2000). 22. Frise´n, J. et al. Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system. Neuron 20, 235–243 (1998). 23. Cutforth, T. et al. Axonal ephrin-As and odorant receptors: coordinate determination of the olfactory sensory map. Cell 114, 311–322 (2003). 24. Flanagan, J.G. & Vanderhaeghen, P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21, 309–345 (1998). 25. Grubb, M.S., Rossi, F.M., Changeux, J.P. & Thompson, I.D. Abnormal functional organization in the dorsal lateral geniculate nucleus of mice lacking the beta 2 subunit of the nicotinic acetylcholine receptor. Neuron 40, 1161–1172 (2003). 26. Adams, D.L. & Horton, J.C. Capricious expression of cortical columns in the primate brain. Nat. Neurosci. 6, 113–114 (2003). 27. Williams, S.E. et al. Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. Neuron 39, 919–935 (2003). 28. Pham, T.A., Rubenstein, J.L., Silva, A.J., Storm, D.R. & Stryker, M.P. The CRE/CREB pathway is transiently expressed in thalamic circuit development and contributes to refinement of retinogeniculate axons. Neuron 31, 409–420 (2001). 29. Huh, G.S. et al. Functional requirement for class I MHC in CNS development and plasticity. Science 290, 2155–2159 (2000). 30. Hanson, M.G. & Landmesser, L.T. Normal patterns of spontaneous activity are required for correct motor axon guidance and the expression of specific guidance molecules. Neuron 43, 687–701 (2004). 31. Demas, J., Eglen, S.J. & Wong, R.O. Developmental loss of synchronous spontaneous activity in the mouse retina is independent of visual experience. J. Neurosci. 23, 2851– 2860 (2003). 32. Huberman, A.D., Murray, K.D., Warland, D.K., Feldheim, D.A. & Chapman, B. Ephrin-As mediate targeting of eye-specific projections to the lateral geniculate nucleus. Nat. Neurosci. 8, 1011–1019 (2005). 33. Flanagan, J.G. In situ analysis of embryos with receptor or ligand fusion protein probes. Curr. Biol. 10, R52–R53 (2000). 34. Tian, N. & Copenhagen, D.R. Visual stimulation is required for refinement of ON and OFF pathways in postnatal retina. Neuron 39, 85–96 (2003). 35. Wong, R.O.L., Meister, M. & Shatz, C.J. Transient period of correlated bursting activity during development of the mammalian retina. Neuron 11, 923–938 (1993).
1027
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Motility-associated hair-bundle motion in mammalian outer hair cells Shuping Jia & David Z Z He Mammalian hearing owes its remarkable sensitivity and frequency selectivity to a local mechanical feedback process within the cochlea. Cochlear outer hair cells (OHCs) function as the key elements in the feedback loop in which the fast somatic motility of OHCs is thought to be the source of cochlear amplification. An alternative view is that amplification arises from active hair-bundle movement, similar to that seen in nonmammalian hair cells. We measured voltage-evoked hair-bundle motions in the gerbil cochlea to determine if such movements were also present in mammalian OHCs. The OHCs showed bundle movement with peak responses of up to 830 nm. The movement was insensitive to manipulations that would normally block mechanotransduction in the stereocilia, and it was absent in neonatal OHCs and prestin-knockout OHCs. These findings suggest that the bundle movement originated in somatic motility and that somatic motility has a central role in cochlear amplification in mammals.
It is generally believed that mechanical amplification by hair cells is necessary to enhance the sensitivity and frequency-selectivity of hearing. In the mammalian cochlea, OHCs function as the key elements in a mechanical feedback loop that most likely involves the OHCs, organ of Corti micromechanics and the tectorial membrane (TM), with inner hair cells (IHCs) responding to the output of the feedback loop1,2. OHCs have a voltage-dependent length change termed electromotility3,4. This somatic motility, when driven by the receptor potential in vivo, is thought to underlie cochlear amplification in mammals1–5. An alternative view is that the amplification arises from active hairbundle motion6,7. Active hair-bundle movements ranging between 5 and 80 nm have been observed in several nonmammalian species and can occur spontaneously with amplitudes in excess of that expected for Brownian motion8–10. Such movements have also been observed as reactions to hair-bundle displacement with compliant probes8,11–13, and in response to changes in membrane potential8,9,13–15. The active hair-bundle movements, intimately related to the reclosure of the mechanotransducer channels8,13 and the myosin motors11,16,17 involved in adaptation, can produce forces that amplify mechanical stimuli6,7. The movements are sensitive to extracellular calcium concentration and can be altered by calcium influx through mechanoelectrical transducer channels8,13,15–17. Active hair-bundle motion has been shown to produce all of the characteristics of the active process in non-mammals, but two recent studies18,19 indicate that hair-bundle motion may also have an important role in cochlear amplification in mammals. One study, using a two-chamber in vitro cochlear preparation of gerbils, showed that nonlinear amplification depends on calcium current through the mechanoelectrical transducer channels18. Small hair-bundle motions of inner hair cells were observed in the same study. Another study
shows that hair bundles of rat OHCs can produce force on a submillisecond timescale19. The force, with a magnitude on the order of 500 pN, is linked to adaptation of the mechanotransducer channels19. To date, however, bundle motion has not been thoroughly examined in mammalian OHCs. To determine whether hair-bundle movements are also present in mammalian OHCs, we evaluated voltage-evoked hair-bundle activity in the cochlea of gerbils and prestin knockout mice5. We found that OHCs show bundle movement with peak responses of up to 830 nm. The movement was insensitive to manipulations that would normally block mechanotransduction in the stereocilia, and it was absent in neonatal OHCs and prestin-knockout OHCs. This result suggests that the bundle movement, under the conditions we studied, was not based on mechanotransducer channels but originated in somatic motility. The motility-associated response seems to overshadow transducer channel–based mechanisms in OHCs. RESULTS Sensory epithelia were dissected from the cochleae of adult gerbils and prestin-knockout mice. The resulting coil preparation was bathed in artificial perilymph and viewed under a water-immersion objective microscope. The sensory epithelium was oriented with the hair bundles pointing up toward the objective. At high magnification, the hair bundles behaved as light pipes13 and appeared as bright V-shaped lines under bright-field illumination (Fig. 1a). To measure bundle motion, the magnified (1,260) image of the edge of the hair bundle was projected onto a photodiode through a rectangular slit. The photodiode-based system, mounted on the photo-port of the microscope, had a 3-dB cutoff frequency of 1,200 Hz and was capable of measuring motion down to roughly 5 nm with moderate averaging and low-pass filtering. Cells were selected if no obvious signs of deterioration in the
Hair Cell Biophysics Laboratory, Department of Biomedical Sciences, Creighton University School of Medicine, 2500 California Plaza, Omaha, Nebraska 68175, USA. Correspondence should be addressed to D.Z.Z.H. (
[email protected]). Published online 24 July 2005; doi:10.1038/nn1509
1028
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
a
b 400 pA
c © 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
0
50
100
150 200 Time (ms)
250
300
d
1.4 mM Ca++ 40 nm
Control 5 µM Ca++
Voltage command 0
100 200 Time (ms)
100 µM streptomycin 300 0
50
100 150 200 Time (ms)
250
Figure 1 Mechanotransducer current and hair-bundle motion of gerbil OHCs. (a) Hair bundles of OHCs under high magnification (63 water-immersion objective) with bright field illumination. The bundles behaved as light pipes and appeared as bright V-shaped lines when focused at their tips. Doubleheaded arrow indicates the direction of bundle motion. Scale bar, 10 mm. (b) Mechanotransducer currents recorded from a gerbil apical-turn OHC from the coil preparation. The bundle was deflected by an oscillating stream from a fluid jet (tip diameter B10 mm) positioned roughly 20–30 mm away from the bundle. The response shown is the average of three trials. The voltage command (102 Hz) to drive the water jet is presented at the bottom of the panel. Inward current is plotted downward. (c) Voltage-evoked bundle motions of a gerbil OHC at two different extracellular calcium concentrations. The 102-Hz voltage command varied the membrane potential from 100 to 40 mV around a holding potential of 70 mV. Positive bundle motion (toward tall cilia) is plotted upward in this and all subsequent figures. (d) Bundle motion before and after perfusion of 100 mM streptomycin into the OHC stereociliary region. The responses in c and d were the averages of 100 trials. The scale bar in c also applies to the responses in d.
300
soma and/or hair bundle were visible at high magnification. Before the voltage-evoked bundle motion was measured, we recorded mechanotransducer currents to verify that the mechanotransducer apparatus in the stereocilia was not damaged. Figure 1b shows an example of such recording from a gerbil apical-turn OHC. The hair bundle was deflected by a fluid jet (with pipette tip diameter of 10 mm) positioned 20–30 mm away from the bundle. Large transducer currents were recorded at the holding potential of 70 mV in the voltage-clamp mode (Fig. 1b). The size of the current was comparable to that observed in previous studies in mammalian OHCs20–22. To determine bundle motions, we applied sinusoidal voltage bursts (102 Hz) to the OHCs through the patch electrode. The voltage command varied the membrane potential from 100 mV to 40 mV, from a holding potential of 70 mV. Examples of the voltage-evoked hair-bundle movements are shown in Fig. 1c (see Supplementary Videos 1,2 for large bundle motion). The observed bundle motion was asymmetrical, with larger bundle motions evoked by depolarization in the direction toward the tallest stereocilia (defined as positive bundle motion) than that evoked by hyperpolarization in the opposite direction (negative bundle motion). The direction of bundle motion during membrane potential change was consistent with that seen in turtle hair cells8,13, but it was of opposite polarity to that seen in bullfrog saccular hair cells14,15. Hair cells of several nonmammalian species show active hair-bundle motion in response to changes in membrane potential8,9,13–15. The active motion, intimately associated with mechanotransducer channel apparatus, is secondary to alteration of calcium influx in the stereocilia and is therefore dependent on the extracellular calcium concentration8,13. We sought to determine whether the bundle motion observed in OHCs operates on a similar basis. We examined bundle motion
when the extracellular calcium concentration was reduced to 5 mM (Fig. 1c). Voltage-evoked bundle motion was compared before and after the ciliary bundle of five cells was perfused with low-calcium medium. We found robust voltage-evoked bundle motion both before and after perfusion, with no statistically significant difference in magnitude. Streptomycin is known to block mechanotransducer channels20 and eliminate active and spontaneous bundle motion13,15. We perfused the ciliary area with 100 mM streptomycin to determine whether it blocked the voltage-evoked bundle motion in OHCs. The bundle motion was not affected by streptomycin (Fig. 1d). Collectively, these results suggest that the observed OHC bundle motion is different from the voltage-evoked bundle motion seen in nonmammalian hair cells. As an alternative to motility derived from mechanotransducer processes, it is possible that bundle motion arises as a consequence of
a 4 DAB
8 DAB 40 nm
12 DAB 0
50
100
150 Time (ms)
200
250
300
b 400 pA
Figure 2 Hair-bundle motion of neonatal gerbil OHCs and mouse OHCs. (a) Voltage-evoked bundle motions measured from 4-, 8- and 12-d-old gerbil OHCs. The voltage command is the same as shown in Fig. 1c. (b) Mechanotransducer currents recorded from an apical-turn OHC of a prestin-knockout mouse. The hair bundle was deflected by a fluid jet (with a tip diameter of 10 mm) positioned roughly 20–30 mm away from the bundle. The cell was held at 70 mV under the voltage-clamp condition. (c) Lack of voltage-evoked bundle motion from the prestin-knockout mouse OHC. (d) Voltage-evoked bundle motion of an apical-turn OHC from wild-type mouse. The stimulus waveform and voltage command for c and d are the same as those shown in Fig. 1c.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
c d
0
40 nm
50
100
150 Time (ms)
200
250
300
1029
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES somatic motility. To examine this possibility, we studied voltage-evoked bundle motion in neonatal gerbil OHCs. Previous studies have shown that the onset of OHC motility occurs around 6–8 days after birth (DAB)23, whereas mechanotransducer apparatus and mechanotransducer current with fast and slow adaptation are apparent before birth in mouse hair cells24. Consequently, mechanotransduction in the hair bundle is mature well before the onset of OHC motility20,21. Voltageevoked bundle motions of apical-turn OHCs were measured from developing gerbils at 4, 8 and 12 DAB (Fig. 2a). When mechanotransduction had developed and somatic motility had not yet developed at 4 DAB, no voltage-evoked bundle motion was detected (n ¼ 10), even though large transducer currents could be measured (data not shown). At 8 DAB, we observed small bundle motion in one of the eight cells examined. At 12 DAB, when all OHCs typically exhibit electromotility23, voltage-evoked bundle motion was detected in all seven cells studied, with a magnitude of approximately 72% of that of the adult OHCs with the same voltage stimulation. The facts that neonatal OHCs do not have voltage-evoked hair-bundle motion before the onset of motility and that the development of bundle movements correlates with the development of somatic motility suggest that bundle motion, in response to membrane potential change, is related to somatic motility. OHC somatic motility is mediated by the voltage-sensitive, membrane-bound motor protein, prestin25. To directly test whether the observed large bundle motion was related to somatic motility of OHCs, we examined the voltage-evoked bundle motion in prestin-knockout mice5. Such experiments are also important to determine whether there is any small transducer channel–based bundle motion that is overshadowed by the dominant motility-associated bundle motion. These knockout mice have normal morphology of the hair bundles and normal mechanotransducer functions, with no OHC somatic motility5,26. We measured transducer currents first to confirm that their mechanotransducer channels were functional and not damaged. When we recorded the transducer current from an apical-turn OHC of the prestin knockout mouse, a large asymmetrical transducer current was observed (Fig. 2b). We measured the voltage-evoked bundle motion from those OHCs. No voltage-evoked bundle motion was seen in any of the 11 cells examined (Fig. 2c). In contrast, when the voltage-evoked bundle motion was measured from OHCs of wild-type mice, large bundle motions were seen in all cells studied (Fig. 2d). To rule out the possibility that the lack of bundle motion in the prestin-null OHCs was due to perilymph solution bathing the stereocilia, we measured the voltage-evoked bundle motion after perfusing the ciliary area with artificial endolymph in five additional prestin-null OHCs. This mimics the in vivo chemical condition. No voltage-evoked bundle motions were observed in any of the five cells examined. This confirms that the voltage-evoked bundle motion is indeed associated with somatic motility. In coil preparations, or under in vivo conditions, OHCs are constrained by adjacent OHCs and by supporting cells. The physical
connection among neighboring OHCs provides a basis for mechanical interaction among OHCs. Indeed, the influence of somatic motility of a stimulated OHC on the adjacent OHC through mechanical coupling has been shown previously27,28. If the observed voltage-evoked hairbundle motion is associated with somatic motility and the consequent rotation of the reticular lamina, then the bundle motion should also be detected from adjacent OHCs, despite the fact that they are not under direct electrical stimulation. We measured the bundle motion of the stimulated cell (Cell 1 in Fig. 3a) and the adjacent unstimulated cell (Cell 2) in the same row. The stimulated cell was held at 70 mV, and its membrane potential varied from 145 mV to 5 mV at 102 Hz. A large response with peak-to-peak magnitude of 253 nm was detected from the stimulated cell (Fig. 3b). Bundle motion was also observed from the adjacent unstimulated OHC (Cell 2), even though only Cell 1 was stimulated electrically. The magnitude of bundle motion of the adjacent cell was roughly one-half that of the stimulated OHC (Fig. 3b). OHC motility and axial stiffness are sensitive to turgor pressure3,29. When OHCs are mechanically constrained by neighboring OHCs and supporting cells, as is the case in vivo and in the coil preparation, the turgor pressure becomes even more important, due to the mechanical load, for the expression of OHC motility and for the motility-driven reticular lamina rotation. We manipulated the turgor pressure of the stimulated cell to determine whether the bundle motion was also sensitive to turgor pressure. We reduced the turgor pressure by applying negative pressure through the patch electrode. The bundle motion of the stimulated OHC disappeared (Fig. 3c). The bundle motion of the adjacent OHC also disappeared after the stimulated cell lost its turgor pressure. The existence of bundle motion of the adjacent OHC and disappearance of bundle motion after turgor pressure loss indicate that the bundle motion results from rotation of the reticular lamina, as a consequence of somatic motility. Subsequently, we examined bundle motion as a function of membrane potential (input-output function). Figure 4a shows an example of the response measured from a gerbil apical-turn OHC when the membrane potential was stepped up and down from a holding potential of 70 mV. The responses were asymmetrical and nonlinear,
a
Row 1
Row 3 Electrode
Cell 1
Cell 2
b Cell 1 100 nm
Cell 2
Figure 3 Hair-bundle motion measured from a stimulated OHC and an adjacent unstimulated OHC. (a) Schematic drawing of method for recording bundle motions from a cell under voltage-clamp (Cell 1) and from an adjacent cell (Cell 2) that is not electrically stimulated but is mechanically coupled to Cell 1. (b) Bundle motion measured from Cell 1 and an adjacent cell (Cell 2). Cell 1 was held at 70 mV and its membrane voltage varied from 145 mV to 5 mV. Waveform is shown in the bottom panel of c. Note that large bundle motion was also observed from Cell 2, even though Cell 2 was not electrically stimulated. (c) Disappearance of voltage-evoked bundle motions in Cell 1 and Cell 2 after Cell 1 lost turgor pressure. Turgor pressure in Cell 1 was reduced by applying a negative pressure inside the patch electrode.
1030
c
Loss of turgor
Cell 1
Cell 2 150 mV Voltage command 0
50
100
150
200
250
300
Time (ms)
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
20 30 Time (ms)
40
50
6 5 4 3 2 1 –120 –80 –40 0 40 Voltage (mV)
c
Figure 4 Input-output function and frequency response of hair-bundle motion. (a) Bundle motions of a gerbil apical-turn OHC as a function of voltage level (from a holding potential of 70 mV). (b) Steady-state response from a was fitted with a second-order Boltzmann function (solid line), and a slope function (dashed line) was obtained as the derivative of the Boltzmann function. The series resistance was 75% compensated. Because membrane conductances were blocked, the uncompensated voltage error (not corrected in the plot) was less than 4 mV at the largest voltage levels. The bundle motion was low-pass filtered at 400 Hz. (c) Motility-associated bundle motions evoked by a series of voltage bursts with different frequencies (frequency is shown on the top of the response waveforms). (d) The peakto-peak response was measured from c and plotted as a function of frequency. The roll-off of the photodiode system was compensated in the frequency response. The response from the photodiode was low-pass filtered at 1,200 Hz.
80
d 50 Hz
100
2
200
70 nm 400 800 1K
0
200
400
600
100
8 6 4 2
10 4 5 6 78
800
2
3
membrane of OHCs right above the nucleus to maximize the motion of the cuticular plate. Such measured motion should represent the total length change of OHCs in situ under the constrained condition. The response was asymmetrical and nonlinear, with saturation in both directions (Fig. 5a), similar to that seen in isolated OHCs29. The peakto-peak magnitude of length change was about 1,384 nm, with a maximal sensitivity of 13 nm/mV (Fig. 5b). This value is similar to the maximal sensitivity of somatic motility (5–25 nm/mV) measured from isolated OHCs29. We also measured the bundle motion from the same cell with the same voltage stimulation. The bundle response measured from the hemicochlea resembled that measured from OHCs in the coil preparation (Fig. 4a). For comparison with OHC somatic motility, we plotted the steady-state response of the bundle motion as a function of voltage (Fig. 5b), along with its Boltzmann fit and the slope function. The slope sensitivity of bundle motion was about one-half of that of somatic motility. To quantify the relation between somatic motility and bundle motion, we plotted the magnitude of bundle motion as a function of somatic motility (Fig. 5c): the amplitude of bundle displacement was about one-half of the length change.
4 5 6 78
100 Frequency (Hz)
Time (ms)
1,000
with saturation in both directions, similar to that seen in OHC somatic motility29. We fitted the response with a second-order Boltzmann function; the maximum sensitivity calculated from the derivative of this function was about 6.2 nm/mV (Fig. 3a). The maximum peak-topeak response shown in the example was 623 nm. The largest peak-topeak response observed among the six cells examined was 832 nm (Supplementary Videos 1,2). We also examined the frequency response of the voltage-evoked bundle motion between 50 and 1,000 Hz using sinusoidal voltage bursts (Fig. 4c). Apparently, large bundle motions were still present at 1,000 Hz. The frequency response of the bundle motion was similar to that of OHC somatic motility measured under the whole-cell voltage-clamp condition30. Finally, we attempted to quantify the relation between the bundle motion and somatic motility of OHCs. Since the bundle motion was measured in the coil preparation, where OHCs were loaded by neighboring OHCs and supporting cells, it was necessary to measure the change in OHC length under similar conditions. We measured the change in OHC length using a gerbil hemicochlear preparation31, which allowed us to measure motions of the cuticular plate and the hair bundle as a result of somatic motility from the same cells. The motion of the reticular lamina was measured in a previous study using an isolated cochlear preparation of the guinea pig32. Since the magnitude of reticular lamina motion depends on where the patch electrode holds the cells27, we chose to approach the basolateral
a
b
DISCUSSION Active hair-bundle motions are likely responsible for mechanical amplification of low-amplitude signals in non-mammals, since hair cells in these species do not possess somatic motility33. There is already evidence for either somatic motility or hair-bundle mechanisms in mammals. According to one recent study using a semi-intact cochlear preparation of adult gerbils, nonlinear amplification depends on the
c
1,200 800 8
400
4
0
600 400 200 0 –200
0
–400 10 ms
Slope (nm/mV)
400 nm
Motions (nm)
12
Bundle motion (nm)
10
Bundle motion (nm)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
0
400 300 200 100 0 –100 –200
Slope (nm/mV)
200 nm
Bundle motion (nm)
b
a
–120 –80 –40 0 40 Voltage (mV)
80
–400 0 400 800 Somatic motility (nm)
1,200
Figure 5 Relationship between OHC somatic motility and hair-bundle motion. (a) Motions of the reticular lamina as a result of somatic motility of an apical OHC when stimulated with voltage steps. The measurement was taken from a 30-d-old gerbil hemicochlea with the TM detached from the OHC hair bundle. The cell was held at 70 mV under whole-cell voltage-clamp. The patch electrode made contact with the basolateral membrane just above the nucleus of the cell. Movement was measured by the photodiode technique. Upward deflections in the trace represent depolarization. The response was filtered at 1,200 Hz. (b) Steady-state response from a was fitted with a second-order Boltzmann function (filled circles with solid line) and a slope function (solid line) was obtained as the derivative of the Boltzmann function. The bundle motion associated with somatic motility was also measured from the same cell, using the photodiode technique. Steady-state response was obtained and plotted in b. The response was also fitted with a second-order Boltzmann function (open circles with dashed line) and a slope function (dashed line) was obtained as the derivative of the Boltzmann function. (c) Bundle motion as a function of somatic motility. The magnitude of bundle motion is about one-half of that of somatic motility.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1031
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES flow of calcium current through the mechanoelectrical transducer channel18. Another study shows that hair bundles of rat OHCs can produce a large force linked to adaptation of the mechanotransducer channels19. Such force can be fed back to the basilar membrane and could thereby amplify basilar membrane vibration6,7. Although the force generated by the hair bundle is almost 20- to 100-fold greater than that predicted by the gating-spring model for mammalian hair cells34, such force is approximately 5 to 10 times less than the force produced by OHC somatic motility (about 3–5 nN)25. The force production based on mechanotransducer channels is also accompanied by a change in stiffness of the bundle19. It is theoretically possible to construct a cochlear amplifier with an in vivo feedback pathway based on ciliary stiffness change35. Our work demonstrates significant hair-bundle motions evoked by OHC electromotility. Yet, in the absence of electromotility (that is, in neonatal gerbil OHCs before the onset of somatic motility and in prestin-knockout mice), ciliary rotation linked to adaptation of the mechanotransducer channels was below the resolution limit of our system (B5 nm). The lack of bundle motion under the condition studied was not due to some malfunction of the mechanotransduction apparatus, since large mechanoelectrical transducer currents were observed. Although we can not rule out small mechanotransducer channel–based bundle motion below the resolution limit of our measurement system, the V-shaped or W-shaped staircase structure of the hair bundle with strong side-links connecting individual stereocilia is not well suited for ciliary rotation. The motility-associated bundle motion was large (over 800 nm), approximately ten times (20 dB) larger than the transducer channel–based ciliary rotation observed in nonmammalian hair cells8,9,13–15. The maximal sensitivity of the bundle motion was approximately 6.5 nm/mV, roughly one-half of that of OHC somatic motility. Voltage-evoked bundle motion of IHCs was reported in a recent study18 using a two-chamber preparation. The IHC bundle motion observed was on the order of 13 nm. In our view, the possibility that such motion may have been mediated by OHC motility can not be completely ruled out. The motility-associated response we observed overshadows transducer channel–based mechanisms in OHCs. It is not fully established how OHC length changes result in bundle motion. However, tilting of the cuticular plate during motility has been reported to occur at high frequencies in coil preparations36. Rotation of the reticular lamina as a result of OHC motility is also seen in situ32. Modeling work also supports the existence of reticular lamina rotation in response to OHC length change37. The bundle motion of unstimulated OHCs as a result of the somatic motility of adjacent OHCs provides direct evidence that tilting of the cuticular plate within the reticular lamina and rotation of the reticular lamina along its fulcrum at the pillar heads during OHC length change could produce bundle movement. It has been proposed that OHC somatic motility3–5 and stiffness change38 are responsible for cochlear amplification in mammals. According to some theories, the force generated by OHC somatic motility amplifies the motion of the basilar membrane–organ of Corti complex39,40. These theories are supported by several observations, such as somatic motility upon ciliary deflection41, electromotility-driven movements of the reticular lamina and basilar membrane in situ32, and findings from experiments using prestin-knockout mice5,26. It has not yet been fully determined how active somatic movements of OHCs excite IHCs. Coupling OHC motility to basilar membrane and movements of the reticular lamina in an appropriate phase would certainly boost their displacements. In addition, the bundle motion associated with OHC somatic motility may provide a mechanism for OHC motility to boost the input to
1032
IHCs. The V-shaped or W-shaped staircase structure of the OHC stereocilia is well suited for promoting mechanical coupling between the TM and reticular lamina, which can transfer motility-driven hairbundle motion into the radial motion of the TM (data not shown). Such motion could amplify mechanical input to the IHC by increasing fluid motion in the gap between the TM and reticular lamina. This fluid flow stimulates the freestanding IHC cilia42. It is conceivable that fluid pumping by Hensen’s stripe onto the closely apposed IHC cilia is the excitatory mechanism. It is therefore conceivable that the motilityassociated hair-bundle motion may be part of cochlear amplification in mammals. Under this scheme, OHC somatic motility not only boosts basilar membrane vibration but also drives the hair-bundle motion, which can interact with the TM. Since the bundle motion is associated with somatic motility of OHCs, this scheme is consistent with studies using prestin-knockout mice5,26, which support motility-based amplification as the dominant mechanism in the mammalian cochlea. The principal argument against somatic motility as the amplifier is that the low-pass filter characteristics of OHC membranes attenuate receptor potentials at high frequencies. Therefore, the receptor potentials would be too small to drive somatic motility6,7. It has been proposed, however, that extracellular potential changes within the organ of Corti could drive OHC motility at high frequencies43. These extracellular potentials are not filtered by the membrane. Measurements of basilar membrane vibration and extracellular potentials in the guinea pig cochlea at high frequencies provide evidence that those extracellular potentials can indeed drive OHC motors at high frequencies44–46. Extracellular OHC voltage responses at threshold are large and sharply tuned, and they are at least 100 mV at threshold at 18 kHz45,46. Therefore, the potentials could be large enough to drive OHC motility. Furthermore, theoretical modeling also indicates that the piezoelectric property of OHCs can markedly increase the frequency response of OHCs47,48. Finally, characteristics of the mechanical load of OHCs within the organ of Corti may also improve the frequency response of OHCs49. In summary, we have demonstrated that mammalian OHCs show large hair-bundle motion that is dependent on OHC somatic motility. Such bundle motion may boost the mechanical input to the IHC stereocilia through the radial motion of the TM. While forwardtransduction-based hair-bundle motion may underlie cochlear amplification in non-mammals, mammals have evolved OHC somatic motility to boost basilar membrane vibration and to drive the bundle motion, thereby providing mechanical amplification of low-level signals in the mammalian inner ear. METHODS Care and use of the animals in this study were approved by NIH grants and the Animal Care and Use Committee of Creighton University in Omaha, Nebraska. Preparation of the coil. Gerbils ranging in age from 4 to 35 DAB and prestinknockout mice ranging in age from 4 to 7 weeks after birth were used. The animals were decapitated following a lethal dose of sodium pentobarbital (200 mg/kg, intraperitoneal injection). After the cochlear wall was removed, the basilar membrane–organ of Corti complex was unwrapped from the modiolus, from the basal turn to the apical turn, as described elsewhere50. The coil was digested in L-15 medium (Invitrogen), containing 136 mM NaCl, 5.8 mM NaH2PO4, 5.4 mM KCl, 1.4 mM CaCl2, 0.9 mM MgCl2, 0.4 mM MgSO4 and 10 mM HEPES-NaOH (pH 7.4, 300 mmol/l), plus 0.06 mg/ml protease (type XXIV; Sigma). After the TM was lifted off to expose the hair bundles, the tissue was transferred to the experimental chamber. The coil was firmly attached to the bottom of the chamber by the weight of two thin platinum rods (0.5 mm in diameter), with one of their ends anchored in two small droplets of vacuum
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES grease on the bottom of the chamber. The tissue was mounted with the hair bundle facing upward toward the water-immersion objective. Details for preparing gerbil hemicochlea are given elsewhere31. The coil preparation (or hemicochlea) was bathed in L-15 medium in an experimental chamber mounted on the stage of an upright microscope (Leica DMLFSA) with Burleigh platform (Giblator). Quality control of coils and hemicochlea was based on the physical appearance of the preparation31. In either preparation, OHCs became swollen in less than 25 min after the organ of Corti was exposed to the extracellular medium. Therefore, all the data presented were collected within 20 min. Experiments were done at room temperature (22 ± 2 1C). Whole-cell voltage-clamp. The coil preparation and the hemicochlea were both bathed in the L-15 medium. The pipette solution contained 140 mM CsCl (or KCl), 0.1 mM CaCl2, 3.5 mM MgCl2, 2.5 mM MgATP, 5 mM EGTA-KOH, 5 mM HEPES-KOH (pH 7.4 and 300 mmol/l). In some experiments, the ciliary area was perfused with artificial endolymph (150 mM KCl, 25 mM CaCl2, 1 mM sodium pyruvate, 5 mM D-glucose and 10 mM K2HPO4 at pH 7.35 and 300 mmol/l) through a second pipette positioned approximately 20–30 mm away from the hair bundle, as described previously for turtle hair cell preparation13. The rate of perfusion and the distance of the perfusion pipette from the recording site were adjusted to ensure that the perfusion from this second pipette did not mechanically stimulate the bundle. The bath was perfused with fresh medium at a rate of 0.5 ml/min. Patch pipette resistance was 3–4 MO. Recordings were made in whole-cell voltage-clamp mode, using an Axopatch 200B patch-clamp amplifier (Axon Instruments). Series resistance was 8–14 MO, and about 75% of series resistance was compensated. The uncompensated voltage error was normally less than 4 mV at the largest voltage levels used since the membrane conductances were blocked. Currents were filtered at 2 kHz, and digitized at 10 kHz with a 16-bit A/D converter (Digidata 1322A) and pClamp 9.2 software (Axon Instruments). The cells were held at 70 mV. To measure mechanotransducer currents in the coil preparation, a fluid-jet technique was used to deflect the hair bundle. The home-made fluid jet was controlled by a Burleigh driver/ amplifier (PZ-150M). Sinusoidal voltage commands (102 Hz) were used to drive the fluid jet. The fluid jet was positioned approximately 20–30 mm away from the stereocilia. Measurements of hair-bundle motion. The preparation was obliquely illuminated by a 100-W lamp. The hair bundle was imaged using a 63 waterimmersion objective (Leica) and magnified by an additional 20 relay lens. The magnified image of the tip of the bundle was then split into two paths: one path projected onto the photodiode (Hamamatsu) through a slit and another projected onto a CCD camera so that the bundle could be viewed at all times on a television monitor. During measurements, the magnified image of the tip of the bundle was positioned near the edge of the slit. The slit was rotatable, based on the orientation of the bundle. The output signal from the photodiode amplifier represented the motion of the tip of the hair bundle. The photodiode system had a 3-dB cutoff frequency of 1,200 Hz. The signal was then amplified by a 60-dB fixed-gain dc-coupled amplifier. The amplified signal was then lowpass filtered (400 or 1,200 Hz) before being delivered to one of the A/D inputs of a Digidata 1322A acquisition board (Axon Instruments) in a Microsoft Windows–based computer. The measurement system was capable of measuring bundle tip motions down to about 5 nm with 100 averages. Calibration of bundle motion was obtained by moving the slit a known amount (1 mm) using a piezo driver attached to the slit50. To measure the motions of hair bundle and reticular lamina in the hemicochlea, we used a preparation in which the TM was detached from the OHC hair bundles. In this preparation, the hair bundle of OHCs is clearly visible on the cuticular plate and its motion is easy to measure under high magnification. We measured the hair-bundle motion and reticular lamina motion as described above, using the photodiode technique. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS This work was supported by grants R01 DC 006496 and R21 DC 006039 to D.Z.Z.H. from the National Institutes on Deafness and Other Communicative Disorders (NIDCD). We would like to thank P. Dallos,
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
S. Neely, M.A. Cheatham and R. Hallworth for many helpful discussions and comments on an earlier draft of the manuscript. We thank J. Zuo for providing the prestin-knockout mice. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 31 May; accepted 28 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Dallos, P. The active cochlea. J. Neurosci. 12, 4575–4585 (1992). 2. Santos-Sacchi, J. New tunes from Corti’s organ: the outer hair cell boogie rules. Curr. Opin. Neurobiol. 13, 459–468 (2003). 3. Brownell, W.E., Bader, C.R., Bertrand, D. & de Ribaupierre, Y. Evoked mechanical responses in isolated cochlear outer hair cells. Science 227, 194–196 (1985). 4. Kachar, B., Brownell, W.E., Altschuler, R. & Fex, J. Electrokinetic shape changes of cochlear outer hair cells. Nature 322, 365–368 (1986). 5. Liberman, M.C. et al. Prestin is required for outer hair cell electromotility and the cochlear amplifier. Nature 419, 300–314 (2002). 6. Hudspeth, A.J. Mechanical amplification of stimuli by hair cells. Curr. Opin. Neurobiol. 7, 480–486 (1997). 7. Fettiplace, R., Ricci, A.J. & Hackney, C.M. Clues to the cochlear amplifier from the turtle ear. Trends Neurosci. 24, 169–175 (2001). 8. Crawford, A.C. & Fettiplace, R. The mechanical properties of ciliary bundles of turtle cochlear hair cells. J. Physiol. (Lond.) 364, 359–379 (1985). 9. Ru¨sch, A. & Thurm, U. Spontaneous and electrically induced movements of ampullary kinocilia and stereovilli. Hear. Res. 48, 247–263 (1990). 10. Martin, P. & Hudspeth, A.J. Active hair-bundle movements can amplify a hair cell’s response to oscillatory mechanical stimuli. Proc. Natl. Acad. Sci. USA 96, 14306– 14311 (1999). 11. Howard, J. & Hudspeth, A.J. (1987) Mechanical relaxation of the hair bundle mediates adaptation in mechanoelectrical transduction by the bullfrog’s saccular hair cell. Proc. Natl. Acad. Sci. USA 84, 3064–3068 (1987). 12. Benser, M.E., Marquis, R.E. & Hudspeth, A.J. Rapid, active hair bundle movements in hair cells from the bullfrog’s sacculus. J. Neurosci. 16, 5629–5643 (1996). 13. Ricci, A.L., Crawford, A.C. & Fettiplace, R. Active hair bundle motion linked to fast transducer adaptation in auditory hair cells. J. Neurosci. 20, 7131–7142 (2000). 14. Assad, J.A., Hacohen, N. & Corey, D.P. Voltage dependence of adaptation and active bundle movement in bullfrog saccular hair cells. Proc. Natl. Acad. Sci. USA 86, 2918–2922 (1989). 15. Bozovic, D. & Hudspeth, A.J. Hair-bundle movements elicited by transepithelial electrical stimulation of hair cells in the sacculus of the bullfrog. Proc. Natl. Acad. Sci. USA 100, 958–963 (2003). 16. Gillespie, P.G. & Corey, D.P. Myosin and adaptation by hair cells. Neuron 19, 955–958 (1997). 17. Holt, J.R. et al. A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells. Cell 108, 371–381 (2002). 18. Chan, D.K. & Hudspeth, A.J. Ca(2+) current-driven nonlinear amplification by the mammalian cochlea in vitro. Nat. Neurosci. 8, 149–155 (2005). 19. Kennedy, H.J., Crawford, A.C. & Fettiplace, R. Force generation by mammalian hair bundles supports a role in cochlear amplification. Nature 433, 880–883 (2005). 20. Kros, C.J., Ru¨sch, A. & Richardson, G.P. Mechano-electrical transducer currents in hair cells of the cultured neonatal mouse cochlea. Proc. Biol. Sci. 249, 185–193 (1992). 21. Kennedy, H.J., Evans, M.G., Crawford, A.C. & Fettiplace, R. Fast adaptation of mechanoelectrical transducer channels in mammalian cochlear hair cells. Nat. Neurosci. 6, 832–836 (2003). 22. He, D.Z.Z., Jia, S.P. & Dallos, P. Mechanoelectrical transduction of outer hair cells studied in a gerbil hemicochlea. Nature 429, 766–770 (2004). 23. He, D.Z.Z., Evans, B.N. & Dallos, P. First appearance and development of electromotility in neonatal gerbil outer hair cells. Hear. Res. 78, 77–90 (1994). 24. Ge´le´oc, G.S.G. & Holt, J.F. Developmental acquisition of sensory transduction in hair cells of the mouse inner ear. Nat. Neurosci. 6, 1019–1020 (2003). 25. Zheng, J. et al. Prestin is the motor protein of cochlear outer hair cells. Nature 405, 149–155 (2000). 26. Cheatham, M.A., Huynh, K.H., Gao, J., Zuo, J. & Dallos, P. Cochlear function in prestin knockout mice. J. Physiol. (Lond.) 560, 821–830 (2004). 27. Mammano, F., Kros, C.J. & Ashmore, J.F. Patch clamped responses from outer hair cells in the intact adult organ of Corti. Pflugers Arch. 430, 745–750 (1995). 28. Zhao, H.B. & Santos-Sacchi, J. Auditory collusion and a coupled couple of outer hair cells. Nature 399, 359–362 (1999). 29. Santos-Sacchi, J. Asymmetry in voltage-dependent movements of isolated outer hair cells from the organ of Corti. J. Neurosci. 9, 2954–2962 (1989). 30. Santos-Sacchi, J. On the frequency limit and phase of outer hair cell motility: effects of the membrane filter. J. Neurosci. 12, 1906–1916 (1992). 31. Richter, C.P., Evans, B.N., Edge, R. & Dallos, P. Basilar membrane vibration in the gerbil hemicochlea. J. Neurophysiol. 79, 2255–2264 (1998). 32. Mammano, F. & Ashmore, J.F. Reverse transduction measured in the isolated cochlea by laser Michelson interferometry. Nature 365, 838–841 (1993). 33. He, D.Z.Z. et al. Chick hair cells do not exhibit voltage-dependent somatic motility. J. Physiol. (Lond.) 546, 511–520 (2003).
1033
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 34. van Netten, S.M. & Kros, C.J. Gating energies and forces of the mammalian hair cell transducer channel and related hair bundle mechanics. Proc. Biol. Sci. 267, 1915–1923 (2000). 35. McMullen, T.A. & Mountain, D.C. Model of dc potentials in the cochlea: effects of voltage-dependent cilia stiffness. Hear. Res. 17, 127–141 (1985). 36. Reuter, G., Gitter, A.H., Thu¨rm, U. & Zenner, H.P. High frequency radial movements of the reticular lamina induced by outer hair cell motility. Hear. Res. 60, 236–246 (1992). 37. Dallos, P. Organ of Corti kinematics. J. Assoc. Res. Otolaryngol. 4, 416–421 (2003). 38. He, D.Z.Z. & Dallos, P. Somatic stiffness of cochlear outer hair cells is voltagedependent. Proc. Natl. Acad. Sci. USA 96, 8223–8228 (1999). 39. Neely, S.T. & Kim, D.O. A model for active elements in cochlear biomechanics. J. Acoust. Soc. Am. 79, 1472–1480 (1986). 40. de Boer, E. Mechanics of the cochlea: modeling efforts. in The Cochlea (eds. Dallos, P., Popper, A.N. & Fay, R.R.) 258–317 (Springer-Verlag, New York, 1996). 41. Evans, B.N. & Dallos, P. Stereocilia displacement induced somatic motility of cochlear outer hair cells. Proc. Natl. Acad. Sci. USA 90, 8347–8351 (1993). 42. Dallos, P., Billone, M.C., Durrant, J.D., Wang, C. & Raynor, S. Cochlear inner and outer hair cells: functional differences. Science 177, 356–358 (1972).
1034
43. Dallos, P. & Evans, B.N. High-frequency motility of outer hair cells and the cochlear amplifier. Science 267, 2006–2009 (1995). 44. Fridberger, A. et al. Organ of Corti potentials and the motion of the basilar membrane. J. Neurosci. 24, 10057–10063 (2004). 45. Ko¨ssl, M. & Russell, I.J. The phase and magnitude of hair cell receptor potentials and frequency tuning in the guinea pig cochlea. J. Neurosci. 12, 1575–1586 (1992). 46. Murugasu, E. & Russell, I.J. The effect of efferent stimulation on basilar membrane displacement in the basal turn of the guinea pig cochlea. J. Neurosci. 16, 325–332 (1996). 47. Spector, A.A., Brownell, W.E. & Popel, A.S. Effect of outer hair cell piezoelectricity on high-frequency receptor potentials. J. Acoust. Soc. Am. 113, 453–461 (2003). 48. Weitzel, E.K., Tasker, R. & Brownell, W.E. Outer hair cell piezoelectricity: frequency response enhancement and resonance behavior. J. Acoust. Soc. Am. 114, 1462–1466 (2003). 49. He, D.Z.Z. Mechanical responses of cochlear outer hair cells. in Biophysics of the Cochlea (ed. Gummer, A.W.) 181–184 (World Scientific, Singapore, 2003). 50. He, D.Z.Z. Relationship between the development of outer hair cell electromotility and efferent innervation: a study in cultured organ of Corti of neonatal gerbils. J. Neurosci. 17, 3634–3643 (1997).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
A deafness mutation isolates a second role for the tectorial membrane in hearing P Kevin Legan1, Victoria A Lukashkina1, Richard J Goodyear1, Andrei N Lukashkin1, Kristien Verhoeven2, Guy Van Camp2, Ian J Russell1 & Guy P Richardson1 a-tectorin (encoded by Tecta) is a component of the tectorial membrane, an extracellular matrix of the cochlea. In humans, the Y1870C missense mutation in TECTA causes a 50- to 80-dB hearing loss. In transgenic mice with the Y1870C mutation in Tecta, the tectorial membrane’s matrix structure is disrupted, and its adhesion zone is reduced in thickness. These abnormalities do not seriously influence the tectorial membrane’s known role in ensuring that cochlear feedback is optimal, because the sensitivity and frequency tuning of the mechanical responses of the cochlea are little changed. However, neural thresholds are elevated, neural tuning is broadened, and a sharp decrease in sensitivity is seen at the tip of the neural tuning curve. Thus, using TectaY1870C/1 mice, we have genetically isolated a second major role for the tectorial membrane in hearing: it enables the motion of the basilar membrane to optimally drive the inner hair cells at their best frequency.
The organ of Corti, the mammalian organ of hearing, contains two sensory cell types, the inner and outer hair cells (IHCs and OHCs, respectively), that are sandwiched between two sheets of extracellular matrix, the basilar and tectorial membranes. Sound-induced vibrations of the basilar membrane are detected and transduced by the hair cells, and the resultant electrical signals are transmitted to the brainstem via the cochlear ganglion. The OHCs are mainly innervated by efferent nerve fibers descending from the CNS. They sit directly over the basilar membrane, and their sensory hair bundles are imbedded in the lower surface of the tectorial membrane1. The OHCs are electromotile2 and act as sensory-effector cells that amplify the motion of the basilar membrane at low sound pressure levels and compress it at high levels3–5. The IHCs are extensively innervated by afferent fibers from the cochlear ganglion6 and act primarily as receptors. They are located near the limbal edge of the basilar membrane, and their hair bundles are not directly coupled to the tectorial membrane7. The tectorial membrane is an extracellular matrix with a unique structure1,8. It contains three different types of collagen and three noncollagenous glycoproteins that are expressed at high levels only in the inner ear: a-tectorin, b-tectorin and otogelin9–12. Mutations in a-tectorin are known to cause non-syndromic hereditary hearing loss13. A number of roles have been suggested for the tectorial membrane in hearing14–17, but its precise function in this process has remained relatively obscure. In mice homozygous for a targeted deletion (DENT) in the gene encoding a-tectorin (Tecta), the tectorial membrane lacks all non-collagenous components and is completely detached from the surface of the organ of Corti and the spiral limbus18. The basilar membrane remains tuned in the TectaDENT/DENT mouse but is 35 dB less sensitive18. A comparison of OHC responses in wild-type and
TectaDENT/DENT mice has shown that the tectorial membrane normally allows the OHCs to bias their hair bundles so that they can transduce low-level signals in the most sensitive region of their operating range, and it ensures that the hair bundles of the OHCs respond to basilar membrane displacement rather than basilar membrane velocity18. The tectorial membrane therefore has a key role in cochlear amplification in enabling the OHCs to deliver feedback to the basilar membrane with the appropriate gain and timing. Measurements of basilar membrane motion in wild-type and TectaDENT/DENT mice18 confirm previous data19,20 showing that the tectorial membrane is resonant. For any location along the length of the cochlea the tectorial membrane is tuned to a frequency half an octave below the characteristic frequency of the basilar membrane, the frequency to which the basilar membrane is most sensitive18–21. At the characteristic frequency of the basilar membrane, the tectorial membrane therefore acts as an inertial mass against which the hair bundles can react. As yet, it is not known how the hair bundles of the IHCs are stimulated by basilar membrane vibration. They may be driven by a number of sources of excitation that vary in their contribution with frequency and level22. These include a combination of frictional and inertial fluid movements in the narrow space between the tectorial membrane and the reticular lamina, the apical surface of the organ of Corti that vibrates in response to basilar membrane motion. For sound stimuli above about 1 kHz, the hair bundles of IHCs are driven by inertial forces23–25, as are the freestanding hair bundles in the hearing organ of the lizard, which are driven by vibrations of the reticular lamina26. In the mammalian cochlea, the fluid movements that drive the IHCs are controlled by differential shear between the tectorial membrane and the reticular lamina15,17. The tectorial membrane may
1School of Life Sciences, University of Sussex, Falmer, Brighton, BN1 9QG, UK. 2Medical Genetics Centre, Dept. of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium. Correspondence should be addressed to I.J.R. (
[email protected]) or G.P.R. (
[email protected]).
Published online 3 July 2005; doi:10.1038/nn1496
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1035
ARTICLES
a
b SS
Targeting construct
Xh
S X
TK Neo 16
S
Xh
17 1819
c
Probe A Probe B Kb W H R W H R 15.4
X
15.4
+/+
9.7
S
Wild type 15
16
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
A
17 18 19
20 2122 23
B
15.4 kb
1 kb
5.8
Hit S
Xh
S X
SS TK
15 A
16
Xh
X
S
Neo
17 18 19
16
17 18 19
20212223 B
5.8 kb
d
bp +/+ +/– –/–
+/–
16.0 kb S
Xh
S X
S
Run 15 A
16 5.8 kb
17 1819
20 212223 9.7 kb
400 300 100
B
Figure 1 Targeted integration into the mouse Tecta gene. (a) The targeting construct, the 3¢ region of the Tecta gene spanning exons 15 to 23, and the targeted locus after the first (‘Hit’) and second (‘Run’) rounds of homologous recombination. S, SacI; Xh, XhoI; X, XbaI. (b) Southern blots of SacI-digested genomic DNA from wild-type (W), hit (H) and run (R) embryonic stem cell lines hybridized with probes A or B. Probes A and B hybridize to a 15.4-kb band from the wild-type allele. Probe A hybridizes to a 5.8-kb band from the targeted allele in both the hit (H) and the run (R). Probe B hybridizes to a 16.0-kb band (not resolved from the 15.4 kb band) in the hit (H) and a 9.7 kb band in the run (R). (c) Sequence analysis of the Y1870C allele. The heterozygote carries both A and G at position 5876, confirming the mutation is correctly introduced. (d) PCR of TectaY1870C mice. In Tecta+/+ mice a single product of 403 bp is amplified that is not cut by EcoICRI. In TectaY1870C/+ mice, the product from the mutant allele is cut by EcoICRI, and three bands are seen, a wild-type band of 403 bp and mutant fragments of 307 and 96 bp. In TectaY1870C/Y1870C mice, products from both alleles are cut by EcoICRI, giving bands of 307 and 96 bp.
sharpen the input to the IHCs16, and differences have been observed in the tuning curves of the basilar membrane and the OHCs and those of IHCs and their afferent nerve fibers27,28. The relative contributions of the tectorial membrane and the reticular lamina to IHC excitation remain, however, to be determined. In this study we describe the phenotype of a transgenic mouse with a missense mutation (Y1870C) in Tecta. This mutation is the cause of a moderate-to-severe, dominantly inherited, prelingual hearing impairment in an Austrian family13. The phenotype of the TectaY1870C/+ mouse is distinctly different from that of the TectaDENT/DENT mouse. Although the tectorial membrane shows a number of structural defects in the TectaY1870C/+ mouse, it remains attached to the organ of Corti. Basilar membrane tuning and sensitivity are only mildly affected, but the tuning properties of the IHCs’ neural output are substantially altered both in terms of shape and of sensitivity. The TectaY1870C/+ mouse therefore demonstrates how the tectorial membrane has an additional critical role in hearing in ensuring that the IHCs are excited maximally at their best frequency. RESULTS Two rounds of homologous recombination in embryonic stem cells, a ‘hit’ to provide a 5¢ duplication followed by a ‘run’ to remove the original locus, were used to introduce the single base change (A5876G) into exon 18 of the Tecta locus (Fig. 1a). Integration of the duplicate and its resolution under gancyclovir selection were monitored by Southern blotting (Fig. 1b). The presence of the desired mutation was confirmed by sequencing (Fig. 1c). F1 progeny heterozygous for the mutation were detected by PCR amplification followed by restriction digestion (Fig. 1d). Tectorial membrane is disrupted in TectaY1870C/+ mice The tectorial membrane is a spiral, ribbon-like sheet of matrix that runs along the length of the cochlea. It adheres to the apical surface of the spiral limbus, stretches across the spiral sulcus and lies over the organ of
1036
Corti, attaching to the tips of the OHCs’ hair bundles. The effects of the Tecta Y1870C mutation illustrated in Figure 2a–l are representative of the morphology observed in 11 wild-type, ten TectaY1870C/+ and three TectaY1870C/Y1870C mice. A number of structural abnormalities were observed in the TectaY1870C/+ mouse. The limbal attachment zone of the tectorial membrane was markedly reduced in thickness, and the lower surface into which the OHC hair bundles are imbedded (Kimura’s membrane) was separated from the main body of the tectorial membrane. The marginal band (a dense thickening running around the peripheral margin) and Hensen’s stripe (a ridge that runs longitudinally along the underside of the tectorial membrane adjacent and parallel to the bundles of the IHCs) were absent, and there were large holes visible within the main body of the matrix (compare Fig. 2a,b). Notably, there was considerable enlargement of the subtectorial space in the vicinity of the IHC hair bundles (Fig. 2a,b). In mice homozygous for the mutation, the tectorial membrane was completely detached from the surface of the organ of Corti and was found associated with Reissner’s membrane and/or the stria vascularis (Fig. 2c). The morphological phenotype of the TectaY1870C/Y1870C mouse is very similar to that previously described for the TectaDENT/DENT mouse18. a-tectorin and two other non-collagenous proteins of the tectorial membrane, b-tectorin and otogelin, were all detected in heterozygous TectaY1870C/+ mice (Fig. 2e,h,k), although the levels of otogelin, a component normally concentrated in the sulcal region, appeared to be reduced (Fig. 2k). a-tectorin and traces of b-tectorin were detected in the detached tectorial membranes of TectaY1870C/Y1870C mice, but otogelin was absent (Fig. 2f,i,l). The ultrastructural characteristics of the tectorial membranes in wild-type and TectaY1870C/+ mice are shown in Figure 3. The whip-like nature of Kimura’s membrane, its separation from the main body of the tectorial membrane and loss of the marginal band in TectaY1870C/+ mice were clearly visible at low magnification (Fig. 3a,b). Clearly defined striated-sheet matrix composed of cross-linked light and dark-staining filaments was visible in the region of the tectorial membrane overlying
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Tecta+/+
TectaY1870C/+
TectaY1870C/Y1870C
b
c
d
e
f
g
h
i
α-tectorin β-tectorin
j
k
l
Otogelin
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Toluidine blue
a
the inner and outer hair cells in both wild-type and TectaY1870C/+ mice (Fig. 3c,d). In TectaY1870C/+ mice, however, striated-sheet matrix was not present in the sulcal zone (Fig. 3e,f). Instead, large clumps of dense staining material were visible and the collagen fibrils, rather than projecting radially across the tectorial membrane (Fig. 3e), were oriented almost perpendicular to its surface (Fig. 3f) and were seen erupting through its upper surface (Fig. 3g,h). The limbal zone of the tectorial membrane, a region where the non-collagenous matrix is normally dense and compacted, was extremely reduced in the TectaY1870C/+ mice, and only a few traces of electron-dense material were associated with the microvilli of the interdental cells (Fig. 3i,j). Hair bundle structure is normal in TectaY1870C/+ mice Scanning electron microscopy was used to examine the shape and structure of the hair bundles in the low- and high-frequency turns of the cochlea in wild-type and TectaY1870C/+ mice (Fig. 4a–d). No obvious differences were observed. Remnants of tectorial membrane were observed attached to some of the OHC hair bundles in TectaY1870C/+ mice, mainly those in the first row, but not on those of wild-type mice. These remnants provide evidence that the OHC hair bundles normally contact the tectorial membrane in the TectaY1870C/+ mouse and suggest that Kimura’s membrane is less firmly attached to the main body of the tectorial membrane than it is in wild-type mice, not detaching completely from the hair bundles when the tectorial membrane is removed during sample preparation. Normal mechanotransduction in OHCs of TectaY1870C/+ mice The cochlear microphonic recorded from the round window is dominated by the receptor current of basal-turn OHCs3,18,29. OHCs in this region are sensitive to frequencies above 45 kHz, and therefore the
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
Figure 2 Light microscopic analysis of TectaY1870C mice. (a–c) Toluidine blue–stained, 1-mm-thick sections of the cochlear duct from Tecta+/+ (a), TectaY1870C/+ (b) and TectaY1870C/Y1870C (c) mice. Note the considerable reduction in the thickness of the limbal zone (LZ) of the tectorial membrane, the absence of a marginal band (MB) and Hensen’s stripe (HS), and detachment of Kimura’s membrane (arrowhead in b) in the TectaY1870C/+ mouse. In the TectaY1870C/Y1870C mouse, the tectorial membrane (arrow in c) is completely detached from the spiral limbus and the surface of the organ of Corti. Bars: 50 mm. (d–l) Cryosections of the cochlear duct from Tecta+/+ (d,g,j) TectaY1870C/+ (e,h,k) and TectaY1870C/Y1870C (f,i,l) mice stained with antibodies to a-tectorin (d,e,f), b-tectorin (g,h,i) and otogelin (j,k,l). Otogelin staining is seen in the sulcal region of the wild-type tectorial membrane (arrow in j) but is reduced in the sulcal region of the TectaY1870C/+ mouse (k) and absent from that of the TectaY1870C/Y1870C mouse (l). Bars: 50 mm.
cochlear microphonic recorded in response to much lower frequencies is due to receptor current that has not been subject to amplification. Thus, for frequencies well below the sensitive frequency range of the basal turn of the cochlea, the amplitude of these receptor currents, and hence the amplitude of the cochlear microphonic, is governed by the magnitude of the OHC transducer conductance and not by the amplification process. For a 4-kHz tone, the cochlear microphonic level functions were similar in TectaY1870C/+ and Tecta+/+ mice (Fig. 5a), indicating that sensory transduction by OHCs is not influenced by the changes in tectorial membrane structure caused by the TectaY1870C/+ mutation. Furthermore, at this frequency, the cochlear microphonics recorded from TectaY1870C/+ and Tecta+/+ mice were in phase (Fig. 5a, inset). Mechanical coupling between the stimulus and OHC hair bundles must therefore be very similar in TectaY1870C/+ and Tecta+/+ mice. This similarity is also reflected in the symmetry of the cochlear microphonics. The relation between the magnitude of the cochlear microphonic and sound pressure for unfiltered microphonics measured in response to low-level, 4 kHz tones showed the cochlear microphonic was almost perfectly symmetrical in both Tecta+/+ and TectaY1870C/+ mice (Fig. 5b). The Y1870C mutation has little effect on mechanical tuning OHCs are the source of amplification in the cochlea, and when they do not function optimally the sensitivity and frequency tuning of the cochlea becomes impaired. To determine if the OHCs in TectaY1870C/+ mice are operating as effective amplifiers, or if their interaction with the tectorial membrane and basilar membrane is in any way compromised, the frequency tuning response of the basilar membrane was observed. Iso-response tuning curves measured from the same cochlear region in Tecta+/+ and TectaY1870C/+ mice were very similar in form (Fig. 5c,d). The characteristic low-frequency peak (stars in Fig. 5c,d) that has been attributed to the frequency tuning of the tectorial membrane20 was seen in the tuning curves of both Tecta+/+ and TectaY1870C/+ mice. Measurements from Tecta+/+ (n ¼ 16) and TectaY1870C/+ (n ¼ 10) mice showed that frequency tuning curves of TectaY1870C/+ mice were on average 8 dB less sensitive at the characteristic frequency of the recording site than those of Tecta+/+ mice but were similar in other respects (Table 1).
1037
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES Figure 3 Ultrastructure of the tectorial membrane in TectaY1870C mice. (a–j) Transmission electron micrographs illustrating the ultrastructure of the tectorial membrane in Tecta+/+ (a,c,e,g,i) and TectaY1870C/+ mice (b,d,f,h,j). Regions shown are the lateral edge with the marginal band and Kimura’s membrane (a,b), the central core of the tectorial membrane overlying the organ of Corti (c,d), the core of the tectorial membrane in the region overlying the spiral sulcus (e,f), the upper surface of the membrane in the sulcal region with covernet fibrils (g,h) and the limbal zone (i,j). Inset in b is a magnified view of Kimura’s membrane showing the attachment site (arrow) for the tallest stereocilium of the first row OHC. Bars: 2 mm (a,b), 200 nm (c–f), 500 nm (g–j).
Otoacoustic emissions demonstrate mild loss in sensitivity Distortion product otoacoustic emissions (DPOAEs) recorded from the cochlea are closely associated with cochlear feedback and OHC motility at all primary tone levels30,31. DPOAE generation probably originates from the modulation of electrical current through the OHC mechanoelectrical transducer conductance32–34. DPOAE measurements are noninvasive and can be used to estimate the sensory amplification function of OHCs across the entire frequency range, unlike basilar membrane motion measurements, which are restricted because of laser access to one region of the cochlea. DPOAE measurements across the 5–60 kHz frequency range (Fig. 5e) demonstrated that the cochleae of TectaY1870C/+ mice were slightly less sensitive than those of Tecta+/+ mice. The average threshold across all frequencies was 45.87 7 0.63 dB SPL for TectaY1870C/+ mice (n ¼ 10) versus 32.38 7 0.75 dB SPL for Tecta+/+ mice (n ¼ 10), an average threshold increase of 13.49 dB SPL in TectaY1870C/+ mice. DPOAE threshold curves from TectaY1870C/+ mice were also significantly more variable (P ¼ 0.01, as measured by the mean 7 s.d. of the s.d.) than those from Tecta+/+ mice (5.58 7 2.03 dB SPL for TectaY1870C/+ mice versus 2.97 7 1.23 dB SPL for Tecta+/+ mice, n ¼ 59). DPOAE-grams recorded from TectaY1870C/+ mice were slightly smaller in magnitude (average decrease across all frequencies ¼ 10.21 dB SPL, with f1/f2 levels at 50/40 dB SPL, and 8.06 dB SPL, with f1/f2 levels at 70/60 dB SPL) and significantly more variable (P ¼ 0.01) than those recorded from Tecta+/+ mice (Fig. 5f). These differences indicate that there is only a mild reduction in the sensory amplification function of OHCs across the entire frequency range. Elevated neural response thresholds in TectaY1870C/+ mice The detection threshold for cochlear microphonics recorded from the round window is determined by the sensitivity of basal-turn OHCs to
Tecta+/+
TectaY1870C/+
a
b
c
d
Tecta+/+
TectaY1870C/+
a
b
c
d
e
f
g
h
i
j
the test tone frequency. The round-window neural response to a tone, the compound action potential (CAP), is, however, generated by the type I afferent fibers that innervate IHCs throughout the cochlea35. Thus the CAP threshold for a particular frequency represents the threshold sensitivity of the cochlear region tuned to that frequency36, but the cochlear microphonic threshold for a pure tone at a frequency outside the range of the basal turn will be higher than that of the CAP. As expected, the threshold of the round-window cochlear microphonic to a 22-kHz tone in Tecta+/+ mice was higher than that of the CAP (compare upper and middle trace of Fig. 6a). The cochlear microphonics recorded from Tecta+/+ and TectaY1870C/+ mice to a 22-kHz tone were similar in threshold (45 dB SPL), but the CAP threshold recorded from TectaY1870C/+ mice was much higher (70 dB SPL) than that recorded from Tecta+/+ mice (o20 dB SPL; Fig. 6a,b, upper and middle traces). The low-pass filtered round window recordings (Fig. 6a,b, middle traces) showed that the CAP was associated with a slow after-potential, a potential that is thought to be of neural origin and depends on the presence of the cochlear nucleus37. The concurrent appearance of this slow after-potential and the CAP in TectaY1870C/+ Figure 4 Hair bundle morphology in TectaY1870C mice. (a–d) Scanning electron micrographs illustrating the structure of sensory hair bundles in the apical (a,b) and basal (c,d) regions of the cochlea in Tecta+/+ (a,c) and TectaY1870C/+ mice (b,d). Arrows indicate the single row of IHC hair bundles; arrowheads indicate the three rows of OHC hair bundles. Bars: 5 mm.
1038
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
6 7 8 Time (ms)
20 30 40 50 60 70 80 Sound level dB SPL
0.05 –0.00 –0.05
–0.15 –0.10 –0.05 0.00 0.05 0.10 0.15
d
Tecta+/+ Threshold (dB SPL)
70 60 50 40 30
Sound pressure (Pa) 80
TectaY1870C/+
70 60 50 40 30 20
20 20 30 40 50 60 70 Stimulus frequency (kHz)
20 30 40 50 60 70 Stimulus frequency (kHz)
f
70
DPOAE level (dB SPL)
e
30 40 50 60 70 80 dB SP
–0.10 –0.15
60 50 40 30 20 10 0
10
20
30 40 F2 kHz
50
60
60 50 40 30 20 10 0 –10 –20
Wt5040 Wt7060 Tr5040 Tr7060
0
10
20
30 40 F2 kHz
50
60
mice at levels above 70 dB SPL indicates auditory information is reaching the vicinity of the cochlear nucleus when the auditory nerve is active and that afferent synaptic transmission and neural propagation in the auditory nerve are not impaired in TectaY1870C/+ mice. For frequencies between 5–30 kHz, the CAP threshold of the TectaY1870C/+ mouse (68.3 7 5.37 dB SPL, n ¼ 10) was on average 55 dB higher than the CAP threshold of the Tecta+/+ mouse (13.68 7 3.95 dB SPL, n ¼ 10; Fig. 6c). Broad and insensitive neural tuning in TectaY1870C/+ mice Simultaneous masking tuning curves from Tecta+/+ mice were measured using a 22-kHz probe tone at 30 dB SPL and from TectaY1870C/+
Figure 6 Cochlear microphonics, CAPs and neural masking tuning curves in TectaY1870C mice. (a,b) Cochlear microphonics (CM) and the tonic components (DC) of the cochlear voltage response recorded from the round window to 22-kHz tones, at the levels indicated, from Tecta+/+ (a) and TectaY1870C/+ (b) mice. Upper traces: unfiltered CM response, bandwidth 0–125 kHz. Middle traces: CM response filtered at 0–3 kHz. Lower traces: timing of tone bursts. DC, tonic components of the cochlear voltage response. CAP, compound action potential. SafP, slow after-potential. (c) CAP thresholds as a function of stimulus frequency for Tecta+/+ (red squares) and TectaY1870C/+ (blue squares) mice (mean 7 s.d. from ten Tecta+/+ and ten TectaY1870C/+ mice). (d) Simultaneous masking tuning curves of CAP recorded from the round window. Red squares: masking tuning curve from Tecta+/+ mice (frequency and level of probe: 22 kHz, 30 dB SPL), Q10 dB (bandwidth measured 10 dB from tip/probe frequency) ¼ 5.6. Blue squares: masking tuning curve from TectaY1870C/+ mice, (frequency and level of probe: 22 kHz, 70 dB SPL), Q10 dB ¼ 3.9. Black open circles: masking tuning curve from Tecta+/+ mice, (frequency and level of probe: 22 kHz, 70 dB SPL), Q10 dB ¼ 7.2. Arrow indicates notch at probe frequency in TectaY1870C/+ mice. Colored squares represent mean 7 s.d. for measurements from ten mice; black open circles represent mean 7 s.d. from four mice.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
mice using a 22-kHz probe tone at 70 dB SPL (n ¼ 10 for each genotype, Fig. 6d). The tuning curves measured from the Tecta+/+ mice were sensitive and sharply tuned, while those from the TectaY1870C/+ mice were about 60–70 dB less sensitive at the probe frequency and more broadly tuned. The masking tuning curves measured from the Tecta+/+ mice reached a clear minimum (peak of sensitivity) at 22 kHz, while those measured from the TectaY1870C/+ mice had a prominent notch of insensitivity at the probe frequency (arrow, Fig. 6d). Simultaneous masking tuning curves from Tecta+/+ mice resembled tuning curves that have been obtained from single-fiber recordings38 and had a steep high-frequency slope and a notch of insensitivity below the tip16. The tuning curves obtained from TectaY1870C/+ mice were at least 20 dB less sensitive on the low-frequency shoulder of the tuning curve; that is, at frequencies below the low-frequency notch of the Tecta+/+ mice. The tuning curves from the TectaY1870C/+ mice did not have the lowfrequency notch but had a high-frequency peak at 33 kHz, about one-half octave above the peak. The differences in the frequency tuning curves are not a consequence of the different masker levels. Increasing the probe level to 70 dB in Tecta+/+ mice caused a sharpening and a downward shift in peak frequency of the masking tuning curve (Fig. 6d), as has been previously demonstrated38. The increased
a
b 20 µV 0.2 mV
5
0.10
22 kHz SafP DC
22 kHz
DC
20
30
40
50
60
70
80 dB SPL
c
d 110 90 70 50 30 10 –10 0
SafP
CAP
CAP
10 20 Stimulus frequency (kHz)
30
20
Masking threshold (dB SPL)
0.00
–0.35
CM magnitude (mV)
CM (mV)
0.25
80 Threshold (dB SPL)
0.15
Figure 5 Cochlear microphonics, basilar membrane tuning and DPOAEs in TectaY1870C mice. (a) Mean 7 s.d. of cochlear microphonic (CM) magnitude as a function of sound pressure level (SPL) for 4 kHz tones from four Tecta+/+ (red circles) and four TectaY1870C/+ mice (blue squares). Inset: CMs from Tecta+/+ (red) and TectaY1870C/+ mice (blue) in response to 4-kHz tones at 80 dB SPL. (b) CM magnitude as a function of sound pressure (in Pascals) for 4-kHz tones from Tecta+/+ (red) and TectaY1870C/+ (blue) mice. Inset: unfiltered CM from Tecta+/+ (red) and TectaY1870C/+ (blue) mice in response to 4-kHz tones at the SPLs indicated; vertical bars: 0.2 mV. (c,d) Basilar membrane displacement tuning curves for two Tecta+/+ mice (c, open and filled red circles; Q10 dB ¼ 10.0 and 10.2, respectively) and two TectaY1870C/+ mice (d, open and filled blue squares; Q10 dB ¼ 10.9 and 8.5, respectively). Black circles in b and d: post-mortem measurements. Threshold criterion is 0.2 nm; stars indicate low-frequency resonance. (e) DPOAE threshold curves (level of f2 required to produce a 2f1–f2 amplitude of 0 dB SPL) as a function of f2 frequency measured as mean 7 s.d. from ten Tecta+/+ mice (red circles) and ten TectaY1870C/+ mice (blue squares). (f) DPOAE-grams (level of 2f1–f2 DPOAEs as functions of F2 frequency) measured as mean 7 s.d. from ten Tecta+/+ mice (red circles) and ten TectaY1870C/+ mice (blue squares). Curves are identified by f1/f2 (dB SPL) levels and identity of mouse strain. Wt: Tecta+/+, Tr: TectaY1870C/+.
0.2 mV
4 kHz Tecta+/+ TectaY1870C/+
20 µV
b
80 70 60 50 40 30 20 10
CAP threshold (dB SPL)
c
dB SPL required to produce 0dB SPL DPOAE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
a
CM magnitude (dB re 0.1 µV)
ARTICLES
30
40
50
60
70
80 dB SPL
110 100 90 80 70 60 50 40 30 20 10
15 20 25 30 35 Frequency (kHz)
1039
ARTICLES Table 1 Frequency tuning curve characteristics of Tecta+/+ and TectaY1870C/+ mice
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Parameter
Tecta+/+
TectaY1870C/+
Q10dB Threshold (dB SPL)
10.0 7 1.2 25.4 7 2.7
10.2 7 1.7 33.0 7 3.7
PM sens. change Fh/Fl
30.2 7 1.9 1.27 7 0.02
26.0 7 2.4 1.28 7 0.04
16
10
No. of animals
Q10dB: tip frequency/bandwidth, 10 dB from tip. PM sens. change: post-mortem change in sensitivity of the tuning curve tip. Fh/Fl: ratio of the frequencies of the tip of the tuning curve (Fh) and the low-frequency peak (Fl).
probe level had little effect on the low-frequency shoulder of the tuning curve and did not cause the appearance of a high-frequency peak (open circles, Fig. 6d). DISCUSSION The results of this study demonstrate how the tectorial membrane is critical in shaping the frequency tuning of the cochlea’s neural responses through its interaction with the IHCs, a role that can be genetically isolated in the TectaY1870C/+ mouse and is independent of its role in ensuring that feedback from the OHCs is delivered to the basilar membrane at the correct time and with optimal gain. Furthermore, the results show the structural and physiological basis for a type of non-syndromic human hereditary deafness resulting from a missense mutation in the human a-tectorin gene, TECTA. The TectaY1870C mutation is semi-dominant The TectaY1870C mouse demonstrates that the mutation is semi-dominant, with a heterozygous phenotype that is distinctly different from that of the homozygote and a homozygous phenotype that is nearly identical to that observed in TectaDENT/DENT mice with a functionally null deletion in Tecta18. The Y1870C mutation is located in the zona pellucida domain of a-tectorin, a domain that is required for the polymerization of extracellular proteins39 and that is defined by a large amino acid motif40 that is common to more than 100 structural proteins, including b-tectorin, the second major non-collagenous protein of the tectorial membrane11, and the proteins that form the zona pellucida surrounding the unfertilized egg: ZP1, ZP2 and ZP3 (ref. 41). A mutation in the corresponding conserved tyrosine residue of ZP2 (Y430C) considerably reduces the incorporation of the mutated ZP2 protein into the zona pellucida and prevents its secretion from transfected cell lines39. Although this suggests that the mutation may reduce the incorporation of a-tectorin into the tectorial membrane, heterozygous Tecta+/DENT mice have no defects in tectorial membrane structure and function18 and the heterozygous carriers of presumed null mutations in TECTA have normal hearing42, so it is unlikely that the structural anomalies observed in the tectorial membranes of TectaY1870C/+ mice are simply due to haploinsufficiency. Although it is unclear why the mutation causes loss of striated-sheet matrix specifically in the sulcal region of the tectorial membrane, this loss leads to a disruption in the organization of the collagen fibrils in this area, indicating that their normal, radial orientation within the tectorial membrane is critically dependent upon the matrix in which they are imbedded. Reticular lamina drives inner hair cells in Y1870C mutants The frequency tuning characteristics of the basilar membrane in Tecta+/+ and TectaY1870C/+ mice are similar in most respects, although
1040
a slight reduction in sensitivity is seen at the characteristic frequency in TectaY1870C/+ mice. The mechanical properties of the tectorial membrane in the TectaY1870C/+ mice are therefore sufficient to excite the OHCs and drive the cochlear amplifier. Weaker coupling between the tectorial membrane and OHC bundles, as a consequence of the partial detachment of Kimura’s membrane, may be the cause of the reduction in sensitivity and the variability observed in the DPOAE-grams of TectaY1870C/+ mice. In homozygous TectaDENT/DDENT mice where the tectorial membrane is completely detached from the organ of Corti, the hair bundles of IHCs and OHCs can be driven by vibrations of the reticular lamina, but there is a 30–40 dB loss in basilar membrane sensitivity18. In the TectaY1870C/+ mouse, basilar membrane sensitivity and OHC function are normal, but the increase observed in the subtectorial space in the IHC region and the lack of Hensen’s stripe implies that motion of the reticular lamina alone must drive the IHC hair bundles. The TectaY1870C/+ mouse therefore provides a unique opportunity to investigate the relative contributions of the tectorial membrane and the reticular lamina to IHC excitation in a cochlea where basilar membrane tuning is sharp and sensitive. Matrix drives inner hair cells at their best frequency Masker tuning curves recorded from TectaY1870C/+ mice differ from those of Tecta+/+ mice. The most notable feature is the presence of a sharp notch of insensitivity at the characteristic frequency. This loss in neural sensitivity (60–70 dB) at the characteristic frequency is similar in magnitude to the hearing impairment reported for the affected members of the Austrian DFNA8/12 family with the Y1870C a-tectorin mutation13. Two other major features of the masker tuning curves in TectaY1870C/+ mice are the absence of a notch of insensitivity on the lowfrequency shoulder and the appearance of a lobe of sensitivity on the high-frequency side. If basilar membrane responses were passively transmitted to the IHCs, a loss in coupling of the IHC bundles to the tectorial membrane caused by an enlargement of the subtectorial space would simply desensitize, and possibly broaden, the neural frequency tuning curves. The appearance of a sharp notch rather than a peak at the characteristic frequency in the neural tuning curves of TectaY1870C/+ mice indicates that IHC bundle movements, and hence reticular lamina movements, are specifically reduced at the characteristic frequency in TectaY1870C/+ mice. Basilar membrane vibrations, therefore, are not faithfully relayed to the IHCs through vibration of the reticular lamina over the entire frequency range, and the tectorial membrane must, in wild-type mice, normally dominate the input to IHCs at their characteristic frequency. These observations suggest the vibrations of the basilar membrane are normally transmitted to the IHCs by means of the tectorial membrane rather than through the reticular lamina at the characteristic frequency. Insensitive notches at frequencies below the characteristic frequency are a feature of neural tuning curves from fibers that innervate the highfrequency region of the cochlea43, and high-frequency plateaus have been described in the basilar membrane tuning curves from a variety of mammals44. The absence of a notch on the low-frequency side of the TectaY1870C/+ neural tuning curve and the appearance of a lobe on the high-frequency side can both be attributed to a failure in phase cancellation. Enlargement of the subtectorial space in the IHC region of the TectaY1870C/+ mouse will abrogate interactions between the tectorial membrane and the reticular lamina and prevent such phase cancellation. Low-frequency notches normally generated by phase cancellation will no longer be seen, and high-frequency lobes that are normally suppressed by cancellation will become visible. In the latter case, it should be noted that high-frequency plateaus or lobes are
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES expected to become visible only in basilar membrane tuning curves measured from the basal, high-frequency region of the mouse cochlea at frequencies greater than 70 kHz, outside the limits of our recording system, so the tuning curves presented do not exclude the presence of high-frequency lobes in the basilar membrane vibrations. Shaping of IHC and neural tuning curves through phase cancellation of reticular lamina and tectorial membrane vibrations for frequencies above and below the characteristic frequency provides a mechanism for sharpening the frequency response of the neural tuning curves without incurring a temporal trade-off. In conclusion, these data from the TectaY1870C/+ mouse demonstrate the basis for a form of human hereditary deafness resulting from a missense mutation in a-tectorin. Furthermore, they show that the frequency tuning of IHCs and auditory nerve fibers is not a simple, direct consequence of the mechanical tuning of tone-evoked basilar membrane vibrations and their amplification by the OHCs but rather is due to the interaction of two mechanically complex structures, the reticular lamina and the tectorial membrane. Transverse vibrations of the basilar membrane, particularly at the characteristic frequency, are not faithfully transmitted to the IHCs simply through vibrations of the reticular laminar. In addition to ensuring the gain and timing of cochlear feedback are optimal, the tectorial membrane provides the principal drive to the IHCs at the characteristic frequency, interacting with the reticular lamina to shape the frequency responses of IHCs, and hence determining the sharpness and sensitivity of the neural tuning curves. METHODS Construction of the Tecta targeting vector. Clone MG492/2 was isolated from a mouse 129/SvEvBrd genomic DNA library in lFIX (Stratagene) and shown to span exons 15 to 19 of the Tecta gene. An 11-kb SacI fragment of MG492/2 was blunt end ligated into XhoI-cut pBluescript SK+. Two point mutations were introduced by in vitro mutagenesis, an A4G mutation at position 23 of exon 18, corresponding to the human A5610G mutation in DFNA8/12, and a G4C mutation at position 335 of intron 17, introducing a SacI site. The insert was fully sequenced on both strands to confirm only the desired mutations had been introduced. To construct the targeting vector, the HSVtk cassette was cut out of pTBPNS3 (ref. 45) by digestion with SacII and HindIII and the neoR cassette was cut out of pGKneopA with HindIII and XbaI, and both fragments were ligated into pBluescript SK+ cut with SacII and XbaI to create pHSVtk-neo. A 1.5-kb XbaI to XhoI fragment of MG492/2 was then ligated into XbaI/XhoIcut pHSVtk-neo. The resultant clone was cut with SacII and XhoI, and the fragment containing HSVtk, neoR and the 1.5-kb XbaI-XhoI fragment of MG492/2 was ligated into the SacII and XhoI sites of the mutagenized clone. The resulting targeting vector was extensively restriction mapped to confirm correct construction. Isolation of targeted embryonic stem cells. The targeting vector was linearized with XhoI and transfected into CCB embryonic stem cells by electroporation. After eight days of selection with geneticin, resistant colonies were picked, trypsinized and plated into individual wells of duplicate 96-well plates. Genomic DNA was prepared from each clone, digested with SacI and transferred to Hybond-N membranes (Amersham) by Southern blotting. Blots were probed with external probes 5¢ (probe A) and 3¢ (probe B) to the region targeted to identify correctly targeted integrants (‘Hits’). Probes were amplified by PCR using 83GF3 (5¢-CATGTGACAATGTGCACATC-3¢) with MG492-1351R (5¢-GACGTCATGGTGGAGCTGAG-3¢) for probe A, and maZPDF1 (5¢-TTA TGTGGCTGCATTTAACGAACTCAGGGT-3¢) with maZPDR2 (5¢-ATCAGA CTTCTGTAGCCAGA-3¢) for probe B. After gel purification, PCR products were random primer labeled with [a32P]dCTP and hybridized to the blots. To resolve integrants, targeted clones were cultured for 8 d under gancyclovir selection and resistant colonies were picked into individual wells of duplicate 96-well plates and grown to confluence. Genomic Southern blots were prepared and probed as described above to identify correctly resolved integrants (‘Runs’). One cell line was used to generate chimeric mice by microinjection of C57/BL6J
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
blastocysts. All physiological and morphological data from wild-type and heterozygous animals were from F1 progeny on a 50:50 129SvEv:C57BL/6J genetic background. Genotyping. Founder mice and their offspring were genotyped by Southern blotting as described above. PCR products spanning exon 18 were amplified from genomic DNA prepared from Tecta+/+ and TectaY1870C/+ mice using primers E18seqF1 (5¢-TTCCATGCTGA TGTATTCTAGCCTC-3¢) and E18 seqR1 (5¢-CTACTCTGATGCTGCTAACCTTAGC-3¢) and directly sequenced. Routine genotyping of mice in the Y1870C mutant colony was performed by amplifying a 403-bp region flanking the G4C mutation at position 335 of intron 17, which introduces a SacI site, and digesting the PCR product with the isoschizomer EcoICRI. Genomic DNA was isolated from tail snips according to previously published reports46. Aliquots (2 ml) of tail DNA were added to PCR mixtures containing primers E18genoF1 (5¢-GACTTCCGTTGGCTCTCTTAT GCTTC-3¢) and E18genoR1 (5¢-GAGATAGCAGCAATGCCAGGTGAAC-3¢). Reactions were heated to 98 1C for 2 min and cycled through 98 1C for 15 s, 52 1C for 15 s, 72 1C for 30 s, for a total of 40 cycles. After the PCR, 1 unit of EcoICRI (Promega) was added and the reactions were digested at 37 1C overnight. PCR products were analyzed by 1.5% agarose, 1 TBE gel electrophoresis. Morphological analysis. Procedures for the preparation of cochlear tissues for light and electron microscopy were as described previously18. Antisera R9 and R7 (ref. 47) to chicken a- and b-tectorin were used at dilutions of 1:1,000 and 1:200, respectively, and an antiserum to recombinant mouse otogelin (a gift from C. Petit, Institut Pasteur) was used at 1:2,000. Homozygous TectaY1870C/Y1870C mice used for morphology were obtained by inbreeding heterozygous TectaY1870C/+ F1 mice. Physiological measurements. Mice, normally o3 months of age, were anesthetized with ketamine (0.12 mg/g body weight, intraperitoneal (i.p.)) and xilazine (0.01 mg/g body weight, i.p.) for nonsurgical procedures or with urethane (ethyl carbamate, 2 mg/g body weight, i.p.) for surgical procedures. The animals were tracheotomized, and their core temperature was maintained at 38 1C. To measure basilar membrane displacements, cochlear microphonics, and CAPs, a caudal opening was made in the ventrolateral aspect of the right bulla to reveal the round window. DPOAEs measured before and after surgery indicate that the bulla of the mouse can be opened without loss of sensitivity. Cochlear microphonics and CAPs were measured from the round window membrane using pipettes filled with artificial perilymph with tip diameters of 50–100 mm (recording bandwidth 430 kHz). Signals were amplified with a recording bandwidth of 0–100 kHz. Tone-evoked basilar membrane displacements were measured by focusing the beam of a self-mixing, laser-diode interferometer48 through the round window membrane to form a 20-mm spot on the center of the basilar membrane in the 48–61 kHz region of the cochlea. The interferometer was calibrated at each measurement location by vibrating the piezo stack, on which it was mounted, over a known range of displacements. Tone pulses (rise-fall time 1 ms) during basilar membrane measurements were generated with a Phillips PM 5193 programmable synthesizer and attenuated with digitally controlled attenuators. Voltage responses from the interferometer were measured with a two-channel lock-in amplifier (Princeton 5210) and digitized at 250 kHz with a Data Translation 3010 data acquisition board, and the peak response was stored on a PC. Experimental control, data acquisition and data analysis were performed using a PC with programs written in TestPoint (CEC). Sound was delivered via a probe with its tip within 1 mm of the tympanic membrane and coupled to a closed acoustic system comprising two MicroTech Gefell 1-inch MK102.1 microphones for delivering tones and a Bruel & Kjaer 3135 one-quarter–inch microphone for monitoring sound pressure at the tympanum. The sound system was calibrated in situ for frequencies between 1–70 kHz using a measuring amplifier, and known SPLs were expressed in dB SPL re 2 105 Pa. The position of the coupler was adjusted to minimize peaks and dips in the calibration curve. White noise and tone pulses with risefall times of 0.2 ms were synthesized by a Data Translation 3010 data acquisition board, attenuated and used for sound system calibration and the measurement of electrical and acoustical cochlear responses. Data were digitized at 250 kHz and stored on a PC. To measure DPOAEs, primary tones were
1041
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES set to generate 2f1–f2 distortion products at frequencies between 1 and 70 kHz. DPOAEs were measured for levels of f1 ranging from 10–80 dB SPL, with the levels of the f2 tone set 10 dB SPL below that of the f1 tone. DPOAE threshold curves were constructed from measurements of the level of the f2 tone that produced a 2f1–f2 DPOAE with a level of 0 dB SPL where the frequency ratio of f2:f1 was 1.23. System distortion during DPOAE measurements was 80 dB below the primary tone levels. CAP tuning curves were derived from simultaneous tone-on-tone masking38 using a 10-ms probe tone centered on a 40-ms masker tone. The probe tone was set to a level where a stable CAP appeared just above the recording noise floor. The frequency of the masker was set and its attenuation was adjusted until the probe tone CAP was suppressed. The masker frequency and level was noted, a new masker frequency was set and the process repeated. In a second group of experiments the probe level was set to increasingly higher values to see how the CAP tuning curves varied with probe tone level. All procedures involving animals were performed in accordance with UK Home Office regulations with approval from the local ethics committee. ACKNOWLEDGMENTS The authors would like to thank M. Mellado, M. Ko¨ssl and M. Drexl for their helpful criticisms of the manuscript and J. Hartley for expert technical assistance. Supported by grants from The Wellcome Trust, Defeating Deafness and the Fonds Wetenschappelijk Onderzoek – Flanders. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 9 March; accepted 3 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Lim, D.J. Functional structure of the organ of Corti: a review. Hear. Res. 22, 117–146 (1986). 2. Brownell, W.E., Bader, C.R., Betrand, D. & de Ribaupierre, Y. Evoked mechanical responses of isolated cochlear outer hair cells. Science 227, 194–196 (1985). 3. Patuzzi, R.B., Yates, G.K. & Johnstone, B.M. Outer hair receptor currents and sensorineural hearing loss. Hear. Res. 42, 47–72 (1989). 4. Ruggero, M.A. & Rich, N.C. Furosemide alters organ of Corti mechanics: evidence for feedback of outer hair cells upon the basilar membrane. J. Neurosci. 11, 1057–1067 (1991). 5. Ko¨ssl, M. & Russell, I.J. The phase and magnitude of hair cell receptor potentials and frequency tuning in the guinea pig cochlea. J. Neurosci. 12, 1575–1586 (1992). 6. Spoendlin, H. Anatomy of cochlear innervation. Am. J. Otolaryngol. 6, 453–467 (1985). 7. Kimura, R.S. Hairs of the cochlear sensory cells and their attachment to the tectorial membrane. Acta Otolaryngol. (Stockh.) 61, 55–72 (1966). 8. Hasko, J.A. & Richardson, G.P. The ultrastructural organization and properties of the mouse tectorial membrane matrix. Hear. Res. 35, 21–38 (1988). 9. Richardson, G.P., Russell, I.J., Duance, V.C. & Bailey, A.J. Polypeptide composition of the mammalian tectorial membrane. Hear. Res. 25, 45–60 (1987). 10. Thalmann, I. et al. Composition and supramolecular organization of the tectorial membrane. Laryngoscope 97, 357–367 (1987). 11. Legan, P.K., Rau, A., Keen, J.N. & Richardson, G.P. The mouse tectorins: modular matrix proteins of the inner ear homologous to components of the sperm-egg adhesion system. J. Biol. Chem. 272, 8791–8801 (1997). 12. Cohen-Salmon, M., El-Amraoui, A., Leibovici, M. & Petit, C. Otogelin: a glycoprotein specific to the acellular membranes of the inner ear. Proc. Natl. Acad. Sci. USA 94, 14450–14455 (1997). 13. Verhoeven, K. et al. Mutations in human a-tectorin cause autosomal dominant nonsyndromic hearing impairment. Nat. Genet. 19, 60–62 (1998). 14. Davis, H. Transmission and transduction in the cochlea. Laryngoscope 68, 359–382 (1957). 15. Zwislocki, J.J. Theory of cochlear mechanics. Hear. Res. 2, 171–182 (1980). 16. Zwislocki, J.J. Analysis of cochlear mechanics. Hear. Res. 22, 155–169 (1986). 17. Allen, J.B. Cochlear micromechanics - a physical model of transduction. J. Acoust. Soc. Am. 68, 1660–1670 (1980). 18. Legan, P.K. et al. A targeted deletion in a-tectorin reveals the tectorial membrane is required for the gain and timing of cochlear feedback. Neuron 28, 273–285 (2000). 19. Gummer, A.W., Hemmert, W. & Zenner, H.P. Resonant tectorial membrane motion in the inner ear: Its crucial role in frequency tuning. Proc. Natl. Acad. Sci. USA 93, 8727– 8732 (1996).
1042
20. Hemmert, W., Zenner, H.P. & Gummer, A.W. Three-dimensional motion of the organ of Corti. Biophys. J. 78, 2285–2297 (2000). 21. Lukashkin, A.N., Lukashkina, V.A., Legan, P.K., Richardson, G.P. & Russell, I.J. Role of the tectorial membrane revealed by otoacoustic emissions recorded from wild-type and transgenic Tecta (deltaENT/deltaENT) mice. J. Neurophysiol. 91, 163–171 (2004). 22. Lin, T. & Guinan, J.J. Auditory-nerve-fiber responses to high-level clicks: Interference patterns indicate that excitation is due to the combination of multiple drives. J. Acoust. Soc. Am. 107, 2615–2630 (2000). 23. Dallos, P., Billone, M.C., Durrant, J.D., Wang, C. & Raynor, S. Cochlear inner and outer hair cells: functional differences. Science 177, 356–358 (1972). 24. Russell, I.J. & Sellick, P.M. Low-frequency characteristics of intracellularly recorded receptor potentials in guinea-pig cochlear hair cells. J. Physiol. (Lond.) 338, 179–206 (1983). 25. Patuzzi, R.B. & Yates, G.K. The low-frequency response of inner hair cells in the guinea pig cochlea: implications for fluid coupling and resonance of the stereocilia. Hear. Res. 30, 83–98 (1987). 26. Aranyosi, A.J. & Freemann, D.M. Sound-induced motions of individual cochlear hair bundles. Biophys. J. 87, 3536–3546 (2004). 27. Russell, I.J., Ko¨ssl, M. & Murugasu, E. A comparison between tone-evoked voltage responses of hair cells and basilar membrane displacements recorded in the basal turn of the guinea pig cochlea. in Advances in Hearing Research (eds. Manley, G.A., Klump, G.M., Ko¨ppl, C., Fastl, H. & Oeckinghaus, H.) 125–135 (World Scientific, Singapore, 1995). 28. Narayan, S.S., Temchin, A.N., Recio, A. & Ruggero, M.A. Frequency tuning of basilar membrane and auditory nerve fibers in the same cochleae. Science 282, 1882–1884 (1998). 29. Kletsky, E.J. & Zwislocki, J.J. CM tuning can be compatible with sharply tuned receptor potentials. Hear. Res. 2, 549–557 (1980). 30. Frolenkov, G.I., Belyantseva, I.A., Kurc, M., Mastroianni, M.A. & Kachar, B. Cochlear outer hair cell electromotility can provide force for both low and high intensity distortion product otoacoustic emissions. Hear. Res. 126, 67–74 (1998). 31. Lukashkin, A.N., Lukashkina, V.A. & Russell, I.J. One source for distortion product otoacoustic emissions generated by low- and high-level primaries. J. Acoust. Soc. Am. 111, 2740–2748 (2002). 32. Santos-Sacchi, J. Harmonics of outer hair cell motility. Biophys. J. 65, 2217–2227 (1993). 33. Lukashkin, A.N. & Russell, I.J. A descriptive model of the receptor potential nonlinearities generated by the hair cell mechanoelectrical transducer. J. Acoust. Soc. Am. 103, 973–980 (1998). 34. Mom, T., Telischi, F.F., Martin, G.K. & Lonsbury-Martin, B.L. Measuring the cochlear blood flow and distortion-product otoacoustic emissions during reversible cochlear ischemia: a rabbit model. Hear. Res. 133, 40–52 (1999). 35. Robertson, D. Horseradish peroxidase injection of physiologically characterized afferent and efferent neurones in the guinea pig spiral ganglion. Hear. Res. 15, 113–121 (1984). 36. Davis, H., Tasaki, I. & Goldstein, R. The peripheral origin of activity, with reference to the ear. Cold Spring Harb. Symp. Quant. Biol. 17, 143–154 (1952). 37. Sellick, P., Patuzzi, R. & Robertson, D. Primary afferent and cochlear nucleus contributions to extracellular potentials during tone-bursts. Hear. Res. 176, 42–58 (2003). 38. Dallos, P. & Cheatham, M.A. Compound action potential (AP) tuning curves. J. Acoust. Soc. Am. 59, 591–597 (1976). 39. Jovine, L., Qi, H., Williams, Z. & Wassarman, P.M. The ZP domain is a conserved module for polymerisation of extracellular proteins. Nat. Cell Biol. 4, 457–461 (2002). 40. Bork, P. & Sander, C. A large domain common to sperm receptors (Zp2 and Zp3) and TGF-beta type III receptor. FEBS Lett. 300, 237–240 (1992). 41. Wassarman, P.M., Jovine, L. & Litscher, E.S. A profile of fertilization in mammals. Nat. Cell Biol. 3, E59–E64 (2001). 42. Mustapha, M. et al. An alpha-tectorin gene defect causes a newly identified autosomal recessive form of sensorineural pre-lingual non-syndromic deafness, DFNB21. Hum. Mol. Genet. 8, 409–412 (1999). 43. Liberman, M.C. & Kiang, N.Y.-S. Acoustic trauma in cats. Acta Otolaryngol. Suppl. 358, 1–63 (1978). 44. Robles, L. & Ruggero, M.A. Mechanics of the mammalian cochlea. Physiol. Rev. 81, 1305–1352 (2001). 45. Brookes, A.J., Stevenson, B.J., Porteous, D.J. & Dorin, J.R. A series of vectors that simplify mammalian gene targeting. Transgenic Res. 2, 238–244 (1993). 46. Malumbres, M., Mangues, R., Ferrer, N., Lu, S. & Pellicer, C. Isolation of high molecular weight DNA for reliable genotyping of transgenic mice. Biotechniques 22, 1114–1119 (1997). 47. Knipper, M. et al. Thyroid hormone-deficient period prior to the onset of hearing is associated with reduced levels of beta-tectorin protein in the tectorial membrane: implication for hearing loss. J. Biol. Chem. 276, 39046–39052 (2001). 48. Russell, I.J. & Ko¨ssl, M. Micromechanical responses to tones in the auditory fovea of the greater mustached bat’s cochlea. J. Neurophysiol. 82, 676–686 (1999).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses Wade Morishita, Helene Marie & Robert C Malenka Although long-term depression (LTD) of AMPA receptor–mediated postsynaptic currents (AMPAR EPSCs) has been extensively examined, little is known about the mechanisms responsible for LTD of NMDA receptor (NMDAR)-mediated EPSCs. Here we show differences in the intracellular signaling cascades that mediate LTD of AMPAR EPSCs versus NMDAR EPSCs in rat hippocampus. Both forms of LTD were blocked by inhibitors of protein phosphatase 1, but only LTD of AMPAR EPSCs was affected by inhibition of calcineurin. Notably, in contrast to LTD of AMPAR EPSCs, LTD of NMDAR EPSCs was unaffected by endocytosis inhibitors. A role for calcium-dependent actin depolymerization in LTD of NMDAR EPSCs was supported by the findings that the actin stabilizer phalloidin and a cofilin inhibitory peptide each blocked LTD of NMDAR EPSCs but not AMPAR EPSCs. These results suggest that the same pattern of afferent activity elicits depression of AMPAR- and NMDAR-mediated synaptic responses by means of distinct triggering and expression mechanisms.
Long-term potentiation (LTP) and LTD of excitatory synaptic transmission in the mammalian brain have been extensively studied, and much has been learned about their detailed molecular mechanisms1. Although most excitatory synapses contain both AMPARs and NMDARs, because basal synaptic responses are solely or primarily mediated by AMPARs, much of the mechanistic work on synaptic plasticity has focused on changes in AMPAR-mediated excitatory postsynaptic responses. Indeed, it is controversial whether NMDAR-mediated excitatory responses increase during LTP in the CA1 region of the hippocampus, although recent work suggests that they can show a delayed enhancement following LTP induction2. However, even when NMDAR-mediated responses are potentiated, little is known about the detailed molecular mechanisms responsible for this enhancement. In contrast to LTP, it has consistently been reported that NMDAR-mediated excitatory postsynaptic potentials (EPSPs) or EPSCs decrease during that form of LTD triggered by NMDARs3–7. Notably, analysis of changes in the coefficient of variation of AMPAR EPSCs and NMDAR EPSCs suggests that the mechanisms underlying LTD of AMPAR EPSCs and NMDAR EPSCs differ5. In support of this conclusion, it is possible to elicit LTD of one component of synaptic responses without affecting the other5. However, as is the case for LTP of NMDAR EPSPs and EPSCs, little is known about the triggering and expression mechanisms that underlie LTD of NMDAR-mediated synaptic transmission. The paucity of knowledge about the mechanisms by which synaptic activity modulates NMDAR-mediated synaptic transmission during LTP and LTD is particularly surprising, given that since the cloning of specific NMDAR subunits, much has been learned about the
modulation of NMDARs by various intracellular signaling pathways8,9. In the context of NMDAR-dependent LTD, which involves endocytosis of AMPARs1,10, of particular note is the demonstration that NMDARs can be internalized both constitutively and in response to agonist application11–13. This form of LTD also involves an NMDAR-dependent increase in intracellular calcium and activation of protein phosphatases1, both of which also modulate NMDAR function8,9. In this study, we focused on the role of protein phosphatases, dynamin-dependent endocytosis and the actin cytoskeleton in LTD of NMDAR EPSCs. We present evidence that the intracellular mechanisms responsible for LTD of AMPAR EPSCs and LTD of NMDAR EPSCs differ. The findings suggest that the same pattern of synaptic activation of NMDARs can initiate signaling cascades that modulate AMPARs and NMDARs through different mechanisms. Such parallel but independent activity-dependent regulation of synaptic AMPARs and NMDARs provides great flexibility to individual synaptic sites and has implications for the roles of NMDARs in both adaptive and pathological brain function. RESULTS LTD of NMDAR EPSCs depends on NMDARs and calcium To examine LTD of NMDAR EPSCs we made whole-cell voltage-clamp recordings from CA1 pyramidal cells in acute hippocampal slices in conditions that isolated the NMDAR EPSC. Applying a 5-Hz, 3-min train of afferent stimulation elicited reliable LTD of NMDAR EPSCs (56 ± 2% of baseline, n ¼ 36; Fig. 1a,b). This was not due to dialysis of cells by the pipette solution, as LTD of isolated NMDAR-mediated field EPSPs was induced by a similar protocol (64 ± 3% of baseline, n ¼ 8; Fig. 1c). Furthermore, two pathway experiments demonstrated
Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 1201 Welch Rd., Palo Alto, California 94304, USA. Correspondence should be addressed to R.M. (
[email protected]). Published online 17 July 2005; doi:10.1038/nn1506
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1043
a
3
–90
2 1
b
50 pA D-AP5 50 ms
–60
2 1
–30
3
0 0
10
20
30
40
50
NMDAR EPSC (%)
NMDAR EPSC (pA)
ARTICLES
125 100 75 50 25 0
60
–10 –5
0
5
10 15 20 25 30 35 40
NMDAR EPSP (%)
d
125 100 75 50 25 0 –10
–5
0
5
10
15
20
25
BAPTA
75 50 25 0 –10 –5
30
0
5
f
D-AP5
125 100 75 50 25 0
–10 –5
0
5
10
15
20
25
30
35
20
25
30
35
Time (min) LY 341495
NMDAR EPSC (%)
NMDAR EPSC (%)
e
Control
125 100
Time (min) 125 100 75 50 25 0
10 15 20 25 30 35 40 45
–10 –5
0
5
10
15
LTD of NMDAR EPSCs requires PP1 but not PP2B Figure 1 LTD of NMDAR-mediated synaptic transmission at Schaffer collateral–CA1 synapses is Ca2+Inhibitors of protein phosphatase 1 (PP1) dependent and requires activation of NMDARs and not mGluRs. (a) Sample experiment illustrating LTD activity1 or PP1 synaptic targeting14 impair of NMDAR EPSCs. Downward arrow in this and all subsequent figures indicates time at which 5-Hz, LTD of AMPAR EPSCs. Therefore, we next 3-min stimulation train was applied. Complete block of EPSC by D-AP5 (100 mM) confirms that EPSC tested whether loading CA1 cells with PP1 was mediated by NMDARs. In this and all subsequent figures, traces above the graph show averaged EPSCs (5–10 consecutive responses) taken at the times indicated by the numbers on the graph. inhibitors also affected LTD of NMDAR (b) Summary graph of LTD of NMDAR EPSC (n ¼ 36). In this and all subsequent summary graphs, EPSCs. Consistent with a role for PP1, adding points represent mean ± s.e.m. (c) Summary graph of LTD of NMDAR field EPSPs (n ¼ 8). (d) Summary either okadaic acid (1 mM) or membranegraphs comparing LTD of NMDAR EPSC in cells loaded with BAPTA (n ¼ 6) and interleaved control impermeable microcystin LR (20 mM) to cells (n ¼ 6). (e) Summary graph demonstrating that LTD of NMDAR EPSC was not elicited when 5-Hz, the pipette solution prevented LTD of 3-min stimulation train was delivered in the presence of D-AP5 (100 mM; n ¼ 10). (f) Summary graph demonstrating normal LTD of NMDAR EPSC was elicited when 5-Hz, 3-min stimulation train was applied NMDAR EPSCs (okadaic acid, 93 ± 10%, in the presence of the mGluR antagonist, LY341495 (100 mM; n ¼ 5). n ¼ 6, Fig. 2a,b; microcystin LR 93 ± 7%, n ¼ 7, Fig. 2c,d) whereas interleaved control cells showed robust LTD (n ¼ 4 that LTD of NMDAR-mediated synaptic responses was input specific and 7 for okadic acid and microcystin LR experiments, respectively; (control pathway: 92 ± 2% of baseline; LTD pathway: 67 ± 1%; n ¼ 7; P o 0.05; Fig. 2b,d). According to one prominent hypothesis15, PP1 activity increases data not shown). Previous work has demonstrated that LTD of NMDAR EPSCs during LTD induction by means of a disinhibition mechanism requires a rise in postsynaptic calcium5 and activation of involving calcium-dependent activation of protein phosphatase 2B NMDARs3,5. Because our experimental conditions differed and because (PP2B, calcineurin). Consistent with this model, PP2B inhibitors of evidence for a metabotropic glutamate receptor (mGluR)-triggered impair LTD of AMPAR EPSCs16. Therefore, we tested whether these form of LTD in CA1 cells1, we examined whether the rise in same inhibitors blocked LTD of NMDAR EPSCs. Loading cells with the Time (min)
2
Time (min)
1+2 50 pA
–125
c
50 ms
–100 –75 –50
1
2
–25 0 0
5
10
15
20
25
30
35
40
45
1
NMDAR EPSC (pA)
1
NMDAR EPSC (pA)
a
2
50
2
1
0
5
10
15
Okadaic acid
125
75 50 25 0 –5
0
5
10
15
Time (min)
1044
d
Control
100
–10
20
25
30
35
40
45
50
Time (min)
NMDAR EPSC (%)
b
1+2 50 mV 50 ms
–150 –125 –100 –75 –50 –25 0
Time (min)
NMDAR EPSC (%)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
c
Time (min) NMDAR EPSC (%)
Time (min)
calcium and activation of NMDARs was still required for LTD of NMDAR EPSCs. Consistent with a critical role for increases in postsynaptic calcium levels, loading CA1 cells with the calcium chelator BAPTA (30 mM) blocked LTD of NMDAR EPSCs (93 ± 12%, n ¼ 6; interleaved control cells 62 ± 5%, n ¼ 6, P o 0.05; Fig. 1d). This rise in calcium is likely to be due to NMDAR activation, as blocking NMDARs with D-AP5 (50–100 mM) during the induction protocol prevented LTD of NMDAR EPSCs (90 ± 15%, n ¼ 10, Fig. 1e) whereas blockade of mGluRs with the antagonist LY341495 (100 mM) had no effect (55 ± 7%, n ¼ 5, Fig. 1f). Thus, like LTD of AMPAR EPSCs1, these results suggested that LTD of NMDAR EPSCs requires an NMDAR-dependent rise in postsynaptic calcium.
20
25
30
35
Microcystin LR
125
Control
100
Figure 2 Protein phosphatase 1/2A inhibitors block LTD of NMDAR EPSCs. (a) Sample experiment in which attempt was made to elicit LTD in a cell loaded with okadaic acid. (b) Summary graphs comparing LTD of NMDAR EPSC in cells loaded with okadaic acid (n ¼ 6) and interleaved control cells (n ¼ 4). (c) Sample experiment in which the cell was loaded with microcystin LR. (d) Summary graphs comparing LTD of NMDAR EPSC in cells loaded with microcystin LR (n ¼ 7) and interleaved control cells (n ¼ 7).
75 50 25 0 –10
–5
0
5
10
15
20
25
30
35
Time (min)
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES NMDAR EPSC 2
1
AMPAR EPSC
c
1+2
1
–75
2
1
–50 –25 0 0
5
10 15 20 25 30 35 40 45 50 55
100 pA 50 ms 2
1
5
0
10
15
20
Time (min)
NMDAR EPSC FK-506
125
25
30
35
40
45
50
Time (min)
AMPAR EPSC
d
Control
FK-506
125
100 75 50 25
Control
100
EPSC (%)
b NMDAR EPSC (%)
Figure 3 The protein phosphatase 2B (calcineurin) inhibitor FK-506 blocks LTD of AMPAR EPSCs but not LTD of NMDAR EPSCs. (a) Sample experiment in which cell was loaded with FK-506 and LTD of NMDAR EPSCs was elicited. (b) Summary graphs comparing LTD of NMDAR EPSCs in cells loaded with FK-506 (n ¼ 12) and interleaved control cells (n ¼ 7). (c) Sample experiment in which the cell was loaded with FK-506 while attempting to elicit LTD of AMPAR EPSCs. (d) Summary graphs comparing LTD of AMPAR EPSCs in cells loaded with FK-506 (n ¼ 7) and interleaved control cells (n ¼ 7).
75 50 25
0
0 –10
–5
0
5
10
15
20
25
30
35
–10
–5
0
5
10
Time (min)
15
20
PP2B inhibitor FK-506 (50 mM) had no effect on this form of LTD (49 ± 4%, n ¼ 12, Fig. 3a,b), the magnitude of which was comparable to interleaved control cells (55 ± 6%, n ¼ 7, Fig. 3b). To ensure that the FK-506 was effective, we tested the same batch of FK-506 on LTD of AMPAR EPSCs. This blocked LTD of AMPAR EPSCs (93 ± 9%, n ¼ 7, Fig. 3c,d), whereas interleaved control cells exhibited robust LTD of AMPAR EPSCs (48 ± 8%, n ¼ 7, P o 0.05, Fig. 3d). We also examined the effects of a calcineurin inhibitory peptide16 (500 mM), and similar to FK-506, loading cells with this peptide had no effect on LTD of NMDAR EPSCs (48 ± 6%, n ¼ 4, data not shown).
30
35
dynamin-dependent endocytosis, we loaded cells with GDPbS, which should impair all GTP-dependent activity, including that of dynamin. Indeed, this manipulation has been found to block LTD of AMPAR EPSCs17. However, loading cells with GDPbS (600 mM) had no effect on LTD of NMDAR EPSCs (53 ± 4%, n ¼ 7, Fig. 4a) compared with interleaved control cells (59 ± 9%, n ¼ 4, Fig. 4a). We confirmed the efficacy of this manipulation by examining LTD of AMPAR EPSCs in cells loaded with GDPbS. As expected17, this blocked this form of LTD (94 ± 9%, n ¼ 5, Fig. 4b), which was reliably elicited in interleaved control cells (59 ± 9%, n ¼ 4, P o 0.05, Fig. 4b). Another manipulation that inhibits dynamin and blocks LTD of AMPAR EPSCs is loading CA1 cells with a small peptide (termed D15) that interferes with the binding of dynamin to amphiphysin17. However, similar to the lack of effect of GDPbS, this peptide (2 mM) had no effect on LTD of NMDAR EPSCs (45 ± 2%, n ¼ 8, Fig. 4c) when compared with interleaved cells loaded with a scrambled version of this peptide (S15, 2 mM; 47 ± 5%, n ¼ 7, Fig. 4c). In contrast, loading cells with D15 inhibited LTD of AMPAR EPSCs (84 ± 9%, n ¼ 9, Fig. 4d) when compared with S15-loaded cells (57 ± 5%, n ¼ 8, P o 0.05, Fig. 4d). We have demonstrated that two different inhibitors of dynamin both block or substantially inhibit LTD of AMPAR EPSCs with no effect on
Dynamin inhibitors do not block LTD of NMDAR EPSCs Regardless of the signaling cascades that trigger LTD, strong evidence suggests that LTD of AMPAR EPSCs is due, at least in part, to the dynamin-dependent endocytosis of AMPARs1,10. Does LTD of NMDAR EPSCs also involve endocytosis of NMDARs and/or associated synaptic proteins such as PSD-95 (ref. 1)? Such a mechanism would seem to be the most parsimonious, as it could involve the formation of clathrin-coated pits that could simultaneously remove both AMPARs and NMDARs. Furthermore, NMDARs in cell lines and cultured neurons can be internalized both constitutively and in response to agonist application11–13. As an initial attempt to block
a NMDAR EPSC
GDPβS
50 2
25
1
75 50
2
0 –5
0
5
10
15
20
25
30
–10
35
–5
0
5
Time (min)
c NMDAR EPSC
D15 1+2
d
50 ms
1
75
15
20
50 25
2
D15 1+2
25
30
35
S15 1+2 100 pA
125
50 ms
EPSC (%)
100
AMPAR EPSC
50 pA
50 pA
125
10
Time (min) S15 1+2
100 pA
25 ms
25 ms
100 75
1
50 2
25 0
0 –5
0
5
10
15
Time (min)
[
100 pA 25 ms
100
25
0 –10
NUMBER 8
Control 1+2
100 pA 25 ms
125 50 ms
1
75
GDPβS 1+2
50 pA
50 pA 50 ms
100
AMPAR EPSC
1+2
125
–10
[
b
Control
1+2
NMDAR EPSC (%)
Figure 4 LTD of NMDAR EPSCs is not blocked by inhibitors of dynamin-dependent endocytosis. (a) Summary graphs comparing LTD of NMDAR EPSCs in cells loaded with GDPbS (n ¼ 7) and interleaved control cells (n ¼ 4). (b) Summary graphs comparing LTD of AMPAR EPSCs in cells loaded with GDPbS (n ¼ 5) and interleaved control cells (n ¼ 4). (c) Summary graphs comparing LTD of NMDAR EPSCs in cells loaded with D15 (n ¼ 8), a peptide that inhibits dynamin activity, and cells loaded with an inactive, scrambled version of the peptide, S15 (n ¼ 7). (d) Summary graphs comparing LTD of AMPAR EPSCs in cells loaded with D15 (n ¼ 9) and cells loaded with S15 (n ¼ 8).
NATURE NEUROSCIENCE VOLUME 8
25
Time (min)
NMDAR EPSC (%)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
–300 –250 –200 –150 –100 –50 0
50 ms
–100
EPSC (pA)
NMDAR EPSC (pA)
50 pA
–125
1+2
2
EPSC (%)
a
AUGUST 2005
20
25
30
35
–10
–5
0
5
10
15
20
25
30
35
Time (min)
1045
EPSC (%)
NMDAR EPSC (%)
LTD of NMDAR EPSCs. Nonetheless, because a b the conclusions based on these results were unexpected, we performed a third manipulation to inhibit dynamin activity. Specifically, we generated a Sindbis virus that expressed a dominant-negative form of dynamin 1 coexDyn1-K44A Control Dyn1-K44A Control AMPAR EPSC NMDAR EPSC 1+2 1+2 1+2 1+2 pressed with GFP (Dyn1-K44A-IRES-GFP). c d 50 pA 50 pA 25 pA This dynamin mutant has been used exten25 pA 150 125 25 ms 25 ms 50 ms 50 ms sively to study the role of dynamin in endo100 100 1 cytosis by clathrin-coated pits18 and inhibits 75 1 50 agonist-dependent endocytosis of AMPARs in 50 2 25 2 cultured neurons19. To facilitate comparisons 0 0 with previous results, we stereotaxically –10 –5 0 5 10 15 20 25 30 –10 –5 0 5 10 15 20 25 30 35 injected the virus into the CA1 region of the Time (min) Time (min) hippocampus and then prepared standard acute hippocampal slices the next day Figure 5 In vivo expression of a dominant-negative form of dynamin blocks LTD of AMPAR EPSCs but not LTD of NMDAR EPSCs. (a) Left: 4 differential interference contrast (DIC) image of a slice cut from (Fig. 5a,b), a procedure that we have used a hippocampus that was injected 18 h earlier with Sindbis virus encoding a dominant-negative form of previously to study the effects of expressing dynamin 1, Dyn1-K44A, that was co-expressed with GFP (scale bar ¼ 250 mm). Right: corresponding recombinant proteins20. The efficacy of this 4 epifluorescent image. (b) Left: a 40 DIC image of the CA1 region captured from another manipulation was demonstrated by the find- hippocampal slice taken from an injected hippocampus (scale bar ¼ 10 mm). Right: corresponding ing that LTD of AMPAR EPSCs in cells epifluorescent image. (c) Summary graphs comparing LTD of AMPAR EPSCs in cells expressing Dyn1expressing Dyn1-K44A was blocked (107 ± K44A (n ¼ 5) with uninfected cells recorded from the same slices (n ¼ 5). (d) Summary graphs 14%, n ¼ 5, Fig. 5c), whereas uninfected cells comparing LTD of NMDAR EPSCs in cells expressing Dyn1-K44A (n ¼ 7) with uninfected cells recorded from the same slices (n ¼ 5). in the same slices showed robust LTD (55 ± 14%, n ¼ 5, P o 0.05, Fig. 5c). In contrast, robust LTD of NMDAR EPSCs was generated in cells expressing Dyn1- by its blockade by phalloidin23. We therefore examined whether K44A (56 ± 6%, n ¼ 7, Fig. 5d), and this was similar to the LTD of loading cells with phalloidin (100 mM), which inhibits actin depolyNMDAR EPSCs elicited in neighboring cells (64 ± 7%, n ¼ 5, Fig. 5d). merization and stabilizes actin, affects LTD of NMDAR EPSCs and/or Thus, on the basis of the lack of effect of three different inhibitors LTD of AMPAR EPSCs. LTD of NMDAR EPSCs was essentially blocked of dynamin on LTD of NMDAR EPSCs, along with their documented in cells loaded with phalloidin (90 ± 8%, n ¼ 7, Fig. 6a), whereas effects on LTD of AMPAR EPSCs, we conclude that LTD of NMDAR interleaved control cells showed robust LTD (56 ± 4%, n ¼ 6, P o 0.05, EPSCs does not involve dynamin-dependent endocytosis of NMDARs. Fig. 6a). In contrast, phalloidin had no effect on LTD of AMPAR EPSCs (65 ± 5%, n ¼ 5; interleaved controls: 61 ± 7%, n ¼ 6, Fig. 6b) indicating that the block of LTD of NMDAR EPSCs by phalloidin was LTD of NMDAR EPSCs requires actin depolymerization If LTD of NMDAR EPSCs does not require NMDAR internalization, not due to nonspecific effects. We also examined effects of latrunculin B and cytochalasin D, both what calcium-dependent processes might contribute? There is extensive evidence that calcium-dependent modulation of the actin cytos- of which inhibit actin polymerization and promote depolymerization. keleton can have significant effects on NMDARs21–27. Of particular Soaking slices in latrunculin B (20 mM) blocked LTD of both NMDAR interest is the calcium-induced rundown of NMDAR channel activity EPSCs (99.4 ± 4%, n ¼ 3) and AMPAR EPSCs (98 ± 12%, n ¼ 6), but in cultured neurons that involves actin depolymerization, as evidenced these results were difficult to interpret because, as previously
a NMDAR EPSC
b AMPAR EPSC
Control
Phalloidin 1+2
1+2
100 1
75 50
2
25
50 pA 50 ms
100 pA 50 ms
100 75
1
50 2
25 0
0 –10
–5
0
5
10
15
20
25
30
–10
35
–5
0
5
Time (min) S3P
d AMPAR EPSC
S3
1+2
25
30
35
S3 1+2 100 pA
125
1
75
20
S3P
50 pA 50 ms
50 ms
100
15
1+2
1+2 50 pA
125
10
Time (min)
EPSC (%)
c NMDAR EPSC
50 2
25
100 pA
25 ms
Figure 6 LTD of NMDAR EPSCs is blocked by the actin stabilizing agent, phalloidin, and a peptide that inhibits cofilin. (a) Summary graphs comparing LTD of NMDAR EPSCs in cells loaded with phalloidin (n ¼ 7) and interleaved control cells (n ¼ 6). (b) Summary graphs comparing LTD of AMPAR EPSCs in cells loaded with phalloidin (n ¼ 5) and interleaved control cells (n ¼ 6). (c) Summary graph comparing LTD of NMDAR EPSCs in cells loaded with phosphorylated cofilin peptide (S3P; n ¼ 11) and nonphosphorylated peptide (S3; n ¼ 10). (d) Summary graph comparing LTD of AMPAR EPSCs in cells loaded with S3P peptide (n ¼ 6) and S3 peptide (n ¼ 6).
25 ms
100 75
1
50 2
25 0
0 –10
–5
0
5
10
15
Time (min)
1046
Control 1+2
125
50 ms
50 ms
EPSC (%)
NMDAR EPSC (%)
125
Phalloidin 1+2
50 pA
50 pA
NMDAR EPSC (%)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
20
25
30
35
–10
–5
0
5
10
15
20
25
30
35
Time (min)
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
EPSC (%)
EPSC (%)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
EPSC (%)
1+2 1+2 scaled AMPAR reported28, this manipulation has presynaptic component a b + D-AP5 Dual-component EPSC effects, as shown by an increase in the NMDAR a b 50 pA component paired-pulse ratio (data not shown). We 25 pA 125 50 ms 50 ms 100 next loaded CA1 cells directly with latrunculin 75 1 B (200 mM, n ¼ 5) or cytochalasin D (200 mM, a+b 50 n ¼ 3). This caused a rundown of NMDAR 25 2 EPSCs (to 30–40% of initial responses), 0 AMPAR NMDAR –10 –5 0 5 10 15 20 25 30 which did not reach a stable level even after component component Time (min) 40–50 min of recording (data not shown). AMPAR AMPAR 1+2 1+2 1+2 1+2 Although these results were consistent with c component component 50 pA d 50 pA NMDAR NMDAR 5 ms 50 pA 50 pA the hypothesis that actin depolymerization 5 ms component component 25 ms 25 ms 125 125 reduces NMDAR EPSCs, because of the 100 100 difficulty in obtaining a stable baseline, we 1 75 75 1 could not determine whether LTD of 50 50 2 NMDAR EPSCs was reduced or ‘occluded’ 25 2 25 by these manipulations. 0 0 15 20 25 30 –10 –5 0 5 10 15 20 25 30 –10 –5 0 5 10 Several actin-binding proteins may have Time (min) Time (min) roles in activity-induced alterations in synaptic actin dynamics29. To examine a require- Figure 7 Dual-component EPSCs demonstrate selective block of LTD of either AMPAR or NMDAR ment for gelsolin, which may have a role in the components by D15 and phalloidin, respectively. (a) Traces illustrating that a dual component EPSC is calcium-dependent rundown of NMDA- recorded when the membrane voltage is held at –40 mV (trace a). Subsequent application of D-AP5 evoked currents in cultured neurons27, we (trace b) yields an AMPAR EPSC. Superimposition of the traces (a+b) reveals that an ‘AMPAR component’ can be measured early during the rising phase of the EPSC, and an ‘NMDAR component’ prepared slices from knockout mice lacking can be measured later in the tail of the EPSC. (b) Summary graphs showing LTD of the AMPAR 30 this protein . However, robust LTD of component and NMDAR component of the dual-component EPSC (n ¼ 7). (c) Summary graphs NMDAR EPSCs was still elicited in the comparing LTD of the NMDAR component with LTD of the AMPAR component in cells loaded with D15 absence of gelsolin (61 ± 2%, n ¼ 7; data (n ¼ 7). (d) Summary graphs comparing LTD of the NMDAR component with LTD of the AMPAR not shown). To examine the role of cofilin, component in cells loaded with phalloidin (n ¼ 8). Superimposed representative traces above graphs in which, upon dephosphorylation, depoly- b, c, and d are averages of ten consecutive EPSCs recorded before and after the LTD-inducing stimulus merizes actin29,31, we loaded cells with a (arrow). Traces at right in c and d are shown at an expanded time scale. phosphorylated cofilin peptide that competes with endogenous phosphorylated cofilin as a substrate for phospha- synaptic responses mediated solely by AMPARs or NMDARs. An tases and prevents the dendritic spine shrinkage that accompanies alternative approach is to make recordings under conditions in LTD32. LTD of NMDAR EPSCs was blocked by this phosphorylated which both AMPARs and NMDARs contribute to EPSCs. An advancofilin peptide (S3P; 92 ± 5%, n ¼ 11, Fig. 6c) but not by a nonphos- tage of this approach is that, in the same cell at the same time, it is phorylated version (S3; 63 ± 3%, n ¼ 10, Fig. 6c). Neither peptide possible to compare the effects of a manipulation on the AMPARaffected LTD of AMPAR EPSCs (S3P peptide, 60 ± 7%, n ¼ 6; S3 mediated component versus the NMDAR-mediated component of the peptide, 65 ± 4%, n ¼ 6; Fig. 6d). These results suggest that cofilin, but EPSC. A disadvantage is that the two components overlap temporally, not gelsolin, has a role in the actin depolymerization that is required for and therefore it is often difficult to make accurate measurements that solely reflect AMPAR-mediated versus NMDAR-mediated synaptic LTD of NMDAR EPSCs. Calcium/calmodulin can directly interact with the cytoplasmic C currents. Nonetheless, by using a time window on the rising phase of terminus of the NR1 subunit of NMDARs and competitively inhibit the the EPSC (2 ms after EPSC initiation) and a later time window (50 ms binding of a-actinin21,33. This contributes to the calcium-dependent after EPSC initiation) at which the AMPAR-mediated EPSC has inactivation of recombinant NMDARs, presumably by releasing the entirely or largely returned to baseline, it is possible to make measureNMDAR from its anchoring to the actin cytoskeleton21,22,26. To test ments that largely reflect AMPAR-mediated versus NMDAR-mediated whether a similar mechanism contributes to LTD of NMDAR EPSCs synaptic currents respectively (Fig. 7a). Therefore, to further test our we loaded cells with the calmodulin inhibitor W7 (1 mM) and found hypotheses, we recorded dual-component EPSCs and examined the that this manipulation had no effect on LTD of NMDAR EPSCs (56 ± effects of two manipulations that dissociated the mechanisms of LTD of 6%, n ¼ 4, data not shown). To test the efficacy of loading cells with W7 AMPAR EPSCs and LTD of NMDAR EPSCs. We first confirmed that the induction protocol caused depression of we examined its effects on LTD of AMPAR EPSCs, which was significantly lower in W7 loaded cells than in interleaved control cells both the AMPAR-mediated and NMDAR-mediated components of (80 ± 12%, n ¼ 7; control cells, 46 ± 7%, n ¼ 6, P o 0.05, data not EPSCs. Indeed, both components decreased proportionately, as shown). We also examined the effects of a different calmodulin demonstrated by quantitative measurements (AMPAR-mediated cominhibitor, calmidazolium (50 mM), which has been shown to impair ponent: 54 ± 4%; NMDAR-mediated component: 46 ± 5%, n ¼ 7, LTD of AMPAR EPSCs34. This manipulation had no discernable effect Fig. 7b) and by the fact that the EPSC following LTD induction scaled on LTD of NMDAR EPSCs (61 ± 8%, n ¼ 6, data not shown). Thus, to that obtained during the baseline (traces in Fig. 7b). We then calcium/calmodulin binding to cytoplasmic tails of NMDAR subunits examined the effects of loading cells with either the dynamin inhibitory peptide D15 (2 mM) or with phalloidin (100 mM), two manipulations does not seem to be critical for LTD of NMDAR EPSCs. that had opposite effects on LTD of AMPAR EPSCs and LTD of NMDAR EPSCs. In cells loaded with D15, LTD of the AMPARAnalysis of dual-component EPSCs Recording isolated AMPAR EPSCs or NMDAR EPSCs allowed us to mediated component was greatly reduced (86 ± 14%, n ¼ 7, make unequivocal measurements of the effects of manipulations on Fig. 7c), whereas LTD of the NMDAR-mediated component was
AUGUST 2005
1047
ARTICLES AMPAR EPSCs; both require NMDAR activation, yet most manipulations affected only one of the two. This dissociation suggests 100 that the early triggering events required for these forms of LTD—NMDAR activation and 75 the consequent rise in calcium—were not affected by the experimental perturbations 50 but rather that downstream signaling or expression mechanisms were impaired. It is 25 conceivable that dialysis of cells owing to the whole-cell recording configuration may have 0 influenced the intracellular signaling processes that are responsible for the two forms of LTD. However, this caveat applies to all work that involves whole-cell recording, and Figure 8 Graph summarizing the effects of all of the experimental manipulations on LTD of NMDAR we think it is unlikely to account for our EPSCs and LTD of AMPAR EPSCs. Bars represent average size of EPSCs 30–35 min after the LTD results, given that robust LTD of NMDARinduction protocol as percentage of baseline EPSCs. LFS, low-frequency stimulation. mediated synaptic transmission was also observed when NMDAR-mediated field EPSPs were recorded. Our results (summarized in Fig. 8 and Supplementary Fig. 1) normal (57 ± 12%, Fig. 7c). This differential effect of D15 on the two EPSC components can be visualized by comparing the EPSC waveform suggest that, in contrast to the critical role of AMPAR endocytosis in following LTD to the baseline EPSC (Fig. 7c). The later EPSC LTD of AMPAR EPSCs, dynamin-dependent internalization of components are reduced, whereas the rising phase of the EPSC, NMDARs does not contribute to LTD of NMDAR EPSCs. Instead, which is largely mediated by AMPARs, is unaffected. Cells loaded calcium-dependent modulation of the actin cytoskeleton is important with phalloidin showed the opposite results. LTD of the AMPAR- for this activity-dependent depression of NMDAR-mediated synaptic mediated component was still present (59 ± 7%, n ¼ 8, Fig. 7d) transmission. Indeed, there is abundant evidence that calcium influwhereas LTD of the NMDAR-mediated component was blocked (99 ± ences the actin cytoskeleton29,31 and that in turn the actin cytoskeleton 21%, Fig. 7d). Again, scaling the EPSCs before and after LTD illustrates influences NMDAR function21–27. Of particular relevance is that the this differential effect, although in this case the EPSC tail generated by calcium-dependent rundown of NMDAR channels in cultured neurons NMDARs was unaffected, whereas the early components were reduced. was blocked by phalloidin, suggesting that calcium-induced actin These results provide further support for the conclusion that the depolymerization reduces NMDAR channel activity23. This has been mechanisms underlying LTD of AMPAR EPSCs and LTD of NMDAR suggested to be attributable, at least in part, to competitive displacement EPSCs differ. of a-actinin from the C0 domain of the C terminus of NR1 (ref. 26). Several additional results support the hypothesis that LTD of DISCUSSION NMDAR EPSCs involves depolymerization of the actin cytoskeleton Given the role of NMDARs in experience-dependent and develop- but not internalization of synaptic NMDARs. First, in cultured neurons, mental plasticity as well as in several pathological states, the activity- there is a calcium-dependent rundown of NMDAR-mediated synaptic dependent regulation of synaptic NMDARs has important functional currents35,36 that is suppressed by the actin stabilizing agent jasplakiimplications. Although the complex modulation of NMDAR function nolide36. This rundown was not associated with decreased surface has been documented8,9, much of this work has focused on extra- expression of NMDARs, as would have been expected if NMDAR synaptic or recombinant NMDARs, and thus little is known about how endocytosis contributed36. Conversely, depolymerizing F-actin with patterns of activity that trigger synaptic plasticity modify NMDAR- latrunculin-A in cultured neurons reduced synaptic NMDAR-mediated mediated synaptic transmission. We provide evidence that the decrease currents but not synaptic AMPAR-mediated currents24. Second, bindin NMDAR-mediated synaptic responses during LTD is triggered and ing of NMDARs to PSD95 or other synaptic scaffolding proteins expressed through mechanisms that differ from those responsible for inhibits NMDAR endocytosis13, suggesting that synaptic NMDARs the depression of AMPAR-mediated synaptic responses. Specifically, we are resistant to endocytosis compared with extrasynaptic NMDARs. found that (i) two different PP2B inhibitors that block LTD of AMPAR Third, in cultured neurons, manipulations that stimulate endocytosis of EPSCs had no effect on LTD of NMDAR EPSCs; in contrast, similar to synaptic AMPARs and a depression of AMPAR-mediated synaptic LTD of AMPAR EPSCs, two different inhibitors of PP1 blocked LTD of currents do not affect synaptic NMDARs37–39. Fourth, manipulations NMDAR EPSCs; (ii) three different inhibitors of dynamin, including a of endo- and exocytosis affect AMPAR EPSCs but not NMDAR dominant-negative version of dynamin, all blocked LTD of AMPAR EPSCs17, as does insulin, which causes endocytosis of AMPARs but EPSCs with no discernable effect on LTD of NMDAR EPSCs; and (iii) not NMDARs40. Similarly, manipulations of F-actin affect AMPARs inhibiting actin depolymerization with phalloidin or a cofilin inhibi- and NMDARs in different ways, and NMDARs, but not AMPARs, are tory peptide did not impair LTD of AMPAR EPSCs but blocked LTD of detergent insoluble28,41. Together these and related results have led to NMDAR EPSCs. Furthermore, two of the most critical results, which the conclusion that AMPARs undergo cycling at synaptic plasma support a dissociation between the mechanisms underlying LTD of membranes, but NMDARs are relatively stable10,42. This does not AMPAR EPSCs versus LTD of NMDAR EPSCs, were confirmed by mean that NMDARs are absolutely fixed at synapses. There is evidence examining the effects of manipulations on dual component EPSCs. that synaptic NMDARs in cultured neurons can be internalized12 and An important feature of these experiments was that the exact same that NMDARs can move laterally between synaptic and extrasynaptic induction protocol was used to trigger LTD of NMDAR EPSCs and pools43,44, a transition that may contribute to LTD of NMDAR EPSCs. NMDA
AMPA
1048
W 7
S3
P
S3
4A al lo id in
K4
Ph
1-
yn
D
5
15
S-
S
-1
D
Pβ
G D
50
6
l
FK
tro
on
C
C
on tro BA l PT D A LY -AP 34 5 O ka 14 9 M dai 5 ic ro c ac cy st id in LR
EPSC (% 30–35 min post-LFS)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
125
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES The importance of our results is that they suggest that during NMDARdependent LTD, dynamin-dependent endocytosis of NMDARs does not contribute. One important factor may be that as synapses mature, the subunit composition of NMDARs changes in a manner that inhibits endocytosis of synaptic NMDARs13. Imaging of actin dynamics in hippocampal slices has directly demonstrated that prolonged low-frequency stimulation, which typically triggers LTD, induces actin depolymerization45. The robust LTD of NMDAR EPSCs in gelsolin knockout mice, however, suggests that this actin-severing protein31 is not required for this form of synaptic plasticity. Instead, the inhibition of LTD of NMDAR EPSCs, but not AMPAR EPSCs, by a phosphorylated cofilin peptide make cofilin an attractive candidate for a key role in modulating the actin cytoskeleton during LTD31,32. Upon dephosphorylation, cofilin depolymerizes actin, and its activation by dephosphorylation can be mediated by PP1 (ref. 31). It is also possible that calcium contributes to LTD of NMDAR EPSCs by directly interfering with the binding of a-actinin to NMDAR subunits26 and that PP1 contributes by dephosphorylating proteins that help preserve the actin cytoskeleton and NMDARs in the state that is necessary to maintain LTD14,26,34. There are two general ways NMDARs might be modulated so as to lead to LTD of NMDAR EPSCs (Supplementary Fig. 1). First, their biophysical properties could be modified such that their overall conductance or probability of opening is reduced. The latter possibility seems the most likely, as this has been related to calcium-induced inactivation of NMDARs via modulation of the actin cytoskeleton23,26. Alternatively, actin depolymerization might facilitate the diffusion of NMDARs from synaptic to extrasynaptic sites in the plasma membrane43. Such lateral diffusion could reduce the concentration of synaptically released glutamate to which the NMDARs are exposed and also modify their biophysical properties36,46. Our results provide further evidence that synaptic AMPARs and NMDARs can be independently regulated by activity through different mechanisms. They also point out the importance of examining synaptic responses in intact preparations and not relying solely on cell biological assays or recordings from cell lines or cultured neurons. Although the latter approaches have provided important information, they often involve examining extrasynaptic receptors, which are not embedded in normal synaptic architecture and therefore often have properties different from those of synaptic receptors (for example, see refs. 14,36,46). The delayed increase in NMDAR-mediated synaptic responses during LTP observed in cortical cells has been suggested to be a mechanism that preserves the relative contribution of AMPARs and NMDARs to synaptic transmission2. Similarly, the depression of NMDAR EPSCs during LTD will accomplish this same task. In addition, not only should LTP be more difficult to elicit at synapses at which LTD has occurred, but patterns of synaptic activity that normally elicit no changes in synaptic strength or even LTP might now elicit LTD (see ref. 47). Such a change in the responsiveness of synapses to afferent input might be important for facilitating the shrinkage or loss of dendritic spines that occurs during LTD32,48. Notably, however, after LTD induction, depressed NMDAR EPSCs can be potentiated5, a result that we have replicated in this study (data not shown). Thus, as is the case for AMPAR-mediated synaptic transmission, activity can exert bidirectional control over NMDAR-mediated synaptic responses, albeit using mechanisms distinct from those controlling synaptic AMPAR function. METHODS Electrophysiology. Hippocampal slices (300 mm) were prepared from 3to 4-week-old Sprague-Dawley rats14. Briefly, slices were cut in ice-cold
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
oxygenated (95% O2/5% CO2) solution containing (in mM) sucrose 238, KCl 2.5, NaH2PO4 1, MgSO4 2, CaCl2 0.5, NaHCO3 26.2, glucose 11 (pH 7.4). Slices were stored in warm (B28 1C) oxygenated artificial cerebrospinal fluid (ACSF) containing (in mM) NaCl 119, KCl 2.5, NaH2PO4 1, MgSO4 1.3, CaCl2 2.5, NaHCO3 26.2, glucose 11 and recovered for at least 1.5 h. Slices were visualized in a chamber on an upright microscope (Olympus BX50WI) with transmitted and epifluorescent illumination and were perfused with warm (28–30 1C), oxygenated ACSF. Whole-cell voltage-clamp recordings were made from CA1 pyramidal cells with an Axopatch 1D amplifier (Axon Instruments). Recording pipettes (3–5 MO) were filled with a solution containing (in mM) CsMeSO4 117.5, HEPES 10, TEACl 10, CsCl 15.5, NaCl 8, EGTA 0.25, MgATP 4, NaGTP 0.3, QX-314 5 (pH adjusted to 7.3 with CsOH, 290–305 mOsM). EPSCs were evoked with a glass pipette containing external ACSF. The stimulating pipette was placed in stratum radiatum near the stratum pyramidal boarder to activate proximal Schaffer collateral-CA1 synapses. Following whole cell access synapses were stimulated (at 0.05 Hz) for a minimum period of 5 min prior to data acquisition. During this ‘warmup’ period stimulation intensity was adjusted to obtain stable baseline responses. NMDAR EPSCs and field EPSPs were isolated with the addition of 50 mM picrotoxin and 5 mM NBQX to the ACSF. Baseline NMDA EPSCs were recorded at –40 mV while stimulating afferents at 0.05 Hz. AMPAR and dual-component EPSCs were recorded at –65 mV and –40 mV, respectively, in the presence of 50 mM picrotoxin. LTD was induced with a 5-Hz, 3-min train. LTD of AMPAR EPSCs was induced by depolarizing the cell to –40 mV for the duration of the train. Field recording pipettes were filled with external ACSF. When recording NMDAR field EPSPs, Mg2+ in the ACSF was reduced to 0.5 mM. The peak current amplitudes (average of a 2-ms window) of NMDAR and AMPAR EPSCs were measured online using custom data acquisition software (Igor Pro). Dual-component EPSCs were quantified by measuring the amplitude 2 ms (AMPAR component) and 50 ms (NMDAR component) after EPSC onset. Field NMDAR EPSPs were quantified by measuring the initial slope of the synaptic response. Unless otherwise indicated, drugs and peptides were added to the patch solution and allowed to diffuse into the cell for a minimum period of 15 min before the LTD induction protocol. Series and input resistance were continually monitored throughout an experiment. If the series resistance changed by more than 20%, data were not included in analysis. Results are expressed as mean ± s.e.m. Experimental data were compared with data from interleaved ‘same-day’ control experiments and assessed for statistical significance using an unpaired or paired Student’s t-test with a level of significance (P value) o 0.05. All drugs were made as concentrated stock solutions and diluted 100–1,000 to their test concentrations. The drugs used in the study were D-AP5, NBQX, LY341495, W7 (Tocris); okadaic acid, microcystin LR, FK-506, phalloidin, latrunculin B, cytochalasin D, calmidazolium (Calbiochem); picrotoxin, GDPbS (Sigma) and CsBAPTA (Molecular Probes). The peptides used were calcineurin inhibitor peptide (Calbiochem), purified D15 and S15 (Stanford PAN facility), and purified phosphorylated and nonphosphorylated cofilin peptides32 (Stanford PAN facility). Gelsolin knockout mice (Gsntm1Djk) were obtained from Mutant Mouse Regional Resource Centers (Taconic/SUNY Albany; http://www.mmrrc.org). Virus cloning and production. The dominant-negative dynamin 1 contains a point mutation in the GTPase domain (K44A; construct provided by S.L. Schmid, Scripps Research Institute, via P. DeCamilli, Yale University). The cDNA was introduced into a pSINREP5-IRES-GFP backbone vector derived from pSINREP5 (Invitrogen) and pIRES2-EGFP (Clontech) by PCR cloning. Recombinant Sindbis pseudo-virions were generated using the Sindbis expression kit (Invitrogen). Viral supernatant was harvested 36 h after transfection of BHK cells and concentrated. In vivo injections. Sprague-Dawley rats (3–4 weeks old) were anesthetized with ketamine (50 mg/kg body weight) and xylazine (4.5 mg/kg body weight) by intraperitoneal injection. Experiments were approved by the Administrative Panel on Laboratory Animal Care of Stanford University. After immobilization on a stereotaxic instrument, a hole was drilled at –3.9 mm posterior and 2.5 mm lateral to bregma for injection in the CA1 region of the hippocampus.
1049
ARTICLES Viral solution (0.5 ml) was injected through a stainless steel cannula at a depth of 2.4 mm using a microinfusion pump (Harvard Apparatus) at a rate of 0.1 ml/min. Note: Supplementary information is available on the Nature Neuroscience website.
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ACKNOWLEDGMENTS We thank S.Y. Lee for technical assistance and members of the Malenka lab for constructive comments. This work was supported by US National Institutes of Health grant MH063394 to R.C.M. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 16 May; accepted 24 June 2005 Published online at http://www.nature.com/natureneuroscience/
1. Malenka, R.C. & Bear, M.F. LTP and LTD: an embarrassment of riches. Neuron 44, 5–21 (2004). 2. Watt, A.J., Sjostrom, P.J., Hausser, M., Nelson, S.B. & Turrigiano, G.G. A proportional but slower NMDA potentiation follows AMPA potentiation in LTP. Nat. Neurosci. 7, 518–524 (2004). 3. Gean, P.W. & Lin, J.H. D-2-amino-5-phosphonovaleate blocks induction of long-term depression of the NMDA receptor-mediated synaptic component in rat hippocampus. Neurosci. Lett. 158, 170–172 (1993). 4. Xiao, M.Y., Wigstrom, H. & Gustafsson, B. Long-term depression in the hippocampal CA1 region is associated with equal changes in AMPA and NMDA receptor-mediated synaptic potentials. Eur. J. Neurosci. 6, 1055–1057 (1994). 5. Selig, D.K., Hjelmstad, G.O., Herron, C., Nicoll, R.A. & Malenka, R.C. Independent mechanisms for long-term depression of AMPA and NMDA responses. Neuron 15, 417–426 (1995). 6. Montgomery, J.M. & Madison, D.V. State-dependent heterogeneity in synaptic depression between pyramidal cell pairs. Neuron 33, 765–777 (2002). 7. Xie, X., Berger, T.W. & Barrionuevo, G. Isolated NMDA receptor-mediated synaptic responses express both LTP and LTD. J. Neurophysiol. 67, 1009–1013 (1992). 8. Dingledine, R., Borges, K., Bowie, D. & Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51, 7–61 (1999). 9. Kotecha, S.A. & MacDonald, J.F. Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission. Int. Rev. Neurobiol. 54, 51–106 (2003). 10. Carroll, R.C., Beattie, E.C., Von Zastrow, M. & Malenka, R.C. Role of AMPA receptor endocytosis in synaptic plasticity. Nat. Rev. Neurosci. 2, 315–324 (2001). 11. Vissel, B., Krupp, J.J., Heinemann, S.F. & Westbrook, G.L. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nat. Neurosci. 4, 587–596 (2001). 12. Nong, Y. et al. Glycine binding primes NMDA receptor internalization. Nature 422, 302–307 (2003). 13. Roche, K.W. et al. Molecular determinants of NMDA receptor internalization. Nat. Neurosci. 4, 794–802 (2001). 14. Morishita, W. et al. Regulation of synaptic strength by protein phosphatase 1. Neuron 32, 1133–1148 (2001). 15. Lisman, J. A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc. Natl. Acad. Sci. USA 86, 9574–9578 (1989). 16. Mulkey, R.M., Endo, S., Shenolikar, S. & Malenka, R.C. Involvement of a calcineurin/ inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369, 486–488 (1994). 17. Lu¨scher, C. et al. Role of AMPA receptor cycling in synaptic transmission and plasticity. Neuron 24, 649–658 (1999). 18. Schmid, S.L., McNiven, M.A. & De Camilli, P. Dynamin and its partners: a progress report. Curr. Opin. Cell Biol. 10, 504–512 (1998). 19. Carroll, R.C. et al. Dynamin-dependent endocytosis of ionotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 96, 14112–14117 (1999). 20. Marie, H., Morishita, W., Yu, X., Calakos, N. & Malenka, R.C. Generation of silent synapses by acute in vivo expression of CaMKIV and CREB. Neuron 45, 741–752 (2005).
1050
21. Zhang, S., Ehlers, M.D., Bernhardt, J.P., Su, C.T. & Huganir, R.L. Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors. Neuron 21, 443–453 (1998). 22. Wyszynski, M. et al. Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature 385, 439–442 (1997). 23. Rosenmund, C. & Westbrook, G.L. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron 10, 805–814 (1993). 24. Sattler, R., Xiong, Z., Lu, W.Y., MacDonald, J.F. & Tymianski, M. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J. Neurosci. 20, 22–33 (2000). 25. Lei, S., Czerwinska, E., Czerwinski, W., Walsh, M.P. & MacDonald, J.F. Regulation of NMDA receptor activity by F-actin and myosin light chain kinase. J. Neurosci. 21, 8464–8472 (2001). 26. Krupp, J.J., Vissel, B., Thomas, C.G., Heinemann, S.F. & Westbrook, G.L. Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors. J. Neurosci. 19, 1165–1178 (1999). 27. Furukawa, K. et al. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 8178–8186 (1997). 28. Kim, C.H. & Lisman, J.E. A role of actin filament in synaptic transmission and long-term potentiation. J. Neurosci. 19, 4314–4324 (1999). 29. Carlisle, H.J. & Kennedy, M.B. Spine architecture and synaptic plasticity. Trends Neurosci. 28, 182–187 (2005). 30. Witke, W. et al. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81, 41–51 (1995). 31. dos Remedios, C.G. et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol. Rev. 83, 433–473 (2003). 32. Zhou, Q., Homma, K.J. & Poo, M.M. Shrinkage of dendritic spines associated with longterm depression of hippocampal synapses. Neuron 44, 749–757 (2004). 33. Ehlers, M.D., Zhang, S., Bernhadt, J.P. & Huganir, R.L. Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84, 745–755 (1996). 34. Mulkey, R.M., Herron, C.E. & Malenka, R.C. An essential role for protein phosphatases in hippocampal long-term depression. Science 261, 1051–1055 (1993). 35. Rosenmund, C., Feltz, A. & Westbrook, G.L. Calcium-dependent inactivation of synaptic NMDA receptors in hippocampal neurons. J. Neurophysiol. 73, 427–430 (1995). 36. Li, B. et al. Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat. Neurosci. 5, 833–834 (2002). 37. Carroll, R.C., Lissin, D.V., von Zastrow, M., Nicoll, R.A. & Malenka, R.C. Rapid redistribution of glutamate receptors contributes to long-term depression in hippocampal cultures. Nat. Neurosci. 2, 454–460 (1999). 38. Ehlers, M.D. Reinsertion or degradation of AMPA receptors determined by activitydependent endocytic sorting. Neuron 28, 511–525 (2000). 39. Lin, J.W. et al. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat. Neurosci. 3, 1282–1290 (2000). 40. Man, H.-Y. et al. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25, 649–662 (2000). 41. Allison, D.W., Gelfand, V.I., Spector, I. & Craig, A.M. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18, 2423–2436 (1998). 42. Wenthold, R.J., Prybylowski, K., Standley, S., Sans, N. & Petralia, R.S. Trafficking of NMDA receptors. Annu. Rev. Pharmacol. Toxicol. 43, 335–358 (2003). 43. Tovar, K.R. & Westbrook, G.L. Mobile NMDA receptors at hippocampal synapses. Neuron 34, 255–264 (2002). 44. Groc, L. et al. Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors. Nat. Neurosci. 7, 695–696 (2004). 45. Okamoto, K., Nagai, T., Miyawaki, A. & Hayashi, Y. Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat. Neurosci. 7, 1104–1112 (2004). 46. Li, B., Otsu, Y., Murphy, T.H. & Raymond, L.A. Developmental decrease in NMDA receptor desensitization associated with shift to synapse and interaction with postsynaptic density-95. J. Neurosci. 23, 11244–11254 (2003). 47. Cummings, J.A., Mulkey, R.M., Nicoll, R.A. & Malenka, R.C. Ca2+ signaling requirements for long-term depression in the hippocampus. Neuron 16, 825–833 (1996). 48. Nagerl, U.V., Eberhorn, N., Cambridge, S.B. & Bonhoeffer, T. Bidirectional activitydependent morphological plasticity in hippocampal neurons. Neuron 44, 759–767 (2004).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Regulation of NMDA receptor trafficking by amyloid-b Eric M Snyder1,6, Yi Nong2, Claudia G Almeida3, Surojit Paul4, Timothy Moran2, Eun Young Choi1, Angus C Nairn1,5, Michael W Salter2, Paul J Lombroso4, Gunnar K Gouras3 & Paul Greengard1 Amyloid-b peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-b reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-b promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-b by treating neurons with a c-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-b application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-b– dependent endocytosis of NMDA receptors required the a-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-b can cause synaptic dysfunction and contribute to Alzheimer disease pathology.
Alzheimer disease is a progressive neurodegenerative disease in which patients have declarative memory impairments and increasingly severe dementia. Numerous pathological changes have been described in the postmortem brains of Alzheimer disease patients, including plaques, tangles, inflammation, neuron loss and synapse loss. Cortical and hippocampal synapse density is reduced early in the disease process, and the loss of these synapses correlates strongly with memory impairments1,2. The prevention and treatment of Alzheimer disease may therefore require a detailed understanding of how synapses are affected in the disease process. In patients with Alzheimer disease, a 40- or 42-amino-acid peptide called amyloid-b is elevated in the brain. The amount of amyloid-b correlates with the onset and severity of memory impairments, consistent with an important role for this peptide in the disease process. This peptide, particularly the 42-amino-acid form (amyloid-b1–42), is highly hydrophobic and accumulates both extracellularly in plaques and intracellularly in multivesicular bodies3. Soluble extracellular amyloid-b may initiate memory impairments before the accumulation of plaques4. The pathogenic 40- and 42-amino-acid forms of amyloid-b are produced by sequential cleavage of the amyloid precursor protein (APP) by enzymatic complexes known as b- and g-secretases. In all familial forms of Alzheimer disease yet examined, mutations in the APP or in the presenilins, essential components of the g-secretase, increase production and/or aggregation of amyloid-b (ref. 5). Transgenic mice that overexpress wild-type human APP or APP with a human familial mutation produce increased amyloid-b and have alterations in synaptic transmission, plasticity and memory6,7. These
memory impairments and synaptic alterations precede neuronal death and plaque formation, indicating that synaptic alterations may be important events that contribute to the memory deficits associated with Alzheimer disease. Amyloid-b can reduce long-term potentiation (LTP), a form of synaptic plasticity that is closely associated with learning and memory and can facilitate long-term depression (LTD), an opposing form of synaptic plasticity4,8. LTP and LTD involve postsynaptic phosphorylation and glutamate receptor trafficking9. The observation that amyloid-b reduces LTP and facilitates LTD is suggestive of a role for amyloid-b in regulating trafficking of glutamate receptors and postsynaptic phosphorylation, but this has not been previously examined. In the current study, we investigated the mechanisms by which amyloid-b affects signaling through NMDA-type glutamate receptors. Amyloid-b deposits first occur in the entorhinal and frontal cortices of Alzheimer disease patients, and the amount of amyloid-b in these regions correlates with memory loss10. Therefore, we examined the effects of amyloid-b on cortical neurons. In cultured cortical neurons, amyloid-b promoted endocytosis of NMDA receptors, without affecting trafficking of GABAA-type receptors. Application of amyloid-b produced a persistent depression of NMDA-evoked currents and reduced signaling to the cAMP response element binding protein (CREB), a transcription factor required for long-term memory and neuronal survival. A reduction in surface-expressed NMDA receptors was also found in neuronal cultures prepared from mice bearing APP with the familial Swedish mutation, with no change in total receptor amounts. Together, these data indicate that amyloid-b can regulate glutamatergic receptor endocytosis and that it does so in a genetic
1Laboratory for Molecular and Cellular Neuroscience, Rockefeller University, 1230 York Avenue, New York, New York 10021, USA. 2Program in Brain and Behavior, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada. 3Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, New York, New York, 10021, USA. 4The Child Study Center, Yale University School of Medicine, 230 South Frontage Road, New Haven, Connecticut 06520, USA. 5Department of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, Connecticut 06508, USA. 6Current address: McKinsey and Company, 600 Campus Drive, Florham Park, New Jersey 07932, USA. Correspondence should be addressed to E.M.S. (
[email protected]).
Published online 17 July 2005; doi:10.1038/nn1503
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1051
Total Ctl. Aβ42
NR2B
NR1
c
Surface Ctl. 42–1 NR1
Total Ctl. 42–1
125
d
NR2B NR1 GABAAβ
e Surface Ctl. Strip
100 75
*
*
Total Ctl. Aβ
NR2B
50
NR1
25 0 Aβ:
Internal Ctl. Aβ
GABAAβ2/3 – +
– +
– +
250
NR2B NR1 GABAAβ
*
*
200 150 100 50 0 Aβ:
– +
– +
– +
Figure 1 Amyloid-b1–42 promotes endocytosis of glutamate receptor subunits. (a) Neurons were treated with control medium (Ctl) or with medium containing amyloid-b1–42 (Ab42) and then surface proteins were measured by biotinylation (see Methods). (b) Quantification of biotinylation immunoblots. NR2B: P o 0.03, n ¼ 4; NR1: P o 0.03, n ¼ 7; GABAAb2/3: P 4 0.1, n ¼ 5. Error bars indicate s.e.m. (c) Measurement of surface NR1 after treatment of cultured neurons with the reverse amyloid-b peptide 42–1. (d) Internalization of surface receptors was measured using a cleavable biotin protocol in cortical cultures. Left panel shows that stripping removes biotin labeling of surface receptors NR2B, NR1 and GABAAb2/3. Center panel shows the amount of internalized surface receptor protein under control conditions, which is measured by biotinylating surface receptors and stripping after 15 min at 37 1C in control medium or in medium containing 1 mM amyloid-b. Right panel shows a western blot of total receptor protein in control and amyloid-b–treated cultures. (e) Quantification of immunoblots for receptors labeled with cleavable biotin. NR2B: P o 0.03, n ¼ 5; NR1: P o 0.05, n ¼ 5.
Amyloid-b1–42 promotes endocytosis of NMDA receptors Amyloid-b could decrease surface expression of NMDA receptors either by promoting endocytosis of receptor proteins or by preventing surface delivery. Endocytosis of NMDA receptors was examined in cultured cortical neurons using cleavable biotin18. Amyloid-b promoted the endocytosis of biotin bound to the NMDA receptor subunits NR2B and NR1 (to 209 ± 31% and 171 ± 16% of control internal biotin amounts, respectively; Fig. 1d,e). Amyloid-b did not, however, promote endocytosis of GABAAb 2/3 receptors (Fig. 1d,e). These data indicate that amyloid-b promotes endocytosis of NMDA receptors, without generally promoting endocytosis of other ionotropic neuronal receptors. These data indicate that APP processing regulates NMDA receptor surface expression.
model of Alzheimer disease. The effect of amyloid-b on endocytosis of NMDA receptors is likely to contribute to synaptic dysfunction in Alzheimer disease. RESULTS Amyloid-b decreases surface expression of NMDA receptors Low amounts of secreted soluble amyloid-b regulate glutamatergic currents mediated by both NMDA and AMPA receptors without affecting GABA receptor currents11. The effect of amyloid-b on NMDA currents is of particular interest as this receptor regulates synapse density and memory formation. NMDA receptors undergo regulated endocytosis12–15. To examine the effect of amyloid-b on NMDA receptor endocytosis, cultured cortical neurons were treated with amyloid-b (1 mM for 1 h; Supplementary Methods), and cell surface receptors were quantified using biotinylation12,16. Amyloid-b reduced the surface expression of the NMDA receptor subunit proteins NR2B and NR1 to 55 ± 8% and 64 ± 6% of control amounts, respectively; however, no change was observed in the total amount of NR2B or NR1 (Fig. 1a,b). As a control for the amyloid-b1–42 peptide, we treated neurons with the reverse peptide 42–1 (1 mM, 1 h) and found that it had no effect on the surface expression of NR1 (95 ± 8% of control; Fig. 1c). NMDA and GABAA receptors are coexpressed on the cell surface of forebrain neurons but at different synapses17. Amyloid-b1–42 did not affect the surface expression of GABAAb 2/3receptor subunits (amyloid-b: 93 ± 7% of control; Fig. 1a,b), indicating that amyloid-b1–42 affected NMDA receptors but not all other ionotropic receptors.
Figure 2 Amyloid-b (Ab) reduces synaptic NMDA receptors. (a–f) Cultured cortical neurons were treated with control medium (a–c) or medium containing 1 mM amyloid-b (d–f). Neurons were immunostained for synapsin 1 (a,d) and NR1 (b,e). Overlays of stained neurons are shown in c and f. (g) Quantification of staining. NR1: P o 0.05, n ¼ 10 cells, 150 synapses; synapsin 1: P 4 0.2, n ¼ 150 synapses in 10 cells. Error bars indicate s.e.m.
a
d
Control Synapsin 1
Aβ Synapsin 1
Amyloid-b1–42 reduces synaptic NMDA receptors We used immunocytochemistry to assay whether amyloid-b can reduce the density of NMDA receptors at synapses. Cortical cultures were treated with control medium or with medium containing amyloidb1–42 (1 mM) for 1 h and were then fixed, permeabilized and stained for the synaptic marker synapsin 1 and the NMDA receptor subunit NR1. NR1 staining showed a punctate distribution that localized with a majority of synapsin 1 in control neurons (Fig. 2). Treatment with amyloid-b did not affect staining intensity for synapsin 1 but did significantly reduce the presence of NR1 at synaptic sites. In amyloid-btreated cultures, NR1 background staining appeared unchanged, and some puncta were observable; however, localization with synapsin 1 was greatly reduced. Quantification showed that although staining for
b
e
c
Control NR1
Aβ NR1
f
Control Overlay
Aβ Overlay
g
Fluorescence intensity (% control)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
GABAAβ2/3
b
Internal receptor (% control)
Surface Ctl. Aβ42
a
Surface/total receptor (% control)
ARTICLES
125 NR1
75
VOLUME 8
[
NUMBER 8
[
*
50 25 0 Aβ:
1052
Synapsin 1
100
–
+
–
+
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES WT
a
APPSwe/∆9
b
100 Surface NR1 (% control)
Time in conditioned media (min) 0 30 60 0 30 60 Surface NR1
c
0
d
DAPT (200 nm) 0.1% DMSO WT APPSwe/∆9 WT APPSwe/∆9 Secreted Aβ
*
30 Time (min)
0.1% DMSO WT
60
DAPT (200 nm)
APPSwe/∆9
WT
APPSwe/∆9
Surface NR1
e –
f
APPSwe
WT DAPT:
* WT APPSwe/∆9
50 25
+
–
+
Surface NR1
125 Surface/total NR1
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Total NR1
75
100 75 *
50 25
0 + – + Aβ: – WT APPSwe WT APPSwe
Total NR1
0.1% DMSO
synapsin remained at 97 ± 6% of control amounts, amyloid-b reduced staining for NR1 at synaptic sites to 61 ± 8% (Fig. 2g). Given that we see no change in total NR1 with western blots, we believe these data reflect a redistribution of NMDA receptors away from synaptic sites and toward nonclustered extrasynaptic sites. Although we did not observe an increase in extrasynaptic staining for NMDA receptors, these observations are consistent with other published accounts of NMDA receptor redistribution19. Naturally-secreted amyloid-b reduces surface NMDA receptors Because of its hydrophobicity and predilection toward aggregation, synthetic amyloid-b may induce effects that are different from those induced by naturally secreted amyloid-b. We therefore treated cultured cortical neurons with medium from a neuronal cell line that secretes high amounts of amyloid-b: N2A cells that stably express APPSwe and presenilinD9 (APPSwe/D9; ref. 20). As a control, medium from untransfected wild-type N2A cells, which secrete little endogenous amyloid-b, was used. Medium from untransfected N2A cells did not affect surface or total NR1 (Fig. 3a). In contrast, medium from APPSwe/D9 N2A cells reduced surface NR1 within 30 min but did not change the total amount of NR1 (Fig. 3a). Quantification showed a significant difference (P o 0.04) in surface NR1 after a 30-min exposure to the amyloidb–containing cell medium (Fig. 3b). The decrease persisted through 60 min of treatment. Treatment of APPSwe/D9 N2A cells with the g-secretase inhibitor DAPT (200 nM for 72 h) substantially reduced the amount of amyloid-b (Fig. 3c). DAPT treatment completely blocked the ability of APPSwe/D9 medium to reduce surface expression of NR1 (APPSwe/D9 in DAPT: 97 ± 5% of wild-type surface NR1; Fig. 3d). These data indicate that processing of APP is necessary for the effects of conditioned medium from APPSwe/D9-transfected N2A cells on surface expression of NMDA receptors. Reduced surface NR1 in neurons from APPSwe mice We next investigated whether surface expression of NR1 is reduced in a genetic model of Alzheimer disease. Cortical neurons were cultured
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
Figure 3 Naturally secreted amyloid-b reduces surface NMDA receptors. (a) Wild-type medium had no effect on surface NR1 (upper left) or total NR1 (lower left). APPSwe/D9 medium reduced surface NR1 (upper right) without affecting total NR1 (lower right). (b) Quantification shows that APPSwe/D9 medium reduced NR1 amounts to 75 ± 5% within 30 min and 77 ± 7% after 60 min. Error bars indicate s.e.m. (c) Analysis of amyloid-b in conditioned medium from APPSwe/D9 cells in the presence of the g-secretase inhibitor DAPT or 0.1% DMSO (vehicle). (d) Left: surface NR1 after 60 min in wild-type or APPSwe/D9 medium from cells grown in 0.1% DMSO. Right: surface NR1 after 60 min in wild-type or APPSwe/D9 medium from cells grown in the presence of 200 nM DAPT. (e) Primary cortical neurons were prepared from APPSwe mice or wild-type littermates. Surface expression of NR1 was reduced in neurons from APPSwe mice but was restored by DAPT. Total amount of NR1 was not affected by APPSwe expression or DAPT treatment (lower panel). (f) Quantification of treated cortical neurons.
DAPT (200 nm)
from mice that express human APP with the familial Swedish mutation. These mice have deficiencies in LTP in vivo, which correlate with reduced learning and memory6. Neurons from these mice survive in culture, extend processes and seem to be generally healthy for up to 3 weeks in vitro3. Using the biotinylation assay, we found that surface expression of NR1 was much lower in 12-day-old cultured neurons from APPSwe mice than in neurons from wild-type littermates, although total receptor protein was not affected (Fig. 3e). Surface expression of NR1 in neurons from APPSwe mice was 46.2 ± 8.8% of that observed in wild-type littermates (n ¼ 10; P o 0.01; Fig. 3f). Treatment of wild-type neurons with the g-secretase inhibitor DAPT for 24 h slightly reduced surface NR1 (control, 100 ± 9.8%; DAPT, 84.2 ± 6%; n ¼ 10). Treatment of APPSwe neurons with DAPT restored surface NR1 (80 ± 4.2%; n ¼ 7). Role of a-7 nicotinic receptor and protein phosphatase 2B Amyloid-b binds to the a-7 nicotinic receptor with picomolar affinity21 and promotes Ca2+ influx in neurons22. In cortical neurons, a-7 nicotinic receptors are expressed postsynaptically at over 70% of synapses, where they may regulate glutamate receptors23. Pretreatment with the a-7 nicotinic receptor antagonist a-bungarotoxin (BTX; 10 mM) for 30 min before treatment with amyloid-b partially inhibited the reduction in surface expression of NR1 (BTX, 98 ± 5% of control; amyloid-b + BTX, 90 ± 11% of control; Fig. 4). A structurally distinct antagonist, methyllycaconitine (MLA; 1 mM) also substantially inhibited the reduction in surface NR1 (MLA, 90 ± 6% of control; amyloid-b + MLA, 87 ± 8% of control; n ¼ 3; see Supplementary Fig. 1 online). These data are consistent with a role for the a-7 nicotinic receptor in mediating the effects of amyloid-b on NMDA receptor endocytosis. The a-7 nicotinic receptor can activate PP2B, a Ca2+-sensitive enzyme that regulates NMDA receptor transmission and synaptic plasticity24,25. Inhibition of PP2B with cyclosporin (20 mM) markedly reduced the effects of amyloid-b1–42 on surface expression of NR1 (cyclosporin, 90 ± 6% of control; cyclosporin + amyloid-b, 84 ± 5% of
1053
ARTICLES
– – Ctl.
– – Aβ
+ – Ctl.
+ – Aβ
– + Ctl.
Figure 4 Amyloid-b reduces surface expression of NMDA receptors through a-7 nicotinic receptors and PP2B. (a) Surface NR1 amounts were monitored in neuron cultures that were incubated in parallel in the absence or presence of BTX or cyclosporin for 30 min before amyloid-b treatment (1 mM for 1 h). Inhibitors were included during the 1-h amyloid-b treatment. (b) Quantification shows that amyloid-b reduced surface NR1 to 54 ± 10% of control amounts (n ¼ 4; P o 0.05). BTX with control or amyloid-b medium: n ¼ 6; P 4 0.05; cyclosporin with control or amyloid-b medium: n ¼ 4; P 4 0.05. Error bars indicate s.e.m.
– + Aβ
Surface NR1 125 Surface NR1 (% control)
100 75 50 25 0 + Aβ: – No BTX No cyclo
–
+ BTX
– + Cyclo
control; Fig. 4). Neither BTX or cyclosporin altered the total amount of NR1. These data indicate that PP2B activity is necessary for amyloidb–induced endocytosis of NMDA receptors. Amyloid-b activates the tyrosine phosphatase STEP Tyrosine phosphorylation regulates NMDA receptor function26 and surface expression27. One tyrosine phosphatase that has been shown to regulate NMDA receptor function is the striatal-enriched phosphatase (STEP)28. STEP is expressed in brain regions that receive dopaminergic input including the striatum, hippocampus and cortex. STEP is alternatively spliced to produce a 61-kDa membrane-associated protein (STEP61) and a 46-kDa cytosolic fragment (STEP46). STEP61 is present in postsynaptic densities and coimmunoprecipitates with the NMDA receptor complex28, although its specific binding partners within the complex remain unknown. STEP activity reduces NMDA currents and the induction of LTP28. Both STEP61 and STEP46 are phosphorylated by protein kinase a A (PKA) at a common site (STEP61 at Ser221 Ctl. and STEP46 at Ser49) within its substratePhosphobinding domain. Phosphorylation of STEP STEP at this site by PKA reduces the affinity of STEP for its substrates, whereas dephosphorTotal STEP ylation by PP2B activates STEP29.
We hypothesized that the amyloid-b–induced activation of PP2B might lead to dephosphorylation and activation of STEP. Amyloid-b treatment reduced phosphorylation of STEP to 64 ± 5% of control amounts without affecting total amounts of STEP61 (Fig. 5a,b). We measured the phosphorylation of STEP in vivo in the cerebral cortices of 10-month-old APPSwe mice. Phosphorylation of STEP was significantly lower in the brains of the APPSwe mice than in their wild-type littermates (83 ± 3% of wild-type amounts; Fig. 5a,b). To study the role of STEP in NMDA receptor trafficking further, we used a dominant-negative fusion protein. We made a recombinant fusion protein of STEP46 with two mutations: an inactive enzymatic domain (C300S) and a mutation to mimic dephosphorylation (S49A). These two mutations make the fusion protein a dominant negative, as it promotes substrate interaction but not dephosphorylation29. The fusion protein was coupled with the HIV-Tat peptide, which efficiently enters neurons (dnSTEP-Tat). We also coupled Tat to myc, to control for any effect of the Tat protein on its own (myc-Tat). A series of control experiments showed that the Tat fusion proteins were efficiently transduced into cells within 30 min when treated at 1–5 mM (data not shown). Pretreatment with dnSTEP-Tat (5 mM for 45 min) caused no significant change in surface NR1 (99.5 ± 10% of myc-Tat control)
Aβ
WT
APPSwe
b
125
125
100
100
75 50 25
75 50 25
0
0 Ctl.
1054
c
myc-Tat Ctl. Aβ
dnSTEP-Tat Ctl. Aβ
d
Surface NR1 Total NR1
150 Surface NR1 (% control)
Figure 5 Amyloid-b promotes dephosphorylation of STEP, which controls glutamate receptor trafficking. (a) Left: neurons were treated with control medium or medium containing amyloid-b, and the tyrosine phosphatase STEP was immunoprecipitated. Right: STEP protein was immunoprecipitated from the cortices of 10-month-old APPSwe mice or their wild-type littermates. (b) Amyloid-b treatment reduced phosphorylation of STEP (n ¼ 5, P o 0.04). In the brains of APPSwe mice, STEP phosphorylation was reduced (n ¼ 4, P o 0.05). Error bars indicate s.e.m. (c) dnSTEP-TAT reduces the effect of amyloid-b on NR1, whereas myc-Tat has no effect. (d) Quantification shows that in myc-Tat, amyloid-b reduced surface NR1 to 54 ± 8% of myc-Tat alone (n ¼ 5; P o 0.05). (e) dnSTEP-Tat blocks the dephosphorylation of Tyr1472 that occurs in the presence of amyloid-b. Total NR2B was not affected. (f) Quantification shows that amyloid-b reduced phosphorylation of NR2B at Tyr1472 (n ¼ 5; P o 0.05).
Aβ
WT APPSwe
myc-Tat dnSTEP-Tat
100
50
0 Ctl. Aβ Ctl. Aβ
e
myc-Tat Ctl. Aβ
dnSTEP-Tat Ctl. Aβ
Phospho-Tyr1472 NR2B
Total NR2B
VOLUME 8
[
f
NR2B phosphorylation (% control)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
b
(% WT)
BTX Cyclo
STEP phosphorylation (% control)
a
NUMBER 8
150
myc-Tat dnSTEP-Tat
100
50
0 Ctl. Aβ
[
Ctl. Aβ
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Aβ1–42
a
NMDA
b
35 min after
NMDA
Aβ1–42 3
4
5
2
1
200 pA
1,600
NMDAR peak current amplitude (pA)
40 Voltage (mV)
–80
20 40 Current (pA)
–40
1
1,200
400 200 pA
2
200
1s
–60 –40 –20 800 3
5
4
–400 400 –600 –800
–120
20 40 60 Voltage (mV)
0 0
10
20
30
40
50
Time (min)
c
Aβ1–42
120
or ECS
1.5
100 ECS 1.0 Aβ1–42
80
0.5 60 –60
–40
–20 20
40 –0.5
ECS Aβ1–42 without current
20
Aβ1–42 with current
–1.0
0 0
5
10
15
20
25
30
35
–1.5
Normalized current (pA)
Normalized Ipeak
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
80
–60 –40 –20
600 1s
Aβ1–42
1s
NMDAR current (pA)
30 pA
800
40 60 Voltage (mV)
Figure 6 Amyloid-b depresses NMDA receptor (NMDAR) currents. (a) Top: recordings from a cultured cortical neuron showing responses to two applications of amyloid-b Bottom: current-voltage (I-V) relationship for currents evoked by amyloid-b from another cortical neuron. (b) Left: the NMDAR peak current amplitude recorded in a cultured cortical neuron is shown before and after treating the neuron with amyloid-b Traces above the graph illustrate responses to the test applications recorded from this cell; NMDA and glycine were applied during the period indicated by the bar above each trace. The traces were taken before and after treating with amyloid-b peptide at the time points indicated by numbers, which correspond to those in the graph. Right: The I-V relationship of the peak current 35 min after treatment with amyloid-b. Traces above the I-V curve illustrate superimposed responses to the test applications recorded at membrane potentials from 60 mV (bottom) to +60 mV (top) in increments of 20 mV. (c) Left: normalized NMDAR peak currents (mean ± s.e.m.) are plotted before and after treatment with amyloid-b. Peak currents were normalized to the average of first six responses. The cells were treated either with regular ECS (filled squares); with ECS plus amyloid-b peptide, which did not induce an inward current (open circles), or with ECS plus amyloid-b peptide, which did induce an inward current (filled triangles). Right: the normalized I-V relationship of NMDA-evoked peak currents from cells 20 min after treatment with ECS only (filled circle; n ¼ 3 cells) or ECS plus amyloid-b (filled triangles).
Time (min)
but blocked amyloid-b–induced endocytosis of NR1 (Fig. 5c,d). In the presence of dnSTEP-Tat, amyloid-b treatment slightly increased surface NR1 to 121 ± 12% of control amounts (n ¼ 5; Fig. 5c,d); however, this increase was not significant as compared with treatment with dnSTEPTat alone (P 4 0.16). The Tat peptides did not alter total amounts of NR1 (Fig. 5c). The NR2B subunit regulates NMDA trafficking and is phosphorylated at three tyrosine residues in its C terminus. One phosphotyrosine residue (Tyr1472) is in a region that regulates NMDA receptor endocytosis13 and binding of the receptor to the synaptic scaffolding protein PSD-95 and the clathrin adaptor protein AP-2 (ref. 30). We hypothesized that the amyloid-b–induced activation of STEP would promote dephosphorylation of Tyr1472. Amyloid-b (1 mM for 1 h) promoted dephosphorylation of NR2B to 62 ± 7% of control amounts (in the presence of myc-Tat; Fig. 5e,f). In the presence of dnSTEP-Tat, however, this dephosphorylation was blocked (107 ± 11% of control amounts; n ¼ 5). These data are consistent with the hypothesis that amyloid-b promotes dephosphorylation and endocytosis of the NMDA receptor by activating STEP. Amyloid-b rapidly depresses NMDA-evoked currents Reducing the density of NMDA receptors at the cell surface is expected to reduce NMDA receptor–mediated currents as well. Accordingly, we carried out whole-cell patch-clamp recordings in pyramidal neurons. Amyloid-b (1 mM), when applied by rapid local perfusion, caused an inward current that developed over the first 1 s of the start of the application and ended within 1 s after the application ceased
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
(Fig. 6a). The reversal potential for this current was approximately 0 mV, indicating that, with the ionic composition of the recording solutions used, it was a nonselective cation current. The amplitude of the current recorded at 60 mV ranged from 40 to 800 pA. This current was reliably evoked with repeated amyloid-b application but was observed in fewer than half the neurons tested. These cells appeared morphologically similar to cells that responded to amyloid-b and did not differ in holding current, input resistance or characteristics of NMDA-evoked responses (data not shown). It is not clear if the cells that had no response to amyloid-b are indicative of a population of neurons that are resistant to amyloid-b under these experimental conditions. To investigate the effect of amyloid-b on NMDA currents, we probed NMDA receptors with regularly timed test applications (3-s duration) of NMDA (50 mM) and glycine (1 mM). Under these conditions, currents evoked by NMDA are stable for more than 45 min14. We recorded test NMDA-evoked currents for at least 10 min to establish a stable baseline and then applied amyloid-b (1 mM) for 5 min; the test applications of NMDA were not made during the period when amyloid-b was applied. In neurons where amyloid-b evoked an inward current (which was sustained for the 5-min application; data not shown), the amplitude of NMDA-evoked currents was decreased and remained decreased for the remainder of the recording period (up to 30 min; Fig. 6b,c). On average, the amplitude of the NMDAevoked currents was reduced to 63.1 ± 4.6% of the amplitude before amyloid-b application (n ¼ 8 cells; Fig. 6c). By contrast, in cells where amyloid-b did not evoke an inward current, we found that NMDA
1055
ARTICLES dysfunction, synapse loss and neuronal death. The most notable result from the current study is that amyloid-b is capable of regulat15 Aβ Ctl. ing the surface expression and endocytosis of PhosphoNMDA-type glutamate receptors. Our results 10 CREB are consistent with recent findings demon* strating that nontoxic amounts of secreted 5 amyloid-b reduce LTP and glutamatergic Total transmission11. Prolonged depression of 0 CREB Ctl. Aβ Ctl. Aβ Ctl. Aβ NMDA receptor–mediated transmission may + forskolin + NMDA initiate the pathological changes observed in Alzheimer disease. Figure 7 Amyloid-b reduces NMDA-induced CREB phosphorylation. (a) Cultured neurons were treated Synaptic NMDA receptor activation prowith amyloid-b for 1 h and then were treated with forskolin (100 mM) or NMDA (10 mM) for 10 min. Immediately after treatment, western blotting was performed for CREB phosphorylated at Ser133 (top) motes the phosphorylation of CREB and or for total CREB (bottom). (b) Both forskolin and NMDA induced CREB phosphorylation. Amyloid-b did transcription of target genes. These target not affect basal CREB phosphorylation (which decreased slightly to 0.94 ± 0.1 of control values; n ¼ 5; genes include those involved in synapse forP 4 0.2). NMDA increased CREB phosphorylation in control cultures, but the phosphorylation was mation, neuronal survival (BDNF33,34, BCL-2 significantly reduced in amyloid-b–treated cultures (n ¼ 6; P o 0.03). (ref. 35)) and long-term memory formation (C/EBP)36. Decreased CREB phosphorylation currents were not altered and remained at 98.4 ± 1.3% of the has been detected in the brains of Alzheimer disease patients37, baseline (n ¼ 5 cells; Fig. 6c). Likewise, after a 5-min control indicating that amyloid-b may reduce neuronal growth and survival application of extracellular solution (ECS), NMDA-evoked currents through this transcription factor. remained at 97.6 ± 1.1% of the baseline (n ¼ 5 cells; Fig. 6c). Amyloid-b binds to several cell surface proteins and initiates The depression of NMDA currents by amyloid-b1–42 was not associated numerous signaling cascades. We find that amyloid-b-induced endowith a change in the reversal potential, which was near 0 mV cytosis of NMDA receptors involves the activation of the a-7 nicotinic after applying amyloid-b1–42 or ECS (Fig. 6c). Thus, the whole-cell receptor and PP2B (Supplementary Fig. 2). These findings are conNMDA-evoked conductance, rather than the driving force, was sistent with previous data demonstrating that amyloid-b can bind and activate a-7 nicotinic receptors and that this class of receptors can decreased by amyloid-b. reduce NMDA receptor signaling through PP2B24,25. Given that we did not see a complete blockade of NMDA receptor endocytosis with the Amyloid-b reduces NMDA signaling to CREB We examined whether amyloid-b could influence NMDA receptor– nicotinic receptor antagonist BTX, there may be additional receptor mediated biochemical signaling. Stimulation of synaptic NMDA mechanisms involved in this process. PP2B promotes dephosphorylation of the tyrosine phosphatase receptors promotes transcriptional activation through phosphorylation of CREB at Ser133 (ref. 31). Pharmacological or genetic inhibition STEP. PP2B may act directly on STEP as a substrate or through PP1 of adenylyl cyclase or PKA significantly reduces NMDA-induced and inhibitor-1 or DARPP-32 (ref. 38). Either way, dephosphorylation phosphorylation of CREB31. In addition, NMDA receptor activation of STEP via PP2B promotes its activity and interaction with subcan also lead to phosphorylation of CREB through direct activation of strates29. STEP gates NMDA receptor activation and LTP28. The present the RAS/MAP kinase pathway and/or CaMKIV31. data suggest a mechanism by which this occurs and indicate that Amyloid-b regulates activity-dependent CREB phosphorylation32. amyloid-b promotes dephosphorylation and activation of STEP in To test whether this effect is mediated by NMDA receptors, cultured neurons and in the brains of 10-month-old APPSwe mice. In neurons that were cultured for 7–10 d were first treated with tetrodo- addition, STEP regulates amyloid-b–induced endocytosis of NMDA toxin (1 mM) for 2 h to reduce basal CREB phosphorylation and receptors. These findings are consistent with a role for STEP in then for an additional 1 h with tetrodotoxin and either amyloid-b1–42 regulation of NMDA transmission. Although it remains unclear which STEP substrates are essential (1 mM) or control medium. To stimulate CREB phosphorylation, neurons were treated with NMDA (10 mM) or the adenylyl in regulating receptor trafficking, our data indicate that STEP cyclase activator forskolin (100 mM) for 10 min. Treatment with regulates NR2B phosphorylation. Phosphorylation of the NR2B subamyloid-b did not affect basal phosphorylation of CREB (Fig. 7a). unit of the NMDA receptor at Tyr1472 is positively correlated with Treatment with NMDA robustly increased phosphorylation of NMDA currents39. This tyrosine is of interest as it regulates binding CREB, although this effect was reduced by amyloid-b treatment of the NMDA receptor to PSD-95 as well as to the clathrin adaptor (Fig. 7a). In control cultures, NMDA treatment increased CREB protein AP-2, and phosphorylation of this tyrosine may regulate phosphorylation by a factor of 7.1 ± 0.39 over basal amounts, interactions with endocytosis machinery30. Dephosphorylation of whereas in amyloid-b-treated cultures, NMDA treatment increased NR2B may trigger clathrin-coated endocytosis. Future studies should CREB phosphorylation by a factor of 4.20 ± 0.41 over basal address the role of the clathrin-coated machinery in the pathology of amounts (Fig. 7b). In control studies, forskolin increased CREB Alzheimer disease. phosphorylation by a factor of 14.9 ± 1.1 (Fig. 7b). After amyloid-b Alzheimer disease involves multiple neurological changes ranging treatment, forskolin increased CREB phosphorylation by a factor of from plaques and tangles to reduced synapse and neuron density and 13.7 ± 1.2 (n ¼ 4; Fig. 7b). inflammatory responses. Our data indicate that a critical signaling pathway allows amyloid-b to regulate synaptic function and plasticity. DISCUSSION Genetic or pharmacological inhibition of NMDA receptors reduces Despite a wide consensus that amyloid-b is a central causative factor in learning and memory in rodents, indicating that amyloid-b–induced Alzheimer disease, it remains unclear how this peptide causes synaptic loss of surface NMDA receptors may markedly affect memory
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
1056
Forskolin 100 µM 10 min Aβ Ctl.
NMDA 10 µM 10 min Aβ Ctl.
20
b
Relative phospho-CREB
a
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES and behavior. Further studies will be necessary to understand precisely how NMDA receptor endocytosis is regulated by amyloid-b and if and how this contributes to dementia. In addition, it will be of great interest to understand how secreted amyloid-b interacts with the amyloid-b that accumulates intracellularly, proximally to synapses. Both secreted and intracellular amyloid-b seem to affect synapses. Further exploration of the interaction of intracellular and extracellular amyloid-b at synapses may lead to a better understanding of Alzheimer disease pathology and may promote new therapeutic approaches for the disease.
ACKNOWLEDGMENTS We thank M. Greenberg for the gift of phospho-NR2B antibody and G. Thinakaran and S. Sisodia for the gift of stably transfected N2A cells. We also thank J. Shepherd and members of the Greengard and Gouras labs for helpful discussions. This work was supported by the Fisher Foundation for Alzheimer’s Research, US National Institutes of Health grant AG09464 (P.G.T. and G.K.G.) and National Institute of Mental Health grant 52711 and 01527 (P.J.L.). COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests.
METHODS Patch-clamp recordings. Whole-cell recordings were made from cortical neuron cultures using procedures described in detail previously14. All experiments were done in accordance with guidelines on animal research of Rockefeller University, University of Toronto or Cornell University. Recordings were made at room temperature (20–22 1C). After attaining the whole-cell configuration, the recorded neurons were voltage clamped using an Axopatch 1-D amplifier to 60 mV, except where indicated otherwise. The neurons were continually perfused with electrophysiological saline (ECS), containing 140 mM NaCl, 1.3 mM CaCl2, 5 mM KCl, 25 mM HEPES, 33 mM glucose, 500 nM tetrodotoxin and 10 mM bicuculline (pH 7.35, osmolarity 330 mOsm)), by a computer-controlled, multibarreled fast perfusion system. NMDA receptor currents were induced by 50 mM NMDA and 1 mM glycine. Data were recorded, digitized with DigiData1200A, filtered (2 kHz) and acquired by the pClamp8.1 program. Recordings in which the series resistance varied by more than 10% were rejected. The intracellular solution contained 20 mM CsCl, 125 mM CsCH3SO3, 2 mM MgCl2, 0.2 mM EGTA, 10 mM HEPES and 4 mM K2ATP, with pH 7.28 and 285 mOsm. Surface biotinylation assay. After treatment, neurons were placed on ice and rinsed in cold PBS. Neurons were then incubated in PBS containing 1.5 mg/ml sulfo-NHS-LC-biotin (Pierce) for 20 min at 4 1C. Neurons were rinsed twice in PBS and then lysed in 200 ml PBS with complete protease inhibitor cocktail (Roche) + 0.1% SDS + 1% Triton X-100. To determine the total protein concentration by immunoblotting, 10% of the cell lysate was removed and diluted in sample buffer. To isolate biotinylated proteins, 80% of the cell lysate was incubated with NeutrAvidin agarose (50 ml; Pierce). Western blots were carried out and data were quantified by comparing the ratio of biotinylated to total protein for a given culture and normalizing to control untreated cultures, unless stated otherwise. Cleavable biotinylation assay. Neurons were rinsed in PBS and then incubated with cold 1.5 mg/ml cleavable biotin reagent in PBS (EZ-Link Sulfo-NHS-SS biotin; Pierce) at 4 1C for 20 min. Cultures were then rinsed in warm medium and incubated at 37 1C in control medium or in medium containing amyloid-b for 15 min. Immediately after treatment, neurons were placed on ice and rinsed in cold stripping buffer (50 mM glutathione, 75 mM NaCl, 75 mM NaOH, 10% FBS, pH 8.5–9.0). Neurons were then lysed in 200 ml PBS with complete protease inhibitor cocktail (Roche) + 0.1% SDS + 1% Triton X-100. Lysates were briefly sonicated and centrifuged to remove insoluble material. Biotinylated proteins were isolated by incubation with NeutrAvidin agarose (50 ml; Pierce). Isolated proteins were rinsed in buffer three times and then boiled in 20 ml sample buffer. Western blots were then carried out. Quantification was done by comparing the densitometric value for internalized biotinylated protein in the presence of amyloid-b to the value in control cultures and normalizing to the value in control cultures. Generation and purification of myc-Tat and Tat-STEP46 S-A/C-S fusion protein. STEP46 S-A/C-S was rendered cell permeable by inserting Tat (YGRKKRRQRRR), the cell membrane transduction domain of HIV type 1 (ref. 40), at the amino terminus using PCR. Tat-STEP46 S-A/C-S (dnSTEP-Tat) was then cloned in the bacterial expression vector pTrcHis2-TOPO (Invitrogen) and transformed into Escherichia coli BL21 for high expression of the fusion protein. The fusion protein was purified using TALON metal affinity resin (Clontech) according to manufacturer’s protocol. The myc-Tat peptide was synthesized by the W.M. Keck Biotechnology Resource Center at Yale University.
NATURE NEUROSCIENCE VOLUME 8
Note: Supplementary information is available on the Nature Neuroscience website.
[
NUMBER 8
[
AUGUST 2005
Received 18 April; accepted 22 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Perdahl, E., Wu, W.C., Browning, M.D., Winblad, B. & Greengard, P. Protein III, a neuronspecific phosphoprotein: variant forms found in human brain. Neurobehav. Toxicol. Teratol. 6, 425–431 (1984). 2. Terry, R.D. et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580 (1991). 3. Takahashi, R.H. et al. Oligomerization of Alzheimer’s b-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 3592–3599 (2004). 4. Selkoe, D.J. Alzheimer’s disease is a synaptic failure. Science 298, 789–791 (2002). 5. Hardy, J. & Selkoe, D.J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002). 6. Chapman, P.F. et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271–276 (1999). 7. Freir, D.B., Holscher, C. & Herron, C.E. Blockade of long-term potentiation by b-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85, 708– 713 (2001). 8. Kim, J.H., Anwyl, R., Suh, Y.H., Djamgoz, M.B. & Rowan, M.J. Use-dependent effects of amyloidogenic fragments of (b)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J. Neurosci. 21, 1327–1333 (2001). 9. Malenka, R.C. Synaptic plasticity and AMPA receptor trafficking. Ann. NY Acad. Sci. 1003, 1–11 (2003). 10. Naslund, J. et al. Correlation between elevated levels of amyloid b-peptide in the brain and cognitive decline. J. Am. Med. Assoc. 283, 1571–1577 (2000). 11. Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925–937 (2003). 12. Snyder, E.M. et al. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat. Neurosci. 4, 1079–1085 (2001). 13. Roche, K.W. et al. Molecular determinants of NMDA receptor internalization. Nat. Neurosci. 4, 794–802 (2001). 14. Nong, Y. et al. Glycine binding primes NMDA receptor internalization. Nature 422, 302–307 (2003). 15. Scott, D.B., Michailidis, I., Mu, Y., Logothetis, D. & Ehlers, M.D. Endocytosis and degradative sorting of NMDA receptors by conserved membrane-proximal signals. J. Neurosci. 24, 7096–7109 (2004). 16. Mammen, A.L., Huganir, R.L. & O’Brien, R.J. Redistribution and stabilization of cell surface glutamate receptors during synapse formation. J. Neurosci. 17, 7351–7358 (1997). 17. Rao, A. & Craig, A.M. Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron 19, 801–812 (1997). 18. Ehlers, M.D. Reinsertion or degradation of AMPA receptors determined by activitydependent endocytic sorting. Neuron 28, 511–525 (2000). 19. Ehlers, M.D. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6, 231–242 (2003). 20. Cai, D. et al. Presenilin-1 regulates intracellular trafficking and cell surface delivery of b-amyloid precursor protein. J. Biol. Chem. 278, 3446–3454 (2003). 21. Wang, H.Y. et al. b-Amyloid(1–42) binds to a7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathology. J. Biol. Chem. 275, 5626– 5632 (2000). 22. Dineley, K.T. et al. b-amyloid activates the mitogen-activated protein kinase cascade via hippocampal a7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer’s disease. J. Neurosci. 21, 4125–4133 (2001). 23. Levy, R.B. & Aoki, C. a7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 22, 5001–5015 (2002). 24. Shi, J., Townsend, M. & Constantine-Paton, M. Activity-dependent induction of tonic calcineurin activity mediates a rapid developmental downregulation of NMDA receptor currents. Neuron 28, 103–114 (2000). 25. Stevens, T.R., Krueger, S.R., Fitzsimonds, R.M. & Picciotto, M.R. Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J. Neurosci. 23, 10093–10099 (2003). 26. Wang, Y.T. & Salter, M.W. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369, 233–235 (1994).
1057
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 27. Vissel, B., Krupp, J.J., Heinemann, S.F. & Westbrook, G.L. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nat. Neurosci. 4, 587–596 (2001). 28. Pelkey, K.A. et al. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron 34, 127–138 (2002). 29. Paul, S., Nairn, A.C., Wang, P. & Lombroso, P.J. NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci. 6, 34–42 (2003). 30. Lavezzari, G., McCallum, J., Lee, R. & Roche, K.W. Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology 45, 729–737 (2003). 31. Shaywitz, A.J. & Greenberg, M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem. 68, 821–861 (1999). 32. Tong, L., Thornton, P.L., Balazs, R. & Cotman, C.W. b-amyloid-(1–42) impairs activitydependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J. Biol. Chem. 276, 17301–17306 (2001). 33. Shieh, P.B., Hu, S.C., Bobb, K., Timmusk, T. & Ghosh, A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20, 727–740 (1998).
1058
34. Tao, X., Finkbeiner, S., Arnold, D.B., Shaywitz, A.J. & Greenberg, M.E. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709–726 (1998). 35. Riccio, A., Ahn, S., Davenport, C.M., Blendy, J.A. & Ginty, D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358–2361 (1999). 36. Taubenfeld, S.M., Milekic, M.H., Monti, B. & Alberini, C.M. The consolidation of new but not reactivated memory requires hippocampal C/EBPb. Nat. Neurosci. 4, 813–818 (2001). 37. Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rosler, M. & Riederer, P. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res. 824, 300–303 (1999). 38. Valjent, E. et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. USA 102, 491–496 (2005). 39. Alvestad, R.M. et al. Tyrosine dephosphorylation and ethanol inhibition of N-methyl-Daspartate receptor function. J. Biol. Chem. 278, 11020–11025 (2003). 40. Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569–1572 (1999).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy Inma Cobos1, Maria Elisa Calcagnotto2, Alex J Vilaythong3, Myo T Thwin1, Jeffrey L Noebels3, Scott C Baraban2 & John L R Rubenstein1 Dlx homeodomain transcription factors are essential during embryonic development for the production of forebrain GABAergic interneurons. Here we show that Dlx1 is also required for regulating the functional longevity of cortical and hippocampal interneurons in the adult brain. We demonstrate preferential Dlx1 expression in a subset of cortical and hippocampal interneurons which, in postnatal Dlx1 mutants, show a time-dependent reduction in number. This reduction preferentially affects calretinin1 (bipolar cells) and somatostatin1 subtypes (for example, bitufted cells), whereas parvalbumin1 subpopulations (basket cells and chandelier cells) seem to be unaffected. Cell transplantation analysis demonstrates that interneuron loss reflects cell-autonomous functions of Dlx1. The decrease in the number of interneurons was associated with a reduction of GABA-mediated inhibitory postsynaptic current in neocortex and hippocampus in vitro and cortical dysrhythmia in vivo. Dlx1 mutant mice show generalized electrographic seizures and histological evidence of seizure-induced reorganization, linking the Dlx1 mutation to delayed-onset epilepsy associated with interneuron loss.
GABAergic interneurons are central to the regulation of cortical and hippocampal intrinsic activity through their direct inhibitory effects on excitatory neurons. Defects in GABAergic function, through either alterations in presynaptic GABA levels or postsynaptic response at GABA receptors, lead to an imbalance in inhibitory and excitatory circuits, which can cause epilepsy1. At the cellular level, GABAergic inhibition is important in regulating local circuit processes (that is, information coding and synaptic plasticity)2 and synchronizing network oscillations (gamma and theta rhythms implicated in cognitive processes)3,4. Cortical inhibition is mediated by a complex set of distinct GABAproducing interneuron subtypes5. Cortical interneurons have been classified according to their axonal or dendritic morphology (for instance, basket, chandelier, bitufted and bipolar cells)6,7 using neurochemical markers such as Ca2+ -binding proteins and neuropeptides8–10 as well as by analyzing their intrinsic neuronal firing properties11 and network interconnections12,13. Approaches that integrate morphological, molecular and physiological characteristics are providing insights into the diversity and functions of interneurons. Most GABAergic interneurons in the telencephalon are derived from subpallial progenitors in the medial ganglionic eminence (MGE) and migrate tangentially to cortex and hippocampus14–18, although in humans there is evidence for a pallial origin as well19. Several transcription factors have been identified that control interneuron development. Mice lacking function of Nkx2.1, a homeobox gene required for MGE specification, form only one-half as many
cortical interneurons as normal mice15,17,18. The Dlx family of homeobox transcription factors (Dlx1, Dlx2, Dlx5 and Dlx6) is expressed in overlapping domains at different stages of cell differentiation in the subpallium and controls differentiation of GABAergic neurons20. Whereas neonatal Dlx single mutants show no overt defects in GABAergic development21,22, tangential migration is blocked in Dlx1/Dlx2 double mutants, and the mutants show a 475% reduction of interneurons in neocortex and 495% reduction in hippocampus20,23. The Arx homeobox transcription factor, which is regulated by Dlx genes24, is also required for migration of interneurons. Mutations in the human ortholog ARX cause X-linked mental retardation and epilepsy25. Although little is known about mechanisms that control later steps of interneuron differentiation, aside from the role of neural activity and neurotrophins26, it is probable that transcription factors (such as Dlx1) expressed in these cells27 participate in their maturation and function. Here, we report that mice lacking Dlx1 function show an agedependent, cell subtype–specific reduction of cortical and hippocampal interneurons. This cell loss is due to apoptotic cell death of subsets of Dlx1-expressing cells. Using transplantations of Dlx1/ interneuron precursors into wild-type neonatal mice, we demonstrate cellautonomous functions of Dlx1 in controlling interneuron maturation and survival. Reduced interneuron numbers are associated with a reduction of GABA-mediated synaptic inhibition in neocortex and hippocampus. As a result, Dlx1/ mice develop behavioral, histological and electrographic signs of epilepsy.
1Nina Ireland Laboratory of Developmental Neurobiology, Department of Psychiatry, University of California San Francisco, San Francisco, California 94158, USA. 2Epilepsy Research Laboratory, Department of Neurological Surgery, University of California San Francisco, San Francisco, California 94143, USA. 3Developmental Neurogenetics Laboratory, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA. Correspondence should be addressed to I.C. (
[email protected]) or J.L.R.R. (
[email protected]).
Published online 10 July 2005; doi:10.1038/nn1499
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1059
ARTICLES Gad67
Dlx1
a
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
d
Dlx1+PV
g
Dlx1+SOM
h
b
c
e
f
Dlx1+NPY
i
Lhx6
Dlx1+CR
j
Lhx6+PV
k
Lhx6+SOM Lhx6+NPY
l
RESULTS Cell subtype–specific expression of Dlx1 in interneurons During forebrain development, the expression of Dlx genes coincides with that of Gad genes Gad1 and Gad2 (also known as Gad67 and Gad65, respectively), which encode the 67- and 65-kDa isoforms, respectively, of glutamate decarboxylase, the enzyme that synthesizes GABA23,27. Here we analyzed expression of Dlx1, the member of the Dlx family with most robust expression in postnatal cortex27,28. Comparison of Dlx1 and Gad67 expression in neocortex and hippocampus showed that not all GABAergic neurons were Dlx1+; rather, only 45% of Gad67+ neurons were Dlx1+ (1-month-old; n ¼ 5; Fig. 1a,b,d,e). To address whether specific subtypes of cortical interneurons express Dlx1, we conducted double-labeling for Dlx1 (detected by in situ hybridization) and either parvalbumin, somatostatin or calretinin (detected by immunohistochemistry; 1-month-old; n ¼ 3; Fig. 1g–j). Parvalbumin+, somatostatin+ and calretinin+ cortical cells are largely nonoverlapping subgroups of interneurons in rodents10,29. We detected Dlx1 expression in B5% of parvalbumin+ interneurons (5.2 7 3.1%). In contrast, we detected Dlx1 expression in the majority of somatostatin+ (90.8 7 5.2%) and calretinin+ interneurons (98.7 7 3%). Neuropeptide Y+ (NPY+) interneurons, some of which are also somatostatin+ (ref. 9), were nearly all Dlx1+ (97.5 7 4.8%). Notably, expression of Lhx6, a LIM-homeobox transcription factor that also regulates cortical interneuron development30, was detected primarily in parvalbumin+ interneurons (93.8 7 5.1%) and a subset of somatostatin+ interneurons (54.8 7 4.8%), and was not detected in NPY+ (3.1 7 2.2%) and calretinin+ neurons (2.2 7 3.7%; Fig. 1c,f,k–n). These cellular expression patterns were maintained in older animals (2–6 months old; data not shown). Thus, in the adult cortex, Dlx1 expression marks calretinin+ and somatostatin+/NPY+ interneurons and is nearly excluded from parvalbumin+ interneurons. Age-dependent reduction of GABAergic neurons in Dlx1/ Homozygous Dlx1 mutant mice have a normal appearance at birth22. We maintained Dlx1/ mice on a mixed genetic background (C57BL/6J;CD1); 50% of the pups had survival rates and weight comparable to wild-type littermates. To study Dlx1 function in interneurons, we analyzed the phenotype of Dlx1 mutants through
1060
m
Lhx6+CR
Figure 1 Dlx1 is expressed in subsets of cortical and hippocampal GABAergic interneurons. (a–f) Expression of Gad67 (a,d), Dlx1 (b,e) and Lhx6 (c,f) mRNA in coronal sections through somatosensory cortex (a–c) and hippocampus (d–f) in 1-month-old mice. Roman numerals denote cortical layers. (g–n) Double in situ hybridization and immunohistochemistry staining for either Dlx1 or Lhx6 mRNAs (blue) and either parvalbumin (PV), somatostatin (SOM), neuropeptide Y (NPY) or calretinin (CR; brown) in neocortex of 1-month-old mice. Arrowheads indicate double-positive cells. Abbreviations: DG, dentate gyrus; h, hilus. Scale bars: 250 mm (a–c, d–f); 25 mm (g–n).
n
postnatal stages and adulthood. First, we examined expression of Gad67 (at postnatal day 12 (P12); P20; and 1, 2 and 6 months). At P12, Gad67+ cells appeared normal in Dlx1/ pups, based on number and layer distribution (Supplementary Fig. 1), suggesting that tangential migration of GABAergic precursors from MGE and ability to integrate into the cortical plate was not perturbed. In contrast, the number of Gad67-expressing neurons in neocortex and hippocampus had decreased by the time mice were 1 month old (Fig. 2). Although Dlx1 is also expressed in other regions of the forebrain, including olfactory bulb interneurons, thalamic reticular nucleus and some hypothalamic nuclei27,28, no changes in Gad expression were detected in these locations (Fig. 2a,e; data not shown). The reduction of Gad67 did not show substantial regional differences within the examined cortical areas (cingulate cortex, piriform cortex, somatosensory and visual cortex). We selected somatosensory cortex and hippocampus (dentate gyrus, CA3 and CA1) to quantify the number of Gad67+ neurons in Dlx1/ and wild-type littermates (Fig. 2m). In somatosensory cortex, mutants between 1 and 2 months of age showed a B22% reduction of Gad67+ cells (1 month: 22.3 7 2.1%, P ¼ 0.03, n ¼ 6; 2 months: 22 7 0.8%, P ¼ 0.03, n ¼ 5; Fig. 2f–h,m). In hippocampus, this reduction was 33.6 7 3% in dentate gyrus, 26.4 7 3.5% in CA3 and 29 7 2.7% in CA1 at 2 months of age (P o 0.05, n ¼ 5; Fig. 2i–m). In older mutants (6 months old) the number of Gad+ cells did not show further reductions (somatosensory cortex: 17.4 7 3.3%, P ¼ 0.02; CA1: 26.7 7 3.9%, P ¼ 0.039, n ¼ 5; Fig. 2h,m). GABAergic neuron subtype–specific reduction in Dlx1/ As Dlx1 was specifically detected in distinct neurochemical subtypes of GABAergic neurons, including somatostatin- and calretinin-expressing neurons, we tested the hypothesis that these specific subtypes would be reduced in Dlx1/ mice. As with Gad67, we did not observe significant differences in expression of interneuron markers at early postnatal stages (P12). In contrast, somatostatin+ and calretinin+ interneurons were significantly reduced in animals older than one month (Fig. 3 and Supplementary Figs. 2,3). Somatostatin+ neurons were reduced by B23% in somatosensory cortex and by B33% in CA1 in 1- to 2-month-old mutants (cortex; 1 month: 23 7 2.9%, P ¼ 0.04; 2 months: 24.5 7 3.8%, P ¼ 0.04; CA1; 1 month: 33 7 1.4%, P ¼ 0.01; 2 months: 33.8 7 2.1%, P ¼ 0.001, n ¼ 5; Fig. 3g,p,s).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES Figure 2 Number of GABAergic interneurons is reduced in neocortex and hippocampus of Dlx1/ mice. (a–h) Expression of Gad67 mRNA in coronal sections from 1- to 6-month-old wild-type (a–d) and Dlx1/ (e–h) littermates. Sections (b–d; f–h) correspond to somatosensory cortex (bregma level –0.82 mm); roman numerals denote cortical layers. (i–l) Expression of Gad67 mRNA (10-mm-thick sections) and GABA (40 mm-thick sections) in hippocampus of 2-month-old wild-type and Dlx1/ littermates. (m) Quantification of the number of Gad67+ cells in somatosensory cortex (black) and CA1 field of hippocampus (gray) from P12, P20 and 1-, 2- and 6-month-old mice. Values are normalized to wild-type (white). A, amygdala; DG, dentate gyrus; HT, hypothalamus; RN, reticular nucleus of the thalamus; Cx, neocortex; m, month. Scale bars: 500 mm (a,e); 250 mm (b–d; f–h; i–l).
Gad67
a
b
c
d
+/+
e
1 month
f
2 months
6 months
g
h
–/–
Gad67
i
m
j
+/+ 2 months
k
l
–/–
Finally, consistent with nearly undetectable Dlx1 expression in the parvalbumin interneuron subclass, the number of parvalbumin+ cells did not change significantly in Dlx1/ mice. Lhx6+ and calbindin+ interneurons, which both label some parvalbumin+ cells8,9, were not affected either (Supplementary Fig. 2). Thus, using a diverse set of interneuron molecular markers we identified a specific reduction of somatostatin+ and calretinin+ subclasses in Dlx1/ mice.
+/+ –/–, neocortex –/–, hippocampus
GABA
Percentage Gad67 + cells (normalized)
1.0
** * ** *
0.8 0.6 0.4 0.2 0
Apoptotic cell death of GABAergic neurons in Dlx1/ We next investigated whether reduction of interneuron markers in Dlx1/ mice was due to reduced transcription of these markers or to cell death. This is important given that Dlx transcription factors are able to induce Gad expression33. On the other hand, we obtained evidence that Dlx genes do not regulate expression of other markers that were reduced in Dlx1/ mice (Supplementary Fig. 4). To resolve this question, first we analyzed GABA expression in interneurons of Dlx1/ and wild-type littermates (1 month old, Fig. 4a–h). We took advantage of easily discernible laminar organization of the hippocampus, with GABAergic neurons localized in specific layers (for example, stratum oriens), to quantify the numbers of GABA+ profiles among NeuN+ (a general neuronal marker) cells. Whereas the number of both NeuN+ and GABA+ cells was reduced by one-third in Dlx1/ mice, GABA expression was not reduced in NeuN+ cells, as shown by the similar percentage of double-labeled
P11 P20 1 m 2 m 6 m
The number of NPY+ interneurons, some of which are also somatostatin+ (ref. 9), decreased 42.3 7 2.1% in somatosensory cortex and 34.5 7 1.1% in CA1 at 2 months (P o 0.001, n ¼ 5; Fig. 3h,q,s). The enzyme nitric oxide synthase (NOS) is expressed by a small fraction of somatostatin+ interneurons10. In Dlx1/ mice, the number of NOS+ cells was diminished (Fig. 3i). Calretinin+ interneurons, a separate interneuron subclass5,10,29, decreased 30.1 7 3.4% in somatosensory cortex and 52 7 2% in CA1 in 2-month-old mutants (P o 0.05, n ¼ 5; Fig. 3j,r,s). Expression of reelin, which is largely restricted to subsets of GABAergic interneurons that co-express somatostatin/NPY and calretinin in adult neocortex31, was reduced, both at the mRNA (Fig. 3f) and protein level (data not shown). Expression of the helix-loop-helix-PAS transcription factor N-PAS1, which overlaps with calretinin and reelin in cortical interneurSOM ons32, was also diminished (Fig. 3l). These a b reductions were no larger in older mutants (2–6 months; data not shown).
NPY
NOS
CR
Reelin
N-PAS1
c
d
e
f
i
j
k
l
+/+
Figure 3 Subtype-specific reduction of interneurons in Dlx1/ mice. (a–f) Expression of somatostatin (SOM), NPY, nitric oxide synthase (NOS), calretinin (CR), reelin and N-PAS1 in somatosensory cortex of 2-month-old wild-type (a–f) and Dlx1/ (g–l) littermates, shown by either in situ RNA hybridization (SOM, reelin and N-PAS1; 10-mm-thick sections) or immunohistochemistry (NPY, NOS and CR; 40-mm-thick sections). (m–r) Expression of SOM, NPY and CR in hippocampus of 2-month-old wild-type and Dlx1/ littermates. Insets in d, j, o, and r show higher-magnification images from the boxed areas. (s) Number of SOM+, NPY+ and CR+ cells in somatosensory cortex (black) and CA1 field of hippocampus (gray) in P12 and 1- and 2-month-old mice. Values are normalized to wild-type (white). Scale bars: 250 mm (a–l; m–r).
NATURE NEUROSCIENCE VOLUME 8
[
g
h
–/–
SOM
m
NPY
n
CR
o
+/+
p –/–
NUMBER 8
q
r
s
+/+ 1.2
Percentage positive cells (normalized)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
2 months
AUGUST 2005
SOM
–/–, hippocampus
NPY
0.8 0.6
CR
*
1.0
* * * *
*
* * *
* * *
0.4 0.2 0
[
–/–, neocortex
P12 1 m 2 m P12 1 m 2 m P12 1 m 2 m
1061
ARTICLES
a
b
g
c
Dlx1 –/–
Dlx1 +/+
f
20
* *
15 10 5
80 60 40 20
0
0
j
k
r
s
l
m
n
–/–
o –/–
p
q
Percentage TUNEL+ cells (normalized)
–/– 5 4 3 2 1 0
*
Percentage caspase-3+ cells (normalized)
i
G
N
eu
–/–
100 Gaba+/NeuN+
e
25
N AB A
d
Number of interneurons
+/+
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
h
4 3
*
2 1 0
GABA/NeuN+ cells in the mutant and control conditions (Fig. 4g,h), suggesting that neuronal loss, rather than reduction of GABA expression, accounts for the reduction in number of interneurons. To assess programmed neuronal death in Dlx1/ mice we performed two different apoptosis assays, TUNEL staining and anti–active caspase-3 immunohistochemistry (P20–P60; Fig. 4i–s). TUNEL+ and active caspase-3+ profiles were rarely observed in neocortex of wild-type mice. In contrast, the number of TUNEL+ nuclei was roughly fivefold greater in P20–P30 Dlx1/ mice than in wild-type littermates (Fig. 4r and Supplementary Fig. 5). Similarly, active caspase-3+ profiles increased approximately fourfold (Fig. 4s). Animals older than P30 did not show a significant increase in apoptosis (data not shown). At least some of the cells that underwent apoptosis in Dlx1/ mice were interneurons, as shown by TUNEL or anti–active caspase-3 labeling along with anti-NeuN fluorescence immunohistochemistry, in hippocampus (stratum radiatum; Fig. 4i–n), and by TUNEL and anti-NPY immunohistochemistry in neocortex (Fig. 4o–q). Thus, these results show increased levels of GABAergic neuron cell death in Dlx1/ mice during the period when there is a reduction in Gad67+ interneurons. Cell-autonomous loss of GABAergic neurons in Dlx1/ To determine whether interneuron loss in Dlx1/ mice was due to cell autonomous defects, we performed transplantations of GFP-expressing interneuron precursors from Dlx1/ embryos into wild-type neonatal brains (Fig. 5). Grafted interneuron precursors from embryonic MGE are able to migrate to neocortex and differentiate into distinct GABAergic neuron suptypes16. We quantified the percentage of neurons that differentiated into GABA-, parvalbumin-, somatostatin- and NPY-expressing cells after transplants from Dlx1/ and Dlx1+/+ littermate donors (Fig. 5a–d). In adult brains (2–6 months old), approximately 75% of GFP-expressing cells were immunoreactive for GABA for both Dlx1+/+ and Dlx1/ transplants. Parvalbumin-expressing cells represented nearly half of GFP+ cells from both donors. In contrast, somatostatin-expressing neurons were reduced by about one-third and NPY-expressing cells were reduced B60% in grafted cells from Dlx1/ transplants, as compared with Dlx1+/+ transplants (Dlx1/: somatostatin, 23.88 7 2.32%; NPY, 3.2 7 0.3%; Dlx1+/+: somatostatin, 37.45 7 2.9%, P ¼ 0.01; NPY: 8.2 7 0.6%, P ¼ 0.005; Fig. 5d). Brains analyzed 2–3 weeks after transplantations did not show significant differences (data
1062
Figure 4 The reduction of GABAergic neurons in Dlx1/ mice is due to apoptotic cell death. (a–f) Confocal immunofluorescence images of antiNeuN and anti-GABA staining in CA1 of 1-month-old Dlx1/ and wild-type littermates. Arrows in c,f indicate double-positive cells. (g) Total number of NeuN+ cells and total number of GABA+ cells in stratum oriens (so) is lower in Dlx1/ mice (NeuN: 16.56 7 1.16; GABA: 15.11 7 1.02) than in controls (NeuN: 23.33 7 1.52, P o 0.01; GABA: 22.67 7 1.62, P o 0.01). (h) Percentage of GABA/NeuN+ cells in Dlx1/ mice did not change compared with controls (mutant: 92.23 7 4.8%; control: 97.94 7 5.3%; P ¼ 0.38). (i–k) Double fluorescence–labeled interneurons shown by TUNEL or with anti-active caspase-3 immunohistochemistry combined with anti-NeuN and anti-NPY staining from 1-month-old Dlx1/ mice. i–n correspond to stratum radiatum of hippocampus; o–q correspond to neocortex. (r,s) Number of TUNEL+ and active caspase-3+ profiles in neocortex from 1-month-old Dlx1/ and wild-type littermates. Values are normalized to wild-type. Student’s t-test shows a significant increase in apoptotic figures in Dlx1/ mice compared with controls (TUNEL: 4.74 7 0.34, P o 0.001; caspase-3: 3.74 7 0.43, P o 0.001). Abbreviations: so, stratum oriens, sp, stratum pyramidale. Scale bars: 50 mm (a–f); 10 mm (i–q).
not shown). These data are consistent with a cell-autonomous defect of somatostatin+/NPY+ interneurons that affects their survival. To further characterize deficits in transplanted somatostatin+/NPY+ interneurons, we analyzed the morphology of bitufted cells (somatostatin+) at early stages after transplantation (10 d), when the number of interneurons was unaffected. Dendritic arborization of grafted bitufted cells was apparent in relatively isolated interneurons in neocortex (Fig. 5e–j). Quantification of dendrite morphology showed that mutant bitufted cells have poorly differentiated dendrites. Notably, total interneuron branch length was reduced B45% and total number of branches was reduced B40% in mutant bitufted cells compared with wild-type donors (Dlx1/: total interneuron branch length, 282.07 7 17 mm; number of branches: 8.68 7 0.57; Dlx1+/+: total interneuron branch length, 510.13 7 24.36 mm, P o 0.001; number of branches, 14 7 0.74, P o 0.001; Fig. 5k–n). In adult brains (2–6 months), few cells with clear bitufted morphology were observed in grafts from Dlx1/ donors. In contrast, Dlx1/ donor cells differentiated, like wild-type donors, into basket and chandelier cells, both of which are parvalbumin+ (Fig. 5o–q). Taken together, these data are consistent with a cell-autonomous role of Dlx1 in controlling dendritic maturation and survival of subsets of cortical interneurons. Reduction of GABA-mediated synaptic inhibition in Dlx1/ To determine whether fewer GABA-producing neurons and/or interneurons with poorly differentiated dendrites would result in a functional change, we compared whole-cell inhibitory postsynaptic currents (IPSCs) from Dlx1/ and wild-type littermates. We first compared the kinetic properties of spontaneous and miniature IPSCs (sIPSCs and mIPSCs) recorded from neocortical layer II/III and hippocampal CA3 pyramidal neurons and found that 10 mM bicuculline abolished IPSCs (n ¼ 30), confirming the involvement of GABAA receptors. Recordings were made at a holding potential of 0 mV (the reversal potential for glutamate-mediated currents) in artificial cerebrospinal fluid (ACSF) containing glutamate receptor antagonists34 (20 mM CNQX or DNQX plus 50 mM AP5). Spontaneous IPSC analysis showed significant reductions in frequency and amplitude in 2-monthold mutants. Average sIPSC frequency was reduced in neocortical (B50%; n ¼ 37) and CA3 pyramidal cells (B60%; n ¼ 21) when compared with controls (n ¼ 16, 21); amplitude was reduced to B70% of control for neocortical (and B65% of control for CA3) pyramidal cells (Fig. 6 and Supplementary Fig. 6). To further characterize the
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
–/–
b
–/–
d
GFP+NPY
c
–/–
Dlx1+/+ graft Dlx1–/– graft
1.0 0.8 0.6 0.4
* 0.2
*
0 G ab
a P SO V M N PY
a
GFP+SOM
Percentage co-labeled cells
GFP+PV
E14.5 + 10 d
f
g
k
l 600
+/+
500 400
*
300 200 100
Number of branches
e
Total dendritic length
Figure 5 Cell transplantation experiments show a cell-autonomous role for Dlx1 in controlling maturation and survival of subsets of cortical interneurons. (a–c) Neocortical interneurons differentiated from GFPexpressing Dlx1/ precursors, as shown by double immunofluorescence with either anti-PV, anti-SOM or anti-NPY along with anti-GFP antibodies. (d) Percentage of double-labeled cells (GFP+GABA, GFP+PV, GFP+SOM, GFP+NPY) in neocortex of 2- to 6-month-old mice grafted with Dlx1+/+ (white) and Dlx1/ (black) cells. (e–j) Morphology of bitufted interneurons in neocortex of early postnatal animals with grafts from control (e–g) and mutant (h–j) cells, as shown by anti-GFP immunohistochemistry. (k–n) Quantification of dendrite branching of bitufted interneurons differentiated from Dlx1+/+ (white) and Dlx1/ (black) grafts. (o–q) Morphology of grafted neocortical interneurons in 2-month-old mice, as shown by anti-GFP immunohistochemistry: basket cell (o) and chandelier cell (p) differentiated from mutant interneuron precursors (inset: highermagnification image of area in box; note typical vertical axons of these cells (arrows)); bitufted cell (q) differentiated from wild-type graft. Scale bars: 50 mm (a–c; e–j); 100 mm (o–q).
0
Behavioral and histological signs of epilepsy in Dlx1/ Interneuron loss and reduction in synaptic inhibition may contribute to a hyperexcitable and epileptic phenotype35. Loss of NPY-containing and somatostatin-containing interneurons could lead to further functional deficit as these neuropeptides exert endogenous antiepileptic properties36. Therefore, we observed Dlx1/ mice for seizure activity. Seizures were reliably induced in animals over 2 months of age by mild stressors, such as noise or handling (n ¼ 25). To assess the severity of seizures, we exposed 19 mutants to noise and handling (30 s) and scored behavioral seizure activity on a five-stage scale, as described previously37. Fourteen mice (73.7%) showed seizure-like behavior; four showed stage III seizures, three stage IV, and seven stage V. Two of these seven mice (10.5%) died following a generalized tonicclonic seizure. Seizures are often associated with specific changes in immediateearly gene expression35. To determine whether similar changes occur in
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
h
i
j
m
–/–
15 12 9
*
6 3 0
n 120
40 Longest dendrite
reduction in GABA-mediated synaptic inhibition, tetrodotoxin (1 mM) was added to the ACSF to isolate mIPSCs. Significant decreases in mIPSC frequency were observed in 1-month-old Dlx1 mutants, in neocortical (B60%) and CA3 pyramidal neurons (B70%). In 2month-old mutants, mIPSC frequencies in both cell types were reduced by B50% (Fig. 6d,f and Supplementary Fig. 6). Cumulative probability plots and Kolmogorov-Smirnov statistical analysis further confirmed reductions in IPSC amplitude or frequency (Fig. 6c–j). Histograms of sIPSC amplitudes for all cells showed a shift to smallamplitude events in Dlx1/ mice (Fig. 6h,j). Finally, to assess selective defects in interneurons that potentially innervate dendrites of excitatory neurons (that is, somatostatin+ interneurons5,29) we analyzed the kinetics of individual mIPSCs. Reductions in the relative number of slow-decay, small-amplitude IPSC events, characteristic of dendriteinnervating interneurons, were not detected (Supplementary Fig. 7). On the other hand, no significant changes in sIPSC decay time constant or 10–90% rise time were noted, suggesting that GABA receptor or transporter function is not altered in these mice (Supplementary Table 1). Consistent with this, analysis of evoked GABAmediated inhibitory postsynaptic currents (eIPSC) showed no differences in amplitude, 10–90% rise time or decay time constant between mutant and control neurons (n ¼ 20; data not shown). Thus, decreased IPSC frequency with no change in eIPSCs suggests a reduction in inhibitory synaptic input in neocortex and hippocampus of Dlx1/ mice; this is consistent with histological observations of a reduction in the number of GABAergic interneurons.
Average dendritic length
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
30 20 10 0
100 80
*
60 40 20 0
E14.5 + 2 months
o
–/–
p
q
+/+
–/–
Dlx1/ mice, four animals that had stress-induced tonic-clonic stage V seizures were killed 90 min after one episode and were immunoassayed for expression of c-Fos, a calcium-dependent immediate-early gene product. Consistent with seizure activity, c-Fos expression in the hippocampus was elevated in pyramidal cells of CA1 and CA3 and was most intense in dentate granule cells (Fig. 7a–c). Epilepsy is often associated with complex seizure-induced histological changes in cerebral cortex and hippocampus (for example, neuronal death; increased levels of Gad, somatostatin and NPY in interneurons; ectopic expression of NPY in projecting neurons and axonal sprouting)35,36. Many of these histological changes were detected in Dlx1 mutants that were at least 2 months old (Fig. 7d– h). We found increased NPY immunoreactivity in hippocampus, neocortex, piriform cortex and amygdala (Fig. 7d,e). Notably, in hippocampus, ectopic NPY immunoreactivity was detected in mossy fibers of dentate granule cells (DGC; Fig. 7g,h). This was observed in 10 out of 12 mutants, both in animals with and without observed seizures. Ectopic NPY immunoreactivity was also detected in the inner molecular layer of the dentate gyrus in two of these mutants (Fig. 7h). This ectopic NPY expression corresponded to sprouting of mossy fibers, as shown by their labeling with Timm’s staining (Fig. 7i,j). Neither ectopic
1063
ARTICLES
a
+/+
Cortical pyramidal cell –/–
b
–/–
1s
sIPSC
sIPSC
1s
CA3 pyramidal cell +/+
mIPSC
mIPSC
20 pA 100 ms
20 pA 100 ms
20 pA 100 ms
*
Bin size = 100 0
0
1
2
3
4
5
1
2
2
*
1 0
3
0.6 0.4 0.2 0
sIPSC amp. (pA)
1.0 0.8
0
30
60
20
*
10 0
90 120 150
0.8 0.6 0.4 0.2 0
0.8 0.6
4 5 0 1 Inter-event interval (s)
h Number of events
g
0
4
1.0
1.0
4
2
3
0
4
i 300 250 200 150 100 50 0
0.4 0.2
*
2
0
5
0
10
20
30
0 40 50 0 30 Amplitude (pA)
0
3 2 1 0
*
1
2
3
4
5
10
20
30
40
50
j
1.0 0.8 0.6 0.4 0.2
mIPSC
mIPSC freq. (Hz)
2
f sIPSC
sIPSC amp. (pA)
4
1.0 0.8 0.6 0.4 0.2 0
mIPSC freq. (Hz)
1.0 0.8 0.6 0.4 0.2 0
e
+/+ –/–
mIPSC
sIPSC freq. (Hz)
d sIPSC
sIPSC freq. (Hz)
Cumulative probability
c
Cumulative probability
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
20 pA 100 ms
60
20 10
*
0
90 120 150
NPY immunoreactivity in DGC mossy fibers nor mossy fiber sprouting was detected in 1-month-old Dlx1 mutants (n ¼ 6), consistent with the absence of seizures at this age. Cortical dysrhythmia and epilepsy in Dlx1/ Because these histological, electrophysiological and behavioral studies are consistent with a hypothesis that aged Dlx1/ mice may develop a spontaneous epileptic phenotype, we monitored four animals (6–10 months old) using a video electroencephalogram (EEG) system. Background cortical activity recorded in Dlx1/ mice showed an approximately twofold increase in theta rhythm amplitudes during exploratory activity compared with wild-type littermates (Fig. 8a,b). These rhythms, shaped by inhibitory interneuron firing patterns in response to novel environments, are a normal feature of hippocampal function in the behaving rodent; however, they are weakly expressed in neocortex38. A second abnormality was the occurrence of generalized interictal synchronous discharges at rates from 0.5 to 20 min1 (not shown).
300 250 200 150 100 50 0
0
Figure 6 GABAergic synaptic inhibition is decreased in neocortex and hippocampus of Dlx1/ mice. Recordings obtained in ACSF containing DNQX and AP5. (a, b) Representative traces of sIPSCs and mIPSCs from cortical layer II/III and CA3 pyramidal cells of 2-month-old Dlx1+/+ and Dlx1/ mice. (c–f) Cumulative probability plots of sIPSCs and mIPSCs interevent intervals from neocortical and CA3 pyramidal cells show lower IPSC frequencies for Dlx1/ mice (Dlx1/, red; Dlx1+/+; black; Kolmogorov-Smirnov test, P o 0.001). Average sIPSC and mIPSC frequencies (inset) were lower in neocortical and CA3 pyramidal neurons from Dlx1/ mice (sIPSC: neocortex, 1.2 7 0.3 Hz; CA3, 1.5 7 0.2 Hz; mIPSC: neocortex, 1.1 7 0.1 Hz; CA3, 1.3 7 0.2 Hz) than in controls (sIPSC neocortex, 3.2 7 0.4 Hz; CA3; 4.2 7 0.7 Hz; mIPSC neocortex: 2.4 7 0.2 Hz; CA3, 2.9 7 0.2 Hz). (g,i) Cumulative probability plots of sIPSC amplitude from neocortical and CA3 pyramidal cells show lower IPSC amplitudes for mutants (Dlx1/, red; Dlx1+/+, black; Kolmogorov-Smirnov test, P o 0.001). Average sIPSC amplitude (inset) was lower in mutants (neocortex, 12.8 7 1.4 pA; CA3, 11.3 7 1.4 pA) than in controls (neocortex, 20 7 0.6 pA; CA3; 21 7 0.6 pA). (h,j) Distribution of sIPSC amplitudes from neocortical and CA3 pyramidal cells. Dlx1+/+: black (n ¼ 5); Dlx1/: red (n ¼ 5). Error bars: s.e.m. *P o 0.01; ANOVA.
Two distinct spontaneous seizure types were repeatedly observed during monitoring of Dlx1/ mice. The first was characterized by a rapid onset of generalized spike and slow spike-wave discharges, gradually increasing in frequency until the abrupt termination of the ictal event, typically lasting 20–40 s (Fig. 8c). This type of seizure showed no associated behavioral component, and the mutants consistently showed normal exploratory behaviors throughout the synchronous activity. The early stage of the second seizure type resembled the first but then progressed to higher spike discharge frequencies, at which point the EEG seizures were accompanied by sustained behavioral arrest, myoclonic movements and Straub tail. These seizures lacked any tonic posturing and the mouse rapidly resumed normal behavior. Notably, no thalamocortical spike-wave absence seizures were observed in Dlx1/ mice. These seizures
c-Fos
NPY
Handled +/+
a Figure 7 Dlx1/ mice have histological changes associated with seizures. (a–c) c-Fos immunoreactivity in hippocampus of a 4-month-old wild-type mouse (a), a Dlx1/ mouse analyzed 90 min after a stress-induced epileptic episode (b) and an unhandled Dlx1/ mouse (c). Granule cells from the mutant mouse with induced seizure show strong c-Fos expression. (d–h) NPY immunoreactivity in 4-month-old wild-type mice (d,f) and Dlx1/ mice with recurrent seizures (e,g,h). In hippocampus of Dlx1/ mice, NPY is ectopically expressed by mossy fibers (arrowheads in g and h). A subset of mutants show ectopic NPY expression in the inner molecular layer (iml) of dentate gyrus (DG) (arrows in h). (i,j) High magnifications of dentate gyrus from the brains shown in g and h, respectively, stained with Timm’s method (black) and counterstained with cresyl violet. Timm’s labeling in the iml (j) demonstrates mossy fiber sprouting. A, amygdala; Cx, cortex; gc, granule cells; iml, inner molecular layer; mf, mossy fibers; PiCx, piriform cortex. Scale bars: 250 mm (a–c; f–h); 500 mm (d,e); 50 mm (i,j).
1064
Cx
+/+
d
–/–
e
Handled –/–
b
f
+/+
h
–/–
–/–
g
Unhandled –/–
c
VOLUME 8
[
NUMBER 8
i
[
Timm –/–
j
–/–
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
a
b
Dlx1–/–
Dlx1+/+
F1 F2 P1 P2 T1 200 µV
T2
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
O1 2s
O2
c
Figure 8 Dlx1/ mice show cortical dysrhythmia and generalized electroencephalographic seizures. Traces from bilateral cortical electrodes (left hemisphere ¼ ‘1’, right hemisphere ¼ ‘2’) positioned over frontal (F), parietal (P), temporal (T) and occipital (O) regions. (a,b) EEG of freely moving adult Dlx1/ mice. Enhanced cortical theta rhythmicity during exploratory movement (black horizontal line) that terminates immediately upon arrest of movement (a). Absence of high amplitude theta rhythms in freely moving Dlx1+/+ mouse (b). (c) Spontaneous generalized spike and slow spike-wave seizure discharge in adult Dlx1/ mouse. The mouse showed normal exploratory behavior throughout the seizure episode. Lower tracing begins after a 10-s interval of continuous seizure activity.
Dlx1–/–
are believed to reflect altered inhibitory signaling from the thalamic nucleus reticularis, the histology of which appears normal in Dlx1/ mice. DISCUSSION We demonstrate that the Dlx1 transcription factor is preferentially expressed in distinct interneuron subtypes, including the somatostatin+ and calretinin+ subtypes. By analyzing Dlx1/ mice, we show that Dlx1 is required for regulating the functional longevity of these interneurons. Dlx1/ mice demonstrate an age-dependent reduction of somatostatin+ and calretinin+ interneurons in neocortex and hippocampus. This interneuron loss is attributable at least in part to apoptotic cell death. Furthermore, using a cell transplantation assay, we demonstrate cell-autonomous functions of Dlx1 in the control of interneuron maturation and survival. Finally, we show that the decrease in interneuron number is associated with decreased synaptic inhibition in neocortex and hippocampus and cortical dysrhythmia. Dlx1/ mice develop behavioral, histological and electrographic signs of epilepsy. Dlx1 expression is maintained in subsets of interneurons Although Dlx1 is expressed by distinct subpopulations of mature GABAergic interneurons, we suggest that all mouse cortical interneuron subtypes originate from Dlx+ precursors and that subsets of their derivatives maintain Dlx1 expression, on the basis of the following lines of evidence. First, the expression of Dlx genes coincides with that of Gad during forebrain development23,27,33. Second, b-galactosidase expression from a Dlx5/Dlx6 enhancer is present in virtually all interneurons migrating from the MGE to cortex, and this expression persists after lacZ mRNA expression wanes in virtually all mature cortical interneurons27. Third, newborn Dlx1/Dlx2/ mice lack the majority of cortical interneurons, including somatostatin+ and NPY+ subtypes17,23. Because these mutants die at P0, one cannot assess their in vivo expression of parvalbumin and calretinin in interneurons, which begins postnatally. However, primary
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
culture experiments from Dlx1/Dlx2/ cortices demonstrate that parvalbumin interneurons are reduced and calretinin interneurons are absent in Dlx1/Dlx2 mutants17. There is evidence that both parvalbumin and somatostatin/NPY interneuron subtypes derive from the MGE, whereas calretinin interneurons derive from the CGE (caudal ganglionic eminence)17,39. For instance, in Nkx2.1/ mice, in which the MGE fails to form and the CGE is less affected15, parvalbumin and somatostatin+/NPY+ interneurons are absent and calretinin interneurons are present. Calretinin interneurons are absent in Dlx1/ Dlx2/ mice, in which both MGE and CGE are abnormal17. These data are consistent with a model in which parvalbumin and somatostatin+/NPY+ interneurons originate from MGE (where Nkx2.1, Lhx6 and Dlx are expressed), and calretinin interneurons originate from CGE (where neither Nkx2.1 nor Lhx6 is expressed, but Dlx is expressed). MGE-derived interneurons turn off Nkx2.1 as they migrate to cortex18. As the cortex matures, Dlx1 expression is maintained in somatostatin/NPY and calretinin cells and is downregulated in parvalbumin cells, and Lhx6 is maintained in parvalbumin cells and a subset of somatostatin cells. Dlx function in forebrain GABAergic neurons Previous studies have demonstrated that Dlx genes regulate differentiation of progenitors that produce GABAergic and dopaminergic neurons18,20–23,40. Until now, the requirement for Dlx genes in postmitotic neurons has been unknown. Here we show that Dlx1/ mice have a progressive loss of molecular markers expressed in GABAergic neurons (somatostatin, NPY, NOS, calretinin, reelin, N-PAS1). Although it is possible that reductions in Gad and other markers might be due to reduced transcription of these genes, either directly or indirectly because of loss of Dlx1 function, we suggest that this reduction is primarily due to apoptotic death of interneurons, on the basis of the following lines of evidence. First, a gain-of-function assay has shown that Dlx1 is weak in inducing Gad expression (compared with Dlx2 and Dlx5)33. Second, we found reduction of seven interneuron markers in Dlx1 mutants. In contrast to Gad, several lines of experimentation suggest that some of these markers are not regulated by Dlx genes. For instance, in the gainof-function assay, Dlx genes did not induce somatostatin or NPY expression33, and Dlx1/ Dlx2/ mutants show preserved expression of somatostatin and NPY in cells that fail to migrate to cortex (Supplementary Fig. 5). Third, using TUNEL and anti-active caspase-3 immunohistochemistry assays, we detected increased neuronal death in neocortex and hippocampus of Dlx1/ mice. Furthermore, our cell transplantation analysis demonstrates that the loss of somatostatin+/NPY+ interneurons in Dlx1/ mice reflects cellautonomous functions of Dlx1. Notably, analysis of the morphology of bitufted interneurons (somatostatin+) from Dlx1/ precursors showed defects in dendrite morphogenesis. Although at this point we do not know why interneurons die in Dlx1 mutants, dendrite morphogenesis deficits in mutant cells might result in insufficient trophic support from synaptic partners, resulting in their apoptosis.
1065
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES The relatively late onset of GABAergic deficits observed in Dlx1/ mice might be explained by redundant functions of Dlx1 with other Dlx genes. Indeed, the distribution of Dlx1, Dlx2 and Dlx5 is very similar in early postnatal cortex27,28. The subsequent downregulation of Dlx2 and Dlx5 (after the second postnatal week) in both wild-type and Dlx1 mutants temporally correlates with the onset of GABAergic deficits (Supplementary Fig. 8). On the other hand, distinct functions for individual Dlx genes have been observed21,22. For instance, Dlx2/ mice have a reduction in tyrosine hydroxylase expression in interneurons of the olfactory bulb periglomerular layer21. Although the majority of somatostatin/NPY+ and calretinin+ interneurons express Dlx1, these cell subtypes showed only a partial loss in Dlx1/ mice, suggesting the existence of molecular properties that distinguish which Dlx1+ interneurons survive in the mutants. For example, our data suggest the existence of two molecularly distinct subtypes of somatostatin+ cells, one expressing both Dlx1 and Lhx6, and the other one expressing only Dlx1. The latter was selectively reduced in Dlx1/ mice. Loss of GABAergic neurons and epilepsy in Dlx1/ Many known mutations that cause epilepsy in humans and mice reduce the efficiency of GABAergic signaling. For instance, mutations that decrease presynaptic GABA availability (Gad65 mutants) or postsynaptic GABA responses (GABARa1 or GABARb3 mutants) result in epileptic phenotypes1. Defects in development of GABAergic neurons can also be epileptogenic. For example, mice homozygous for a mutation in urokinase plasminogen activator receptor (uPAR, also known as Plaur), which encodes a regulator of hepatocyte growth factor (also known as scatter factor) function, demonstrate myoclonic seizures41. uPAR is required for the migration of GABAergic interneurons to neocortex; in uPAR/ mice, interneurons (primarily parvalbumin+) are reduced41. Finally, mutation of ARX in humans, which is also required for migration of GABAergic interneurons in rodents, causes epilepsy25. A loss of interneurons is a common pathological feature in human and experimental animal models, although it is not clear whether this loss precedes or follows the onset of seizures35,42–44. Dlx1/ mice are unique in this regard, because the interneuron loss occurs during early adulthood and precedes the onset of seizures by several weeks. In Dlx1/ mice, there are reduced numbers of cells (such as somatostatin+ interneurons) with projections primarily innervating dendrites29. A simple reduction in only these neurons and subsequent loss of exclusively dendritic input could eliminate primarily smallamplitude, slow-decay IPSCs45. However, our analysis of IPSC kinetics does not support a model in which GABAergic inhibition to dendrites is selectively reduced but rather is more consistent with a general reduction in GABA tone that affects soma and dendrites of pyramidal cells. This result could arise through the following three mechanisms: first, subsets of interneurons expressing somatostatin, NPY and calretinin are reported to make somatic and axo-axonic synapses5,46,47. Second, Dlx1, through its expression in most or all immature interneurons, may have an early role in the differentiation of parvalbumin+ somatic-innervating interneurons. Likewise, although we do not readily detect Dlx1 mRNA expression in mature parvalbumin+ interneurons, Dlx1 expression may persist and be important for their function, even if not for their survival. Finally, age-dependent deafferentation in Dlx1/ mice is likely to be associated with pre- and postsynaptic reorganization that complicates mechanistic interpretations of physiological data. Irrespective of their precise synaptic defects, Dlx1/ mice show a reduction in GABA-mediated inhibition that is consistent with the observed seizure phenotype.
1066
Notably, interneuron loss precedes the onset of seizure expression by B4 weeks, suggesting that additional mechanisms may serve a compensatory role for the initial loss of interneurons. Several mechanisms have been suggested to compensate for hyperexcitability, including increased excitatory synaptic input on surviving interneurons (increased feedback inhibition), increased expression of GABAA receptors per synapse, decreased paired-pulse depression of IPSCs in principal cells and sprouting of surviving interneurons35,44. These mechanisms might be unable to control hyperexcitation when the inhibitory synaptic input is reduced to a critical level. In addition, plastic changes associated with hyperexcitation, including changes in neurotransmitter receptors, immediate early genes, transcription factors, neurotrophic factors and axon guidance molecules, may in turn contribute to epileptogenesis and permanent alterations leading to recurrent seizure activity35,44. Investigation of the electrophysiological and molecular adaptive mechanisms involved in epileptogenesis in Dlx1/ mice will be the subject of future experiments. Besides contributing to epilepsy, loss of interneurons could also contribute to alterations in the development and function of neural systems underlying cognition, memory and affect. We observed increased amplitude of cortical theta rhythms, an indication of altered network synchronization. Shifts in these rhythms could be associated with neuropsychiatric disorders. Indeed, it has been postulated that defects in cortical inhibition underlie the etiology of autism and schizophrenia48,49. As such, Dlx1/ mice could serve as a model for poorly understood neurological disorders. METHODS Animals. Mutant mice lacking Dlx1 were generated previously in our laboratory as described22. Homozygous Dlx1 mice, maintained on a C57BL/ 6J background, were viable and had normal appearance at birth, but B90% of them were smaller than their littermates and died within the first three postnatal weeks for unknown reasons. To circumvent this early lethality the mice were crossed with the CD1 outbred strain. All Dlx1/ mice used in this study were the F2 generation of C57BL/6J CD1 crossings. On this mixed genetic background, 50% of Dlx1/ pups had weight and survival rates comparable to wild-type littermates. Pups that were 425% smaller that littermates were not studied. Wild-type littermate mice were used as controls for all experiments (histology, electrophysiology and in vivo physiology). Transgenic mice expressing green fluorescent protein (GFP) mice on a CD1 background were mated to Dlx1+/ C57BL/6J mice to generate Dlx1+/ GFP+/ animals (F1). Matings of F1 F1 mice were used to generate the Dlx1/ GFP+/ (that is, either GFP+/ or GFP+/+) and Dlx1+/ GFP+/ embryos that served as donors for transplantations. Mouse colonies were maintained at the University of California, San Francisco, in accordance with National Institutes of Health and UCSF guidelines. Histology. Mouse pups (P5–P21) and adult mice (1–6 months) were deeply anesthetized with Avertin (Sigma; 0.2 ml/10 g body weight) and perfused intracardially with 4% paraformaldehyde (PFA) in phosphate-buffered solution (PB 0.1 M, pH 7.4). The brains were removed, cut through the sagittal midline, postfixed overnight in the same fixative and cryoprotected by immersion in 30% sucrose. One hemibrain was sectioned at a thickness of 40 mm on a sliding microtome and used for free-floating immunohistochemistry. The other hemibrain was embedded in Tissue-Tek OCT compound (Sakura), cut at a thickness of 10 mm on a cryostat and mounted on Fisher Superfrost/Plus slides for in situ RNA hybridization, double in situ hybridization, immunohistochemistry staining, apoptosis assays and Timm’s staining. Details of these techniques are available online in Supplementary Methods. Cell counting methods used to compare the number of neuronal bodies stained by immunohistochemistry or in situ RNA hybridization in Dlx1/ and Dlx1+/+ littermate mice are described in detail in Supplementary Methods.
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Transplantation of interneuron precursors. Cell transplantations of interneuron precursors from GFP-expressing Dlx1/ and Dlx1+/+ embryos into wild-type neonates were performed as described previously16. Embryos aged E14.5 from Dlx1+/;GFP+/ Dlx1+/;GFP+/ crossings were used as donors. Dissections of the ventricular and subventricular zones from the anterior part of the medial ganglionic eminences (MGE) were performed. MGE cells were dissociated and transplanted into the parietal cortex of P2–P3 wild-type pups. Details of the transplantation method and analysis of the transplanted mice are available in Supplementary Methods. Dendrite analysis. Quantification of dendritic morphology was performed in GFP-expressing interneurons differentiated from Dlx1/ and Dlx1+/+ interneuron precursors grafted into wild-type neonates after 10 d of survival. We selected interneurons with bitufted morphology in layers II/III of the somatosensory cortex, because these neurons are selectively lost at later stages in Dlx1/ mice. Bitufted cells have ovoid somata and primary dendrites emerging from opposite poles; their axons produce radially oriented plexuses with some horizontal spans6. We sampled 50 interneurons whose processes could be clearly distinguished from those of other GFP+ cells and whose dendritic trees were entirely confined within the sections (100 mm thick). For dendrite quantifications of bitufted cells, the dendrites were drawn using a camera lucida. The drawings were scanned and the electronic files were exported to Image J (with the Neuron J plugin; National Institutes of Health) to trace and quantify dendritic arbors. Sampling and data analysis was performed while the investigator was blind to genotype. Total dendritic length, total number of branches (filopodia longer than 3 mm were considered dendritic branch tips), average dendritic length and length of longest dendrite were determined for each cell. To compare results between mutant and control cells, the Student’s t-test was used. P o 0.05 was considered significant. Electrophysiology. Acute brain slices were prepared from Dlx1/ and Dlx1+/+ mice (1 and 2 months old). Briefly, the mice were decapitated, and the brain was rapidly removed in ice-cold oxygenated slicing artificial CSF (sACSF) consisting of (in mM) 220 sucrose, 3 KCl, 1.25 NaH2PO4, 2 MgSO4, 26 NaHCO3, 2 CaCl2, and 10 dextrose (295–305 mOsm). Horizontal hippocampal or coronal cortical (300- mm-thick) slices were cut in 4 1C oxygenated (95% O2/5% CO2) sACSF. The slices were immediately transferred to a holding chamber where they remained submerged in oxygenated recording ACSF consisting of (in mM) 124 NaCl, 3 KCl, 1.25 NaH2PO4, 2 MgO4, 26 NaHCO3, 2 CaCl2, and 10 dextrose (295–305 mOsm). Slices were held at 37 1C for 45 min and then at B22 1C. Whole-cell voltage-clamp recordings were obtained from visually identified neurons using an infrared differential interference contrast (IR-DIC) video microscopy system. Patch electrodes (3–7 MO) were pulled from borosilicate glass capillary tubing (World Precision Instruments), coated with Sylgard (Dow Corning) and fire polished. Intracellular patch pipette solution contained (in mM) 120 Cs-gluconate, 10 HEPES, 11 EGTA, 11 CsCl2, 1 MgCl2, 1.25 QX314, 2 Na2-ATP, and 0.5 Na2-GTP, pH 7.25 (285–290 mOsm). To isolate GABAergic currents, slices were perfused with ACSF containing either 20 mM 6-ciano-7dinitroquinoxaline-2,3-dione (CNQX) or 6,7-dinitroquinoxaline-2,3-dione (DNQX), and 50 mM D-(–)-2-amino-5-phosphonovaleric acid (D-AP5). Whole-cell voltage-clamp data were low-pass filtered at 1 kHz (3 dB, eightpole Bessel), digitally sampled at 10 kHz, and monitored with pClamp software (Axon Instruments) running on a Pentium PC (Dell Computer). Whole-cell access resistance was carefully monitored throughout the recording, and cells were rejected if values changed by 425% (or exceeded 20 MO); only recordings with stable series resistance of o20 MO were used for analysis. Spontaneous IPSCs were analyzed using Mini Analysis 5.6.28 software (Synaptosoft). Each event was manually selected based on rise time, amplitude, and decay properties. Between 100 and 200 individual events were analyzed for each cell. Kinetic analysis of the IPSCs was performed with a single-exponential function. Results are presented as mean 7 s.e.m. To compare the results between different cell types, we used the Student’s t-test. Similar data were obtained using a one-way ANOVA. P o 0.05 was considered significant. Chronic electroencephalographic (EEG) recordings. Adult Dlx1/ and Dlx1+/+ littermate mice (aged 6–10 months) were implanted for chronic EEG
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
recordings. For that, mice were anesthetized with Avertin (1.25% tribromoethanol/amyl alcohol solution, intraperitoneal) using a dose of 0.02 ml/g. Tefloncoated silver wire electrodes (0.005-inch diameter) soldered to a microminiature connector were implanted bilaterally into the subdural space over frontal, central, parietal, and occipital cortices. Digital EEG activity was monitored daily for up to 2 weeks during prolonged overnight and random 2-h sample recordings (Stellate Systems, Harmonie v. 5.0b). A digital video camera was used to simultaneously monitor behavior during the EEG recording periods. All recordings were carried out at least 24 h after surgery on mice freely moving in the test cage. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS We thank R. Nicoll for physiological advice. I.C. thanks J. Palop and U. Borello for helpful discussions, M. Alvarez-Dolado for advice in cell transplantations, and the L. Mucke laboratory (Gladstone Institute of Neurological Disease, UCSF) for sharing the BioQuant Image Analysis. This work was supported by funds to J.L.R.R. (Nina Ireland, National Institute of Mental Health RO1 MH49428 and K05 MH065670), I.C. (National Alliance for Research on Schizophrenia and Depression Young Investigator Award), S.C.B. (US National Institutes of Health RO1 NS40272 and Citizens United for Research in Epilepsy) and J.L.N. (National Institute of Neurological Disorders and Stroke NS 29709 and National Institute of Child Health and Human Development HD24064, Baylor Mental Retardation and Developmental Disabilities Research Center). COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 15 March; accepted 13 June 2005 Published online at http://www.nature.com/natureneuroscience/ 1. Noebels, J.L. The biology of epilepsy genes. Annu. Rev. Neurosci. 26, 599–625 (2003). 2. Paulsen, O. & Moser, E.I. A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci. 21, 273–278 (1998). 3. Whittington, M.A. & Traub, R.D. Interneuron diversity series: inhibitory interneurons and network oscillations in vitro. Trends Neurosci. 26, 676–682 (2003). 4. Freund, T.F. Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci. 26, 489–495 (2003). 5. Markram, H. et al. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 5, 793–807 (2004). 6. Ramon y Cajal, S. Histology of the Nervous System. (Oxford University Press, New York, 1911). 7. Jones, E.G. Varieties and distribution of non-pyramidal cells in the somatic sensory cortex of the squirrel monkey. J. Comp. Neurol. 160, 205–267 (1975). 8. DeFelipe, J. Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. Cereb. Cortex 3, 273–289 (1993). 9. Kubota, Y., Hattori, R. & Yui, Y. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 649, 159–173 (1994). 10. Gonchar, Y. & Burkhalter, A. Three distinct families of GABAergic neurons in rat visual cortex. Cereb. Cortex 7, 347–358 (1997). 11. McBain, C.J. & Fisahn, A. Interneurons unbound. Nat. Rev. Neurosci. 2, 11–23 (2001). 12. Gupta, A., Wang, Y. & Markram, H. Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science 287, 273–278 (2000). 13. Klausberger, T. et al. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature 421, 844–848 (2003). 14. Lavdas, A.A., Grigoriou, M., Pachnis, V. & Parnavelas, J.G. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J. Neurosci. 19, 7881–7888 (1999). 15. Sussel, L., Marin, O., Kimura, S. & Rubenstein, J.L. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development 126, 3359–3370 (1999). 16. Wichterle, H., Garcia-Verdugo, J.M., Herrera, D.G. & Alvarez-Buylla, A. Young neurons from medial ganglionic eminence disperse in adult and embryonic brain. Nat. Neurosci. 2, 461–466 (1999). 17. Xu, Q., Cobos, I., De La Cruz, E., Rubenstein, J.L. & Anderson, S.A. Origins of cortical interneuron subtypes. J. Neurosci. 24, 2612–2622 (2004). 18. Marin, O., Anderson, S.A. & Rubenstein, J.L. Origin and molecular specification of striatal interneurons. J. Neurosci. 20, 6063–6076 (2000). 19. Letinic, K., Zoncu, R. & Rakic, P. Origin of GABAergic neurons in the human neocortex. Nature 417, 645–649 (2002). 20. Panganiban, G. & Rubenstein, J.L. Developmental functions of the Distal-less/Dlx homeobox genes. Development 129, 4371–4386 (2002).
1067
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 21. Qiu, M. et al. Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain. Genes Dev. 9, 2523–2538 (1995). 22. Qiu, M. et al. Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches. Dev. Biol. 185, 165–184 (1997). 23. Anderson, S.A., Eisenstat, D.D., Shi, L. & Rubenstein, J.L. Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science 278, 474–476 (1997). 24. Cobos, I., Broccoli, V. & Rubenstein, J.L. The vertebrate ortholog of Aristaless is regulated by Dlx genes in the developing forebrain. J. Comp. Neurol. 483, 292–303 (2005). 25. Kitamura, K. et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 32, 359–369 (2002). 26. Marty, S., Berzaghi Mda, P. & Berninger, B. Neurotrophins and activity-dependent plasticity of cortical interneurons. Trends Neurosci. 20, 198–202 (1997). 27. Stuhmer, T., Puelles, L., Ekker, M. & Rubenstein, J.L. Expression from a Dlx gene enhancer marks adult mouse cortical GABAergic neurons. Cereb. Cortex 12, 75–85 (2002). 28. Saino-Saito, S., Berlin, R. & Baker, H. Dlx-1 and Dlx-2 expression in the adult mouse brain: relationship to dopaminergic phenotypic regulation. J. Comp. Neurol. 461, 18– 30 (2003). 29. Kawaguchi, Y. & Kubota, Y. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb. Cortex 7, 476–486 (1997). 30. Alifragis, P., Liapi, A. & Parnavelas, J.G. Lhx6 regulates the migration of cortical interneurons from the ventral telencephalon but does not specify their GABA phenotype. J. Neurosci. 24, 5643–5648 (2004). 31. Alcantara, S. et al. Regional and cellular patterns of Reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 18, 7779–7799 (1998). 32. Erbel-Sieler, C. et al. Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc. Natl. Acad. Sci. USA 101, 13648– 13653 (2004). 33. Stuhmer, T., Anderson, S.A., Ekker, M. & Rubenstein, J.L. Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 129, 245–252 (2002). 34. McBain, C.J., Eaton, J.V., Brown, T. & Dingledine, R. CNQX increases spontaneous inhibitory input to CA3 pyramidal neurones in neonatal rat hippocampal slices. Brain Res. 592, 255–260 (1992).
1068
35. Morimoto, K., Fahnestock, M. & Racine, R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73, 1–60 (2004). 36. Baraban, S.C. & Tallent, M.K. Interneuron Diversity series: Interneuronal neuropeptides–endogenous regulators of neuronal excitability. Trends Neurosci. 27, 135–142 (2004). 37. Racine, R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281–294 (1972). 38. Buzsaki, G. Theta oscillations in the hippocampus. Neuron 33, 325–340 (2002). 39. Nery, S., Fishell, G. & Corbin, J.G. The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations. Nat. Neurosci. 5, 1279–1287 (2002). 40. Yun, K. et al. Modulation of the notch signaling by Mash1 and Dlx1/2 regulates sequential specification and differentiation of progenitor cell types in the subcortical telencephalon. Development 129, 5029–5040 (2002). 41. Powell, E.M. et al. Genetic disruption of cortical interneuron development causes regionand GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J. Neurosci. 23, 622–631 (2003). 42. Kobayashi, M. & Buckmaster, P.S. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J. Neurosci. 23, 2440–2452 (2003). 43. Cossart, R. et al. Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. Nat. Neurosci. 4, 52–62 (2001). 44. Cossart, R., Bernard, C. & Ben-Ari, Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci. 28, 108– 115 (2005). 45. Maccaferri, G., Roberts, J.D., Szucs, P., Cottingham, C.A. & Somogyi, P. Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitro. J. Physiol. (Lond.) 524, 91–116 (2000). 46. Gonchar, Y., Turney, S., Price, J.L. & Burkhalter, A. Axo-axonic synapses formed by somatostatin-expressing GABAergic neurons in rat and monkey visual cortex. J. Comp. Neurol. 443, 1–14 (2002). 47. Wang, Y. et al. Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat. J. Physiol. (Lond.) 561, 65–90 (2004). 48. Levitt, P., Eagleson, K.L. & Powell, E.M. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci. 27, 400–406 (2004). 49. Horike, S., Cai, S., Miyano, M., Cheng, J.F. & Kohwi-Shigematsu, T. Loss of silentchromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37, 31–40 (2005).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression Newton H Woo1, Henry K Teng2, Chia-Jen Siao2, Cristina Chiaruttini1, Petti T Pang1, Teresa A Milner3, Barbara L Hempstead2 & Bai Lu1 Pro- and mature brain-derived neurotrophic factor (BDNF) activate two distinct receptors: p75 neurotrophin receptor (p75NTR) and TrkB. Mature BDNF facilitates hippocampal synaptic potentiation through TrkB. Here we report that proBDNF, by activating p75NTR, facilitates hippocampal long-term depression (LTD). Electron microscopy showed that p75NTR localized in dendritic spines, in addition to afferent terminals, of CA1 neurons. Deletion of p75 NTR in mice selectively impaired the NMDA receptor–dependent LTD, without affecting other forms of synaptic plasticity. p75 NTR2/2 mice also showed a decrease in the expression of NR2B, an NMDA receptor subunit uniquely involved in LTD. Activation of p75NTR by proBDNF enhanced NR2B-dependent LTD and NR2B-mediated synaptic currents. These results show a crucial role for proBDNF-p75NTR signaling in LTD and its potential mechanism, and together with the finding that mature BDNF promotes synaptic potentiation, suggest a bidirectional regulation of synaptic plasticity by proBDNF and mature BDNF.
Persistent modifications of synapses, also known as long-term synaptic plasticity, are believed to be a fundamental mechanism for information storage and processing in the brain. These modifications include either strengthening or weakening of synaptic connections, respectively termed long-term potentiation (LTP) and long-term depression (LTD). An emerging concept is that synaptic plasticity is tightly controlled by neurotrophic factors, which themselves are produced and secreted in an activity-dependent manner1,2. Brain-derived neurotrophic factor (BDNF) is the best-studied neurotrophic protein that elicits diverse and profound effects on central synapses, including the regulation of hippocampal LTP3–5. Biological actions of BDNF are mediated by two separate receptors, the TrkB receptor tyrosine kinase and p75NTR. Like other neurotrophins, BDNF is first synthesized as a precursor (proBDNF), which is proteolytically cleaved to form mature BDNF (mBDNF)6–9. Mature BDNF interacts preferentially with TrkB to activate its intrinsic tyrosine kinase activity, which in turn triggers multiple intracellular signaling pathways10,11. In contrast, pro-neurotrophins bind p75NTR with high affinity12. Although p75NTR lacks intrinsic enzymatic activity, it can trigger signaling transduction through its association with adaptor proteins distinct from Trk signaling cascades10,11. The finding that pro-neurotrophins serve as signaling molecules rather than inactive precursors has brought a new dimension of complexity to neurotrophin function12–14. Indeed, a number of recent studies showed that pro-neurotrophins, by activating p75NTR, promote apoptosis in the peripheral nervous system12,15–18. This is in marked contrast to mature neurotrophins, which act to enhance neuronal
survival. As a member of the tumor necrosis factor receptor family, p75NTR encodes a type II death domain and is known to promote apoptosis, a function opposite to that of Trk receptors16,19,20. Thus, pro- and mature neurotrophins may elicit diametrically opposite cellular responses, through two distinct receptor-signaling systems. Recently, studies have shown that endogenous proBDNF is secreted from neuronal cells18,21 and accounts for a substantial proportion of total BDNF secreted extracellularly8,22,23. Although p75NTR, a receptor for pro-neurotrophins, has been thought to be involved in cell death, the relative paucity of changes in cell death in brains of mice that lack full-length p75NTR suggests that proBDNF-p75NTR interaction may mediate neuronal functions other than apoptosis24. Recently, extracellular cleavage of proBDNF has been shown to be crucial for the expression of late-phase LTP in the hippocampus25. Because a major function of BDNF in the brain is to regulate hippocampal LTP, we asked whether proBDNF, if uncleaved, modulates synaptic plasticity through p75NTR. In this study, we show that proBDNF, signaling through p75NTR, selectively facilitates NMDA receptor–dependent LTD in the mammalian hippocampus. Furthermore, we show that this enhancement of LTD by proBDNF-p75NTR is mediated through an upregulation of NR2B, an NMDA receptor subtype uniquely involved in LTD26,27. RESULTS Normal hippocampal synaptic properties in p75 NTR/ mice As an initial step toward characterizing p75 NTR/ mice, we examined basal synaptic function in hippocampal area CA1. We observed no difference in the input-output curves in p75 NTR+/+ and p75 NTR/
1Section on Neural Development and Plasticity, LCSN, NICHD, Porter Neuroscience Research Center, 35 Lincoln Drive, Bethesda, Maryland 20892-3714, USA. 2Division of
Hematology, Department of Medicine, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York 10021, USA. 3Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 411 East 69th Street, New York, New York 10021, USA. Correspondence shold be addressed to B.L. (
[email protected]). Published online 17 July 2005; doi:10.1038/nn1510
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1069
ARTICLES
p75 NTR–/– n = 32 slices, 4 mice
40 30 20 10 0
p75 NTR+/+ n = 8 slices, 200 5 mice
p75 NTR–/– n = 8 slices, 5 mice
150 100 50 0 0
50 100 150 200 250 300 Stimulus number
synapses (Fig. 1a), suggesting that the deletion of p75 NTR does not alter basal synaptic transmission. Similarly, paired-pulse facilitation at various interstimulus intervals, a commonly used method to infer changes in probability of neurotransmitter release, was virtually identical in both genotypes (Fig. 1b). We next examined the readily releasable pool of synaptic vesicles by applying a brief train of highfrequency stimulation (HFS; 100 Hz, 100 pulses) to the CA1 afferents in the presence of AP5, an NMDA receptor antagonist (50 mM). Field
160
ii
140
i
120
ii
100 i
80 60 40 20 0
0
20
p75 NTR+/+ n = 11 slices, 7 mice
160
40 60 Time (min)
80
100
120 100 80 60 40 20 0 0
20
40 Time (min)
60
80
c
p75 NTR+/+ REX antibody n = 9 slices, 4 mice
160 140 120 100 80 60 40
REX antibody 50 µg/ml
20
p75 NTR+/+
0 0
e
p75 NTR–/– n = 6 slices, 5 mice 20 µM NMDA
140
p75 NTR+/+ vehicle control n = 8 slices, 4 mice
b
ii
i
d fEPSP slope (percent of baseline)
p75 NTR–/– n = 14 slices, 10 mice
fEPSP slope (percent of baseline)
fEPSP slope (percent of baseline)
p75 NTR+/+ n = 19 slices, 11 mice
fEPSP slope (percent of baseline)
a
excitatory postsynaptic potential (fEPSP) slopes showed a continuous decline over time, indicative of a gradual depletion of docked vesicles, with no obvious differences between mutant and control slices (Fig. 1c). We also recorded synaptic responses to a prolonged train of repetitive stimulation (14 Hz, 300 pulses) in the presence of AP5 to determine the size of the reserve pool of vesicles28. Again we observed no difference between p75 NTR+/+ and p75 NTR/ slices (Fig. 1d). Thus deletion of p75 NTR does not alter basic properties of CA1 synapses.
20
40 60 Time (min)
p75 NTR+/+ n = 16 slices, 11 mice
80
ii
ii
120
i
i
100 80 60 40 20 0
0
20
40 60 Time (min)
140 120 100 80 60 40 20 0
f
160 140
160
100
p75 NTR–/– n = 15 slices, 10 mice
80
100
p75 NTR–/–
tro l
50
50 100 150 200 Interstimulus interval (ms)
p75 NTR–/– n = 5 slices, 3 mice
p75 NTR+/+ n = 5 slices, 3 mice
400
AP 5
d
p75 NTR+/+ n = 30 slices, 3 mice
0
on
0.2 0.4 0.6 0.8 1.0 Fiber volley amplitude (–mV)
C
0
Ife np ro di l R EX
0
tro l AP V
2
on
4
C
6
170 160 150 140 130 120 110 100
fEPSP slope 60 min post LFS (percent of baseline)
8
Figure 1 Intact presynaptic properties in CA1 synapses of p75 NTR/ mice. Field recordings were performed in hippocampal slices derived from p75 NTR+/+ and p75 NTR/ animals. (a) Normal input-output curves in p75 NTR/ slices. We plotted fEPSP slopes against their corresponding presynaptic fiber volley amplitude and found no difference in the distribution of values obtained from p75 NTR/ and age-matched controls. (b) Normal paired-pulse facilitation (PPF). We calculated PPF from the ratio of the second fEPSP slope to the first fEPSP and plotted it against different interstimulus intervals. There was no significant difference between p75 NTR/ and p75 NTR+/+ mice at all interstimulus intervals tested. (c) Normal synaptic responses to brief, HFS (100 Hz, 100 pulses) at p75 NTR/ synapses. Top, representative recordings of EPSP traces from p75 NTR+/+ (black) and p75 NTR/ (gray) hippocampi; bottom, summary results. (d) Normal synaptic responses to prolonged repetitive stimulation (14 Hz, 300 pulses) in p75 NTR/ mice, as compared with wild-type hippocampal slices. Time course of the effects of the stimulus trains is shown. Experiments in c and d were performed in the presence of AP5. Error bars, s.e.m.
p75 NTR–/– n = 14 slices, 8 mice
p75 NTR+/+ n = 8 slices, 4 mice
fEPSP slope (percent of baseline)
Percent paired pulse facilitation
b
fEPSP slope (percent of first pulse)
fEPSP slope (–mV/ms)
10
c 20th fEPSP slope (percent of first pulse)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
p75 NTR–/– n = 9 slices, 4 mice
p75 NTR+/+ n = 8 slices, 3 mice
a
2 × 100 Hz
350 300 250 200 150 100 50 0 0
20
40 Time (min)
60
80
Figure 2 Selective deficit for NMDA receptor–dependent LTD in p75 NTR/ mice. (a) Lack of LTD induced by LFS in p75 NTR/ synapses. LFS (1 Hz, 15 min) was applied to the Schaeffer collaterals. Sample traces are shown at indicated time points labeled ‘i’ and ‘ii’. Scale bars, 5 mV and 5 ms. (b) Blockade of LTD in p75 NTR+/+ mice by REX antibody. Hippocampal slices were incubated in REX during recovery and was also present throughout the experiment as indicated. (c) Summary bar graph depicting the lack of NMDA receptor–mediated LTD in p75 NTR/ animals. (d) Lack of LTD induced by NMDA perfusion in p75 NTR/ slices. NMDA was applied to slices, as indicated by the gray bar. (e) Intact NMDA receptor–independent LTD in p75 NTR/ slices. Paired stimulation (50 ms interval) was applied to the Schaeffer collaterals at low frequency (1 Hz, 15 min). (f) Normal LTP in p75 NTR/ slices. Two trains of HFS (100 Hz, 1 s) were applied. Error bars, s.e.m.
1070
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
a
b
p75 NTR+/+ (2 wks)
p75 NTR+/+ (8 wks)
c
p75 NTR–/–
SP
d
f
p75 NTR
g
h
Merge
i
75 kDa
e 2.0 1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0
) w ks ) 2 ex 93 p o p7 res ver 5 NT sin R g
–/
–
(3
w ks (8
+/ +
+/ +
(3
w ks
)
40 kDa
p75NTR protein levels (normalized to actin)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
SR
+/+ (3 wks) +/+ (8 wks)
*
p75 NTR/ mice lack NMDA receptor–dependent LTD To test the hypothesis that p75NTR may have an opposing role to TrkB in LTP, we monitored the induction of LTD by applying a prolonged train of low-frequency stimulation (LFS; 1 Hz, 15 min) to hippocampal slices from juvenile p75 NTR+/+ and p75 NTR/ mice (3–4 weeks old). LFS applied to the Schaeffer collaterals elicited robust LTD in slices derived from p75 NTR+/+ mice (Fig. 2a). In marked contrast, slices from aged-matched p75 NTR/ mice did not show LTD. LFS induced an initial decrease in fEPSP slopes, which subsequently recovered back to baseline (Fig. 2a). Immediately after LFS, mean fEPSP slopes were 58 ± 2% and 65 ± 4% (P 4 0.5), whereas those 60 min after LFS were 70 ± 4% and 95 ± 3% (P o 0.05) for p75 NTR+/+ and p75 NTR/ mice, respectively. To test whether p75NTR has an indispensable role in LTD under genetically unmodified conditions, hippocampal slices from p75 NTR+/+ mice were perfused with REX function-blocking antibody, a reagent known to block p75 NTR function29. In slices that were incubated in REX antibody (50 mg/ml, 2 h), LFS did not induce LTD (Fig. 2b). In both genotypes, LFS-induced LTD was completely blocked by the general antagonist of NMDA receptor, AP5, suggesting that this form of LTD depends on the NMDA receptor (Fig. 2c and Supplementary Fig. 1 online). Consistent with previous reports26,27, application of ifenprodil (10 mM), an antagonist of NR2B involved in LTD, selectively blocked this form of LTD without affecting LTP in slices prepared from p75 NTR+/+ mice (Fig. 2c and Supplementary Fig. 1). The NMDA receptor–dependent form of LTD can also be induced by bath application of NMDA. As in the case of LFS-induced LTD, LTD elicited by brief perfusion of NMDA was also impaired in juvenile p75 NTR/ mice (Fig. 2d). Application of NMDA (20 mM) for a period of 10 min induced LTD that lasted for the duration of the recording in p75 NTR+/+ slices, and this LTD was not observed
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
PSD95
Figure 3 Localization of p75NTR immunoreactivity in mouse hippocampus. (a,b) By light microscopy, we found p75NTR immunoreactivity in fine, varicose fibers that were dense near stratum pyramidale (SP) and scattered throughout stratum radiatum (SR) of the hippocampal CA1 region. The number of p75NTR-immunoreactive processes seemed greater in the hippocampi of 2-week-old than 8-week-old p75 NTR+/+ mice. (c) p75NTR immunoreactivity was absent in the hippocampi of p75 NTR/ mice. All photographs from sections labeled with the R & D antibody. Scale bar, 100 mm. (d) Western blot showing the levels for p75NTR protein. Measurements of protein levels were taken from hippocampal lysates prepared from young p75 NTR+/+ (3 weeks old), mature p75 NTR+/+ (8 weeks old) and p75 NTR/ (3 weeks old) mice. We observed an age-dependent increase in p75NTR protein levels, with young mice having higher levels than the mature mice. p75NTR protein was absent in p75 NTR/ mice. (e) Quantification of p75NTR protein levels normalized to an actin control. *P o 0.05. (f–i) Expression of p75NTR in dendrites of hippocampal cultured neurons. Punctate staining of (f) p75NTR and (g) PSD95 was observed in cultured hippocampal neurons (day 14) prepared from E16 mice and were often colocalized in the soma and dendrites (h,i). Error bars, s.e.m.
in p75 NTR/ slices (Fig. 2d). In both genotypes, complete suppression of synaptic transmission occurred shortly after NMDA application. But fEPSP slopes slowly recovered to baseline values of 96 ± 7% in p75 NTR/ slices, whereas in p75 NTR+/+ slices the response remained depressed at a mean value of 62 ± 5% (P o 0.01). Coapplication of AP5 with NMDA blocked this form of LTD (data not shown). In addition to NMDA receptor–dependent LTD, the young hippocampus expresses an NMDA receptor–independent form of LTD, which is induced by a twin-pulse LFS protocol30,31. Notably, the NMDA receptor–independent form of LTD was not altered in young juvenile p75 NTR/ mice. A 15-min train of twin pulses (50 ms apart) at 1 Hz elicited a robust and long-lasting depression in both genotypes (Fig. 2e). The mean fEPSP slope values recorded 60 min after the application of this protocol were 74 ± 4% and 72 ± 3% in wild-type and p75 NTR/ slices (P 4 0.2), respectively. In agreement with previous studies32, this twin-pulse LFS protocol induced a form of LTD that was independent of NMDA receptor activation. Perfusion of 50 mM AP5, which blocked the expression of LTD induced by 1 Hz, 15 min (Fig. 2c), did not affect the expression of LTD elicited by twinpulse LFS stimulation (Supplementary Fig. 1). Finally, we examined whether p75 NTR/ regulates NMDA receptor–dependent LTP. Application of tetanic stimulation (100 Hz, 1 s, 2 trains separated by 20 s) induced almost identical LTP in slices from p75 NTR+/+ and p75 NTR/ mice, suggesting that deletion of p75 NTR does not affect either induction or expression of LTP (Fig. 2f). Immediately after tetanus, the mean fEPSP slopes were 259 ± 17% and 283 ± 12% (P 4 0.5) in p75 NTR+/+ and p75 NTR/ mice, respectively. At 60 min after HFS, fEPSP slopes remained potentiated above baseline with mean values of 167 ± 6% and 177 ± 14% (P 4 0.5) for wild-type and p75 NTR/ mice, respectively. These results show a
1071
ARTICLES
a
Figure 4 Electron microscopic localization of p75NTR immunoreactivity in CA1 region of the p75 NTR+/+ mouse. (a) Within stratum pyramidale, we found p75NTR immunoreactivity (arrowhead) in an axon terminal that contained numerous small synaptic vesicles and abuted a pyramidal cell perikaryon (py). (b) A p75NTR-immunoreactive axon terminal with a preterminal axon was found in the neuropil of stratum radiatum. (c) An aggregate of p75NTR immunoreactivity (arrowhead) was found near the plasma membrane of a dendritic shaft (D). (d–f) Within stratum radiatum, p75NTR immunoreactivity was detected in dendritic spines that received contacts (curved arrows) from unlabeled terminals (uT). (e) p75NTR immunoreactivity was denser near the synapse. Scale bars for a–c, 500 nm. Scale bars for d–f, 250 nm.
c py
d uT
e
f uT
uT
selective role for p75NTR in one form of hippocampal synaptic plasticity: the NMDA receptor–dependent form of LTD. Expression of p75NTR in the mouse hippocampus To assess whether p75NTR could directly mediate these effects, we sought to localize p75NTR immunoreactivity in the mouse hippocampus, using an antibody that detects the extracellular domain of p75NTR. Light microscopic analysis of sections showed p75NTR immunoreactivity in very fine varicose fibers throughout the hippocampus (Fig. 3a,b), which was absent in the p75 NTR/ mouse (Fig. 3c). Within the CA1 region, p75NTR-immunoreactive fibers were concentrated near stratum pyramidale and were more evenly dispersed in strata oriens and radiatum. Side-by-side comparison showed that sections of hippocampi from young juvenile mice (postnatal day (P) 14; Fig. 3a) seemed to express greater p75NTR immunoreactivity than did older juvenile mice (P60; Fig. 3b). Similar results were obtained using an antibody against the intracellular domain of p75NTR (data not shown). Western
b
3 wks- proBDNF n = 4 slices, 3 mice
180 160 140 120 100 80 60 40 20 0
b
a
b
a
2 ng/ml proBDNF
0
10
20 30 40 Time (min)
50
60
fEPSP slope (percent of baseline)
a
3 wks- vehicle control n = 7 slices, 5 mice 160 140 120 100 80 60 40 20 0
a
3 wks- proBDNF n = 7 slices, 4 mice b
b
a
p75 NTR–/–
3 wksn = 4 slices, 3 mice a
b 2 ng/ml proBDNF 0
10 20 30 40 50 60 70 80 Time (min)
c
3 wks- vehicle control n = 5 slices, 4 mice
160 140 120 100
3 wks- proBDNF n = 8 slices, 4 mice
1 Hz, 5 min
80 60 40 20 2 ng/ml proBDNF 0 0 20 40 60 Time (min)
80
d fEPSP slope (percent of baseline)
b
blot analysis confirmed that p75NTR expression levels are inversely related to age (Fig. 3d). Quantitative analysis indicated that younger mice (P21) had significantly higher p75NTR receptor levels than did older mice (P60; Fig. 3e). These results are consistent with the observation that robust LTD is induced more readily in younger juvenile hippocampus33,34. To determine the subcellular localization of p75NTR, we performed double staining on mouse hippocampal neurons derived from embryonic day 16 (E16) wild-type mice, using antibodies against p75NTR and a dendritic spine marker PSD95. After 14 d in vitro, we observed p75NTR immunoreactivity as punctate staining around the cell body as well as dendrites (Fig. 3f), with distribution very similar to that of PSD95 immunoreactivity (Fig. 3g). The majority of p75NTR immunoreactivity was colocalized with PSD95 immunoreactivity in the dendrites of hippocampal neurons, suggesting their localization in spines (Fig. 3h,i). To firmly establish that p75NTR is localized at CA1 synapses, we performed immunoelectron microscopy in stratum radiatum of the hippocampal CA1 region. In agreement with a previous study in adult rats35, we observed p75NTR immunoreactivity in axons and axon terminals (Fig. 4a,b). Axon terminals (0.4–0.6 mm in diameter) contained numerous small synaptic vesicles and often abutted pyramidal cell perikarya (Fig. 4a). But many CA1 pyramidal neurons also expressed p75NTR immunoreactivity. We observed the immunoreactive profiles in dendritic shafts (Fig. 4c), spines (Fig. 4d–f) and glial profiles (data not shown). Within dendritic profiles, p75NTR immunoreactivity was usually aggregated near the plasma membrane, and was denser in the spine head near the synaptic specialization. Additional examples of p75NTR-labeled dendritic spines are shown in Supplementary Figure 2. Labeling of axon, terminal and spine profiles was absent in the p75 NTR/ mice. Taken together, our immunoelectron microscopy experiments raise the possibility that activation of p75NTR on the CA1
fEPSP slope (percent of baseline)
py
fEPSP slope (percent of baseline)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
D
3 wks- vehicle control n = 5 slices, 4 mice
3 wks- mBDNF n = 7 slices, 4 mice
160 140 120 100 80 60 40 200 ng/ml mBDNF 20 0 0 10 20 30 40 50 60 Time (min)
70
80
Figure 5 Enhancement of NMDA receptor–dependent LTD by proBDNF. (a) Lack of effect on basal transmission. Application of proBDNF, a ligand for p75NTR, did not induce synaptic depression. (b) Effect of proBDNF on the expression of NMDA receptor–dependent LTD. Hippocampal slices were incubated with purified, cleavage-resistant proBDNF for at least 1 h before recording. proBDNF enhanced LTD in young p75 NTR+/+ hippocampal slices as compared with vehicle control, but not in p75 NTR/ slices. (c) Pairing proBDNF with a weak LFS protocol did not induce LTD. (d) Opposing actions of mBDNF on LTD. Incubation of mBDNF inhibited the expression of LTD. Error bars, s.e.m.
1072
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
b
40 20 2 ng/ml proBDNF 0 0
10 20 30 40 50 60 70 80 Time (min)
7 wks- proBDNF n = 9 slices, 5 mice 160 140 120 100
7 wks- proBDNF + REX n = 9 slices, 4 mice
50 µg/ml REX antibody
80 60 40 2 ng/ml proBDNF 20 0 0 10 20 30 40 50 60 70 80 Time (min)
c
7 wks- proBDNF + Ifenprodil n = 5 slices, 3 mice
160 140 Ifenprodil 120 100 80 60 40 2 ng/ml proBDNF 20 0 0 10 20 30 40 50 60 70 80 Time (min)
d
7 wks- atropine n = 8 slices, 4 mice
fEPSP slope (percent of baseline)
b a
b
fEPSP slope (percent of baseline)
7 wks- proBDNF n = 11 slices, 6 mice
fEPSP slope (percent of baseline)
fEPSP slope (percent of baseline)
7 wks- vehicle control n = 6 slices, 3 mice 160 b 140 a 120 100 a 80 60
7 wks- proBDNF + atropine n = 7 slices, 4 mice
160 140 Atropine 120 100 80 60 40 2 ng/ml proBDNF 20 0 0 10 20 30 40 50 60 70 80 Time (min)
Figure 6 Enhancement of hippocampal LTD by proBNDF is mediated by p75NTR and NR2B. (a) Pronounced enhancement of LTD by proBDNF in mature mice (7–8 weeks old). Hippocampal slices derived from older mice that normally expressed attenuated levels of LTD showed robust LTD in the presence of proBDNF. (b,c) Inhibition of proBDNF-mediated enhancement of LTD by blocking p75NTR or NR2B function. (b) Incubation of hippocampal slices in REX (50 mg/ml) blocked the effects of proBDNF. (c) Ifenprodil blocked the enhancement of LTD normally observed with proBDNF. (d) Facilitation of LTD by proBDNF is not dependent on the cholinergic system. Atropine (5 mM) did not affect LTD or the enhancement of LTD by proBDNF. Error bars, s.e.m.
pyramidal-cell dendrites or their afferents contributes to the expression of NMDA receptor–dependent LTD. Facilitation of NMDA receptor–dependent LTD by proBDNF Because proBDNF is a high-affinity ligand for p75NTR that can be secreted from hippocampal neurons22, we tested whether activation of p75NTR by proBDNF regulates NMDA-dependent LTD. Perfusion of a cleavage-resistant form of proBDNF (2 ng/ml) to hippocampal slices had no effect on basal synaptic transmission recorded over an extended period of time (Fig. 5a). Next, we treated the hippocampal slices from p75 NTR+/+ mice with proBDNF for more than 1 h before inducing LTD. In young juvenile slices that already showed pronounced LTD, treatment with proBDNF, but not vehicle, resulted in a small but notable increase in LTD (Fig. 5b). The mean values of fEPSP slopes 60 min after the application of LFS for vehicle- and proBDNF- treated slices were 70 ± 7%, and 56 ± 3%, respectively. Moreover, application of proBDNF to slices from p75 NTR/ mice elicited little effect, suggesting that proBDNF facilitated LTD through activation of p75NTR (Fig. 5b; fEPSP slope at 60 min after LFS, 96 ± 8%). Application of proBDNFcontaining perfusates collected at the end of several hippocampal slice experiments, but not control perfusates, to cultured neuromuscular
b
p75 NTR1
160 140 120
Ifenprodil
100 80 60 40
AP5
20 0 0
5
10 15 Time (min)
20
p75 NTR+/+ n=4
25
synapses resulted in a marked reduction in synaptic transmission. This suggests that proBDNF in the slice-recording chamber remains intact and biologically active for many hours (data not shown). To determine whether proBDNF reduced the threshold of LTD induction, we stimulated hippocampal slices using a weaker stimulation protocol (1 Hz, 5 min) in the presence of proBDNF. This protocol did not induce LTD in vehicle-treated slices, and treatment with proBDNF had little effect (Fig. 5c; fEPSP slope at 60 min in control and proBDNFtreated slices were 100 ± 13% and 90 ± 5%, respectively). In contrast to proBDNF, incubation of hippocampal slices with mBDNF attenuated LTD expression (Fig. 5d). This is consistent with a previous study that examined the modulation of hippocampal LTD by mBDNF36. In older juvenile slices in which LTD is attenuated, incubation of slices in proBDNF elicited a stronger facilitatory effect on LTD than it did in young juvenile slices (Fig. 6a). The mean values of fEPSPs 60 min after LFS were 94 ± 7% and 71 ± 2% for slices that received vehicle control and those that received proBDNF, respectively. Moreover, pretreatment with the p75NTR-blocking REX antibody completely prevented the effect of proBDNF on LFS-induced LTD (Fig. 6b), indicating the effect of proBDNF is mediated by p75NTR. In slices treated with proBDNF and the NR2B antagonist ifenprodil
c
p75 NTR–/– n=4
160 140 120 100 80 60 40 20 0
Percent normalized NMDAmediated EPSC
p75 NTR+/+
Percent normalized NMDAmediated EPSC
a Percent normalized NMDAmediated EPSC
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
a
Ifenprodil
0
5
10
15 20 Time (min)
25
30
p75 NTR+/+ proBDNF, n=5
p75 NTR+/+ ifenprodil/proBDNF, n=4
200 180 160 140 120 100 80 proBDNF 60 40 20 Ifenprodil 0 0 5 10
15 20 Time (min)
p75 NTR–/– proBDNF, n = 3
25
30
Figure 7 Relationship between p75NTR and NR2B at hippocampal CA1 synapse. (a) Reduced expression of NR2B-mediated synaptic currents in p75 NTR/ mice. Evoked whole-cell responses were recorded from CA1 pyramidal neurons in the presence of AHPA receptor antagonist DNQX and GABA receptor antagonist bicuculline. Application of ifenprodil selectively decreased NMDA-mediated synaptic currents recorded from p75 NTR+/+ but not in p75 NTR/ hippocampal slices. Arrowheads indicate timepoints of sample NMDA-mediated current traces during baseline (black), after ifenprodil application (red) and after final AP5 application (green), which verified that evoked synaptic currents were mediated by NMDA receptors. (b) Summary plot depicting the sensitivity of NMDA currents to ifenprodil is dependent on p75NTR. Normalized averaged traces depicted a slower decay rate of NMDA receptor–mediated EPSC in p75 NTR+/+ than p75 NTR/ mice. (c) Recruitment of NR2B by proBDNF-p75NTR. Application of proBDNF rapidly enhanced NMDA receptor–mediated currents in slices derived from p75 NTR+/+ but not in p75 NTR/ animals. In the presence of ifenprodil, the potentiation of NMDA receptor currents by proBDNF was inhibited. Scale bars, 50 pA and 40 ms. Error bars, s.e.m.
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
1073
ARTICLES
a
NR2B
b
NR2A
180 kDa
c
1
*
+ +/ TR
) 5N (8 TR+ w /+ p7 ks) 5N (3 TR– w /– ks )
p7
N
ks w
5
(3
p7
d 1.6
0.6
0.4
NR2A protein levels (normalized to actin)
0.8 1.2
0.8
0.4
0
0
p7
p7
5N (3 TR+ w /+ p7 ks 5N ) (8 TR+ w /+ p7 ks 5N ) (3 TR– w /– ks )
0.2
5N (3 TR w +/+ p7 ks) 5N (8 TR+ w /+ p7 ks) 5N T (3 R– w /– ks )
NR2B protein levels (normalized to actin)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
p7
5N (3 TR+ w /+ k p7 s) 5N (8 TR+ w /+ k p7 s) 5N (3 TR– w /– ks )
40 kDa
(10 mM), LFS no longer induced LTD (Fig. 6c), suggesting that proBDNF regulates NR2B-mediated LTD. Because a previous report showed that application of carbachol facilitates LTD37, we tested whether proBDNF enhances LTD by regulating cholinergic inputs to the hippocampus. In the presence of the muscuranic receptor antagonist atropine (5 mM), proBDNF still facilitated LTD (Fig. 6d). Thus, it is less likely that proBDNF enhanced LTD by regulating cholinergic inputs. Finally, proBDNF selectively regulated LTD without affecting LTP. When hippocampal slices were incubated with proBDNF and subsequently subjected to two trains of HFS, LTP was readily induced and was not different from slices that were only incubated with the vehicle control (Supplementary Fig. 3). In addition, proBDNF also had no effect on late-phase LTP, induced either with long theta burst stimulation (Supplementary Fig. 3) or four trains of tetanic stimulation (4 100 Hz, 1 s; data not shown). These results suggest that the proBDNF selectively facilitates hippocampal LTD through the activation of p75NTR. Regulation of NR2B expression by proBDNF-p75NTR An emerging concept in the field of hippocampal plasticity is that LTP and LTD are differentially controlled by two different subtypes of NMDA receptors: NR2A and NR2B, respectively26,27. Given that the NMDA-dependent LTD, but not LTP, was selectively impaired in the p75 NTR/ mice, we tested whether proBDNF-p75NTR regulated specific subtypes of NMDA receptors by performing whole-cell voltageclamp recordings of CA1 pyramidal neurons. Resting membrane potential and input resistance of CA1 neurons were not different between p75 NTR/ and p75 NTR+/+ mice (data not shown). We stimulated Schaffer collaterals in the presence of AMPA and GABA receptor antagonists to induce synaptic NMDA currents. We observed a marked difference in the subunit composition of NMDA receptors between the two genotypes. Application of ifenprodil at a concentration that blocked LTD expression reduced isolated synaptic NMDA currents by more than 50% in slices derived from p75 NTR+/+ young juvenile mice (Fig. 7a,b). In contrast, application of ifenprodil had little or no effect on synaptic NMDA currents in age-matched p75 NTR/ slices (Fig. 7a,b). When we applied a high concentration of AP5, a
1074
Figure 8 Attenuated levels of NR2B expression in p75 NTR/ mice. (a,b) Western blot showing the levels for NR2B and NR2A protein. NR2B levels were substantially higher in hippocampal tissues taken from young animals than in older animals. Furthermore, NR2B probed in young p75 NTR/ tissue samples showed significantly lower levels (P o 0.05). (c,d) Quantification of protein levels of NR2B and NR2A normalized to an actin control. Error bars, s.e.m.
general antagonist for all subtypes of NMDA receptors, the NMDAmediated excitatory postsynaptic currents (EPSCs) were eliminated in both p75 NTR+/+ and p75 NTR/ slices (Fig. 7a). Thus, although the NR2B-containing NMDA receptor accounts for a substantial proportion of total NMDA channels at the p75 NTR+/+ CA1 synapses, which is made evident by the ifenprodil sensitivity and by the slower decay rate of the NMDA receptor–mediated EPSC (Fig. 7b), p75 NTR/ mice primarily express NMDA receptors that contain subunits other than NR2B. To investigate whether proBDNF directly regulates NR2B-mediated synaptic currents, we applied proBDNF to hippocampal slices. Such application markedly potentiated the NMDA currents at the CA1 synapses (Fig. 7c). The mean amplitude of the NMDA current after proBDNF treatment was 147 ± 12% when normalized to the baseline. In two extended recordings, the amplitude of the NMDA currents returned to near baseline levels after application of ifenprodil (data not shown). When the slices were pretreated with ifenprodil, application of proBDNF no longer potentiated the NMDA currents (Fig. 7c). Similarly, proBDNF did not enhance NMDA currents when applied to slices derived from p75 NTR/ mice. These results suggest that proBDNF through p75NTR selectively potentiates the NR2B component of the NMDA currents. We next examined the changes in the expression of NMDA receptor subtypes by immunohistochemistry and western blot analysis. Immunostaining showed that in the CA1 area, the NR2B staining of soma and apical dendrites seemed to be reduced in sections derived from young juvenile p75 NTR/ mice as compared with slices from p75 NTR+/+ mice of the same age (Supplementary Fig. 4). Older juvenile p75 NTR+/+ mice also seemed to show lower levels of NR2B immunoreactivity (Supplementary Fig. 4). Western blots confirmed this developmental decrease of NR2B, paralleling the developmental decrease in LTD expression (Fig. 8a). As a comparison, we also probed NR2A expression and observed that it was higher in younger juvenile (3-week-old) than in older juvenile (8-week-old) mice (Fig. 8b). Quantitative analysis showed the level of NR2B in p75 NTR/ hippocampus was significantly lower than that in wild-type hippocampus (Fig. 8c). But there was no difference in the level of NR2A protein between p75 NTR+/+ and p75 NTR/ mice (Fig. 8d; P 4 0.5). These results suggest that p75NTR mutation selectively alters the expression of NR2B-containing NMDA receptors in hippocampal CA1. DISCUSSION Recent studies suggest that pro-neurotrophins serve as signaling molecules rather than inactive precursors. Several studies have indicated that proBDNF, rather than mBDNF, is the major form secreted from CNS neurons8,22,23. But whether proBDNF has any biological function in synaptic plasticity remains unknown. The fact that p75 NTR/ mice have impairments in several learning and memory tasks38,39 and findings in a recent study showing a lack of LTD40 suggest that proBDNF may have a role in hippocampal synaptic plasticity. Here we provide evidence that proBDNF, signaling through p75NTR, is important for NMDA receptor–dependent LTD in the hippocampus.
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES Our electrophysiology experiments showed that deletion of p75 NTR in mice selectively impaired the NMDA receptor–dependent form of LTD, without affecting other forms of synaptic plasticity tested. As p75NTR is known to interact with Nogo66, myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, pro–nerve growth factor (proNGF) and proBDNF41, it is important to identify the endogenous ligand that activates p75NTR under physiological conditions. Here, application of the p75NTR-blocking antibody REX virtually abolished LTD in wild-type mice, probably by inhibiting the interaction between endogenous proBDNF with p75NTR. Moreover, application of proBDNF to hippocampal slices enhanced LTD. Such potentiating effects were absent in p75 NTR/ mice, and were prevented by the REX antibody. Thus, we have identified proBDNF as an endogenous ligand that activates p75NTR to promote LTD. Growing evidence now supports the notion that LTP and LTD in the hippocampus are mediated by the NR2A and NR2B subunits of NMDA receptor, respectively26,27. We have shown that deletion of p75NTR selectively impaired, and proBDNF selectively enhanced, the NMDA receptor–dependent form of LTD. Neither p75NTR mutation nor proBDNF affected the NMDA receptor–dependent LTP. In parallel, the p75 NTR/ mice showed not only a selective decrease in NR2B (but not NR2A) expression in the hippocampus, but also a marked reduction in NR2B-mediated currents at the CA1 synapse. Notably, application of proBDNF potentiated the NR2B-mediated currents at CA1 synapses, suggesting that activation of p75NTR by proBDNF increased NR2B at the synapses. The enhancement of LTD by proBDNF was prevented by the NR2B antagonist ifenprodil. These results provide strong support for the idea that endogenously secreted proBDNF, by acting on p75NTR, promotes NMDA-dependent LTD by enhancing the expression of NR2B at CA1 synapses. To fully establish a causal link, however, it must still be shown that expression of NR2B in the hippocampus rescues the LTD impairment in p75 NTR/ slices. Exactly how proBDNF signals through p75NTR to regulate NR2B remains to be established. Immunostaining and western blotting experiments showed a substantial reduction in NR2B, but not NR2A, throughout the hippocampus of the p75 NTR/ mice, suggesting that proBDNF-p75NTR controls the expression of NR2B. This could possibly be achieved through activation of c-Jun kinase42 or NF-kB43, which are both expressed in hippocampal neurons. On the other hand, application of exogenous proBDNF enhanced NR2B-mediated synaptic currents in a p75NTR-dependent manner. Because the increase in NR2B currents occurred fairly rapidly after proBDNF application, this effect is less likely to be the result of p75NTR-mediated transcription and translation. It is possible that proBDNF facilitates the membrane insertion, trafficking into synapses or the channel properties of NR2B, all of which could, in theory, enhance LTD. Further investigation is necessary to distinguish these possibilities. Another finding that sheds light on the mechanisms of proBDNF regulation of LTD is the localization of p75NTR in CA1 synapses. It has long been believed that p75NTR protein in the hippocampus is primarily derived from basal forebrain cholinergic afferents44,45. It is possible that proBDNF is acting at p75NTR on the cholinergic afferents to induce the release of acetylcholine, which would also facilitate LTD37. But we have shown that atropine, a cholinergic antagonist, did not significantly alter the effect of proBDNF on LTD. Rather than an indirect mechanism, the enhancement of LTD may be the result of proBDNF directly binding to p75NTR expressed by CA1 hippocampal neurons. In support of this notion, immunohistochemistry at light and electron microscopic levels showed robust p75NTR expression in CA1 dendritic spines in addition to the afferent terminals
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
in the hippocampus. Moreover, double staining conducted on cultured hippocampal neurons showed that p75NTR is colocalized with PSD95, a marker for postsynaptic density often localized in dendritic spines. Collectively, these results raise the possibility that proBDNF regulates hippocampal LTD by acting directly on p75NTR in the dendritic spines of CA1 neurons. Our study has several important implications. First, we have identified a new and specific function for proBDNF-p75NTR signaling in synaptic plasticity, which is in marked contrast to the conventional view of pro-neurotrophins and p75NTR in regulating neuronal apoptosis. Second, we have provided some insights into the mechanisms by which proBDNF controls hippocampal LTD. Our results suggest that proBDNF is an endogenous ligand for p75NTR receptors, which are localized on CA1 dendritic shafts and spines. Moreover, proBDNF promotes hippocampal LTD by regulating the expression of the NR2B subunit. Finally, our study suggests a bidirectional control of hippocampal plasticity by BDNF. Our recent work showed that tissue plasminogen activator, by activating the extracellular protease plasmin, converts the precursor proBDNF to the mBDNF, and such conversion is required for late-phase LTP in the hippocampus25. We now show that proBDNF, if not cleaved, enhances hippocampal LTD. These results support a provocative ‘yin-yang’ hypothesis46: uncleaved proBDNF enhances LTD through p75NTR, whereas activation of TrkB by mBDNF facilitates LTP and also inhibits LTD. Thus, proteolysis of the precursor form of BDNF becomes an important control mechanism for the direction of hippocampal plasticity. METHODS Mice. p75NTR/ mice, as characterized previously47, were backcrossed onto a C57BL/6 background for more than five generations. All animal procedures conformed to the US National Institutes of Health animal welfare guidelines. Electrophysiological recording. We prepared transverse hippocampal slices (400 mm) from p75 NTR/ and age-matched wild-type mice that were young (3–4 weeks old) or mature (8–10 weeks old). We maintained slices in an interface chamber exposed to a humidified atmosphere of 95% O2 and 5% CO2. After a minimum recovery period of at least 2 h, we recorded fEPSPs using an Axoclamp-2B amplifier (Axon Instruments) with an artificial cerebral spinal fluid (ACSF; composition was as previously described25)–filled glass microelectrode (1–3 MO) positioned in the stratum radiatum of hippocampal area CA1. We applied tetanic stimulation or LFS after stable baseline was established. Stimulus intensity was adjusted to evoke fEPSP approximately 40% of the maximum. We induced LTP by two trains of HFS (100 Hz, 1 s, separated by 20 s), whereas we induced LTD by either single (for NMDA receptor– dependent LTD) or twin pulses (for NMDA receptor–independent LTD, 50 ms interstimulus interval) applied at a rate of 1 Hz for 15 min. We made whole-cell recordings from CA1 pyramidal neurons of hippocampal slices using the blind patch method. We filled recording electrodes (5–8 MO) with intracellular solution containing (in mM): 130 K-gluconate, 10 HEPES, 2 Mg2ATP, 0.5 Na3GTP, 11 EGTA, 10 phosphocreatine and 5 QX314. We evoked EPSCs at a rate of 0.05 Hz by a placing a stimulating electrode in the stratum radiatum. We monitored access resistance throughout experiments, and it ranged from 10–25 MO. We discarded data when access resistance changed by 420% during an experiment. To isolate NMDA-mediated EPSCs, we voltage clamped neurons at –50 mV in the presence of 20 mM DNQX and 10 mM bicuculline methiodide. We recorded signals using an Axopatch 200B, filtered them at 5 kHz and digitized them at 10 kHz. We initially prepared NMDA (Tocris) and the antagonists atropine (Sigma), ifenprodil (Sigma), AP5 (Sigma), NMDA (Sigma), DNQX (Sigma) and bicuculline (Sigma) as concentrated stock solutions and diluted them with ACSF to the specified concentrations before each experiment. We added 1% BSA to proBDNF25 before perfusion. The vehicle control consisted of 1% BSA and the proteinase inhibitors. We incubated hippocampal slices with either mBDNF or proBDNF for at least 1 h before experiments.
1075
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES p75NTR immunohistochemistry and electron microscopy. We deeply anesthetized mice (n ¼ 5) and perfused them through the ascending aorta sequentially with 1,000 units/ml heparin in normal saline followed by 40 ml of a mixture of 3.75% acrolein and 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). We removed brains and postfixed them for 30 min, and then cut them into 40 mm sections using a Vibratome and collected them in phosphate buffer. We transferred free-floating sections to 1% sodium borohydride for 30 min and washed them extensively. We then then transferred them to 0.1 M Tris-saline (TS, pH 7.6) and incubated them sequentially in: (i) 0.5% BSA, 30 min; (ii) p75-specific antibody (Promega, 1:1,000; R&D Systems, 1: 400) in 0.1% BSA and 0.25% Triton X-100, 48 h; (iii) biotinylated rabbit-specific goat antibody or goat-specific rabbit antibody (Vector Laboratories) at 1:400 in 0.1% BSA, 30 min; (iv) avidin-biotin complex (VectaStain Elite kit, 30 min); (v) diaminobenzidine and H2O2, 8 min. Finally, we mounted sections onto slides previously coated with 1% gelatin, dried them and dehydrated them through an alcohol series into xylenes, and put them on coverslips using DPX (Aldrich). We took photographs using a Nikon Eclipse 80i microscope and a Photometrix digital camera. For electron microscopy, we prepared sections as previously described48. We counterstained ultrathin hippocampal sections containing CA1 with uranyl acetate and Reyonold lead citrate. We examined final preparations using a Tecnai Biotwin electron microscope (FEI). We identified hippocampal processes as neuronal using previously described criteria49. In particular, dendritic profiles contained regular microtubular arrays and were usually postsynaptic to axon terminal profiles. Terminal profiles had minimal diameters greater than 0.2 mm, contained numerous small synaptic vesicles and often contacted other neuronal profiles. Cleavage-resistant proBDNF. We purified the histidine-tagged, cleavageresistant proBDNF as previously described25. We introduced point mutations into the proconvertase cleavage site of proBDNF to convert the Arg-Arg (amino acid positions 129,130) to Ala-Ala. In vitro experiments showed that this proBDNF is resistant to cleavage by plasmin. We dialyzed the protein against ACSF, and stored it in small aliquots at 801C until use. p75NTR and PSD95 immunocytochemistry in cultured neurons. We cultured mouse hippocampal neurons as previously described50. Briefly, we dissected hippocampi from embryonic day 16 (E16) mice, dissociated them in tyrosine solution and plated them on coverslips coated with polylysine and laminin at 5,000 cells/coverslip. We grew cells in serum-free medium Neurobasal plus B27 (Life Technologies) at 371C, 5% CO2 incubator. After 14 d in vitro, we fixed the cells in 4% paraformaldehyde, permeabilized them with 0.1% Triton X-100 and incubated them with a p75NTR-specific rabbit antibody (Promega, 1:1,000 dilution), PSD95-specific mouse antibodies (1:300, Cell Signaling) in 3% BSA, followed by incubation with and Alex Fluor 488 (green for PSD95)– and Alex Fluor 546 (red for p75NTR)–conjugated secondary antibodies (Molecular Probes). We obtained images with a Zeiss confocal laser-scanning microscope using a 60 and a 100 (NA 1.40) objective. NMDA receptor immunohistochemistry. We anesthetized mice and transcardially perfused them with saline, then fixed them with 4% paraformaldehyde in PBS. We removed intact brains, post-fixed them in 4% paraformaldehyde for an additional 2 h, and placed them in 30% sucrose cryoprotectant solution for 48 h. Then we embedded the brains in OCT medium and stored them at 801C. We then sectioned frozen brains coronally at 40 mm using a Leica cryotome. For immunolabeling experiments, we blocked the prepared sections in normal serum, incubated them with NR2B-specific antibody (Chemicon) overnight at 41C and then incubated them with biotinylated secondary antibody. Next we processed sections using an immunoperoxidasebased Vectastain system. Western blot. We separated proteins from homogenized hippocampal tissues electrophoresis, and transferred them to PVDF membranes. After blocking using 5% BSA, we then incubated membranes with a rabbit polyclonal antibody against one of the following: NR2B (Chemicon 1:500); 9992 p75NTR-specific antibody (generated in the laboratory of B.L.H.; 1:1,000); or b-actin (ABCAM; 1:10,000) followed by a peroxidase-labeled rabbit-specific goat IgG. We processed blots and developed them using a chemilumininescent
1076
substrate (ECL plus). We scanned developed blots at high resolution and analyzed them using ImageJ software gel analyzer. We used band intensity normalized to an actin loading control to assess the protein levels. Statistical analysis. We used a Student t-test (two groups) or an analysis of variance (ANOVA) with a Tukey-Kramer post-test (three or more groups) for statistical comparisons of mean fEPSP slopes, with a significance level of P o 0.05. All values shown are mean ± s.e.m., with n ¼ number of slices. Note: Supplementary information is available on the Nature Neuroscience website.
ACKNOWLEDGMENTS This work is supported by funds from National Institute of Child Health and Human Development intramural program (to B.L.), and US National Institutes of Health grants NS30658 (to B.L.H.) and HL18974 (to T.A.M.). N.H.W. is supported by fellowships from Alberta Heritage Foundation for Medical Research and Natural Sciences and Engineering Research Council of Canada. We would like to thank K. Sakata, J. Chang and K. Pelkey for advice and assistance. We also thank L. Tessarollo for providing p75 NTR/ mice and L. Reichardt for the p75NTR-blocking REX antibody. COMPETING INTERESTS STATEMENT The authors declare that they have no competing financial interests. Received 16 May; accepted 28 June 2005 Published online at http://www.nature.com/natureneuroscience/
1. Lu, B. BDNF and activity-dependent synaptic modulation. Learn. Mem. 10, 86–98 (2003). 2. Poo, M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2, 24–32 (2001). 3. Korte, M. et al. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92, 8856–8860 (1995). 4. Figurov, A., Pozzo-Miller, L., Olafsson, P., Wang, T. & Lu, B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381, 706–709 (1996). 5. Patterson, S.L. et al. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16, 1137–1145 (1996). 6. Lessmann, V., Gottmann, K. & Malcangio, M. Neurotrophin secretion: current facts and future prospects. Prog. Neurobiol. 69, 341–374 (2003). 7. Lu, B. Pro-region of neurotrophins: role in synaptic modulation. Neuron 39, 735–738 (2003). 8. Mowla, S.J. et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276, 12660–12666 (2001). 9. Seidah, N.G., Benjannet, S., Pareek, S., Chretien, M. & Murphy, R.A. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 379, 247–250 (1996). 10. Kaplan, D.R. & Miller, F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 10, 381–391 (2000). 11. Huang, E.J. & Reichardt, L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609–642 (2003). 12. Lee, R., Kermani, P., Teng, K.K. & Hempstead, B.L. Regulation of cell survival by secreted proneurotrophins. Science 294, 1945–1948 (2001). 13. Chao, M.V. & Bothwell, M. Neurotrophins: to cleave or not to cleave. Neuron 33, 9–12 (2002). 14. Ibanez, C.F. Jekyll-Hyde neurotrophins: the story of proNGF. Trends Neurosci. 25, 284–286 (2002). 15. Nykjaer, A. et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843–848 (2004). 16. Beattie, M.S. et al. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36, 375–386 (2002). 17. Harrington, A.W. et al. Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc. Natl. Acad. Sci. USA 101, 6226–6230 (2004). 18. Teng, H.K. et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455–5463 (2005). 19. Dechant, G. & Barde, Y.A. The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat. Neurosci. 5, 1131–1136 (2002). 20. Barker, P.A. p75NTR is positively promiscuous: novel partners and new insights. Neuron 42, 529–533 (2004). 21. Lou, H. et al. Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase e. Neuron 45, 245–255 (2005). 22. Mowla, S.J. et al. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J. Neurosci. 19, 2069–2080 (1999). 23. Chen, Z.-Y. et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type bdnf in neurosecretory cells and cortical neurons. J. Neurosci. 24, 4401–4411 (2004). 24. Lee, K.F. et al. Targeted mutation of the gene encoding the low affinity NGF repector p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749 (1992).
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES 25. Pang, P.T. et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487–491 (2004). 26. Liu, L. et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304, 1021–1024 (2004). 27. Massey, P.V. et al. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J. Neurosci. 24, 7821–7828 (2004). 28. Cabin, D.E. et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 22, 8797–8807 (2002). 29. Mischel, P.S. et al. The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA. J. Biol. Chem. 276, 11294–11301 (2001). 30. Oliet, S.H., Malenka, R.C. & Nicoll, R.A. Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Neuron 18, 969–982 (1997). 31. Hempstead, B.L. The many faces of p75NTR. Curr. Opin. Neurobiol. 12, 260–267 (2002). 32. Kemp, N. & Bashir, Z.I. Induction of LTD in the adult hippocampus by the synaptic activation of AMPA/kainate and metabotropic glutamate receptors. Neuropharmacology 38, 495–504 (1999). 33. Mulkey, R.M. & Malenka, R.C. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9, 967–975 (1992). 34. Dudek, S.M. & Bear, M.F. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc. Natl. Acad. Sci. USA 89, 4363–4367 (1992). 35. Dougherty, K.D. & Milner, T.A. Cholinergic septal afferent terminals preferentially contact neuropeptide Y-containing interneurons compared to parvalbumin-containing interneurons in the rat dentate gyrus. J. Neurosci. 19, 10140–10152 (1999). 36. Ikegaya, Y., Ishizaka, Y. & Matsuki, N. BDNF attenuates hippocampal LTD via activation of phospholipase C: implications for a vertical shift in the frequency-response curve of synaptic plasticity. Eur. J. Neurosci. 16, 145–148 (2002). 37. Kirkwood, A., Rozas, C., Kirkwood, J., Perez, F. & Bear, M.F. Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine. J. Neurosci. 19, 1599–1609 (1999).
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
38. Wright, J.W., Alt, J.A., Turner, G.D. & Krueger, J.M. Differences in spatial learning comparing transgenic p75 knockout, New Zealand Black, C57BL/6, and Swiss Webster mice. Behav. Brain Res. 153, 453–458 (2004). 39. Peterson, D.A., Dickinson-Anson, H.A., Leppert, J.T., Lee, K.F. & Gage, F.H. Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75. J. Comp. Neurol. 404, 1–20 (1999). 40. Rosch, H., Schweigreiter, R., Bonhoeffer, T., Barde, Y.A. & Korte, M. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc. Natl. Acad. Sci. USA 102, 7362– 7367 (2005). 41. Bandtlow, C. & Dechant, G. From cell death to neuronal regeneration, effects of the p75 neurotrophin receptor depend on interactions with partner subunits. Sci. STKE 2004, pe24 (2004). 42. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252 (2000). 43. O’Neill, L.A. & Kaltschmidt, C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252–258 (1997). 44. Yan, Q. & Johnson, E.M., Jr. An immunohistochemical study of the nerve growth factor receptor in developing rats. J. Neurosci. 8, 3481–3498 (1988). 45. Van der Zee, C.E., Ross, G.M., Riopelle, R.J. & Hagg, T. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice. Science 274, 1729–1732 (1996). 46. Lu, B., Pang, P.T. & Woo, N.H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci. (in the press). 47. Lee, K.F., Bachman, K., Landis, S. & Jaenisch, R. Dependence of the p75 innervation of some sympathetic targets. Science 263, 1447–1449 (1994). 48. Dougherty, K.D. & Milner, T.A. p75NTR immunoreactivity in the rat dentate gyrus is mostly within presynaptic profiles but is also found in some astrocytic and postsynaptic profiles. J. Comp. Neurol. 407, 77–91 (1999). 49. Peters, A., Palay, S.L. & Webster, H.deF. The Fine Structure of the Nervous System (Oxford University Press, New York, 1991). 50. Ji, Y., Pang, P.T., Feng, L. & Lu, B. Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons. Nat. Neurosci. 8, 164–172 (2005).
1077
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
ARTICLES
Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy Grant R J Gordon1, Dinara V Baimoukhametova1, Sarah A Hewitt1, W R A Kosala J S Rajapaksha2, Thomas E Fisher2 & Jaideep S Bains1 Glial cells actively participate in synaptic transmission. They clear molecules from the synaptic cleft, receive signals from neurons and, in turn, release molecules that can modulate signaling between neuronal elements. Whether glial-derived transmitters can contribute to enduring changes in postsynaptic efficacy, however, remains to be established. In rat hypothalamic paraventricular nucleus, we demonstrate an increase in the amplitude of miniature excitatory postsynaptic currents in response to norepinephrine that requires the release of ATP from glial cells. The increase in quantal efficacy, which likely results from an insertion of AMPA receptors, is secondary to the activation of P2X7 receptors, an increase in postsynaptic calcium and the activation of phosphatidylinositol 3-kinase. The gliotransmitter ATP, therefore, contributes directly to the regulation of postsynaptic efficacy at glutamatergic synapses in the CNS.
Astrocytes1–4 and Schwann cells5 can respond to and influence neuronal signals by releasing glial-derived substances (gliotransmitters). However, until very recently3, the most ubiquitous gliotransmitter, ATP, had been categorized almost exclusively as a paracrine messenger responsible for inter-glial propagation of calcium waves6–8. There is now growing support for the idea that activation of neuronal purinergic receptors can affect synaptic plasticity9–11. Until now, the majority of the characterized actions of ATP on excitatory synaptic transmission, however, have been short-term, presynaptic changes in neurotransmitter release, with little evidence for enduring, postsynaptic changes. Given that ATP-gated P2X channels are calcium permeable12 and that the P2X7 receptor is linked directly to phosphatidylinositol 3-kinase (PI3K)13, an intracellular signaling molecule that is crucial for the insertion of AMPA receptors14 and the expression of LTP in the hippocampus15,16 and amygdala17, it seems plausible to hypothesize that ATP can induce enduring changes in postsynaptic efficacy. To study the putative contributions of glial-derived ATP to postsynaptic changes in synaptic strength, we examined glutamatergic synapses onto magnocellular neurosecretory cells (MNCs) in the paraventricular nucleus (PVN). The glial cells that surround the MNCs and their synaptic contacts show a notable degree of anatomical plasticity. In response to physiological challenges, they undergo a remodeling process that results in a decrease in the astrocytic coverage of synaptic contacts18,19. Taking advantage of this propensity of glial cells to retract when the animal is physiologically challenged, we can study synaptic function during conditions in which there is either a relative paucity or relative abundance of glial cells surrounding the
MNCs. This allows us to address directly the question of glia and, by extension, gliotransmitters in the regulation of synaptic function. Important for the study of ATP and long-term synaptic plasticity in this system is the demonstration that the MNCs have several subtypes of P2X receptors that are permeable to calcium12, the critical trigger for enduring changes in postsynaptic efficacy20. Furthermore, ATP receptors are critical for the increases in activity observed in MNCs in response to physiological perturbations that selectively recruit noradrenergic fibers21 and for facilitating hormone release in response to norepinephrine22. As a large fraction of catecholaminergic (and, more specifically, noradrenergic) terminals in the brain lack postsynaptic contacts23, this raises the possibility that signaling in this vital homeostatic circuit may require dynamic glial-neuronal interactions. Here, we demonstrate that norepinephrine increases the amplitude of miniature excitatory postsynaptic currents (mEPSCs) in MNCs through the release of ATP from glial cells. ATP acts at postsynaptic P2X7 receptors to promote the insertion of AMPA receptors through a mechanism requiring the calcium-dependent activation of PI3K. These data demonstrate a new mechanism by which glial cells can affect synaptic strength at excitatory synapses. RESULTS We examined changes in mEPSC amplitude as a measure of synaptic strength because of the compelling evidence that mEPSCs are important for information transfer in a number of vertebrate preparations24–26. Changes in mEPSC amplitude directly translate into changes in the firing patterns of CNS neurons, and, in particular, the MNCs27.
1Hotchkiss
Brain Institute and the Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1. of Physiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, Saskatchewan, Canada S7N 5E5. Correspondence should be addressed to J.B. (
[email protected]).
2Department
Published online 3 July 2005; doi:10.1038/nn1498
1078
VOLUME 8
[
NUMBER 8
[
AUGUST 2005 NATURE NEUROSCIENCE
60 Norepinephrine
b
30 min posttreatment
50 40 30 20
Cumulative probability
a
Event amplitude (pA)
ARTICLES
10
c
10
20 30 Time (min)
40
Control
0.5 Norepinephrine
0.0
50
0
d
Norepinephrine
50 100 150 Event amplitude (pA)
1.5 Relative amplitude
Control
** **
*
1.0
0.5
ep or
N
or
ep
Ph
Norepinephrine
N
Control
in
C
e
Figure 1 Norepinephrine induces an enduring increase in mEPSC amplitude that is accompanied by an increase in postsynaptic efficacy. (a) Running average of mEPSC amplitudes in 1-min bins. Norepinephrine was bath applied for 5 min (200 mM). Amplitude values were assessed at the time points indicated by gray bands. (b) Cumulative fraction plot of mEPSC amplitudes from the control condition and 30 min after norepinephrine treatment (P o 0.01). (c) Average (black) and raw (gray) mEPSC traces from the same time points as described in a and b. (d) Summary showing the enduring increase in mEPSC amplitude observed after application of norepinephrine (1.22 ± 0.05, P o 0.01, n ¼ 20), phenylephrine (1.23 ± 0.08, P o 0.01, n ¼ 5), norepinephrine in prazosin (0.99 ± 0.05, P 4 0.05, n ¼ 6) and prazosin after norepinephrine (1.22 ± 0.09, P o 0.05, n ¼ 4). (e) Postsynaptic responses to focal AMPA puff; average traces from control condition and 30 min post-norepinephrine shown above graph. (f) Summary showing an increase in postsynaptic responsiveness to AMPA puff 30 min post-norepinephrine (1.41 ± 0.09, P o 0.05, n ¼ 5). Scale bars, a: 20 pA, 5 ms; e: 100 pA, 250 ms. Error bars: s.e.m. *, P o 0.05; **, P o 0.01, here and in all figures.
ep
on
t ro l en hr in yl e Pr in ep ep az hr hr af in in te e e rn i n or pr ep az in ep hr in e
0.0
Norepinephrine
350 300 250
2.0 Relative amplitude
f
*
1.5 1.0 0.5 0.0
200 50
e in hr ep in N
or
ep
40
l
20 30 Time (min)
tro
10
on
0
C
AMPA response (pA)
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
0
1.0
Norepinephrine permanently increases mEPSC amplitude Bath application of norepinephrine (5 min, 200 mM) elicited three sequential changes in mEPSC amplitude. These were, in temporal order, a small enhancement followed by a robust increase lasting approximately 15 min, which in turn relaxed to a new mean and remained elevated even during our longest whole-cell recordings (which exceeded 90 min in length). This manuscript focuses on the enduring increase in mEPSC amplitude and not the initial increases during agonist application. In each cell, control mEPSC amplitudes were compared with those 30 min after treatment (gray demarcations in Fig. 1a). A minimum 5-min recording segment was used for the analysis. The enduring increase in mEPSC amplitude was 1.22 ± 0.05 (P o 0.01, n ¼ 20; Fig. 1a–d); all values are expressed as a fraction or multiple of the control condition. For the remainder of the manuscript, we often use the terms ‘increase in synaptic strength’ or ‘synaptic potentiation’ interchangeably with ‘enduring increase in mEPSC amplitude’. The a1 adrenoceptor mediates the excitatory effects of norepinephrine on MNCs28–31. Here, the a1-adrenoceptor agonist phenylephrine (5 min, 200 mM) effectively mimicked the effects of norepinephrine (1.23 ± 0.08, P o 0.01, n ¼ 5; Fig. 1d), whereas the a1-adrenoceptor antagonist prazosin (10 mM) attenuated them (0.99 ± 0.05, P 4 0.05, n ¼ 6; Fig. 1d). To rule out the possibility that the enduring increase in synaptic strength resulted from a slow washout of the agonist, prazosin was added to the bath immediately after norepinephrine application was terminated. This did not attenuate the enduring increase in synaptic strength (1.22 ± 0.09, P o 0.05, n ¼ 4, Fig. 1d). These data collectively suggest that transient activation of a1-adrenoceptors triggers a robust and enduring enhancement of mEPSC amplitude. This increase in synaptic strength is reminiscent of activitydependent changes in postsynaptic receptor function responsible for long-term potentiation (LTP) at cortical synapses20. Consequently,
NATURE NEUROSCIENCE VOLUME 8
[
NUMBER 8
[
AUGUST 2005
we investigated whether norepinephrine increased the postsynaptic response to exogenous AMPA application. The response to focal application of AMPA (see Methods) directly onto MNCs (mean: 197.4 ± 28.9 pA) was significantly increased after norepinephrine application (1.41 ± 0.09, P o 0.05, n ¼ 5; Fig. 1e,f). Norepinephrine triggers AMPA receptor insertion We used peak-scaled non-stationary noise analysis (PSNA)32 to investigate whether the increase in synaptic strength was associated with an increase in AMPA channel conductance33. To ensure that the fluctuation in mEPSC decay arose mostly from stochastic channel properties, we examined mEPSCs in the control condition and after norepinephrine treatment and confirmed there was no strong relationship between the rise time and decay time of the mEPSCs32 (control: 10– 90 rise-time versus decay-time r2 ¼ 0.15 ± 0.02; 30 min post– norepinephrine treatment: 10–90 rise-time versus decay-time r2 ¼ 0.11 ± 0.03, P 4 0.05, n ¼ 6). To establish that PSNA yielded unitary currents that were linearly related to voltage and predicted the reversal potential of the channel (approximately 0 mV), cells were voltage clamped at different potentials, and unitary current values satisfying these criteria were obtained (40 mV: 1.73 ± 0.29 pA; 60 mV: 2.61 ± 0.39 pA; 80 mV: 3.32 ± 0.44 pA; channel reversal: 4.4 mV, n ¼ 5; Fig. 2a,b). Next, we determined that there was no change in the unitary AMPA conductance upon application of a low dose of the AMPA receptor blocker DNQX (500 nM); this decreases mEPSC amplitude by completely blocking a fraction of AMPA receptors (control: 16.82 ± 2.85 pS; DNQX: 16.35 ± 2.81 pS, P 4 0.05, n ¼ 6; Fig. 2c,d). The mEPSC amplitude in DNQX was 0.73 ± 0.08, P o 0.05, n ¼ 7. The unitary conductance of mEPSCs in the control condition was not different from that after norepinephrine (control: 20.02 ± 3.63 pS; post-norepinephrine: 18.22 ± 2.69 pS, P 4 0.05, n ¼ 7; Fig. 2e,f). These values are consistent with those reported previously for excitatory synapses onto MNCs in the supraoptic nucleus (SON) of the hypothalamus34. It is widely accepted that the insertion of postsynaptic AMPA receptors is a mechanism by which synapses increase their strength20. We tested for this possibility by targeting SNARE-dependent vesicle exocytosis. Inclusion in our patch pipette of botulinum toxin C (5 mg/ ml), which proteolytically cleaves the tSNARE syntaxin35, completely blocked the enduring increase in quantal amplitude caused by norepinephrine (0.96 ± 0.04, P 4 0.05, n ¼ 7; Fig. 3a). Consistent with previous observations20, we found that this exocytotic process requires increases in postsynaptic calcium, as the inclusion of EGTA (10 mM) in
1079
ARTICLES
b
–60
1
–20
20
–40 mV (i = 0.84)
–1
20 –2
10 –3
0 10
30 20 Current (pA)
40
50
d
25
Normalized unitary channel conductance
30 Control (i = 0.77) DNQX (i = 0.74)
20 15 10 5
0.5
l tro
20 10 0 0
20
40
60
D
0.5
0.0
N
or
ep
in
Current (pA)
1.0
e
30
1.5
in
40
N
on
Control (i = 1.32)
hr
50
C
f
Norepinephrine (i = 1.45)
ep
60
60
l
20 40 Current (pA)
Q X
0.0
0
tro
e
1.0
on
0
1.5
C
Variance (pA2)
–4
Normalized unitary channel conductance
c
Variance (pA2)
our internal solution completely blocked the effects of norepinephrine (1.03 ± 0.02, P 4 0.05, n ¼ 6, Fig. 3b). Finally, we examined the cellular signals required for the insertion of AMPA receptors by targeting PI3K, which is important in the expression of LTP in the hippocampus14–16. Inclusion of either of two different PI3K inhibitors in the patch pipette (wortmannin (100 nM) or LY294002 (10 mM)) blocked the effects of norepinephrine on mEPSC amplitude (wortmannin: 1.02 ± 0.02, P 4 0.05, n ¼ 4; LY294002: 1.01 ± 0.02, P 4 0.05, n ¼ 5, Fig. 3c). Collectively, these data suggest that norepinephrine promotes the calcium-dependent, postsynaptic insertion of AMPA receptors through the activation of PI3K. Norepinephrine does not use postsynaptic receptors To examine the possibility that activation of the postsynaptic Gq-coupled a1-adrenoceptor directly increases mEPSC amplitude, we targeted two separate points on the a1-adrenoceptor intracellular
Figure 3 The enduring increase in mEPSC amplitude requires SNARE-dependent exocytosis, an increase in postsynaptic calcium and activation of PI3K. (a) Top: average mEPSCs before and after norepinephrine application with postsynaptic botulinum toxin C (5 mg/ml) to block SNARE-dependent exocytosis. Bottom: cumulative probability plot of mEPSC amplitudes (P 4 0.05) from the same cell. (b) Top: average mEPSCs before and after norepinephrine with postsynaptic EGTA (10 mM) to chelate calcium. Bottom: cumulative fraction plot (P 4 0.05) from the same cell. (c) Top: average mEPSCs before and after norepinephrine with postsynaptic LY294002 (10 mM) to block PI3K activation. Bottom: cumulative fraction plot (P 4 0.05) from the same cell. Scale bars 10 pA, 5 ms.
1080
cascade. First, we introduced thapsigargin (5 mM), which depletes calcium stores, into our patch electrode. This treatment did not block the norepinephrine-mediated increase in quantal amplitude (1.22 ± 0.05, P o 0.01, n ¼ 8, Fig. 4a). Second, we targeted the Gq-protein directly with intracellular perfusion of GDP-bs (1 mM). This experimental manipulation had no impact on the enduring increase in mEPSC amplitude after norepinephrine treatment (1.19 ± 0.02, P o 0.01, n ¼ 6, Fig. 4b). To confirm the validity of this negative result, we conducted an additional experiment in which we bath applied the glucocorticoid receptor agonist, dexamethasone (50 mM, 3 min). Activation of postsynaptic glucocorticoid receptors decreases glutamate release through a mechanism that requires the production of endocannabinoids36. Consistent with this report, dexamethasone decreased mEPSC frequency (0.49 ± 0.04, P o 0.01 compared with control condition, n ¼ 3). This was attenuated when GDP-bs was included in the internal solution (0.86 ± 0.13, P o 0.05 compared with dexamethasone alone, n ¼ 3). Collectively, these data suggest that postsynaptic a1-adrenoceptors are not responsible for the enduring increase in mEPSC amplitude. We have previously shown that norepinephrine transiently increases the frequency of glutamate release through a presynaptic a1-adrenoceptor–mediated mechanism31. This enhanced period of release may activate NMDA and/or metabotropic glutamate receptors (mGluRs) leading to a postsynaptic increase in synaptic strength. Although activation of NMDA receptors is crucial for hippocampal plasticity20, blockade of these receptors (with 100 mM D-L-AP5) did not affect the ability of norepinephrine to increase quantal amplitude (1.25 ± 0.05, P o 0.01, n ¼ 5, Fig. 4c). Although the experiments in which postsynaptic inclusion of GDP-bs and thapsigargin (above) would argue against a role for postsynaptic mGluRs, we directly tested for
Norepinephrine in botulinum toxin
Control botulinum toxin
a
Cumulative probability
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
0
Figure 2 The enduring increase in mEPSC amplitude is not associated with an increase in AMPA channel conductance. (a) Variance versus current for mEPSCs when the postsynaptic cell is held at different potentials. The slope, i, represents the unitary channel current. (b) The unitary AMPA channel current changes linearly with voltage and estimates the reversal potential of the channel (40 mV: 1.73 ± 0.29 pA, 60 mV: 2.61 ± 0.39 pA, 80 mV: 3.32 ± 0.44 pA, channel reversal: 4.4 mV, n ¼ 5). (c) There is no change in the unitary AMPA channel current between control mEPSCs and mEPSCs treated with DNQX (500 nM). (d) Summary of effects of DNQX on channel conductance (0.97 ± 0.07, P 4 0.05, n ¼ 6) (e) There is no change in the unitary AMPA channel current between control mEPSCs and mEPSCs post-norepinephrine. (f) Summary of effects of norepinephrine on channel conductance (0.95 ± 0.06, P 4 0.05, n ¼ 7). Error bars: s.e.m.
1.0
Control 0.5 Norepinephrine
0.0 0
50
100
b
Control EGTA
Norepinephrine in EGTA
1.0
Control 0.5 Norepinephrine 0.0
150
0
Event amplitude (pA)
50
100
150
Event amplitude (pA)
VOLUME 8
[
NUMBER 8
[
c
Control LY294002
Cumulative probability
–60 mV (i = 1.37)
30
Voltage (mV) –100
Current (pA)
Variance (pA2)
–80 mV (i = 2.08)
40
Cumulative probability
50
a
Norepinephrine in LY294002
1.0
Control 0.5 Norepinephrine 0.0 0
50
100
150
Event amplitude (pA)
AUGUST 2005 NATURE NEUROSCIENCE
ARTICLES
1.5
**
Relative amplitude
1.0
0.5
** 1.0
0.5
0.0
N
NATURE NEUROSCIENCE VOLUME 8
[
Control
BzATP
b
1.0
c Control
0.5 BzATP
0.0
25
15 0
50
0
100
10
Event amplitude (pA)
NUMBER 8
Norepinephrine in BBG
e
f
1.0
30
Control 0.5 Norepinephrine
0.0 50
** 1.0
0.5
100
ep or N
Bz AT
P
Event amplitude (pA)
AUGUST 2005
50
0.0 0
[
40
1.5
l
Control BBG
20
Time (min)
ro
d
30 min posttreatment
BzATP 35
in ine BB ph G rine
a
on t
Figure 5 Activation of P2X7 receptors is necessary and sufficient for the expression of the enduring increase in mEPSC amplitude. (a) Average mEPSC traces from control condition and 30 min post-BzATP (30 mM, 3 min). (b) Cumulative fraction plot of mEPSC amplitudes (P o 0.01); same cell as a. (c) Running average of mEPSC amplitude in 1-min bins. (d) Average mEPSC traces from control condition and postnorepinephrine in the presence of the P2X antagonist BBG (1 mM). (e) Cumulative fraction plot (P 4 0.05), same cell as d. (f) Summary: BzATP induces an enduring increase in mEPSC amplitude (1.17 ± 0.02, P o 0.01, n ¼ 8), this effect is blocked by BBG (1.03 ± 0.03, P 4 0.05, n ¼ 5), and the enduring increase in mEPSC amplitude observed after norepinephrine is blocked with BBG (1.04 ± 0.02, P 4 0.05, n ¼ 5). Scale bars: 10 pA, 5 ms. Error bars: s.e.m.
a1-adrenoceptors are colocalized with a glial marker Glial cells possess receptors for norepinephrine38, and in the PVN, a large fraction of noradrenergic terminals lack postsynaptic contacts23, leaving norepinephrine free to activate these cells. As the enduring enhancement of quantal amplitude is independent of glutamate
BB G
P2X7 receptor activation is necessary and sufficient The excitatory effects of norepinephrine on MNC firing observed in vivo are attenuated by blockade of purinergic receptors21. We tested the hypothesis that direct activation of ATP-gated P2X receptors in our
in
N
N
their contribution by applying norepinephrine in the presence of the group I mGluR antagonist MCPG (200 mM). Under these conditions, norepinephrine still increased synaptic strength (1.21 ± 0.01, P o 0.01, n ¼ 5, Fig. 4d). Collectively, these observations argue against a role for postsynaptic a1-adrenoceptors, NMDA receptors or group I mGluRs in mediating the enduring increase in mEPSC amplitude.
P
C M ont C ro PG l
or
ep i AP nep 5 h
rin
C o AP ntro 5 l
or e in pin M ep C h PG rin e
0.0 e
0.0
0.5
C
0.5
** 1.0
Relative amplitude
1.0
Bz AT
1.5
**
Relative amplitude
Relative amplitude
1.5
slice preparation would effectively mimic the effects of norepinephrine on synaptic strength. Our experiments targeting postsynaptic G protein signaling argue against the metabotropic P2Y receptors, but MNCs possess a variety of functional P2X receptors capable of passing calcium12. We first tested ATP directly. Bath application of 30 mM ATP elicited a sustained increase in mEPSC amplitude (1.15 ± 0.02, P o 0.05, n ¼ 7). As ATP can be rapidly broken down by ectonucleotidases, this effect may be an underestimation. We repeated the experiment with BzATP, an analogue that is not readily degraded and can also activate several P2X channels, including P2X1, P2X3 and P2X7 (ref. 37). BzATP (30 mM, 3 min) increased mEPSC amplitude (1.17 ± 0.02, P o 0.01, n ¼ 8, Fig. 5a–c). We next tested the hypothesis that activation of P2X7 receptors was necessary for the norepinephrineinduced increase in synaptic strength. In the continuous presence of brilliant blue G (BBG, 1 mM) a P2X receptor antagonist that blocks P2X7 at the concentration used here37, norepinephrine failed to cause an enduring increase in mEPSC amplitude (1.04 ± 0.02, P 4 0.05, n ¼ 5, Fig. 5d–f). BBG also blocked the increase in synaptic strength induced by BzATP (1.03 ± 0.03, P 4 0.05, n ¼ 5, Fig. 5f). These data indicate that ATP-gated P2X7 receptor activation is both necessary and sufficient for increasing mEPSC amplitude.
Event amplitude (pA)
d
Cumulative probability
c
C G on D tr P- ol βs
th C ap on si tro ga l rg in N in ore th pin ap e si ph ga ri rg ne in
0.0
or in epi G ne D ph P- r βs ine
Relative amplitude
1.5
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
Figure 4 The enduring increase in mEPSC amplitude does not involve postsynaptic a1-adrenoceptors or glutamate signaling. (a) Top: average mEPSCs before and after norepinephrine application with postsynaptic thapsigargin (5 mM) to deplete calcium stores. Bottom: summary of effects of thapsigargin (1.22 ± 0.05, P o 0.01, n ¼ 8). (b) Top: average mEPSCs before and after norepinephrine application with postsynaptic GDP-bs (1 mM) to block G protein signaling. Bottom: summary of effects of GDP-bs (1.19 ± 0.02, P o 0.01, n ¼ 6). (c) Top: average mEPSCs before and after norepinephrine application with the NMDA receptor antagonist AP5 (100 mM). Bottom: summary of effects of AP5 (1.25 ± 0.05, P o 0.01, n ¼ 5). (d) Top: average mEPSCs before and after norepinephrine with the mGluR antagonist MCPG (200 mM). Bottom: summary of effects of MCPG (1.21 ± 0.01, P o 0.01, n ¼ 5). Scale bars: 10 pA, 5 ms. Error bars: s.e.m.
b
Cumulative probability
a
1081
ARTICLES
b ATP fraction
a GFAP
Figure 6 Norepinephrine targets glial cells to release ATP. (a) Slice immunohistochemistry for the glial marker GFAP (top) and for the a1-adrenoceptor (middle). Overlaid confocal images show colocalization (bottom). Each picture comprises a series of stacked images, and each column is an example from a different rat. (b) Top: summary of relative increase in ATP release in response to norepinephrine (10–50 mM) from cultured glial cells (peak ATP release: 2.39 ± 0.17, P o 0.01, n ¼ 18). Bottom: summary demonstrating that norepinephrine-induced release of ATP is blocked in the presence of the fluorocitric acid (1.02 ± 0.07, P 4 0.05, n ¼ 7). Data represent the pooled responses from four separate glial culture systems: pituicytes, neonatal hypothalamus, hippocampus and neocortex. Error bars: s.e.m.
4.0 NA 3.0 2.0 1.0 0 4.0
ATP fraction
3.0 FA 2.0 1.0 0 5
Overlay
10
15
Time (min)
receptors and postsynaptic G protein signaling, yet requires the activation of a1-adrenoceptors, we tested the hypothesis that the observed effect in response to norepinephrine was secondary to the activation of glial cells. We first tested for the presence of a1-adrenoceptors on glial cells in PVN using immunohistochemical techniques. Astrocytes were identified with glial fibrillary acidic protein (GFAP) staining, and long astrocytic processes were clearly labeled in the PVN (Fig. 6a, top). In addition, a primary antibody directed against the a1a-adrenoceptor subunit resulted in both punctate staining and staining characterized by long thin sections (Fig. 6a, middle). Although it is clear that a1-adrenoceptors are not localized exclusively to glial cells, confocal images showed a strong colocalization between the signal for the a1a-antibody and GFAP in the glial processes (Fig. 6a, bottom).
structural reorganization similar to that seen with SON and PVN glia in response to dehydration, parturition and lactation39. Using an ATP bioluminescence assay, we observed an increase in the ATP concentration in the surrounding saline in response to norepinephrine (10–50 mM). We then confirmed the ubiquitous nature of this phenomenon in three separate culture systems in which glial cells were isolated from the neonatal hypothalamus, hippocampus or the neocortex. Again, in each of these preparations, norepinephrine robustly increased the concentration of ATP in the surround media. As the increases in extracellular ATP were qualitatively similar across cultures, the data were pooled. During the first five minutes after norepinephrine application, ATP levels increased 2.39 ± 0.17–fold over the control condition (P o 0.01, n ¼ 18, Fig. 6b, top). We then used a pharmacological tool, fluorocitric acid (100 mM), to examine whether the norepinephrine effect could be abated when the glial Krebs cycle was blocked40. Cultures were incubated for a minimum of 2 h in fluorocitric acid before norepinephrine was applied. Under these conditions, norepinephrine did not trigger the release of ATP (1.02 ± 0.07, P 4 0.05, n ¼ 7, Fig. 6b, bottom).
Norepinephrine releases ATP from cultured glial cells We next investigated whether norepinephrine would elicit the release of ATP from cultured glial cells. To test this directly we used a system of cultured pituicytes. These glial cells engulf the neuropeptide-secreting terminals of the MNCs in the posterior pituitary and undergo
a
Norepinephrine
Control in Norepinephrine in fluorocitric acid fluorocitric acid
b
c
Control dehydrated
Norepinephrine dehydrated
Control dehydrated
d
BzATP dehydrated
Control
0.5 Norepinephrine
0.0 0
50
100
Event amplitude (pA)
1.0
Control
0.5 Norepinephrine
0.0 0
50
Cumulative probability
Norepinephrine in fluorocitric acid
1.0
Cumulative probability
Norepinephrine in BBG
Cumulative probability
© 2005 Nature Publishing Group http://www.nature.com/natureneuroscience
NA α1-adrenoceptor
1.0
Control
0.5 BzATP
0.0 0
Event amplitude (pA)
50
100
Event amplitude (pA)
Figure 7 Glial cells are necessary for the enduring increase in mEPSC amplitude triggered by a1-adrenoceptor activation. (a) Top: inward